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MWCNT); graphene oxide (GO); oxidized-single-wall carbon nanotubes (o-
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GNFs have an average lateral diameter of ∼30 nm.22 ................................. 232 
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(Atmos. Meas. Tech. Discuss., 2018).62 The Infra-red camera is positioned 
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cools; B) Example colour map taken during the course of an experiment. The 
black circle represents a sample nucleating in an individual well (exothermic 
reaction leads to the higher temperature in this well). Warmer temperatures are 
represented in red, transitioning to blue for colder temperatures and finally 
black at −30 ℃ and below. Cooling rates used is 1 ℃ min−1. ..................... 241 
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Figure 5.5. Schematic of concept behind the decision to study Zirconium-based MOFs 
for ice nucleation. A) Concept Underlying the Synthesis of Metal–Organic 
Frameworks; B) Schematic illustration of the structure features of an example 
selection of MOFs that could be studied: UiO-66 (−NH2, −OH), UiO-67, and 
MOF-808, showing their large extended surfaces. Adapted from Zhu et al, (J. 
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Figure 5.7. A) Chemical structures of ligands used for MOFs tested here. 1,4-benzene 
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A) Example DSC traces of liquid water transitioning to Ih (and melting back 
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Abstract 
 
Ice formation and growth is of interest to many different fields, including food science, 
mechanical engineering, agriculture and cryobiology, however little is understood 
about the underlying mechanisms behind the nucleation and growth processes. The 
need to increase our understanding of ice and how it is affected by compounds with 
‘antifreeze’ properties is fundamental to improving techniques for the storage of 
biologics. Nature has evolved to contend with a range of harsh climates; in particular, 
they produce cryoprotectants enabling them to survive sub-zero temperatures. Inspired 
by Nature’s ingenious response a range of synthetic protein mimics have been 
developed, which have ice growth inhibition activity. The scientific principles behind 
ice nucleation and growth, and the materials that affect them, as well as current 
techniques for analysis are detailed in Chapter 1. 
This thesis reports on ice-activity for a range of compounds, studying their micro- and 
macroscopic effects on ice, as well as any potential cryoprotective capabilities, with 
the view to further fundamental understanding of ice growth inhibition and aid in the 
development of future potent cryoprotectants. A diverse range of methods including 
microscopy, X-ray Diffraction (XRD) and solid state nuclear magnetic resonance 
(SSNMR) were used to aid in characterisation and analysis by monitoring structural 
changes as well as the antifreeze macromolecule:ice interface. 
Chapter 2 investigates cryostorage of a range of biological materials using an organic 
solvent-free formulation consisting of an ice growth inhibiting polymer and a 
secondary bulking agent. Chapter 3 details X-ray diffraction (XRD) as a new method 
for studying ice growth continuously as a function of time, confirming its potential as 
a supplementary tool to study ice growth. Chapter 4 builds upon results from 
microscopy and XRD-based methods by using solid state nuclear magnetic resonance 
(SSNMR) to enable the study of molecular-level details experimentally. SSNMR 
provides further evidence for the ‘turning on’ of ice recrystallisation activity (IRI) for 
poly(vinyl alcohol) and ice-binding for a variety of compounds. Chapter 5 focuses 
on ice nucleation specifically. A range of previously untested materials that feature 
design motifs associated with nucleators reported on in the literature were examined 
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for ice nucleation effectiveness and IRI activity, finding none to inhibit ice growth, 
and that structure alone is not enough to infer nucleation effectiveness.  
1 
 
 
Chapter 1 
 
Introduction: From Antifreeze Proteins to 
Antifreeze Materials  
Chapter 1 
2 
 
1.0 Introduction 
It is commonly believed that water freezes at 0 ℃, however this is not the case, a fact 
that continues to surprise people to this day. In fact, nanolitre-scale droplets of pure 
water freeze at closer to -40 ℃,1,2 and ice formation above this is usually seeded by 
impurities (likelihood of nucleation increases as the size of impurity increases).3 Life 
on Earth depends on the presence of considerable amounts of water in all three phases; 
oceans cover over 70 % of the globe,4,5 ice (of many kilometres in depth) currently 
covers 10 % of land mass, up to 60 % of a human adult body consists of water and 
many gallons of water are required in the production of a great range of foods.6 
Snow and ice present a range of issues for industrial processes, including unwanted 
freezing of pipes, freeze/thaw damage to materials such as concrete, disruption of 
transport and negative impacts on biologic survival throughout the cold chain. 
However, they also provide much joy (in snow sports and natural wonders), as well as 
being of great importance in food preservation and essential in the nucleation of clouds 
and rain.4,7–9 
A range of industrial processes require the use of antifreeze formulations to either 
prevent the formation of ice or assist in its removal, e.g. in the de-icing of aircraft 
wings. In most cases, these strategies involve the colligative depression of water’s 
freezing point or the inhibition of ice nucleation. Colligative properties, such as 
freezing point depression, are solution properties caused by solute particles in 
proportion to their concentration, i.e. the higher the concentration, the greater the 
effect on the solution. Examples include salts, glycerol and methanol. Freezing leads 
to irreversible coagulation of paint’s constituent parts10 and reduces the quality of 
foods stored over long periods. For instance, ‘large’ ice crystals in ice cream yield a 
gritty texture.11 Ice can also be a serious problem for the cold chain; cold storage is 
important for the successful transport of biological materials,12 and key challenges for 
many biotechnology or cell-based processes are transport and storage logistics.13 An 
increasing number of biological products require temperature control now including 
at least 20 % of clinical trial supplies, 14-35 %  of vaccine shipments (potentially 
more),14 regenerative medicine12 and organ transplantation, where donor organs can 
only be stored for a few hours.15 Cryopreservation techniques have been introduced to 
enable successful biologic storage, prevention of protein aggregation and the 
Chapter 1 
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reversible arrest of cell metabolism by freezing. There are associated problems with 
freezing (change in osmotic pressure, ice crystal growth) in relation to the materials’ 
intolerance to these temperatures, leading to reduced cell, tissue and organ viability.  
Nature has evolved various adaptations to enable life to flourish in sub-zero climates. 
Organisms (such as extremophiles) tolerate these ice-rich environments by producing 
cryoprotectants (CPAs) that enable either freeze tolerance (ability to be frozen then 
thawed) or freeze avoidance (prevention of ice formation).16–19 These include 
production of small molecule CPAs such as glycerol20,21 and trehalose,22 but also 
macromolecular CPAs such as antifreeze proteins (AFPs, also known as ice-binding 
proteins) and antifreeze glycoproteins (AFGPs). 
In order to begin to address the problems associated with cryopreservation, an 
improved understanding of Nature’s ingenious response to freezing temperatures 
would be indispensable. Enabling us to answer such questions as; how can we choose 
which materials to use for storage of biologics? How do these materials affect ice? By 
what mechanisms of action to they work? Here, ice nucleation and growth are 
discussed (and probed), considering a variety of techniques and how they provide 
insight into micro- and macroscopic effects over differing length scales, so as to assist 
in answering these questions.  
 
1.1 Water and Ice 
Ice, on the atomic scale, consists of water molecules: H2O. These molecules are of 
great importance and have been (and continue to be) an interesting subject of study. 
Water’s properties are anomalous and distinctive:23,24  it has more solid phases and is 
more cohesive than other materials consisting of similar size and shape molecules, it 
has a relatively high melting point, boiling point and surface tension due to this high 
cohesion between the water molecules, its component ions (hydroxide and proton) 
diffuse at faster rates than other ions, its glassy state is neither fragile nor strong, its 
supercooled liquid has divergent thermodynamic response functions, has high thermal 
conductivity and can also be slippery and sticky at the same time, which leads to its 
distinctive feel. Water also has density anomalies that manifest in many ways: it 
expands upon freezing (thus the liquid form is denser than would be expected and the 
solid floats on the liquid), the density maximum (where water has a minimum volume) 
Chapter 1 
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is at 4 °C, differing from volumes of simpler liquids that are always increasing, 
applying pressure will melt the solid phase (applying pressure generally causes a liquid 
to freeze into a solid), it has a large heat capacity as water stores energy in its van der 
Waals and hydrogen bonds.25 Over the years there have been debates over the 
underlying mechanisms behind these behaviours.4  
Hydrogen bonding is a weak interaction between molecules (with typical energies <40 
kJ.mol-1) when compared to the chemical bonding that occurs between two atoms 
(which can be as high as 569 kJ.mol-1 for H-F), though it is stronger than hydrophobic 
interactions such as van der Waals forces. A comparison of these interactions is 
detailed in Table 1.1. Hydrogen bonding in hexagonal ice (Ih) is considered an 
example of a weak hydrogen bonded system,26 though it is this flexibility in the 
hydrogen bonded structure of ice generally that enables the formation of the multiple 
crystal polymorphs. Generally shorter distances between atoms and smaller hydrogen 
bond angles lead to increased hydrogen bond strength; the shortest, and therefore 
strongest, hydrogen bonds to have been recorded in water molecules via molecular 
simulations was 2.43 – 2.61 Å (strength of 82.28 kJ.mol-1).27,28 
Table 1.1. Magnitudes and lengths of different types of interactions between atoms 
and molecules. 
*Hydrogen bond strength in liquid water is ~23 kJ.mol-1 and ~28 kJ.mol-1 in Ih.28 
**Strength of van der Waals forces is for individual atom pairs. 
The general consensus is that some of water’s properties may be due to each 
molecule’s ability to form four hydrogen bonds with its four nearest neighbouring 
water molecules (typical length ranging between 2.6 – 2.9 Å) in an almost tetrahedral 
arrangement.33 This highly directional hydrogen bonding is responsible for some 
Type of Bond Magnitude Energy (kJ. mol-1) Length (in water (Å)) 
Hydrogen bond Weak 4 – 50*29 2.6 – 3.130 
van der Waals 
forces 
Very weak 5**31 1 - 432 
Single covalent 
bond 
Strong ~200-50031 0.97 
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volumetric anomalies, including the hydrophobic effect and ice being of lower density 
than liquid water, as a water molecule can have only four nearest neighbours.24 The 
network is what leads to water’s complex phase diagram, which has a number of triple 
points and possibly two critical points, Figure 1.1A.34 The positions of the hydrogens 
and oxygens in the lattice in turn leads to differing crystal structures 
(polymorphs/phases). These ice phases have the same chemical composition but are 
formed under different conditions; i.e. high/low temperatures and pressures. Currently 
there are 19 known phases of ice, formed under different temperature and pressure 
conditions, they also vary in that they can be proton-ordered or proton-disordered.34–
37 Roman numerals are used to name the phases in chronological order of their 
discovery, with Tammann assigning ‘I’ to his discovery of the first of the high-
pressure ice phases in 1900,38 ice II’s structure elucidated in 1964 by Barclay Kamb,39  
ice X successfully made in the laboratory in 198440 and recently ice XVIII discovered 
via X-ray experiments on laser-shocked water in 2019.41 Hexagonal ice (Ih) is the 
most common form, it is the ice we scrape off our cars in winter, whereas some of the 
other ice phases are only encountered in the interiors of Neptune and Uranus. High 
pressure is required to cause the open structure of Ih (density of 0.92 g.cm-3), the most 
common form, to collapse forming dense interconnected lattices, which make up the 
high density ice phases including, high-density amorphous ice (HDA, density of 1.17 
g.cm-3),42 very high-density amorphous ice (VHDA, 1.25 g.cm-3)43 and many 
crystalline phases e.g. ice VII (1.50 g.cm-3)44 and X (2.51 g.cm-3)45 (shown in Figure 
1.1B). There are also ice phases that occur in the negative pressure regime, these are 
ultralow-density phases that are significantly less dense than Ih, which have open 
cage-like structures similar to those of clathrate hydrates.46,47 There is difficulty in 
determining the existence and structure of these phases, as without guest molecules, 
these open cages may form Ih and are thought to only be stable at negative pressures. 
Thus far ices XVI and XVII are the only known ultralow-density phases (discovered 
in 2014 and 2016 respectively), though simulations have indicated that there are 
further stable structures that have not been found experimentally.48,49 The solid phases 
surrounding water’s liquid phase include ice III and V, which have disordered 
hydrogen bonding, commonly called proton disorder.35 Below these initial proton‐
disordered phases in the diagram is ice II, a proton-ordered phase, which is of 
particular interest since because it is considered to be proton‐ordered at all 
temperatures and pressures.39 Proton-ordered ices are blue and proton-disordered ices 
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are orange/red in Figure 1.1A. Water continues to interest researchers; it is complex, 
many properties are still not well understood and there are still ice phases 
undiscovered. As experimental techniques improve, and with the aid of computer 
simulations we have learnt much of this fascinating molecule and it associated 
structures but there is still much to discover. 
 
Figure 1.1. A) Phase diagram of stable phases of ice and liquid H2O from 0 to 400 K 
over a range of pressures. Including phase boundaries (solid lines), extrapolations of 
boundaries based on experimental results (dashed lines) and excluding metastable 
phases. Dotted lines in the negative pressure regime are based on simulations. The 
different phases of ice are labelled using Roman numerals corresponding to their order 
of discovery; B) The range of structures of other crystalline ice phases. These are 
grouped into proton-disordered/ordered pairs (for those that the ordered form has been 
Chapter 1 
7 
 
discovered) as they have the same lattice structure. Adapted from Loerting et al. 
(Comm. Chem., 2020) and Salzmann et al. (Phys. Chem. Chem. Phys., 2011).23,29 
In ice, the stoichiometry of each molecule must be preserved. This is done by 
observing the Bernal-Fowler rules.50 These rules state that each oxygen must be 
covalently bonded to two hydrogens, and that only one hydrogen may be present along 
each bond. Figure 1.2A shows the structure of Ih, indicating the two positions that 
hydrogen can be positioned along a bond. Because of this, there is a range of possible 
tetrahedral Ih configurations, Figure 1.2B, where the structure has particular angles 
and lengths, Figure 1.2C. The O⋯O distance between two neighbouring water 
molecules (including the length of a hydrogen bond) in liquid water is approximately 
2.81 Å, shortening to 2.76 Å upon freezing to Ih,28 with the proton being of ~0.97 Å 
from one of the oxygen atoms and the associated O-O-O bond angle between three 
water molecules is 109.47 °.4 The hydrogen bonding in Ih gives rise to hexagonal 
symmetry, which is visualised in Figure 1.2D, however there is no long-range order 
in the orientations of the water molecules.4 
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Figure 1.2. A) Structure of hexagonal ice, showing one water molecule within each 
polyhedral joined by covalent bonds (solid) and hydrogen bonds (dashed). B) Possible 
configurations for locations of hydrogens within a hexagonal ice crystal; C) The 
tetrahedral structure forms due to the hydrogen bonding between water molecules. 
These interactions between water molecules in Ih are highlighted here (blue dotted 
lines), with the O-O-O angle (109.47 °) and average O⋯O length (2.76 Å) included, 
as well as the O-H length for free water (0.97 Å) that alters slightly within the Ih 
tetrahedral structure and the H-O-H angle (104.54 °); D) Hexagonal symmetry in Ih 
formed by hydrogen bonding in the crystal, which gives rise to the sixfold symmetry 
observed in snowflakes, with prism plane and basal plane highlighted. Red = oxygen, 
white = hydrogen. Adapted from Salzmann et al. (Phys. Chem. Chem. Phys., 2011)29 
and Brini et al. (Chem. Rev., 2017).23 
X-ray and neutron diffraction are techniques used to determine the crystal structures 
of ice phases.29,51,52 Diffraction patterns, like those in Figure 1.3, show the ice phase 
present; indicating any amorphous/vitreous ice (broad peak, D), and can be compared 
to that of simulated patterns, Figure 1.3B/C, allowing for identification of phases 
formed under a range of conditions. The work here focuses on Ih, named as such due 
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to its hexagonal ‘snowflake’ shaped crystals that form due to its hexagonal close 
packed unit cell and six-fold symmetry,53 therefore peaks such as those in Figure 1.3B 
would be expected. Ih is water’s stable phase that forms at atmospheric pressure below 
0 ℃. This phase is observed all over the natural world, in lakes, tundra and mountain 
ranges, as well as being the phase present (along with amorphous/vitreous ice – 
depending on conditions) in frozen biological material. 
 
Figure 1.3. Experimental and calculated X-ray diffraction patterns for hexagonal and 
cubic ice; A) Experimental result for water droplets frozen (median freezing 
temperature = -41.3 ℃) recorded at -100 ℃; B) Simulated Ih pattern; C) Simulated   
Ic pattern; D) Literature diffraction patterns of amorphous ice; E) Rietveld refinement 
of the experimental pattern in A, assuming a mixture of Ic and Ih. Malkin et al, (Proc. 
Natl. Acad. Sci., 2012).54 
There can be defects, which lead to the formation of other polymorphs,29 or can 
generally affect the crystal’s structure,55 leading to, for example, crystal strain (as 
defects increase the strain energy of a crystal), rather than a phase change. Crystal 
strain is the inhomogeneous local strain on the lattice i.e. slight displacements of atoms 
from their normal lattice positions. Strain can be observed in X-ray diffraction as peak 
broadening (microstrain) and peak shifts (macrostrain). In a polycrystalline sample the 
local stress varies for each grain, and peak width analysis can reveal the extent of 
deviation from the Ih structure.4,56 
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When the Bernal-Fowler rules are violated, water molecules in ice can change their 
orientations. This occurs generally through the formation of protonic point defects that 
migrate through a crystal, helping to break the hydrogen bonds.35 Point defects can be 
intrinsic (present in pure crystals at thermal equilibrium), extrinsic, (introduced with 
impurities), or may be frozen in with non-equilibrium concentrations. Their properties 
are associated with their movement within a crystal through the jumping of atoms or 
molecules from one site to another.4 Ionic and Bjerrum defects are point defects specific 
to ice-like structures.57 Ionic defects occur when one atom is substituted for another, 
leading to oxonium or hydroxide ions forming within the lattice. Dopants such as 
hydroxide (OH-), ammonia (NH3) and chloride from hydrochloric acid (HCl) are 
commonly used to introduce these defects as they accelerate the dynamics of phase 
transitions as they change the thermodynamic state of the ice phase.58–60 Bjerrum 
defects can either be D or L. D occurs where two hydrogens are found along a bond 
between neighbouring oxygens instead of one, and L occurs when no hydrogens are 
found along that bond.35 
 
1.2 Ice Nucleation 
To form ice, water first needs to nucleate; homogeneously (without the assistance of 
other surfaces) or heterogeneously (assistance of particles acting as nucleants). This 
leads to, under ambient pressure at temperatures below 0 ℃ (or below -38 ℃ for 
homogeneous nucleation),61–64 the formation of Ih crystals (or, stacking disordered ice 
(Isd) in high clouds). The stable phase needs to nucleate before any crystal growth can 
occur, thus for homogeneous nucleation the possibility of forming an ice embryo 
(critical nuclei) of a sufficient size only becomes probable at -38 ℃ or below.65 This 
is due to the energy required to overcome the energy barrier for this phase transition, 
Figure 1.4. Often this barrier preventing ice nucleation is overcome by the 
introduction of an ice nucleating particle (INP), leading to heterogeneous nucleation. 
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Figure 1.4. Examples of reaction coordinates for the ice nucleation process at A) 0 
℃; B) -40 ℃; C) 20 ℃. 
Nucleation is a crucial step in ice crystallisation, where in the first instance critical 
nuclei (crystal embryos) form. Heterogeneous ice nucleation has often been described 
by Classical Nucleation Theory (CNT);66–69 where the critical nuclei have to reach a 
certain size in the nucleating system in order to overcome the free energy barrier and 
for crystal growth to occur, Figure 1.5A. The size of the critical nucleus required for 
nucleation increases sharply with rising temperature, seen as an exponential curve in 
Figure 1.5B, with a nuclei of a 1 nm radius nucleating at -38 °C, and nuclei with a 10 
nm radius nucleating closer to -4 °C. The addition of an INP increases the likelihood 
of nucleation, though experimental investigation of the critical nuclei/particles which 
lower the energy barrier for crystallisation is challenging due to the ‘small’ size of the 
nuclei and the spatial rarity of nucleation events. The molecular diameter of a water 
molecule is about 2.75 Å (0.275 nm), highlighting that at higher temperatures crystal 
embryos must consist of many water molecules and that this is not a facile process, 
despite the size slightly decreasing upon freezing due to a decrease in hydrogen bond 
length (and increase in strength).70 The smallest crystals that can form from the nuclei 
grow from ~75 nm to 130 nm.71 
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Figure 1.5. A) Schematic describing the ice nucleation process as explained by 
classical nucleation theory. According to CNT, a critical nuclei can have a 1 nm radius 
or longer; B) Critical radius size (nm) required for ice nucleation as a function of 
temperature. 
The second stage of the freezing process growth, one particular growth process is 
Ostwald ripening, where ‘large’ ice crystals grow at the expense of smaller ones, 
Figure 1.6.72,73 This occurs because the ‘small’ ice crystals are more 
thermodynamically unstable due to their high surface/volume ratio, so possess excess 
surface energy compared to the larger crystals. To reduce the interfacial energy of the 
system the water molecules from the smaller crystals diffuse through the solution into 
the larger, leading to a single ‘large’ crystal remaining. 
 
Figure 1.6. Schematic of Ostwald ripening in ice 
Chapter 1 
13 
 
Throughout the process, the total ice phase volume remains constant, but the number 
of crystals decreases, thus the overall surface area of crystals decreases and the mean 
crystal size increases (and thus the volume).  The increase in mean crystal radius, r, 
during Ostwald ripening is described by: 
𝑟𝑟3(𝑡𝑡) = 𝑟𝑟03 + 𝑘𝑘𝑑𝑑𝑡𝑡 (1.1) 
Where t is time, r0 is the initial mean radius at t = 0, and kd the recrystallisation rate 
constant, which is volume-fraction dependent. 
Many applications and processes, including biomineralisation, food production and 
storage, drug-formulation and anti-icing rely on understanding and controlling 
nucleation and Ostwald ripening. Control can be attempted by exploiting the different 
qualities observed in a variety of materials. 
 
1.3 Materials which Affect Ice 
There are many different materials that are considered ice-active including sugars, 
proteins, small molecules and polymers. These additives can affect freezing in a 
variety of ways due to their ice-activity, which is regarded as any effect on ice that is 
not considered colligative or ‘expected’ due to a change in the overall system i.e. 
decrease in temperature. This can include promotion of heterogeneous nucleation 
(INPs), inhibition of nucleation (anti-nucleants), or inhibition of ice growth (antifreeze 
(glyco)proteins (AF(G)Ps) and their synthetic mimics), this inhibition can be either in 
size or morphology of the crystals, Figure 1.7.  
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Figure 1.7. Representation of changes in state for H2O and the various materials that 
are ice-active. *Antifreeze (glyco)proteins (AF(G)Ps) and their synthetic mimics also 
have other properties (thermal hysteresis (TH)) not shown here. INP = ice nucleating 
particle. 
Of these additives, antifreeze proteins (AFPs), antifreeze glycoproteins (AFGPs) and 
certain polysaccharides have been found in freeze avoidant organisms.74–77 Examples 
including the mealworm beetle (Tenebrio molitor), which can freeze solid over winter, 
winter flounder, which survives sub-zero temperatures, and various cold tolerant 
plants.78 These antifreezes differ from commonly used colligative antifreezes due to 
their ability to depress the freezing point of water whilst minimally affecting these 
organisms’ bodily fluids osmolality, whilst only requiring low concentrations for such 
activity. Carbohydrates are produced in freeze tolerant organisms, such as amphibians 
and reptiles, allowing them to survive freezing over winter and thawing in spring.79,80 
Other ice-active biomaterials also exist, including antifreeze glycolipids, which also 
supress water’s freezing point, that have been found in both freeze tolerant and freeze 
avoidant species.81 INPs and anti-nucleants are also found in a vast range of 
organisms; bacteria, fungi, algae, etc.65,82–88 
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1.3.1 Ice Nucleating Particles 
Freeze tolerance is often achieved by utilising INPs extracellularly; an organism can 
survive ice formation within its bodily fluids by producing INPs, which will promote 
ice nucleation at higher temperatures, thus preventing supercooling and consequently 
averting intracellular damage. Biological INPs can be also used for other reasons, 
particularly by plant pathogens.89  
Research focussed on ice nucleation often aims to quantify and understand INPs that 
may nucleate ice in the atmosphere.90,91 Ice nucleating proteins are particularly ‘large’ 
and efficient biological INPs found on the surface of various bacteria including 
Pseudomonas syringae, Pseudomonas fluorescens and Pantoea Agglomerans.92 The 
most commonly studied naturally occurring INP is from Pseudomonas syringae, 
which promotes frost formation on plant leaves, enabling the pathogen to consume 
nutrients from plants which would otherwise survive cold temperatures by 
supercooling. Pseudomonas syringae can promote ice nucleation at warm 
temperatures (Tn) in the region of -2 ℃ to -4 ℃.93 Biological nucleators also include 
plankton,94–96 fungi97–99 (though the INP from these species may be proteins)65 and 
pollen,65,100 which contain ice nucleating and ice-binding polysaccharides.84 
Mineral dusts emitted into the atmosphere have also been observed nucleating ice in 
clouds.101–103 Kaolinite was thought to be responsible for the observed activity in 
mineral dusts due to its lattice match to Ih. However recent work has shown that 
feldspars are much more efficient nucleators,92 causing ice nucleation at temperatures 
between -3 ℃ and -8 ℃. Whale et al. and Biggs et al. have reported a range of 
synthetic materials that can also promote nucleation; this includes carbon nanotubes, 
graphene nanoflakes, graphene oxide and associated structures.104,105 In particular, 
carbon nanotubes were observed to be more efficient ice nucleators than the flat 
graphene species, with carboxylated graphene nanoflakes being one of the smallest 
nucleators observed so far (~30 nm). AgI has also been observed to effectively 
nucleate ice,106,107 nucleating at much higher temperatures than any of the other non-
biological nucleators tested thus far. 
The mechanism by which INPs act is unclear however,108,109 and the vast range of 
different INPs (with a range of sizes and structures) adds to the challenge in 
determining a relationship between physical and chemical properties and nucleation 
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activity. Lattice matching is considered important for ice nucleation properties,110 in 
that substances that have similar crystal structures to ice structurally match with the 
first layer of ice. Hydrophobicity is thought to be involved,111 and the concentration 
of hydroxyl groups is potentially important in lattice matching. 
 
Figure 1.8. Examples of the effect of protein length on freezing temperature and 
freezing efficiency (∆Tf). A) Ice nucleation temperature (Tn) as a function of INP 
monomer protein length, CNT predicted Tn (blue) consistent with a cooling rate of 1.0 
K.min-1 and experimentally obtained Tn (red) for the INP monomer from P. syringae; 
B) Modelled ∆Tf of TmINP (red closed) (a modelled protein based on stacking 
multiple ice-binding loops from the antifreeze protein Tenebrio molitor with 
fragments of an alcohol INP) compared to ∆Tf alcohol INP (black circle), ∆Tf P. 
syringae INP (blue), ∆Tf TmAFP (green triangle) and ∆Tf TmINP with the same 
number of binding sites as TmAFP (red open square). Inset indicates potential binding 
of TmINP (teal) to critical ice nucleus (grey) by an anchored clathrate (orange) (further 
details in 1.4.4) from three angles. Adapted from Qiu et al. (J. Am. Chem. Soc., 
2019).112 
Experiments have shown that the size of the INP is important to ice nucleation 
efficiency, with the larger ice-binding proteins (IBP) and their aggregates nucleating 
ice at warmer temperatures.112 How size affects nucleation is unclear however. Qiu et 
al. utilised molecular simulations and CNT to study the effect of length and 
aggregation on ice nucleation efficiency (they use the term freezing efficiency (∆Tf)), 
predicting that proteins with longer ice-binding surfaces will nucleate at warmer 
temperatures and that Tn increases with binding site length until the site reaches a 
certain ‘saturation’ length, causing the Tn to plateau. They concluded that IBPs are 
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required to aggregate in order to nucleate ice as efficiently as bacterial and insect INPs, 
Figure 1.8. 
As nucleation temperatures relate to particle size and the characteristics of crystals,113 
nucleation assays are used to observe promotion and inhibition of ice nucleation. Both 
wet dispersion methods (INP dispersed in to water) and dry dispersion methods 
(particles dispersed in air) have been used to quantitatively study nucleation 
efficiency.114 In a wet dispersion method volumes ranging from millilitre to picolitre 
have been used,90,115 though generally microlitre size droplets of water are measured 
(a 1 µL droplet would be ~1 mm in diameter, which is observed to freeze completely 
upon nucleating) and in dry dispersion methods, which include cloud chambers,116,117 
the aerosol size distributions and concentrations can vary and typically lead to crystals 
above 3 – 5 µm. A range of approaches have been used in attempt to mimic the actions 
of biological nucleators as well as to determine ice nucleation efficiency,114 these have 
studied the effect of a range of variables including, INP concentration, temperature, 
cooling rate (or isothermal experiments),118–120 time and droplet size.  
The techniques that relate to the work in this thesis are wet dispersion techniques, in 
particular droplet freezing assays, which involve a sample dispersed in water being 
divided into sub-samples on a cold stage that is subsequently cooled allowing 
monitoring of the freezing process. In general, the temperature at which nucleation 
occurs is recorded alongside video footage, and both linear cooling rates as well as 
isothermal experiments have been performed.118–120 Freezing is observed visually, 
where nucleation is detected by a change in reflection of incident light, using a 
microscope. Other wet dispersion techniques to obtain nucleation temperatures 
include using emulsions of water droplets in oil, microfluidics and calorimetry.1,121,122 
Calorimetry has been used as a method for studying AFP activity since 1988, when 
Hansen and Baust recorded the freezing temperatures of AFP type III from Tenebrio 
molitor suspended in oil.123 Calorimetry, especially when used in combination with 
microfluidics (using microemulsions),124 can provide the option to record nucleation 
temperatures without the problem of contamination from surfaces (as in microscopy 
based techniques), though they may lead to a change of location of INPs in droplets. 
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1.3.2 Antifreeze Glycoproteins 
In 1957, it was observed that Arctic fish survive well in supercooled waters at 
temperatures of 0.7 ℃ below the freezing point of their blood serum (-0.9 ℃ to -10 
℃).125 The peptides that were found to be the cause of this freezing point depression 
(a thermal hysteresis effect), initially called freeze depressing (glyco)proteins 
(FDGPs), were studied in comparison to sodium chloride, and were found to exhibit a 
greater thermal hysteresis capacity.126 These FDGPs have been found to also possess 
two other ice-active properties; ice recrystallisation inhibition, where Ostwald 
ripening is suppressed, and the ability to shape ice crystals into needles by binding 
particular ice faces – known as dynamic ice shaping. This led to the re-characterisation 
of these proteins to antifreeze glycoproteins (AFGPs).18 
When studying the mechanism of action of these macromolecular antifreezes, their 
structure must be considered. AFGPs have a highly conserved structure and are 
produced in a range of chain lengths, with the primary structure (Figure 1.9A) 
consisting of a repeating tripeptide unit (alanyl-alanyl-threonine). O-linked 
disaccharide motifs are attached at the threonine sidechains.127 AFGPs come in a range 
of sizes, and are grouped by isoform into groups; AFGP1-5 (‘large’: with 16 – 52 
repeat amino acid chains) and AFGP7-8 (‘small’: with 4-5 repeat chains),127 the longer 
sequences of which exhibit a greater magnitude of antifreeze activity.128 
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Figure 1.9. A) Structure of AFGP repeat unit. AFGPs with four repeat units and 
molecular weight of 2.6 kDa are AFGP8, and those with molecular weight of 33.7 kDa 
are AFGP1. Molecular weights of AFGP2-7 are between these two values;129 B) 25 
lowest energy structures calculated for a synthetic AFGP3 using NMR-based 
constraints. (Peptide backbone = purple, carbohydrate moieties = blue); C) Synthetic 
AFGP3 structure produced from the closest to average of 25 best calculated models. 
(methyl carbon = yellow, carbohydrate carbon = white, peptide side chain carbon (bar 
methyl carbon) = grey, nitrogen = blue, oxygen = red). Adapted from Tachibana et al., 
(Angew. Chemie. Int. Ed, 2004).130 
The AFGP structure is considered to be flexible (high number of possible conformers 
suggests high flexibility),131,132 and whilst there is general agreement in that they exist 
as left-handed 3-fold helixes (the helix has 3-fold symmetry),133 their secondary and 
tertiary structures have not been crystallographically confirmed.132 Tachibana et al. 
produced a structure for an AFGP3 (essentially identical to naturally occurring 
AFGPs) by modelling lowest energy structures, Figure 1.9B, showing that the peptide 
backbone folds into a left handed helix, from which the three disaccharide moieties 
construct a hydrophilic face on one side, concluding that AFGPs activity is derived 
from its intrinsic conformation.130 The structure function relationship is not fully 
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elucidated, however the disaccharide moiety is vital to AFGP efficacy and studies into 
structural modifications have shown a loss in antifreeze activity upon its 
removal.130,134 
AFGPs have been found to be produced by a range of Antarctic notothenioids and 
cods, thus protecting them from freezing in the sub-zero environments they live. 
 
1.3.3 Antifreeze Proteins 
Antifreeze proteins (AFPs) are proteins which, despite lacking the sugar moiety, have 
similar ice-active properties to AFGPs. A range of isolated species, including 
insects,135 fish,136 bacteria137 and plants,138 developed AFPs through convergent 
evolution.139 Discovered later and found in a wider range of organisms, they have 
many more structural variations (and mass ranges), as well as binding capabilities to 
various ice planes, Table 1.2. These proteins are classed as type I, type II, type III, 
insect AFPs, plant AFPs and ‘other’ (which includes proteins from algae, diatoms, 
fungi, bacteria). Structural uniformity within classes of organisms is low (different 
AFP structures have been observed in the same ocean fish)140 but generally the AFPI 
class are alanine rich and alpha helical, AFPII are globular, cysteine rich proteins, type 
III are smaller globular proteins often with a β-sandwich secondary structure and the 
AFPs from insects, plants, bacteria, diatoms etc. are much more varied, with some 
composed of β-sheets and others polyproline type II coils141 or left-handed β-rolls.142 
Some proteins have been found to bind the same ice planes, for example AFPII, 
AFPIII and plant AFPs have all been observed binding ice’s primary prism plane. 
There is also plane-binding variation within the different AFP types; AFPI from the 
winter flounder and Alaskan plaice bind pyramidal planes and the shorthorn sculpin 
AFPI binds secondary prism planes.143  
These proteins also inhibit ice crystal growth (though to a lesser extent than AFGPs) 
and depress the freezing point of water non-colligatively. Some AFPs, in particular 
type I, have displayed even higher thermal hysteresis activity. This hyperactivity can 
be seen in the example TH activity in Table 1.2, where hyperactive AFPs, such as 
those from T. molitor and M. primoryensis, have a much higher activity than the 
moderately active AFPs at concentrations of at least 10x lower.78,144 Concentrations 
of AFPs in the table vary due to the concentrations recorded in the literature. 
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Table 1.2. Types of antifreeze proteins and respective example masses, structures, 
binding planes and origin. Adapted from Voets, (Soft Matter, 2017) and Barrett (Int. 
J. Biochem. Cell Biol., 2001).145,146 
*Both moderately active AFPs and hyperactive AFPs have been extracted from Winter 
Flounder;156 The hyperactive AFP (dimeric species) has a TH >1 °C at 3 µM, whereas 
at this concentration the moderate AFP has a TH of <0.1 °C. Planes are colour coded: 
Basal plane (0001) = pink, primary (1°) prism plane (10AAA1�0) = yellow, secondary (2°) 
prism plane (112�0) = green, pyramidal plane (202�1) = blue. 
AFPs are easier to synthesise than AFGPs due to the lack of need for post-translational 
modification, and can be more easily modified, e.g. addition of different protein 
expression tags and conjugation to other compounds. This has enabled greater bouts 
 
AFPI AFPII AFPIII Insect 
AFP 
Plant 
AFP 
Other 
Example 
Masses 
(kg.mol-1) 
3-4.5 11-24 6.5-14 6-9 13 24.5 
Example 
structure 
 
 
 
 
 
 
PDB 1WFA147 2PY2148 1KDF149 1M8N150 3ULT142 3VN3151 
Binding 
plane 
Pyramidal 
& 2° prism 
1° prism Pyramidal 
& 1° prism 
Basal 
plane 
Basal & 
1° prism 
Varied 
 
      
Origin Right-eyed 
flounders, 
sculpins 
Herring, 
sea raven, 
smelt 
Eel pout, 
ocean pout, 
wolfish 
Beetles, 
moths, 
midge, 
flies 
Grasses Algae, 
diatoms, 
fungi, 
bacteria 
Example 
TH (ºC) 
Winter 
flounder: 
<0.6 ºC (1 
mM)78* 
Sea 
Raven: 
~0.4 ºC 
(0.2 mM) 
Ocean pout: 
~0.8 ºC (1 
mM)152 
T molitor: 
3.5 ºC 
(0.1 
mM)153 
Lolium 
perenne: 
~0.2 ºC 
(0.04 
mM)154,155 
M. 
primoryensis: 
0.76-1 ºC 
(0.8 µM) 
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of research into their structures and ice-activity. Their structures include a range of β-
barrels and α-helices,19 the snow flea (Hypogastrura harveyi) AFP for example 
consists of 6 stacked helices,141 and the ocean pout (Zoarces americanus) is globular 
and composed of β-sheets.149 Both AFGPs and AFPs have hydrophobic and 
hydrophilic domains, with AFPs generally consisting of a large mixed cluster with an 
ordered ice-binding face. AFPs also consist of a high alanine content (~60 %),157 
whilst remaining water soluble.158  
AFPs essentially have the same ice-activity despite their structural differences, with 
hyperactive AFPs such as H. harveyi and spruce budworm moth (Choristoneura 
fumiferana) having a greater ability to depress water’s freezing point.159 They are 
thought to work by binding ice, however it has been difficult to elucidate the exact 
binding mechanism.140 Site-directed mutagenesis has been performed on AFPs, 
enabling modification of the proteins by the substitution of amino acids thought to be 
involved in ice-binding. This has aided in elucidating the binding site structures, as 
modification of amino acids involved leads to reduced ice-activity, meaning 
investigation into their antifreeze properties is possible.160  
Generally AFPs are thought to bind the prism planes of ice leading to preferential 
growth at the c-axis (basal plane).138,161 Theories first suggested that binding occurs 
due to pattern matching between the growing ice face and the hydroxyl groups of 
AF(G)Ps due to specific spacing between the groups.162 Another more recent theory 
is based on the anchored clathrate mechanism, where the AFP orders nearby water 
molecules to be more ‘ice-like’. This ice-like water can freeze more readily than the 
bulk water and thus bind the AFP to the ice surface.163 The ice-binding mechanism is 
complex and alongside the suggested theories there is also debate as to whether the 
proteins bind reversibly164 or irreversibly.165 
 
1.4 Mechanisms of Action 
There currently is a debate over the mechanism of growth of ice and its inhibition, in 
particular in relation to ice-active materials. Numerous studies have been performed 
and theories proposed. 
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Three key macroscopic effects associated with ice-activity for AF(G)Ps have been 
observed, these are Dynamic Ice Shaping (DIS); morphology of a growing ice crystal 
is changed; Ice Recrystallisation Inhibition (IRI); crystal growth is inhibited; Thermal 
Hysteresis (TH); a non-equilibrium depression of the freezing point.161,166,167  
 
1.4.1 Dynamic Ice Shaping 
DIS is where the growth of certain ice crystal faces is inhibited. This happens when 
an antifreeze binds ice. Different antifreezes have an affinity for different ice planes 
(as seen with AFPs, Table 1.2) leading to variations in crystal shape. 
Assays have been important in gaining knowledge of which ice faces are bound.167,168 
Techniques used have included pitting (allows observation of ice-binding as pits 
observed where binding occurs) and hemispherical etching (pattern of ice layer formed 
indicates the orientations at which AFPs adsorb onto ice).169,162 A more recent 
technique is fluorescence-based ice plane affinity (FIPA), where AFPs are 
fluorescently labelled before incorporation into an ice crystal prior to imaging under 
UV light,170 which provides the option to simultaneously compare different ice-
binding patterns of different AFPs with clearer images in a shorter time frame. More 
commonly microscopy-based assays are used. Concentrated sucrose solutions have 
been used as a solvent for these assays rather than pure water, as this method allows 
for liquid to be present between ice crystals, enabling the study of the morphology of 
the crystals, as well as how they grow without the interference of interactions between 
grain boundaries.171,172 During a sucrose ‘sandwich’ assay a sample of interest is 
pressed and sealed between two glass slides, frozen, warmed briefly and annealed so 
crystal habits can be observed. Generally sucrose solutions are 30 - 45 wt % sucrose, 
depending on the procedure followed.144 
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Figure 1.10. Schematic of the dynamic ice shaping process. A) Pure water crystal 
morphology over time; B) Morphology modification over time, due to binding of 
AF(G)Ps to the prism plane. Scale bar = 100 µm. 
Pure Ih ice crystals are round and flat, leading to hexagonal burst patterns upon further 
cooling, Figure 1.10A. Upon addition of ice-binders the surface curvature of the ice 
increases, depressing the equilibrium freezing temperature.172,173 An increase of 
curvature leads to an increase in vapour pressure, a decrease in melting point and the 
decline in assimilation of further water molecules into the ice at certain points. These 
limit growth and modification of crystal morphology, an example of which is the 
addition of AFGPs which bind the prism plane leading to needle-like crystals, Figure 
1.10B.174 
DIS is problematic for cryopreservation, as when needle-like crystals form they can 
puncture cells. DIS is generally observed in TH active materials, such as AF(G)Ps, this 
makes them less useful for use as CPAs. Thus, colligative antifreezes such as ethylene 
glycol (EG) or dimethyl sulfoxide (DMSO), which prevent crystallisation without 
shaping ice, are the most commonly used. 
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1.4.2 Ice Recrystallisation Inhibition 
Ice recrystallisation (IR) can be accretive, isomass and migratory, the mechanism of 
which depends on size of ice crystals;175 for example accretion dominates when 
crystals are ‘small’ and close together.176 IR is the process of change in number, shape 
and size of ice crystals over time and can be lethal to biological matter as it causes 
dehydration and cellular damage, particularly to cell membranes.172,177 
IRI is the observed effect by which this growth of ice crystals is impacted, slowed, or 
halted when freezing occurs in the presence of an antifreeze, the first measurements 
of which were demonstrated in 1988 by Knight et al.178 177 IRI can be affected by ions 
in solution and must be considered when performing assays to test for this 
activity.179,180 
The most common technique used to analyse IRI activity currently is the ‘splat’ 
cooling assay, which follows Ostwald ripening, Figure 1.11, which enables the 
visualisation of ice growth (at a micrometer scale) and thus the inhibitor 
potency.181,182,183,184 This method is relevant for monitoring inhibitor potency as it 
enables the viewer to monitor crystal growth in real time, isolate grain growth (i.e. not 
observe nucleation) and was introduced due to the need to study how ice 
recrystallisation is affected by the addition of a variety of impurities as there were few 
techniques that performed this successfully.178 In a typical splat assay a sample 
solution is dropped onto an aluminium plate held at -78 ℃ to form a very thin wafer 
of polycrystalline ice. The sample is then transferred to a coldstage (-6 ℃ to -8 ℃) for 
annealing for 30 minutes. The crystal sizes (and how they change over time) are then 
recorded using a microscope; the length of crystals (mean largest grain size, (MLGS)) 
can be measured along any axis and the mean ice grain size (MGS) is calculated from 
the number of crystals observed. Crystals observed through the microscope will be of 
approximately 10-20 µm in diameter at t=0 minutes. These will grow over the 30 
minute anneal and provide a macroscopic visual of inhibitor potency; the smaller the 
crystals, the more potent the IRI inhibitor. Crystal sizes will be compared to that of a 
control sample (PBS only), which will have large crystals (>100 µm) with defined 
grain boundaries. Crystals that are 20 % of the size of control crystals are considered 
to be highly potent IRI inhibitors. 
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Figure 1.11. Example of micrographs of nucleated ice crystals obtained from a splat 
recrystallisation assay before and after 30 minutes annealing, and the difference in 
crystal size as inhibitor potency increases. Approximate crystal diameter at t=0 
minutes: 10-20 µm. Large crystal diameter at t=20 minutes: > 100 µm. Scale bar = 
100 µm. 
Sucrose assays have also been used in a similar manner to follow this ice 
growth.144,168,185  The crystals obtained in this assay are more separated due to the high 
viscosity of the media, and hence image analysis can be used to identify each crystal, 
as shown by Budke et al.185  It is also important to be able measure growth in the media 
of interest, and the 20 - 45 wt % sucrose required168 for this is not relevant for all 
conditions, and it has emerged recently that salts have a profound effect on growth 
rates, hence the appeal of measurement in buffers.186,187 
One considerable downside to these microscopy-based assays is that there is not really 
an easy to implement high-throughput method. Individual samples take many hours 
of set-up, annealing and analysis.185,188 There are also issues with the splat assay in 
particular, as when ‘large’ anomalous crystals form they can skew results, especially 
as only ‘small’ sample areas are analysed. Tomczak et al. presented another technique 
for determining IRI activity of an AFP using 10 µL capillaries.189 These are useful for 
endpoint measurements, however, do not provide much information on the rate or 
change in crystal size during experiments. Yet, they do allow for storage of samples, 
which then can be tested reproducibly in further IRI assays. 
 
1.4.3 Thermal Hysteresis 
Another property of ice-active materials is TH; this kinetic effect (not highlighted in 
Figure 1.7) is the observed difference between the melting point and non-equilibrium 
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(hysteresis) freezing point of ice, which is known as the TH gap (within which 
nucleated ice crystals do not melt or grow), Figure 1.12.146,166,167 This is a non-
colligative freezing point depression effect; i.e. the freezing point (Tf) is lowered 
whilst the melting point (Tm) of the ice remains the same. The effect is much greater 
than it would be if dependent on the concentration of the solute containing solution, 
leading to a microcurvature of the rest of the ice surface making binding of other ice 
molecules thermodynamically unfavourable, thus decreasing the water freezing 
point.172  
 
Figure 1.12. Cartoon depicting thermal hysteresis effect of AF(G)Ps on ice crystal 
growth. Upon addition of AF(G)Ps, ice crystal growth is supressed within the TH gap, 
with growth occurring post the hysteresis freezing point. TH is calculated as the 
difference between Tf and Tm. 
TH has been observed in both freeze tolerant and freeze avoidant organisms, and was 
thought to be linked to IRI activity, deriving from the AF(G)Ps ice–binding 
capabilities.178,190 However, recent studies propose there is no relationship between 
the two, as IRI and TH activity do not increase at the same rate for different AFPs, 
implying different proteins may use different mechanisms of action for ice-
activity.155,191 TH and DIS appear to be correlated as all molecules with TH activity 
cause defined changes in crystal morphologies.161,192 The precise mechanism is 
unknown, however it has been suggested that TH occurs due to the AF(G)P binding a 
single ice crystal in a supercooled solution, which then prevents expansion/melting 
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within the TH gap. The extent to which proteins are TH active has also been studied, 
suggesting that size affects activity.193 
The most common method used to test this mechanism and study TH activity has been 
nanoliter osmometry, where droplets of aqueous samples are observed under a 
microscope.130,167,194,195 Samples are frozen and then melted until a single crystal 
remains. To determine the TH of a sample the crystal is cooled further until there is a 
sudden burst in growth. There are limitations in determining TH in this way, as it 
depends on factors such as cooling and melting rate, the annealing time of the 
experiment and the initial sizes of sample crystals.196 Differential scanning calorimetry 
has more recently also been used to investigate the TH effects of AFP segments.197 
Gaede-Koehler et al. developed a sonocrystallisation-based method, in which a sample 
solution is supercooled slowly to ~-6 ℃, a short ultrasound pulse is then applied, 
which results in nucleation and freezing.198 The samples are then slowly melted and 
the freezing and melting points determined. This method allows for control of the 
degree of supercooling, the rate, and is independent of initial crystal size and has been 
observed to provide highly reproducible measurements.167  
The range of techniques above have enabled researchers to discover and design a range 
of compounds that can mimic the properties of anti-icing, ice growth inhibition and 
morphology modification, though how these ice-active materials work has not been 
wholly confirmed. 
 
1.4.4 Ice-binding  
Ice-binding has been considered important;168,181 research has stated that it was 
necessary for ice-active materials to bind particular ice faces, especially when 
explaining their activity using the adsorption-inhibition mechanism, Figure 1.13, and 
this binding may be the cause of freezing point depression and IRI, as macroscopic ice 
growth is inhibited due to an increased ice crystal curvature between adsorbed proteins 
and thus increased vapour pressure and increased energetic cost of adding a water 
molecule to the ice surface.192 Zepeda et al. researched AFGP adsorption, showing 
that it is not an instant process, but takes seconds to reach maximum coverage, though 
they noted that ice growth halts upon adsorption of only a small number of protein 
molecules to the lattice.199 This led them to conclude that first, protein molecules 
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strongly bind to the ice surface and halt ice growth, after which proteins will bind 
weakly. Potentially if weak enough, water molecules could replace the weakly bound 
proteins enabling ice growth (reversible binding). AF(G)P binding can also be affected 
by cooling rate and annealing time; Takamichi et al. studied TH changes for AFPIII 
based on the adsorption-inhibition model finding that fast cooling rates (0.20 °C.min-
1) decreased TH and that long anneals (3 hours) enhanced TH up to 2.5-fold,196 
proposing this enhancement to be due to additional ice binding occurring. 
 
Figure 1.13. Schematic depicting the adsorption-inhibition mechanism (step-pinning 
model) of ice growth and formation of convex ridges between proteins. As the 
temperature decreases the curvature of the ice crystals between bound AF(G)Ps grows. 
The smaller the spacing between the adsorbed proteins, the lower the temperature 
required for ice propagation due to the increased curvature. This model (and related 
models including the kinetic pinning model) relate to the size and shapes of proteins 
involved.200 
However, recent work suggests that inhibitors may function by occupying a liquid-
like layer (or thin liquid layer),17,166 sometimes referred to as a quasi-liquid later (QLL) 
(which is strictly a definition at surfaces).201 These interfacial waters have been 
suggested to be a thin layer (e.g. 10 – 15 Å wide) on the surface of ice grains, 
occupying the ‘bulk water’ space where the molecules are neither in a rigid solid 
structure nor in the liquid state, within which the ice-like structure gradually changes 
until it is also bulk water.202,203 These may have a different pH to the bulk of the 
solution, this could be important as the ice surface may differ to the bulk.179,180,204 
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Data collected through modelling AFPs supports the anchored clathrate mechanism, 
finding that hyperactive AFPs (such as mpAFP_RIV163 or sbwAFP205) bind ice 
through distinct anchored clathrate motifs rather than by directly binding the ice.206 As 
mentioned in 1.3.3, the mechanism explains that when the temperature of a 
water:AF(G)P solution becomes low enough, the water molecules in the protein’s 
solvation shell become more structured and less dynamic. This region is more ice-like 
thus has a lower energy barrier to ice formation. This mechanism considers the 
QLL/liquid-like layer to be of importance as when the protein approaches ice, it comes 
into contact with the QLL and the ordered waters at the ice-binding site merge with 
it.163 A QLL here is defined as a thin film of liquid water that exists on the surface of 
ice crystals below melting temperatures.207,208 Though there are debates as to the 
definition of a QLL, thus in this thesis we are referring to the behaviour pertaining a 
liquid-like layer. Garnham and co-workers state that this mechanism is applicable to 
any AFP, though their studies are primarily molecular dynamics (MD) simulations, 
meaning studies probing AFPs on the ice surface directly may provide details of the 
process of AFP adsorption and the role of anchored clathrate waters. 
MD has assisted with rationalising and guiding experimentalists, as well as 
complementing results gathered thus far. Recently computational studies have been 
performed to help elucidate an AF(G)P synthetic mimic, poly(vinyl alcohol)’s 
(PVA’s) mechanism of action (for further details see 1.4.5), as well as into how it 
binds ice, indicating that it binds differently to AFGPs, Figure 1.14. Mochizuki et al. 
state that AFGPs are thought to bind through the adsorption of methyl groups of both 
the peptide backbone and disaccharide moieties to ice, and that segregation of 
hydrophilic and hydrophobic groups in the protein’s helix is integral to the ice-binding 
mechanism, Figure 1.14A.164 Their theory is based on work utilising simulation cells 
containing 10,000 water molecules and one AFGP8 molecule to reflect AFGP8’s ice-
activity at low concentration, showing that the disaccharide moieties in AFGP8 lead 
to the highly organised and compact 3-fold helical structure and are key to AFGP8 
binding ice because of the spatial segregation between the disaccharides and 
hydrophobic groups on the peptide. They noted that when hydrophobic groups face 
the growing ice lattice, growth halts but continues if disaccharides face the lattice, and 
that AFGP8 binds this plane exclusively through the hydrophobic groups because the 
distance between nearest CH3 neighbours for each repetition of the 3-fold helix 
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matches twice the distance in the primary prismatic ice face (0.93 nm and ~0.91 nm 
respectively).  
 
Figure 1.14. The differing possible mechanisms of action for PVA and AFGP. A) 
AFGP binding via hydrophobic interactions. Hypothesis supported by work from 
Mochizuki et al. showing the binding is due to hydrophobic interactions between CH3 
groups (0.93 nm between neighbours) and the primary prismatic face of ice where 
twice the lattice distance is ~0.91 nm; B) PVA interacting with ice via hydrogen bonds. 
Hypothesis supported by work from Naullage et al. where they show the OH-OH 
distance in PVA highlighted (*) as 2.92 Å (this distance when between 4 groups is 
7.46 Å), and the distance between O-O in the primary prismatic plane of ice parallel 
to the c-axis as 2.70 Å. 209 C) Example binding configuration of AFGP8 to the primary 
prismatic plane. (Orange and green spheres = methyl groups bound); D) Side and front 
views of PVA bound to ice. Once PVA binds ice, the PVA adopts an isotactic 
configuration, where all the methylene groups orient in the same direction. The 
polymer hydrocarbon backbone lies along the prismatic plane, parallel to the c-axis. 
Adapted from Mochizuki et al., (J. Am. Chem. Soc., 2018) and Naullage et al., (J. 
Phys. Chem. C, 2017).164,209 
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Naullage et al. used large-scale MD simulations and computationally efficient coarse-
grained models to study PVA. They used the monatomic water model mW, where 
each molecule is represented as a single particle that interacts only through short-range 
anisotropic interactions. Their simulation cells used to study the interaction of PVA 
and ice contained water molecules in both liquid and solid phases (minimum 9216 
water molecules in 9.4 × 5.4 × 5.7 nm cells) and were evolved for up to 600 ns. They 
noted that PVA remains bound to the secondary prismatic plane for up to 200 ns out 
of the 600 ns simulation but is remains bound to the primary prismatic plane 
throughout. Their findings led them to state that PVA recognises ice by a zipper 
mechanism where PVA selectively binds prismatic ice faces via hydrogen bonding 
and distance matching between the hydroxyl groups of PVA and water molecules at 
the ice surface, instead of via the use of anchored-clathrate motifs or hydrophobic 
interactions, Figure 1.14B.209 This mechanism involves a random hydroxyl group 
(OH) of PVA binding to the prismatic plane of ice, the PVA chain then continues to 
bind parallel to the c-axis via a cooperative zipper-like process (named as such due to 
its sequential nature) with the PVA methylene groups all oriented in the same 
direction. Naullage et al’s simulations indicate PVA binding via direct hydrogen 
bonding in a regular pattern (two out of every three OH groups hydrogen bond to the 
ice) due to the distances between the OH groups in PVA. Their simulations show the 
average distance between two consecutive OH groups of PVA in liquid water to be 
2.92 ± 0.46 Å, which is comparable to the nearest oxygen-oxygen distance in the 
primary prismatic plane parallel to the c-axis (2.70 Å) and that the distance between 
O-O in the prismatic plane perpendicular to the c-axis is 4.43 Å (4.52 Å in 
experiments), inhibiting PVA from hydrogen bonding to that plane, thus supporting 
the theory of PVA lattice matching. 
Experimentally, research into understanding the ice-binding of proteins has recently 
been undertaken using solid state NMR (SSNMR). By measuring the 1H-1H cross-
saturation and cross relaxation of protons in frozen ice:AFP solutions, more detailed 
structural information has been obtained about the direct contact certain AFPs make 
with ice as the change in dynamics of the ice protons affects the relaxation rates. These 
studies into the ice:AFP interface have presented SSNMR as another technique that 
could be further utilized to study the interactions of more synthetic CPAs and ice.210 
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It is unclear exactly the mechanisms of how these compounds work, the extent of 
actual ice-binding, and whether they may work via different mechanisms;211 with 
different compounds targeting different crystallographic faces of ice, either through 
hydrophobic interactions in AFGPs164 or by anchored clathrates in some AFPs.163 
Despite the range of techniques available to study ice nucleation, the debate continues. 
 
1.4.5 Synthetic AF(G)P Mimics 
Existing strategies for protecting biological materials from freeze-induced damage 
involve the addition of colligative antifreezes. These vitrify the solution, forming a 
glass where no crystal growth occurs, rather than reducing ice growth via IRI activity. 
However large quantities of these antifreezes need to be added, and these are often 
cytotoxic (in particular DMSO)212,213 and require removal post-thaw. AF(G)Ps, due to 
their macroscopic effects on ice, have been suggested as another option. However, 
major obstacles stand in the way of using AF(G)Ps for cryopreservation. The most 
obvious of which is the lack of clarity on their mechanisms of action. The second is 
that AFP production (via recombinant expression/solid phase synthesis) is expensive, 
time-consuming and produces low yields, meaning there is a lack of large quantities 
available for research.19,214 AFGP production is harder again; there are challenges with 
total synthesis, they cannot generally be produced via bacterial protein expression and 
they require post-translational modifications (addition of disaccharide).215 Both AFPs 
and AFGPs also have issues relating to their use in cryopreservation, thus have not 
been widely used. Despite their use in that they inhibit ice crystal growth, thus 
theoretically reducing the potential for cellular damage, they affect ice morphology, 
which in turn damages cells.216–220 These proteins also have potential 
immunogenicity/toxicity problems. These strategies however do provide inspiration 
for new biomimetic-strategies to improve cryopreservation.16,93,154,221–225 
Though synthetically challenging, analogues of AFGPs have been prepared by 
Wilkinson et al.,215 enabling insight into the structure-function relationship leading to 
IRI activity. As a result of this work and the previously addressed issues, research into 
the production of synthetic mimics has been of great interest.226 Mimics have emerged 
that can reproduce their properties as well as benefit from the scalable and tuneable 
synthesis of synthetic polymers.166,227,228 These include C-linked glycopeptides,229–231 
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a range of small molecules,210,232,233 polyampholytes,234,235 Oxidized Quasi-Carbon 
Nitride Quantum Dots (OQCNs),236 safranine-O,237 graphene oxide (GO),238 
zirconium acetate (ZrAc),239 nanocelluloses,240 and poly(vinyl alcohol) (PVA).241–244 
Due to the success of vinyl polymers in a range of biomedical applications and their 
high biocompatibility, there has been much research into their possible use as CPAs. 
PVA, structure shown in Figure 1.15, has been found to be one of the most active 
mimics reported to date.243  
 
Figure 1.15. Chemical structure of PVA 
PVA, first reported as an IR inhibitor in 1995, is a fully flexible compound (in this 
way it differs from the rigid AFPs) and demonstrates high potency, with significant 
IRI activity at 1 mg.mL-1 and the ability to inhibit ice crystal growth to 10 % of a 
control crystal when <0.1 mg.mL-1 is dissolved in solution.241 
PVA is also IRI active over a large range of molecular weights, with an interesting 
‘switching on’ of activity at above 14 repeat units (DP14).242 It does not shape ice 
crystals into needles and only has weak TH activity at less than 50 mg.mL-1,241,245 
making it of interest as a potential CPA; with reports of enhanced cellular recovery 
when used. However, despite PVA’s high IRI activity, biocompatibility,246,247 simple 
synthesis and low cost, it has been observed that its activity cannot be optimised by 
structural modifications, in fact it is often lost;241,247 for example multivalency and 
branched PVAs provide little positive impact.244,248 Thus PVA may not be of use for 
all applications, leading to the need for other synthetic mimics or the creation of CPA 
formulations containing PVA and other compounds that can afford effects that PVA 
cannot/enhance PVA’s qualities. 
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Figure 1.16. Schematic representations of AFP ice-binding. A) Hypothesis for 
beneficial interactions of a monomeric AFP compared to that of various multimeric 
AFP constructs with ice. Adapted from Wilkins (PhD thesis, University of Warwick, 
2019);249 B) Schematic representation of a dendrimer-linked AFPIII (DLTIII) binding 
ice obtained by Davies et al.214 First DLTIII binding a single ice crystal via its ice-
binding site, IBS (purple binds pyramidal plane, blue binds prism plane). Ice 
recrystallisation may then occur and DLTIII will simultaneously bind several ice 
crystals. 
The impact of architecture has also been considered; especially in relation to AFPs 
and PVA. This interest is due to the probability that multivalency will lead to increased 
ice-activity; i.e. multiple compounds could bind the same ice face/bridge between 
other ice faces.214  
Examples of the possibility of multiple binding using multimeric AFPs can be seen in 
Figure 1.16A, where activity may result from the capacity of the multimeric AFP to 
span interstitial space to bind several ice crystals simultaneously. Studies suggest a 
Chapter 1 
36 
 
binding model wherein the size of the scaffold will affect ice-binding; i.e. a larger 
scaffold is key for enabling the whole AFP IBS to be available to bind several ice 
crystals at once, thus linker size (as well as flexibility of linker) will affect binding 
activity.214 Stevens et al. found that attaching multiple type III AFPs to the outer 
termini of a dendrimer to make DLTIII enhanced both TH and IRI activities compared 
to that of monomeric AFPIII due to the increased ability to cross-link multiple ice 
faces, Figure 1.16B. They think that a single ice crystal will bind only a few of the 
cross-linked AFPIIIs, but in three-dimensions there is a higher possibility for 
interaction with multiple ice grains. 
Recent work by Gibson and co-workers reports on the use of polyampholytes as 
another ice-active polymer option.250 These polyampholytes display lower IRI activity 
than PVA, but have been observed to improve red blood cell (RBC) recovery.251 
Matsumura et al. has also studied libraries of polyampholytes, again finding 
cryoprotective capabilities despite their moderate IRI activity.252 Within these libraries 
the polymers only have slight structural variations, which can affect overall IRI 
activity, but the hydrophobic/hydrophilic balance is deemed important.235,252 
Compounds of interest include metal organic frameworks (MOFs), though only 
preliminary work has been performed in this area, which have been observed to have 
limited IRI activity and the potential for ice nucleation as their highly-designable 
nanostructure may be of use in lattice-matching with ice,253 GO, which has significant 
IRI and cryoprotective ability (reducing crystal growth to 20 % MLGS at 5 mg.mL-
1),238 and OQCNs, which have been observed to exhibit TH, IRI and DIS, as well as 
improving sheep RBC recovery compared to the commercially used hydroxyethyl 
starch (HES) are other options.236 
Recently, soluble organic dyes have been screened, finding that compounds with flat 
planar structures can also inhibit IR. Safranine-O specifically, has been identified as 
highly potent and highlights the fact that hydroxyl groups many not be essential for 
IRI activity.254 Drori and co-workers investigated safranine-O suggesting that it self-
assembles in solution, forming a supramolecular structure with hydrophobic and 
hydrophilic regions (similar to the IBS seen in AFGPs), Figure 1.17. Analysis of the 
safranine-O structures show that within the supramolecular stack the gap between each 
molecule is 3.7 Å, with the distance between two amino groups being 7.4 Å, a good 
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distance match with every second oxygen in an ice lattice (7.36 Å), implying that this 
preorganisation of molecules allows for hydrogen bonding to occur along the prism 
planes of ice. 
 
Figure 1.17. Self-assembly of safranine-O. Side and front view of a stack of seven 
safranine-O molecules. Adapted from Drori et al., (J. Am. Chem. Soc., 2016).254 
Ben et al. have reported a range of IRI active AFGP mimetic species (both with and 
without TH)229 consisting of a range of C-linked mimetic probes, which are low 
molecular weight species consisting of a monosaccharide motif attached to peptide 
repeat units.229–231 They tested a range of carbohydrates and peptide backbone lengths, 
finding that IRI activity is highly sensitive to structural modification: the longer the 
side chain between monosaccharide and peptide backbone229 the lower IRI activity; 
choice of sugar residue impacts potency,255 e.g. finding a galactose derivative to be 
the most active and talose the least. This led Ben et al. to put forward an explanation 
for activity relating to hydration of the sugars;256 stating that monosaccharides with 
the highest hydration numbers will bind more water molecules and thus disrupt water’s 
hydrogen bond network. Balcezak et al. and Graham et al. support these findings; 
stating that hydrophobic moieties are important for IRI257 and that segregation of 
hydrophilic and hydrophobic groups (amphipathy) is important.228 
A graphical representation of synthetic compounds with IRI activity compared to 
AF(G)Ps can be seen in Figure 1.18, showing that no synthetic mimic thus far has 
activity as high as the natural antifreezes, and that there is a range of structures that 
are active over a range of concentration. Some materials are not included in the figure 
as they have been tested in other buffers such as NaCl, though these have low or no 
activity; for example CNCs and OQCNs. 
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Figure 1.18 Summary of range of activities observed for different classes of IRI active 
compounds. It is important to note that the size indication is based on the static 30 
minute measurement, and that in all cases the ice crystals keep growing, thus is a 
snapshot of a rate of growth. Grain size is recorded after 30 minutes annealing at -8 
℃. Adapted from Biggs et al. (Macromol. Biosci., 2019)171 
Of many of the above mimics, most are not biocompatible or biodegradable, which 
reduces their potential as CPAs, however understanding their modes of action may 
lead to the development of more suitable mimics. The exact link between AF(G)Ps, 
their mimics and INPs remains unclear, but it has been shown that some synthetic 
AF(G)P mimics also demonstrate some nucleation inhibition properties.87  
 
1.5 Cold storage of biologics 
The physical state of water is key for successful cryopreservation; it makes up 60 % 
of the human body, 70 % of cells and 90 % of blood. This highlights how ice formation 
can be a serious problem for cold storage of these materials as well as a problem in 
the cold chain in general, (Figure 1.19) where there are many stages that require 
specific temperatures i.e. shipment, banking for future use and short-term storage for 
laboratory experiments. Accurate temperature control and successful transfer between 
stages is vital. 
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Figure 1.19. Schematic of cryopreservation cold chain workflow and how it is 
susceptible to variability and thus error. 
Current storage techniques include lyophilisation and cryopreservation. 
Cryopreservation174,177 is the most commonly used, as no infrastructure (other than a 
-80 ºC freezer or liquid nitrogen (-196 ºC)) is required, ensuring it is easy to use, 
whereas lyophilisation requires optimisation and more specialised 
equipment/formulations. Generally freezing is performed with osmolytes e.g. 
glycerol, trehalose and DMSO. These however can be toxic to microorganisms and 
can cause aggregation of proteins. Glycerol is the current gold-standard CPA for 
microorganism cryostorage, but it is intrinsically toxic to most microorganisms: only 
a fraction of cells survive freezing and the presence of glycerol can impact down-
stream applications and assays. The risk of temperature fluctuations (upon opening 
and closing freezers) needs to be considered, so potentially adding IRI active CPAs, 
such as polymer-based formulations, rather than solvents this risk will be reduced. A 
range of techniques are used in research laboratories to study viability of cells and 
proteins post-thaw, these include colony counting, activity-based assays, fluorescence 
and absorbance assays and aggregation studies using dynamic light scattering (DLS). 
These different techniques enable relatively quick and simple data acquisition, 
providing insight into freeze-induced damage for a range of biological materials 
frozen under a range of different conditions. 
Can the above described macroscopic effects be applied to the storage of different 
biological materials? IRI activity is of great use in cryopreservation; it enables storage 
at higher temperatures than vitrified samples (-20 ℃ to -80 ℃ rather than -80 ℃ or 
below), less focus on cooling and warming rates (as ice crystals should not grow in 
the presence of inhibitors thus high rates that would be required to ‘outrun’ the kinetics 
of ice formation are not needed) as well as a lower antifreeze concentration, as 
colligative antifreezes require a higher weight percent in solution to act. TH itself may 
generally not be a useful effect in cryopreservation, however this leads to the selection 
of materials that have minimal or no TH activity but are still IRI active, though there 
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are hopes to transport organs within the TH gap (~ -1 ℃). DIS also needs to be 
monitored, as crystal morphology needs to have no impact on recovery of biological 
materials. By monitoring these macroscopic effects for a range of potential CPAs we 
can potentially choose materials for cold storage of biologics. 
Nucleation is also of interest regarding cryopreservation; controlled rate freezing 
procedures are used in laboratories worldwide due to the importance of ‘slow’ cooling 
(rates of ~ 1 ℃.min-1), some of these include plateaus in the cooling steps to allow for 
nucleation before further cooling and then storage at either -80 ℃ to -196 ℃ 
(depending on freezing method). Ideally ice will nucleate at a warm temperature that 
is as close to the melting point of the CPA formulation/cell media used and externally 
to the cells,258 though this often is not the case as controlled rate freezing procedures 
often do not focus effort onto encouraging external freezing, meaning ice will nucleate 
on the most efficient nucleant available (primarily inside cells). Under these ideal 
nucleation conditions cell damage will be avoided during the remainder of the cooling 
procedure, as the nucleant will maximise the amount of time a particular cell would 
have to dry whilst allowing solidification at a fast-enough rate. If the nucleation 
temperature can be controlled (promoted) by the addition of a particular compound 
these freezing procedures can be improved further. By studying a range of potential 
INPs, efficient nucleators can be determined, and then tested to see whether they 
ensure nucleation occurs at warmer temperatures in cell media, and thus assisting in 
cold storage. 
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1.6 Summary 
Nature has evolved expertly to survive freezing temperatures; in particular through the 
production of AF(G)Ps. These proteins, despite their high IRI activity and ability to 
lower the freezing point of ice, have issues preventing their use in cold storage of 
biologics; ice shaping prevents their use in cryopreservation of organs, tissues and 
cells in general, not to mention their suspected immunogenicity. Synthetic mimics 
have been developed, of which PVA is the most potent IR inhibitor to date. Research 
has shown PVA has effectiveness as a CPA, and due to its biocompatibility has 
potential broad applications. PVA may not be the appropriate CPA in all scenarios, so 
other synthetic AF(G)P mimics and polymeric formulations are required. 
The development of newer, more potent, IR inhibitors is hindered by our lack of 
understanding of the mechanisms of action by which those that are currently available 
work. The range of theories and debate surrounding reversible and irreversible ice-
binding adds to the confusion, as well as the fact that these ice-active materials 
potentially work via multiple mechanisms. An increased understanding of DIS, TH 
and IRI on a microscopic level may provide an insight into the mechanisms of action 
of these ice-active materials. If we can understand the mechanisms of action, it may 
lead to the production of more effective, less toxic mimics.  
The study of ice nucleation has often focused on INPs in the atmosphere; however, it 
is known that they can be of use in cryopreservation, particularly in increasing the 
temperature at which ice nucleates during controlled rate freezing, thus reducing cell 
damage. 
Microscopy has been useful for studying macroscopic effects such as IRI and DIS thus 
far, however it cannot provide detail at an atomic scale or allow us to study the bulk 
ice as only snapshots of these activities can be obtained from micrographs. More 
physical techniques including X-ray diffraction (XRD) and nuclear magnetic 
resonance spectroscopy (NMR) as well as molecular dynamics (MD) have 
increasingly become of use, as a proper physical understanding on an atomic scale will 
assist with an understanding of further up the chain, i.e. at a cellular level.3,68,259–262 
Herein these experimental techniques have been employed in order to gain insight into 
micro- and macroscopic effects over differing length scales for the ice-active materials 
highlighted above with the aim to start connecting these length scales together.  
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1.7 Project Aims and Overview 
Various compounds will be investigated for ice-activity; in particular IRI and DIS 
activity, and then studied for their cryoprotective abilities for a range of 
microorganisms and proteins. These will include a range of AF(G)Ps, of which some 
will be recombinantly expressed, and synthetic AF(G)P mimics. The mechanism of 
action of these same materials will be explored using traditional microscopy 
techniques (splat and sucrose assays) as well as by XRD and SSNMR, with the aim to 
further our knowledge of their microscopic effects on ice as well as their macroscopic 
effects whilst obtaining greater detail on these processes; one such example will be 
studying in more detail how chain length affects PVA’s ice-activity. It is envisioned 
that a polymeric cryoprotective formulation will be produced, tested, and its 
mechanism of action understood. A range of previously untested compounds will be 
studied for their ice nucleation activity with the hope to obtain next-generation 
promoters of ice nucleation that have the potential to be used in cryopreservation.  
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1.8 Thesis Summary 
The following chapters detail potential cryoprotectants for biological materials 
(natural and synthetic) and investigate their ice-activity (macroscopic and 
microscopic), and their relative cryoprotecting abilities for a range of proteins and 
bacteria.  
The research described in Chapter 2 details the need for successful cryostorage of 
biological materials; specifically, microorganisms and proteins. Macromolecular 
mimics of AFPs were studied and a new concept for the storage/transport of biological 
materials using an organic solvent-free formulation is presented. The effect of polymer 
molecular weight and formulations were studied by comparing IRI activity and cell 
recovery post-thaw for a range of biological materials and the addition of secondary 
non-IRI active polymers were tested. A range of Gram negative, Gram positive and 
Mycobacteria were tested, as well as a range of proteins. 
Chapter 3 reports on the use of X-ray diffraction to further understanding of ice-active 
materials, in particular those successfully used as cryoprotectants in Chapter 2. The 
method developed evaluates the total number of ice crystals as a function of time and 
is confirmed to be a new potential supplementary tool to use in the study of IRI 
activity. Ice diffraction patterns for samples that both shape and do not shape ice were 
compared and peak disappearance was confirmed not to relate to specific ice-binding 
in this work. 
Chapter 4 builds upon the work of Chapter 3, where a combination of microscopy 
and SSNMR is used to provide experimental molecular-level details of antifreeze 
macromolecule:ice interactions that cannot be obtained using XRD. The effect of the 
chain length was studied for PVA and compared to previously published IRI activity 
data from the Gibson group, finding a change in proton motions for PVA of a chain 
length ≥20, which is the point at which PVA gains IRI activity. Antifreeze protein type 
I, antifreeze protein type III and AFGP8 are studied alongside PVA and safranine-O 
to investigate the mobility of solid water and how it is affected by antifreeze 
macromolecules (some of which with cryoprotective abilities). Results from a range 
of relaxation rate experiments are presented as well as 2D data investigating ice-
binding. Safranine-O was observed to affect ice in a similar manner to PVA, and ice-
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binding observed for PVA, which was confirmed to be reversible, as well as for AFPIII 
and AFGP8. 
Chapter 5 deals with the study of ice nucleants rather than specifically IRI active 
cryoprotectants. A range of previously untested compounds were tested for ice 
nucleating activity, using droplet freezing assays, in the hope of providing future 
solutions for icing problems and to assist in controlling freezing temperatures during 
cryopreservation. Results from droplet freezing assays were compared to that of 
calorimetry-based assays and were found to be superior here. Metal organic 
frameworks were observed to have no IRI activity or nucleating activity, and lignins 
were observed to be potential nucleants. Concentration, cooling rate and the effect of 
filtering samples were evaluated as variables with the potential to change nucleation 
effectiveness.  
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2.2 Chapter Abstract 
Modern molecular biology and microbiology is underpinned not only by the tools to 
handle and manipulate proteins and microorganisms, but also those to store, bank and 
transport them. Glycerol is currently the cryoprotectant of choice for freezing 
microorganisms and proteins, in academic and industrial settings, however it can be 
toxic to microorganisms, observed by lower cell survival post-thaw, this is partly due 
to the need for use at high concentrations (10 – 25 wt %) as well as causing oxidative 
stress, for example. Glycerol can affect down-stream applications and assays. Freeze-
avoidant organisms have developed their own mechanisms to survive sub-zero 
temperatures and repeated freeze/thaw cycles; these include producing antifreeze 
proteins and antifreeze glycoproteins, which are potent ice recrystallisation inhibitors 
(>80 % reduction in ice growth compared to a buffer control at <0.1 mg.mL-1 
concentrations), though these have their own inherent issues; they cannot be readily 
produced on a large scale, are costly to produce, affect ice morphology leading to 
reduced cell-recovery post-thaw and have limited biomedical applications due to lack 
of sufficient immunological/toxicological data. 
Herein we study synthetic macromolecular (polymer) mimics of antifreeze proteins 
for the cryopreservation of a range of bacteria and proteins and present a new concept 
for the storage/transport of biological materials using an all polymer, organic solvent-
free, formulation. The mechanism of protection is discussed and demonstrated to link 
to inhibition of ice recrystallisation. The polymers are also observed to be significantly 
lower in toxicity than glycerol and prevent irreversible aggregation in proteins. 
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Optimised formulations are presented and shown to be broadly applicable to the 
cryopreservation of a panel of Gram negative, Gram positive and Mycobacteria strains 
as well as for a range of proteins. 
This represents a step-change in how biological materials will be stored by the design 
of new macromolecular ice growth inhibitors; it should enable a transition from 
traditional solvent-based to macromolecular microbiology and protein storage 
methods.  
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2.3 Introduction 
2.3.1 Storage and Transport of Proteins and Cells 
As mentioned in Chapter 1, the cold chain process is extremely important for many 
biotechnology and cell-based processes. In particular, the logistics of this chain 
requires accurate temperature control, as the recovery of intact and viable 
cells/proteins is vital. Academic and industrial settings both use cryopreservation and 
lyophilisation to avoid the need for continuous cell culture and protein expression1,2 
and thus enable these biologics to be available and transportable between laboratories 
and to potential patients. Cryopreservation is a popular choice in research laboratories, 
as only a –80 ºC freezer or liquid nitrogen is required, as well as less need for 
specialised equipment.3,4 However, if there is a risk of temperature fluctuation there 
may be ice recrystallisation. This can irreversibly damage biological materials and 
work is needed to improve storage and negate this effect. 
 
2.3.2 Stability of Biological Materials in Ice 
As water cools and solidifies in a solution containing biological materials, the 
concentration of solutes throughout the medium varies.5 Freezing can damage proteins 
due to the resultant stressors; pH shifts due to selective crystallisation of buffer salts,6–
10 cryoconcentration of proteins11 and increased ice-water interface.12,13 
Cryoconcentration, in particular, can lead to a high increase in protein concentration 
and ionic strength in the non-ice phase, which can lead to an increase in protein 
interactions and potential aggregation.14 Thus the structure of proteins can be greatly 
affected by ice formation. Gonelli et al. observed protein stability and saw that 
temperature (thermal gradient) and size of water pool affect how much impact ice have 
on the proteins.5 The addition of additives has been observed to disrupt ice:protein 
interactions and lead to proteins retaining their native states. Cells do not survive 
extreme temperatures easily; biological metabolism reduces at low temperatures to 
enable preservation, however cryoinjury occurs during cooling, warming and the 
addition/removal of cryoprotectants (CPAs).15 Intracellular water loss can lead to 
rupturing due to volume shrinkage and increased exposure to high concentrations of 
solutes. There can also be ‘solution effects’ that can cause cell injury.3 
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2.3.3 Freezing Challenges 
As stated above, cold storage is important, but it is a multifaceted process. Cooling 
and warming rates need to be optimised,16 storage temperatures determined and 
cryopreservation formulations designed and tested for viability and toxicity. To 
achieve recovery of organisms/proteins from temperatures as low as -196 ºC 
cryoprotectants are required.17 These range from small molecules to those derived 
from natural resources such as antifreeze (glyco)proteins (AF(G)Ps). CPAs are used 
to reduce ice formation during cooling and are often in different concentrations or 
combinations for different materials. Cryopreservation traditionally requires the 
addition of organic solvents to mitigate the damage caused by ice formation and 
growth, as well as membrane rupture and osmotic stress which would otherwise lead 
to cell death.18,19 There are obviously benefits for using these CPAs, however they are 
not without fault.20 For mammalian cells, dimethyl sulfoxide (DMSO) is the most 
widely employed cryoprotectant for both ‘slow’ freezing and vitrification (depending 
on the DMSO concentration), and for bacteria, glycerol is typically used.21 Whilst very 
successful and used globally these require high concentrations (10 – 25 wt %) and the 
solvents potentially have cytotoxic effects necessitating careful addition and rapid 
removal (post-thaw) to maintain viability.22,23 Glycerol toxicity, in particular, has been 
observed in a range of microorganisms, including Staphylococcus, Micrococcus, 
Lactococcus, Streptococcus, Pseudomonas, Corynebacterium diphtheriae, and E. 
coli.24,25 They also do not lead to quantitative recovery of all cells, meaning there is a 
need to investigate innovative cryopreservation methods.  
Cellular damage due to ice growth has been observed to be reduced by the addition of 
IRI active species such as AF(G)Ps, another potential choice of CPA. However there 
can be ice-shaping effects: AF(G)Ps can produce crystals of a needle-like shape that 
in turn damage cells, Figure 2.1.26–30 
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Figure 2.1. Morphology modification over time, due to binding of AF(G)Ps to the 
prism plane. Scale bar = 100 µm. 
Synthetic macromolecular mimics of AF(G)Ps have emerged, which can reproduce 
their properties but benefit from the scalable and tuneable synthesis of synthetic 
polymers.31–33 These have been used to enhance the cryopreservation of mammalian 
cells including blood,34–36 cell lines37 and primary cells.38,39 Their primary function is 
IRI, where the rate of growth (not formation) of ice is slowed, leading to reduced cell 
death during thawing. The most active polymer mimics reported to date are based on 
poly(vinyl alcohol)40–45 but safranine-O,46 polyampholytes,47,48 graphene oxide,49 
zirconium acetate (ZrAc)50 and glycopeptides have high IRI activity.51 
 
2.3.4 Protein Storage 
Proteins are ubiquitous as laboratory reagents, biocatalysts, medicines, and as food 
supplements. For example, in the 1980s insulin became the first protein therapeutic, 
and now >100 are approved in the European Union and the USA.52 Antibody therapies 
in particular have grown and are now used for treatment of cancer,53 inflammatory 
diseases,54 and are the fastest growing class of therapeutics.55 A major challenge, 
however, is the limited storage lifetime of proteins, with degradation being a 
significant issue.56,57 Environmental stressors such as temperature, sunlight and 
dehydration are all crucial deactivation factors that often lead to irreversible protein 
aggregation. 
Current solutions to this challenge include lyophilisation or direct freezing in solution 
with the addition of large concentrations of osmolytes that make unfolding 
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thermodynamically less favourable.58 Whilst these methods are successful, there are 
post-thaw issues to do with the compatibility of high concentrations of osmolytes used 
(e.g. 10 – 20 % glycerol) in subsequent applications. Hence direct therapeutic injection 
or use in biochemical assays may often necessitate an additional purification/dilution 
step. 
 
Figure 2.2. Effect of freezing and thawing (FT) gold nanoparticle (AuNP) solutions, 
with a decrease in absorbance at 520 nm represented by a colour change (pink to blue) 
indicating nanoparticle aggregation. A) AuNP before (black) and post FT (red); B) 
UV-Vis spectra after FT in the presence of 6.8 kDa PVA (black) and 4 kDa PEG 
(blue). [Polymer] = 10 mg.mL-1. Adapted from Mitchell et al. (Sci. Rep., 2015).59 
Mitchell et al. found that the reversible aggregation of gold nanoparticles (visualised 
by a colorimetric response) during freezing could be modulated by addition of PVA.59 
By slowing the rate of ice growth, the effective surface area of the ice crystals is 
increased (i.e. more ‘small’ crystals) and hence the nanoparticles could not approach 
each other to aggregate, Figure 2.2. We therefore hypothesised that IRI active 
compounds might prevent protein aggregation during ice-growth induced stress, 
which normally leads to denaturation/deactivation. This effect could in turn be 
exploited in the solvent-free storage of proteins.  
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2.3.4.1 Proteins Studied Here 
Structures of all proteins studied here are shown in Figure 2.3. 
 
Figure 2.3. Proteins used in this work to study their viability after cold storage in 
different cryoprotectants. A) Recombinant Green fluorescent protein (53.8 kDa); B) 
Insulin (5.8 kDa); C) Lactate dehydrogenase (37.7 kDa). Structures not shown at the 
same scale. (Structures “1GFL”, “3I40” and “5W8L” from the protein data bank).60–
62 
To test protein cryopreservation a model protein was used. This was to see if our assay 
choice worked, as well as to confirm if any particular CPA formulation led to high 
protein recovery post thaw. Green fluorescent protein (GFP) was chosen as the model 
protein; it is naturally fluorescent, easy to recombinantly express and loses 
fluorescence as it denatures.63,64 GFPs fluorophore is protected: shielded from its 
environment by β-sheets.60 This is essential, as otherwise water molecules would 
interact with the chromophore. Upon aggregation/misfolding the chromophore may 
not be shielded and thus not release energy as light photons. We chose to take 
advantage of this process as, upon freezing and thawing, if the protein structure is 
affected, the fluorescence will decrease, and if GFP is successfully stored in a CPA 
formulation fluorescence would be retained. This is easy to follow using fluorescence 
spectroscopy. 
Insulin was chosen as a therapeutic protein of interest. It is an extremely important 
hormone, acting as a molecular messenger assisting in the regulation of blood sugar 
levels. It is a ‘small’ protein consisting of an A-chain and B-chain stabilised by 
disulfide bridges,65–68 which can be present in different oligomerisation states 
depending on physical conditions. These include a hexamer stabilised by two zinc ions 
(in its storage form at neutral pH), and as a monomer in its active form, as well as 
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dimers (when under acidic conditions).69,70 These structures must be considered for 
insulin formulations pre- and post-thaw, as the oligomerisation state relates to protein 
activity. Oligomerisation state has been followed using dynamic light scattering 
(DLS), and changes in structure visualised by monitoring aggregation using this 
technique. If insulin function is impaired or a person is deficient in insulin, such as 
those with diabetes, manual replacement of insulin e.g. via injection/patch/pump is 
required as a treatment.71–73 The biotech industry produces human insulin for use, and 
long-term storage of this hormone is of great interest.74–76 As with GFP, misfolding 
and aggregation leads to inactivity so successful cryopreservation is vital. 
Lactate dehydrogenase (LDH) was also chosen to study. This enzyme comes in two 
forms; M and H. M converts pyruvate to lactate in skeletal muscles and H, lactate to 
pyruvate, and is generally the major form in the heart.77,78 It is used to test for tissue 
damage, as well as to diagnose particular diseases via activity changes and as a marker 
for germ cell tumours, and successful storage is required for transport from patient to 
laboratory for analysis.79–81 Conflicting data on the effect of storage of LDH has been 
reported82–84 thus work here aimed to study cold storage of this enzyme and confirm 
activity retention at these temperatures.  
 
Figure 2.4. Schematic of how aggregation occurs via interfacial stress between the 
ice:liquid interface, leading to inactive proteins. 
Environmental changes, including pH, temperature and ionic strength, can lead to 
aggregation and formation of non-native dimers/oligomers, monomer addition and 
high molecular weight aggregates.85 A schematic of this process is shown in Figure 
2.4. Studies here aim to avoid this process. 
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2.3.5 Cell Storage 
Cryostorage of both prokaryotic (bacterial) and eukaryotic (of which make up humans 
and multi-cellular organisms) cells is of great interest in the cryo-field. Eukaryotic 
cells consist of organelles, with various functions, and can require different, more 
complex CPA formulations for successful storage.17,25,86 Some cells (of which range 
in complexity) studied so far include sperm, oocyte and embryonic,87,88 muscle89 and 
corneal.90 Prokaryotic cells are generally simpler; they do not consist of organelles, do 
not have a nucleus and have a cell wall.  
Bacteria and their study underpin all research in infectious diseases, microbiology, 
structural and molecular biology, as well as being crucial in biotechnology and food 
processes (notably probiotics). The storage of bacteria for supplements such as 
probiotics, is growing and recent research into the microbiome points towards its 
involvement in a host of medical disorders including, but not limited to, irritable bowel 
syndrome, depression, cardiovascular disease and obesity, showing the significant 
need for strategies to store bacteria,91–94 especially if microbiome transplants become 
a reality for the treatment of drug resistant infections, for example,95 this is because 
the therapeutic role of probiotics depends on count of viable cells, which can be 
reduced by inadequate storage.96  
 
2.3.5.1 Cells Studied Here 
Historically, Escherichia coli (E. coli) was used as the general model organism for the 
study of bacterial cells. This was due to the understanding that its membrane lipid 
biochemistry could be generalised to other cells.97 However, different bacteria have 
different cell walls and membrane compositions, of which these can be differently 
affected by environmental conditions. Here, three bacteria species are studied, each 
with different cell wall/membrane compositions consisting of peptidoglycan and 
varying phospholipids, Figure 2.5, to ensure a well-rounded analysis of the CPAs 
cryoprotective abilities on a range of cell types, and that any effects were not unique 
to E. coli. As many factors affect the effectiveness of cryopreservation of bacteria e.g. 
species, strain, cell size, cell water content, composition of cell, it was found to be 
important to test a range.25 Bacillus subtilis was chosen as a Gram-positive strain and 
Mycobacterium smegmatis as a Mycobacteria. These bacteria have distinct cell wall 
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structures; therefore, any cryopreservation formulations that may cause toxic effects 
on types would be observed. Preliminary tests on Lactobacillus delbrueckii subsp. 
bulgaricus, an microorganism of importance in probiotics and research into the 
microbiome, were also performed (see Appendix).95,98–100  
 
Figure 2.5. The three bacteria strains used and their corresponding cell wall structure; 
A) Gram-negative E. coli; B) Gram-positive B. subtilis; C) Mycobacterium M. 
smegmatis. SEM scale bars are 1 µm. Adapted from Deol et al. (J. Bacteriol., 2005), 
Li et al. (Microbiol. Biotechnol., 2010) and Prince et al. (Sci. Rep., 2016).101–103 
Bacteria have adapted to respond to changes in environment, even minor changes such 
as those during protein expression in a flask can affect survival. One response is to 
change their membrane lipid composition. This is a constant process, as nutrient levels 
will reduce and metabolic products can increase, leading to changes in pH and oxygen 
levels. These adaptations, however, are not enough to protect bacteria in extreme 
temperatures, such as those required for cold storage. Research shows that a decrease 
in temperature causes a decrease in membrane fluidity, and leads to increased 
production of unsaturated fatty acid/fatty acids of similar structures as well as 
modification of existing lipids.97 When cells undergo extreme cooling and transient 
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warming cycles, such as freeze/thaw (FT) cycles, these changes are not enough, and 
potentially the change in composition leads to less viable cells post thaw. 
 
2.4  Terminology 
Cryoprotectant (CPA) – formulation tested here for cryoprotective ability, including 
either colligative or non-colligative (IRI active) antifreezes. Based on the definition of 
an additive added to biological materials before freezing that leads to high post-thaw 
survival compared to no additive. CPA used from now on to describe any 
formulation/group of formulations tested. 
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2.5 Chapter Aims 
The primary aim of this study was to evaluate the role of IRI active polymers to enable 
solvent-free cryopreservation of a range of biological materials, including 4 different 
bacteria and three different proteins. 
• Express and purify an antifreeze protein and study its cryoprotective activity 
• Study cryoprotective properties of PEG and PVA in different formulations 
• Optimise a protocol for measuring LDH activity and hence study cryostorage 
of LDH in different CPA formulations 
  
Chapter 2 
75 
 
2.6 Results and Discussion 
2.6.1 Formulation Design 
Taking inspiration from extremophiles, such as Arctic fish and insects, biologic 
cryopreservation has been investigated using polymeric, glycerol-free, formulations. 
The focus is on AF(G)P mimics that do not affect ice crystal morphology. A range of 
synthetic polymers were selected for this based on their previous use in mammalian 
cell cryopreservation. These included poly(vinyl alcohol), PVA, which is a potent IRI; 
poly(ethylene glycol), PEG, which has no IRI but was chosen to provide a hydrophilic 
‘bulking’ agent, which has been shown to be important for blood cell 
cryopreservation;35,104 and a polyampholyte (p(amph)), which has weaker IRI activity 
than PVA.36,105 The polymers were compared to recombinant type III AFP (AFPIII, 
from Ocean Pout), an antifreeze protein originally isolated from ocean pout, and 
glycerol, Figure 2.6.106  
 
Figure 2.6. Structures of compounds used as cryoprotectants or in cryoprotective 
formulations in this work. 
IRI activity of PVA has been observed to improve upon the addition of polymeric 
depletants, such as PEG,107 thus if IRI activity is vital to a polymeric formulation’s 
successful cryoprotection of biologics, then potentially the addition of a secondary 
polymer will improve post-thaw recovery. It is important to note that PVA and PEG 
were particularly of interest as they are low-cost (comparable to glycerol), are 
available in a range of molecular weights and are produced to food/clinical grades 
making them well-suited for translational applications.108 The first step in formulation 
design was to evaluate IRI activity of all candidates by comparing their ice crystal 
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sizes, Figure 2.7. Smaller ice crystals indicate the CPA has more IRI activity and is 
reported as the mean grain size (MGS) where the average size of all crystals is 
measured, or mean largest grain size (MLGS), where the largest crystal in view is 
measured (this is generally recorded as an average of 6). These parameters are the 
most relevant here, as they enable visualisation of crystal formation and growth over 
time, giving information on the effect this CPA will have on ice crystal size in a frozen 
bacteria or protein sample. In this way we could determine the inhibition of ice crystal 
growth and compare to that of AFPIII (currently known to be the most IRI active 
additive). Ice growth inhibitors can be potent (leading to >80 % reduction in ice growth 
compared to a buffer control at <1 mg.mL-1 concentrations), or weak (>80 % reduction 
at <10 mg.mL-1 concentrations). Here, ice wafers were nucleated at -78 ℃ to give 
small (< 10 µm) ice crystals, which were allowed to anneal for 30 minutes at – 8 ℃, 
and then measured and ice crystal size recorded. Some more IRI active samples can 
be harder to count than PBS, particularly those with much smaller crystals or slightly 
more amorphous-looking grain boundaries. ImageJ provides a variety of tools to assist 
in analysis of these photographs, Figure 2.7B, by enhancing brightness and contrast 
of the images, as well as magnification. These issues, however, do highlight the need 
for other complementary techniques to study ice-activity, which are detailed in 
Chapters 3 and 4. 
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Figure 2.7. IRI activity of macromolecules used in this work; A) Cryomicrographs of 
ice wafers grown in the presence of 100 mg.mL-1 PEG + 1 mg.mL-1 PVA, 1 mg.mL-1 
PVA, 100 mg.mL-1 PEG, 1 mg.mL-1 AFPIII, 50 mg.mL-1 polyampholyte, and PBS 
control. Scale bar = 100 µm; B) Example ImageJ analysis of a sample, including i) 
various tools available to use to enhance visualisation of grain boundaries for crystal 
counting and ii) example photo taken during a splat assay, explained in 2.8.3.2, which 
then can be converted to greyscale and the contrast enhanced, as well as magnified to 
enable ease of measurement; C) mean largest grain size (as % of PBS) over a range of 
concentrations for protein (black) and synthetic mimic PVA (red) compared to PEG 
(blue); D) Mean grain size (as % of PBS grain size) of all macromolecules tested in 
A. *PEG (100 mg.mL-1) appears to show IRI activity here, however this is a colligative 
effect caused at this high concentration. 
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A range of concentrations for PVA, PEG and AFPIII were tested showing that PVA 
has great IRI activity, supporting work seen in the literature, Figure 2.7C.40,109,110 
AFPIII was found to be the most IRI active, even at µg.mL-1 concentrations, as in the 
literature. PEG has no IRI activity, though has a colligative effect at higher 
concentrations, Figure 2.7D. The concentrations for the p(amph) are chosen to be 50 
mg.mL-1, as concentrations ≥20 mg.mL-1 are IRI active concentrations observed in the 
literature.47 
It should be noted that PEG has known cryoprotectant properties at very high 
concentrations111 and it has been observed that PEG in a concentration above 50 
mg.mL-1 assists with cryoprotection of proteins, therefore 100 mg.mL-1 was the chosen 
concentration. When the PEG and PVA are combined, the crystal growth continues to 
be inhibited, and potentially is even more effective, due to the increased IRI activity, 
and the slightly more amorphous crystals observed in Figure 2.7A. 
Previous work using red blood cells, which have no nucleus, like bacteria, has shown 
that IRI active PVA has increased cell survival. Other work has shown that the 
cryoprotective activity of IRI active polymers increases when used in combination 
with a hydrating secondary cryoprotectant such as polymer gels or hydroxyl ethyl 
starch (HES).35,104 This led us to test the combination of PEG and PVA; with PEG 
being the bulky hydrating polymer in the formulation. PEG was chosen due to its 
biocompatibility112–115 and commercial availability. 
Storage at -20 ºC was of interest here, as it is cheaper and -20 ℃ freezers are ubiquitous 
in all laboratories, whereas -80 ℃ freezers may not be available to all. Thus, 
formulations were tested for CPA activity for a range of storage temperatures; -20, -
80 and -196 ℃. 
 
2.6.2 Protein Expression and Purification 
In order to study the cryoprotective properties of AFPs and polymers and their toxicity 
on bacteria, recombinant protein expression was needed to produce antifreeze 
proteins, as they are not commercially available. In the first instance E. coli competent 
cells (BL21) were produced, as they are bacterial cells with cell walls that allow 
foreign DNA (e.g. plasmid) to pass through easily. 
Chapter 2 
79 
 
 
Figure 2.8. Characterisation of AFPIII expression in E. coli. A) SDS-PAGE gel 
analysis of nickel affinity chromatography purified AFPIII (lane 2) and FLPC purified 
AFPIII (lane 3) compared to Prism Ultra Protein Ladder (lane 1); B) Full-length 
Western blot image of AFPIII expression. The numbers on the left represent the 
molecular mass in kilodaltons. 
AFPIII (T7, pET21b, P19614) was initially expressed via auto-induction, though a low 
yield was obtained (7.18 mg at concentration of 0.359 mg.mL-1). The AFPIII was 
purified further using fast protein liquid chromatography (FPLC) to remove the 
oligomers that remained after the initial filtering and desalting to ensure freeze thaw 
assays used the purest AFPIII, and sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) analysis performed (Figure 2.8A). The SDS-PAGE 
analytical technique is a method for resolving proteins in complex mixtures by 
separating proteins based on electrophoretic mobility. Sodium dodecyl sulfate (SDS) 
and a reducing agent (e.g. DTT) are used to disrupt the tertiary structure of the proteins 
in the sample, with SDS binding to the protein, giving the proteins a net negative 
charge, this charge is proportional to chain length/molecular weight. A voltage is 
applied across the gel and proteins of different molecular weights, due to their charge, 
will migrate through at different rates and compared to a marker (Figure 2.8A, Lane 
1). Oligomers can be observed in faint bands in Figure 2.8A, Lane 2, after FPLC, 
these no longer appear, and only the AFPIII band that is expected at 6.5 kDa appears. 
An anti-his western blot was also performed to ensure AFPIII was obtained (Figure 
2.8B); a western blot exploits interactions between antigens and antibodies of proteins, 
thus is employed here demonstrating that AFPIII has been produced due to its 
interaction with the antibodies leading to the appearance of bands at 6.5 kDa. The band 
representing AFPIII appeared for more than one lane, which implies our AFP did not 
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stick to the nickel-resin and was washed through; this may be a reason for the low 
yield. AFPIII was then expressed as described in methods (2.8.3.1), leading to a higher 
yield and the His-tag cleaved. Once expressed AFPIII was used immediately or 
lyophilised for later use. 
 
Figure 2.9. Characterisation of GFP expression in E. coli. A) SDS-PAGE gel analysis 
of nickel affinity chromatography purified GFP compared to Prism Ultra Protein 
Ladder (lane 1) highlighting GFP and higher oligomer expression; B) Full-length 
Western blot images of GFP expression. The numbers on the left represent the 
molecular mass in kilodaltons. 
GFP was expressed using BL21 cells as described in 2.8.3.1 (Figure 2.9, lane 10) for 
cryopreservation assays. BCA assays were performed indicating the total mass of GFP 
expressed was 79.3 mg, thus the expression method used was correct for this protein. 
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2.6.3 Cryopreservation of Proteins 
The simplicity of our cryopreservation assays for testing ability of CPAs on proteins 
is highlighted in Figure 2.10. The protocols all consist of dissolving and storing 
proteins in the formulations at three different freezing/storage temperatures and then 
studying their post thaw activity via spectroscopy or DLS. 
Figure 2.10. Schematic of cryopreservation procedures for proteins. Analysis of 
freeze/thawed samples either via dynamic light scattering or fluorescence 
spectroscopy. Data output represented as example graphs of fluorescence retained 
after FT cycles and potential hydrodynamic radii sizes. 
 
2.6.3.1 Green Fluorescent Protein 
To enable continual monitoring of the same sample through many FT cycles, 
recombinant green fluorescent protein (GFP) was used. Upon denaturation, the 
fluorescence decreases providing a convenient readout. 
The cryoprotective ability of PVA, PEG and PEG/PVA mixtures on GFP were 
compared via fluorescence spectroscopy. 4 initial FT cycles were run (Figure 2.11) to 
observe the decrease in GFP fluorescence in PBS buffer (black) due to FT stress, 
showing that the FT process causes aggregation, which in turn decreases the 
fluorescence relating to protein de-activation. Cryoprotectants were subsequently 
added to compare their cryoprotective activities. PVA (red) and PEG (blue) both lead 
to 75 % fluorescence retained after 4 FT cycles, which is much greater than that of 
GFP alone. The addition of PEG/PVA (green), however, leads to 100 % retention of 
fluorescence and thus protein activity. 
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Figure 2.11. Normalised fluorescence recovery of GFP over 4 freeze (-20 ºC)/ thaw 
(25 ºC) cycles with either no added CPA (black) or in the presence of 3 polymer 
formulations; [PVA] = 1 mg.mL-1; [PEG] = 100 mg.mL-1; [PEG/PVA] = 100 + 1 
mg.mL-1. First measurement is before freezing, then consecutive freeze/thaw cycles. 
100 % fluorescence retained corresponds to the highest fluorescence for individual 
samples normalised to 100 % for ease of comparison. 
To study the effect of concentration and polymer molecular weight further FT assays 
were performed, Figure 2.12. PVA at 10 kDa and 23 kDa were both tested over 8 FT 
cycles in combination with 100 mg.mL-1 4 kDa PEG. PEG protects GFP the most in 
combination with 1 mg.mL-1 10 kDa PVA, though fluorescence retention barely 
differs to that of PEG + 2.5 mg.mL-1 10 kDa PVA. There is no need however to use a 
higher concentration of cryoprotectant if not needed so 1 mg.mL-1 10 kDa PVA was 
chosen for later experiments. 
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Figure 2.12. Comparison of cryoprotective activity of PVA at two different molecular 
weights. Fluorescence recovery of GFP after freeze (-20 ℃)/ thaw (25 ℃) in A) 10 
kDa PVA and B) 23 kDa PVA; All solutions containing 100 mg.mL-1 PEG + [PVA] 
indicated in the insert. 
Higher concentrations of PVA were found to be detrimental as was the use of higher 
molecular weight PVA (23 kDa), Figure 2.12B. We hypothesise this is due to dynamic 
ice shaping, a common side effect of antifreeze proteins, which is known to 
compromise cell cryopreservation.27,34 A more dendritic hexagon crystal shape forms 
for 23 kDa PVA; this may lead to the aggregation of GFP, or misfolding due to a 
different ice matrix surrounding the frozen protein. This highlights the delicate balance 
of IRI activity with ice shaping and that the actual polymer composition is crucial to 
success. 
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2.6.3.2 Insulin 
Further assays were performed using insulin as a more challenging protein; GFP is 
particularly hardy (and still fluoresced after multiple FT cycles). DLS was used to 
measure the aggregation of insulin over consecutive FT cycles and whether PVA or 
PEG prevented it, Figure 2.13. 
Figure 2.13. Insulin recovery after 6 and 12 FT cycles. A) DLS curves of insulin 
before (solid) and after (dashed) 12 freeze/thaw cycles. Black = insulin only, Red = 
insulin + PVA, Green = + 2 kDa PEG + PVA, Blue = + 4 kDa PEG + PVA. In all 
cases [PEG] = 100 mg.mL-1; [PVA] =1 mg.mL-1. B) Average size of insulin aggregates 
after 6 or 12 FT cycles stored in PVA alone, PVA + 2 kDa PEG and PVA +4 kDa 
PEG compared to that of all before freezing (0 FT cycles). 
PVA, PEG, PEG/PVA (100 + 1 mg.mL-1) were tested alongside insulin in buffer 
alone. The importance of the PEG molecular weight was also tested, Figure 2.13. 
After 6 FT cycles solutions of PVA with PEG 2 kDa and PEG 4 kDa both were equally 
effective and little aggregation of insulin with no added cryoprotectant had occurred. 
After 12 FT cycles however, only PVA solutions with PEG 4 kDa have protected 
insulin from aggregation. It was also observed that PVA alone does not protect insulin 
from aggregation, observed by the larger particle diameters for insulin alone and 
insulin/PVA being >100 nm after 12 FT. This supports findings of the GFP assays that 
PEG and PVA are required for protection, but also displays that PEG 4 kDa is a more 
optimal molecular weight to use. This is a major advance compared to the current state 
of the art for protein storage, which requires the addition of ‘large’ quantities of 
glycerol or other organic solvents. 
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Figure 2.14. Insulin recovery after A) heat stress and B) agitation stress. A) DLS 
curves of insulin before (solid) and after (dashed) heating to 90 ℃ for 30 minutes; B) 
DLS curves of insulin before (solid) and after (dashed) shaking at 300 RPM for 3 
hours. Black = insulin only, Red = Insulin + PVA, Green = +2 kDa PEG + PVA, Blue 
= + 4 kDa PEG + PVA. In all cases [PEG] = 100 mg.mL-1, [PVA] = 1 mg.mL-1 
Further assays were performed to elucidate whether these polymer formulations have 
any protective activity when insulin is put under heat stress (Figure 2.14A) or 
agitation stress (Figure 2.14B). All formulations were found to not protect insulin 
from heat stress, and despite agitation at 300 RPM for 3 hours, insulin did not 
aggregate whether in a polymer formulation or PBS alone. 
 
2.6.3.3 Lactate Dehydrogenase 
 
Scheme 2.1. Redox reaction of NADH and NAD+ 
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LDH activity here is measured following the conversion of pyruvate to lactate, which 
takes place by oxidising nicotinamide adenine dinucleotide (NADH) to NAD+ 
(Scheme 2.1). This reaction is catalysed by the M type LDH enzyme and measured 
using absorbance spectroscopy at 340 nm. NADH shows more absorbance in 
comparison to NAD+ at 340 nm. The amount of colour product formed as the reaction 
takes place is directly proportional to the activity of LDH in the sample, Figure 2.15. 
A total loss of colour/absorbance represents efficient conversion to lactate as NADH 
has been oxidised, catalysed by LDH. Inefficient/incomplete conversion is observed 
when absorbance is still measured at 340 nm indicating low enzymatic activity. 
 
Figure 2.15. Schematic of cryopreservation protocol for monitoring LDH activity. 
Analysis of freeze/thawed samples either via absorbance spectroscopy. Complete 
NADH conversion indicated by a complete loss of absorbance. 
At high concentrations of pyruvate, LDH exhibits feedback inhibition and the rate of 
conversion of pyruvate to lactate decreases. Thus, the concentrations of pyruvate, 
NADH and LDH have to be considered for this assay. The protocol followed here was 
adapted from an enzymatic protocol from Sigma-Aldrich (2.8.3.5).116 
We wanted to compare different cryoprotectants on LDH under different freezing and 
storage conditions. Firstly, the assay conditions were optimised. The optimal 
concentration of LDH was determined to enable successful monitoring of the NADH 
 NAD+ reaction. FT cycles were also performed on LDH to confirm at which point 
enzymatic activity is lost (number of cycles), Figure 2.16A. 
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Figure 2.16. Optimisation of cryopreservation protocol of LDH. A) LDH activity after 
a range of FT cycles recorded by catalysis of NADH to NAD+ compared to controls 
of NADH (orange) and pyruvate (pink) alone; B) LDH activity after storage in in 
glycerol at a range of concentrations (0.875-50 %) recorded by catalysis of NADH to 
NAD+, observed by a decrease in absorbance, compared to a no CPA control (0 %, 
grey) and unfrozen LDH (yellow). 
After 3 FT there is minimal activity, observed by no change in NADH absorbance. 
From this result it was decided to perform subsequent assays with a minimum of 3 FT 
cycles. To ensure the assay worked, LDH underwent FT cycles in the currently used 
CPA, glycerol. LDH was stored in a range of glycerol concentrations (0.875-50 %), 
finding a loss in enzymatic activity as the glycerol concentration decreases, observed 
as a decrease in gradient of NADH absorbance over time. LDH fully denatures when 
stored in 0.875 % and 0 % glycerol, as the NADH absorbance remains the same 
throughout. From this data it can also be determined that glycerol at concentrations 
≤2.5 % are insufficient to protect this particular enzyme. 15-50 % glycerol led to 
highest LDH activity post thaw, indicating these are the optimal concentrations to use 
for cold storage here. Once the protocol was optimised and confirmed to work our 
most successful CPA, PEG/PVA, was tested on LDH and compared to the gold-
standard glycerol, PEG, PVA and an unfrozen sample. LDH stored in CPAs here 
appear to be slightly more active compared to the non-frozen LDH in PBS buffer 
alone, at this time it is not understood why. 
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Figure 2.17. LDH activity in the presence of indicated cryoprotectants after FT cycles 
and storage. A) 7 FT cycles; B) 24 hours storage at -20 ℃; C) 1 week storage at -20 
℃; D) 1 month storage at -20 ℃. Recorded by catalysis of NADH to NAD+, observed 
by a decrease in absorbance, compared to a no CPA control (black) and a no freeze 
control (grey). All samples were plunge frozen at -196 ℃ and thawed at 25 ℃. In all 
cases [PEG] = 100 mg.mL-1, [PVA] = 1 mg.mL-1, [Glycerol] = 25 wt %. 
Storage of LDH was compared over 4 different time periods, Figure 2.17. After 7 FT 
cycles in liquid nitrogen it can be observed that the polymers protect LDH to a higher 
degree than glycerol, Figure 2.17A. This is also observed for LDH stored at -20 °C 
for 24 hours, Figure 2.17B. There are interesting differences though for the longer-
term storage, with all cryoprotectants leading to similar LDH activity post thaw after 
1 week and 1 month in storage, bar PEG/PVA, where LDH had reduced activity, 
Figure 2.17C/D. The LDH fully denatured after 7 FT cycles as the PBS control (black) 
frozen LDH has no activity - thus NADH absorbance remains the same throughout. 
However, storage at -20 °C does not lead to this inactivity. The CPA results show that, 
for multiple FT cycles and at lower storage temperatures, all polymer formulations 
lead to higher enzymatic activity post-thaw, but at higher freezing temperatures the 
PEG/PVA CPA reduces activity, implying different formulations are required when 
freezing using different temperatures. Rates observed here might be lower due to 
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LDH’s feedback inhibition, i.e. where LDH has lost activity there is a lower 
concentration of active enzyme, which therefore is converting pyruvate much more 
slowly. 
 
Figure 2.18. Waterfall plot of hydrodynamic radius of LDH stored in A) PBS (no 
cryoprotectant) and B) PEG/PVA, over 7 freeze (-196 °C) thaw (25 °C) cycles. 
Dynamic light scattering was used to study the mechanism of action of the polymer 
formulation on LDH upon freezing, Figure 2.18. Over 7 FT cycles the hydrodynamic 
radius of LDH in buffer alone increases, indicating aggregation of the enzyme. When 
stored in PEG/PVA, even after 9 FT cycles, the LDH does not aggregate, with the 
mean hydrodynamic radius being 3.21 ± 0.2 nm leading to successful retention of 
enzymatic activity. These findings confirm that aggregation of proteins leads to 
enzymatic inactivity, and that this formulation works via a mechanism that prevents 
aggregation in this protein. 
 
2.6.4 Cryopreservation of Bacteria 
Following inspiration from mammalian studies,34 and the above success in 
cryopreservation of proteins, the study of biologics continued, this time focussing on 
microorganisms. Our work studying proteins highlighted that PEG/PVA performed 
synergistically to protect proteins from freeze-induced damage and thus retained 
activity post-thaw,117 alongside this knowledge and the high IRI activity of PEG/PVA, 
the combination was chosen for further analysis on its ability to cryoprotect E. coli. 
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To evaluate the performance of the previously selected CPA (PEG/PVA) versus 
glycerol, a series of cryopreservation experiments were undertaken. 
 
Figure 2.19. Schematic of the concept behind the protocol for the bacteria freeze/thaw 
assay performed. 
A FT protocol that allowed the study of bacteria post cryostorage was developed, 
Figure 2.19. In this protocol, cells were added to separate solutions of the different 
cryoprotectants in a 1:1 ratio, and snap frozen in liquid nitrogen (-196 ℃) before 
thawing at 37 °C in a water bath for 5 minutes to ensure cells were fully thawed. The 
samples were exposed to 7 FT cycles and once complete, samples were added to LB 
in 96 well plates and underwent serial dilutions to prevent overgrowth. Samples were 
plated onto agar plates and left to grow at 37 °C overnight for subsequent colony 
counting. This protocol was chosen to mimic laboratory conditions where stocks are 
often frozen and thawed during routine use. 
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2.6.4.1 E. coli 
 
Figure 2.20. Recovered colonies of E. coli after overnight incubation with 
cryoprotectants. Concentrations of cryoprotectants; [PVA] = 1 mg.mL-1; [PEG] = 100 
mg.mL-1; [PEG/PVA] = 100 + 1 mg.mL-1; [polyampholyte] = 50 mg.mL-1). Control is 
LB media alone.  
Glycerol is intrinsically toxic at cryopreservation concentrations, so to test our 
polymeric formulations for intrinsic toxicity they were incubated with E. coli and 
results compared to that of glycerol. Each cryoprotection solution (at the indicated 
cryopreservation concentration) was incubated with E. coli overnight at 4 ºC and 
subsequently the number of colony-forming units determined, Figure 2.20. Glycerol, 
as expected, at 15 or 25 wt % led to a significant reduction in recovered colonies. 
Conversely, none of the polymers showed toxicity to the E. coli. The observed increase 
in recovered colonies for PVA could be due to some metabolism of the polymer. This 
supports our hypothesis that biomimetic macromolecular antifreezes may be 
‘spectator additives’ which only function when ice is present and are ignored by 
microorganisms (and indeed other cells), which is crucial for down-stream 
applications. 
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Figure 2.21. E. coli growth profiles after 7 freeze/thaw cycles then inoculation into 
LB media compared to a growth profile of unfrozen E. coli. A) Freezing at -196 ºC; 
B) Freezing at -20 ºC. Concentrations of cryoprotectants; [Glycerol] = 25 wt %; 
[AFPIII] = 1 mg.mL-1; [PEG/PVA] = 100 + 1 mg.mL-1; [PEG] = 100 mg.mL-1. 
The effect on cell growth after freezing at different temperatures was compared by 
OD600 (turbidity) measurements, Figure 2.21. Turbidity, the cloudiness/haziness of a 
sample, is measured by the detection of optical density/absorbance at 600 nm. This 
represents the growth of bacteria; as the more turbid the sample, i.e. higher cell mass, 
the higher the absorbance value. OD600 measurements over time produce a standard 
growth curve, which should have 4 distinct phases; lag, where cellular metabolism is 
accelerated but no replication occurs (no growth); exponential phase, where 
microorganisms rapidly grow and divide (exponential growth); stationary phase, shift 
in environment and reduction in reproduction (rate stabilised); decline/death phase, 
lack of available nutrients and increased metabolic waste (cell death). The shorter the 
time period required to move into the exponential phase and the longer this phase, the 
healthier the bacteria in a given sample. Growth rates of unfrozen E. coli (black) are 
given as a ‘normal’ curve for comparison. Samples frozen in media alone (red) provide 
a comparison of E. coli growth when not stored in a cryoprotectant. PEG/PVA and 
glycerol lead to almost identical growth profiles when E. coli is frozen at -196 °C, 
whereas glycerol alone appears to lead to a more ‘normal’ growth profile when E. coli 
is frozen at -20 °C. This may be due to the higher storage temperature, where the 
glycerol solutions do not completely freeze thus providing an extra nutrient source. 
AFPIII does not protect E. coli, displaying growth curves, at both temperatures, that 
are of E. coli frozen without a CPA, this potentially could be due to the needle-like ice 
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morphology that AFPIII causes, leading to bursting, thus unviable cells, therefore IRI 
activity is not sufficient for successful cryopreservation when ice-shaping occurs.  
 
Figure 2.22. Recovered colonies of E. coli after 7 freeze (-196 ℃) thaw (20 ℃) cycles. 
Concentrations of cryoprotectants; [Glycerol] = 25 wt %; [AFPIII] = 1 mg.mL-1; 
[PVA] = 1 mg.mL-1; [PEG/AFPIII] = 100 + 0.01 mg.mL-1; [PEG/PVA] = 100 + 1 
mg.mL-1; [polyampholyte] = 50 mg.mL-1). Control is LB media alone. 
Recovered colonies for E. coli (growth curves shown in Figure 2.21A) after FT cycles 
in different formulations are observed in Figure 2.22. Concentrations here were 
chosen based on their relative IRI activity (Figure 2.7) to give similar effects on ice 
growth, and not at equal mass concentration, to enable correlation of physical 
properties to observed biological responses. Post FT the PEG/PVA CPA (100 mg.mL-
1 + 1 mg.mL-1) was found to dramatically increase recovery to 69 colony-forming 
units, which is a >4-fold increase compared to glycerol alone, Figure 2.22. PEG/AFP 
as a CPA lead to similar results (52 colonies) supporting the hypothesis that controlling 
IRI is the key mechanism in protecting bacteria during cryopreservation, by reducing 
ice growth especially during thawing. 25 % glycerol resulted in an average of 15 
recovered colonies compared to 1 for no added cryoprotectant. PVA and AFPIII alone 
gave results almost identical to that of no cryoprotectant. The polyampholyte also 
showed no cryoprotective effect, despite them previously being used for mammalian 
cells, where they appear to function via cell membrane interactions.48 Polyampholytes 
have far weaker IRI than PVA or AFPs thus this supports a mechanism of protection 
based on limiting ice recrystallisation rather than membrane 
plasticisation/stabilisation. 
Chapter 2 
94 
 
 
Figure 2.23. Live/dead viability testing on E. coli immediately after freeze/thaw 
cycles. A) Percentage of green (intact membrane) bacteria determined by confocal 
microscopy (ratio of live cell membranes to total cell membranes); B-D) Live/dead 
micrographs; B) PBS control; C) 25 % glycerol; D) PEG/PVA. [PEG/PVA] = 100 + 
1 mg.mL-1 respectively. Error bars represent S.D. from 6 repeats. Scale bar = 10 µm. 
The previous experiments relied on counting colony-forming units, which shows the 
application of these CPAs, but does not give insight into the mechanisms of cell stress 
during FT. To assess the bacteria immediately after thawing, confocal microscopy was 
employed with a live/dead viability assay that measures the integrity of cell 
membranes, Figure 2.23.  Percentages are used to allow direct comparison of CPAs; 
obtained from the number of intact cell membranes divided by the total number of cell 
membranes, Figure 2.23A. Bacterial cells with intact cell membranes exhibit green 
fluorescence (SYTO-9 dye), while those with compromised cell membranes exhibit 
red fluorescence (propidium iodide dye). Following FT in PBS alone just 2.2 % of the 
E. coli had intact membranes (green), demonstrating that ice growth causes significant 
mechanical damage. Post FT in either 25 % glycerol or PEG/PVA resulted in 15 – 18 
% of the E. coli retaining intact membranes. These observations suggest that the 
mechanism of cryoinjury limitation of both glycerol and our macromolecular 
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antifreezes is very similar. However, the colony counting results confirmed the 
polymer approach to be superior, supporting a hypothesis that the reduced toxicity of 
the polymers means that more, healthier colonies can grow post-thaw.  
 
Figure 2.24. Recovered colonies of E. coli after freezing at -196 ºC and storage at -20 
ºC for 1 week (red) or 1 month (green). Concentrations of cryoprotectants; [Glycerol] 
= 25 wt %; [PEG/PVA] = 100 + 1.0 mg.mL-1. Control is LB media alone. 
The effect of storage at -20 ºC in a standard laboratory freezer after first snap freezing 
(-196 ºC) was also studied after 1 and 4 weeks of storage, Figure 2.24. E. coli frozen 
in buffer alone (control) led to a great reduction in colonies recovered after a week 
frozen and minimal survival after one month; which is to be expected. Cell recovery 
appears similar for E. coli stored in 25 % glycerol and PEG/PVA after one week 
storage (red) but after one month (green) 25 % glycerol yielded more colonies, this 
may relate to the fact that at -20 ºC the glycerol solutions do not completely freeze, 
providing a carbon source to the E. coli and potentially assisting in exponential 
(growth). When storing cells, the aim is to have them in a stationary phase rather than 
growth, even if growth is ‘slow’ (as in the case of 25 % glycerol), as this can lead to 
phenotypic changes, which would negatively affect experiments post-thaw, providing 
‘false’ control cells. PEG/PVA on the other hand actually cryopreserves the cells as 
they are completely frozen at -20 ºC and lead to similar levels of cell recovery (within 
error) after both one week and one month supporting the use of this method for routine 
laboratory manipulations. 
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2.6.4.2 M. smegmatis and B. subtilis 
Additional bacterial strains for cryopreservation were selected to cover a wide range 
of genera to ensure these effects are not unique to E. coli. Using the same conditions 
as for E. coli, B. subtilis and M. smegmatis were exposed to 7 FT cycles and growth 
curves measured as well as recovered colonies counted. 
 
Figure 2.25. Cell growth profiles of M. smegmatis after 7 freeze (-196 ºC) thaw (20 
ºC) cycles with the indicated cryoprotectants followed by inoculation into LB media. 
Different starting culture volumes (A - D) are compared. A) Starting culture = 1 μL, 
B) starting culture = 5 μL, C) starting culture 10 = μL, D) starting culture = 20 μL. 
No clear trend can be obtained from the above M. smegmatis growth curves, Figure 
2.25, this is because M. smegmatis tends to aggregate resulting in absorbance values 
that are difficult to interpret.118 These are included for completeness but should not be 
considered to be full growth curves.  
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Figure 2.26. Cell growth curves of B. subtilis (5 μL starting culture) after 7 freeze (-
196 ºC) thaw (20 ºC) cycles with the indicated cryoprotectants then inoculation into 
LB media. 
Growth curves for B. subtilis can be seen in Figure 2.26, showing similar growth for 
all, indicating similarity in mechanism for limiting cryoinjury by CPAs in this cell 
type. 
To enable comparison of the data and to account for the different growth rates of each 
bacterial strain, the recovered colonies were also normalised to the highest recovery, 
Figure 2.27. Total and normalised colonies are listed in Table 2.1. 
 
Figure 2.27. Normalised cell recovery for 3 different bacteria upon addition of 
different cryoprotectants after 7 freeze (-196 ºC) thaw (20 ºC) cycles, (red = PBS, blue 
= glycerol, black = PEG/PVA), serial dilution and growth on ampicillin plates at 37 
°C overnight. Values obtained are normalised to themselves. [Glycerol] = 25 wt %; 
[PEG] = 100 mg.mL-1; [PEG/PVA] = 100 + 1 mg.mL-1. 
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In all cases, the PEG/PVA formulation gave equal or better levels of recovery than 
glycerol alone. It can be noted that M. smegmatis (which is a slow-growing organism 
compared to other two) gave fewer colonies after a fixed period of growth in all 
conditions, but the PEG/PVA still matched the performance of glycerol. In some cases, 
the PEG alone gave favourable recovery levels also (as any uncharged solute will give 
some protection) but in all cases addition of PVA increased this recovery, showing it 
is an essential component to ensure recovery of viable cells. 
Table 2.1. Mean colonies recovered after 7 freeze/thaw cycles. 
 E. coli M. smegmatis B. subtilis 
 Total 
(-) 
Normalised 
(%) 
Total 
(-) 
Normalised 
(%) 
Total 
(-) 
Normalised 
(%) 
PBS 1 ± 0.4 1 4± 0.5 12 29±10.4 11 
Glycerol 15±2.8 22 30±6.0 88 93±18.9 35 
AFPIII 3± 0.9 4 2± 0.3 6 26 ± 6.7 10 
PVA 0 ± 0.1 0 3 ± 1.5 9 5 ± 0.7 2 
PEG 53±6.7 77 28±4.3 82 150± 10.7 57 
PEG/PVA 69±7.3 100 34± 4.2 100 262±39.3 100 
P(amph) 5 ± 0.6 7 28± 4.5 82 20 ± 5.0 8 
[Glycerol] = 25 wt %; [PEG] = 100 mg.mL-1; [PEG/PVA] = 100 + 1 mg.mL-1 
respectively; [AFPIII] = 0.1 mg.mL-1; Polyampholyte = 50 mg.mL-1. Error represents 
the SD from 6 repeats. Note that the total colonies recovered for each organism varies 
based on their own growth rates hence normalised recovery (verses the highest 
recovery level) is also included.  
These results demonstrate the versatile nature of this approach, and that replacing 
glycerol in laboratories with this polymer formulation is a reliable way to match or 
improve current storage methods; it should enable a transition from traditional 
glycerol-based to macromolecular microbiology storage methods. 
 
2.6.4.3 Formulation Modification: Molecular Weights 
This macromolecular cryoprotection solution using ice-inhibiting polymers is clearly 
suitable for bacteria storage but there are many parameters that can be varied in this 
system including the molecular weight of the polymers and weight ratios. To enable a 
large number of conditions to be screened, the post-thaw growth rate of E. coli was 
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also followed by OD600 (turbidity) measurements, enabling higher-throughput 
measurements in 96 well plates. E. coli were frozen with various formulations of 
different molecular weight PEGs and PVAs, Figure 2.28.  
 
Figure 2.28. Cell growth profiles of E. coli with the indicated molecular weight PVAs 
in combination with different molecular weight PEGs (200 Da – 8 kDa) after 7 freeze 
(-196 ºC) thaw (20 ºC) cycles then inoculation into LB media. [PEG] = 100 mg.mL-1; 
[PVA] = 1 mg.mL-1 
For PVA, 10 kDa and 31 kDa gave approximately identical recovery levels. However 
10 kDa is easier to dissolve into buffer, making it preferable for real-world 
applications where concentrated stock solutions are required. Higher molecular weight 
PVA can also lead to dynamic ice-shaping which is known to reduce recovery of cells 
post-thaw.34 Lower molecular weight PEGs (200-1500 Da) alone appeared to have a 
slightly greater cryoprotective effect than larger PEGs (4 to 8 kDa), as they reach a 
higher OD600 and display slower logarithmic decline phases, indicating improved cell 
health, but these differences were small. Smaller molecular weight polymers in 
combination with PVA have been observed to improve PVA-PVA interactions and 
thus improve IRI activity,107 this ‘depletion-induced enhancement’ may be the reason 
for the slight improved cryoprotective effect observed here. Considering the 
cryoprotective effect of each of the mixtures, and the solubility of each of the 
constituents, it was determined that 10 kDa PVA and 4 kDa PEG were the optimum 
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molecular masses out of the 18 formulations we tested to use to ensure reliable and 
easy to use cryopreservation.  
 
Figure 2.29. Effect of varying PVA concentration on cell recovery. Recovered 
colonies of E. coli after incubation with different concentrations of 4 kDa PEG and 10 
kDa PVA after 7 freeze (-196 ºC) thaw (20 ºC) cycles. [PVA1] = 1 mg.mL-1, [PVA10] 
= 10 mg.mL-1, [PEG100] = 100 mg.mL-1. 
Various concentrations of 10 kDa PVA, in combination with 100 mg.mL-1 4 kDa PEG, 
were also screened, Figure 2.29. In all cases addition of PVA to PEG increased the 
cryoprotective effect. The improvement was most significant in the case of 1 mg.mL-
1 PVA. 
 
Figure 2.30. A) Effect of varying PEG concentration on number of recovered E. coli 
colonies after 7 freeze (-196 ºC) thaw (20 ºC) cycles. Control is LB media alone. 
To further optimise this formulation, the PEG concentration was varied from 100 
mg.mL-1 to 10 mg.mL-1, all with addition of 1 mg.mL-1 PVA, and the number of 
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recovered colonies after 7 FT cycles counted, Figure 2.30. Reducing the concentration 
of PEG to 50 mg.mL-1 and 10 mg.mL-1 led to a significant reduction in the number of 
colonies recovered, compared to 100 mg.mL-1. However, it is important to note that 
10 mg.mL-1 PEG with 1 mg.mL-1 PVA is just a 1.1 wt % solution but performs equally 
to 25 wt % glycerol, representing a remarkable cryopreservation outcome with a 25 
fold reduction in cryoprotectant. It shows that whilst there is an optimum formulation, 
there is scope to vary the components and hence supporting ease of use in a realistic 
laboratory situation. In some down-stream applications (such as food) lowering 
cryoprotectants concentration, rather than maximising total cell recovery is desirable 
and this new polymer-only formulation is clearly suitable. 
 
2.6.4.4 Formulation Modification: Hydrophilic Polymer 
As mentioned in 2.6.1, bulky, hydrophilic polymers have been seen to assist in 
cryopreservation of cells. PEG is a popular choice in drug delivery systems, 
manufacturing processes, as a plasticiser and solubility enhancer as well as acting as 
a nonpermeating CPA.113,119–123 However, recent developments in the fields of 
materials science and polymer chemistry has led to an increase in commercial 
availability of PEG alternatives.112 PEG can undergo oxidative degradation in 
solution, as well as under heat, radiation and mechanical stress. Other water soluble 
hydrophilic polymers have been of interest, particularly as they have a good record of 
clinical use e.g. in modification of proteins, liposomes and biomaterial surfaces, as 
well as playing carriers for a variety of species such as drugs, genes and 
oligonucleotides.124 The target is to produce polymer formulations that are cost 
effective, biocompatible and less toxic, so that they are successful additives 
throughout the cold chain and benefit society.114 Examples of alternative polymers 
include polyvinylpyrrolidone (PVP), hydroxypropyl methyl cellulose (HPMC), 
poly(acrylamide) (PAA), poly[N-(2-hydroxypropyl) methacrylamide (PHPMA), 
poly(oxazoline) (POZ) and hydroxyethyl starch (HES). 
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Figure 2.31. Structures and IRI activity of hydrophilic polymers used here to compare 
to that of PEG used in the original polymer formulation; A) Structures; B) MLGS; C) 
MGS. [Polymer] = 100 mg.mL-1. IRI data for HPMC not shown. 
Here 6 polymers were tested to compare their cryoprotective ability to that of PEG in 
formulations with and without 1 mg.mL-1 PVA, structures shown in Figure 2.31A. 
PVP was chosen (in two molecular weights), partly as it has been used as a 
nonpermeating CPA before25 but also due to its low cost, previous FDA approval in 
certain formulations125 and known lack of IRI activity, ensuring it would not affect ice 
in the same way as PVA.126 HPMC is also low cost, widely available and has generally 
good bioavailability and biodegradability.127,128 It is widely used in the food industry 
due to its tastelessness, lack of odour and FDA approval, thus if successful as a CPA, 
has potential application for probiotic development.129–131 POZ was chosen as it also 
has been in FDA approved formulations132 and has been of recent interest in the 
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biology community:133 it has been investigated (in a similar way to PEG) as a stealth 
polymer, drug carrier and a hydrogel.112,134 HES has also been used as a nonpermeating 
CPA,25,135 successfully storing RBC with a lower toxicity than DMSO. It has also 
previously been used in combination with PVA136 and has been considered a PVP 
alternative.137 PHPMA has been considered a viable alternative to PEG in many 
applications, particularly in nanomedicine,124 as it is non-immunogenic and 
nontoxic.138 PHPMA also, like PVP, has no observed IRI activity.35 
Initially ‘splat’ assays were performed on these polymers to detect any IRI or 
colligative activity, Figure 2.31B/C. Data for HMPC is not shown as above 10 
mg.mL-1 gelation occurs, thus ice growth activity cannot be compared to the other 
polymers. All polymers show similar MLGS and MGS results to that of PEG bar 
PVP10 (PVP of 10 kDa molecular weight), which has even less activity at 100 mg.mL-
1. This indicates, except for PVP10, that these polymers have the potential to replace 
PEG in formulations, as the ice growth should not be affected by their addition. 
Figure 2.32. Recovered colonies of E. coli after 7 freeze thaw cycles using 
formulations consisting of different hydrophilic bulky polymers compared to that of a 
known cryoprotective formulation (PEG/PVA). A) IRI activity of polymers (red) 
compared to that of cell recovery (black), HPMC is omitted due to gelation at high 
concentrations; B) Recovered colonies with (red) and without (black) the addition of 
IRI active PVA. [Polymer] = 100 mg.mL-1 except [HPMC] = 10 mg.mL-1 
The recovered colonies for bulky polymers and bulky polymers+PVA are compared 
to that of MLGS data in Figure 2.32. In general, the lower the IRI activity of the 
polymer, the worse the cryoprotective ability. However, PVA10 is an anomaly again 
in that despite no IRI or colligative activity, it leads to the second highest cell recovery 
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after PEG. There is generally no significant difference in cell recovery for the different 
bulky polymers, with PEG formulations still leading to the highest cell recovery.  
The different polymers may reduce cell recovery for different reasons. To test whether 
these polymers ice shape thus leading to cell death, sucrose assays were performed. 
Figure 2.33 shows crystal morphology of ice when frozen with 100 mg.mL-1 of each 
bulky polymer tested at three different angles. Morphology is similar for all, with no 
particular shaping, except for PHPMA and HPMC, which tend to form more dendritic 
hexagons. This indicates that low cell recovery is not probably related to ice shaping, 
though may have an effect in PHPMA and HPMC samples. All experiments 
performed on HPMC are performed at 10 mg.mL-1 as at higher concentrations gelation 
occurs, this may also be happening upon freezing, which in turn may be causing the 
much lower cell recovery. The high concentrations used or the molecular weights of 
the chosen polymers may also be reasons for low cell recovery; as observed in Figure 
2.29 varying polymer concentrations can lead to different levels of cell recovery. 
Studies over a range of concentrations and molecular weights would need to be 
performed to elucidate further, however, as PEG works well in combination with PVA 
there is little need to. Some of these polymers may also have bactericidal behaviours 
Figure 2.33. Ice crystal morphology upon freezing with different hydrophilic bulky 
polymers. A-C) 3 different angles for the same samples. [Polymer] = 100 mg.mL-1 
except [HPMC] = 10 mg.mL-1. Scale bar = 50 µm. 
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These results show that PEG is important in this particular CPA formulation for 
cryostorage of E. coli, and that bulky hydrophilic polymers, despite their similar 
properties, are not interchangeable. 
 
2.7 Conclusion 
This work highlights a disruptive approach to store bacteria and proteins in the frozen 
state through modulation of ice recrystallisation with synthetic polymer formulations, 
which mimic antifreeze proteins used in nature to survive extreme environments. For 
proteins, the PEG/PVA mechanism of action was proven to be prevention of 
aggregation, with a secondary hydrophilic (non-IRI active) polymer being essential as 
a ‘bulking’ agent. Overall, the PEG/PVA cryopreserving formulation was seen to be 
highly IRI active and the least bactericidal, resulting in a 4-fold increase in E. coli 
yield post-thaw, compared to glycerol, and is equal to or better than glycerol for other 
cell types, and utilises lower concentrations - with successful cryopreservation at just 
1.1 weight percent of additive. The mechanism of protection for cells is demonstrated 
to be synergistic and linked to inhibiting ice recrystallisation (by comparison to a 
recombinant antifreeze protein) but also to the significantly lower toxicity of the 
polymers compared to glycerol. Confocal microscopy showed that similar numbers of 
bacteria with intact membranes are recovered for both systems, but that the polymer 
cryoprotectants lead to more viable colonies suggesting their lower toxicity is crucial. 
This new cryopreservation approach is shown to be suitable for a range of bacterial 
genera including Gram negative/positive and Mycobacteria. It was found that the 
synergistic effect on cell survival was linked to PVAs IRI activity and the PEG bulking 
agent, as addition of type III antifreeze proteins (at similar total IRI activity) also 
enabled cryopreservation; although these proteins are significantly more expensive 
and not practical for routine cryopreservation compared to the polymer formulations. 
These results highlight the contrast with traditional solvent-based cryoprotectants, 
which function by distinct mechanisms. Optimal conditions for use of this system in a 
laboratory or application-focused environment are presented, and as both PEG and 
PVA are commodity polymers available to food grade standards,108,139 this system will 
have wide application across molecular biology, microbiome research and for 
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translation into the food or biotechnology industry, which are underpinned by the 
storage and transport of specific bacterial strains.  
The polymer additives, PEG and PVA, are both widely used in pharmaceutical 
products, are available as clinical-grade materials, are biocompatible and non-
immunogenic, and are compatible with current biologics, with no additional bio-
conjugation being required. These antifreeze protein-inspired polymers will be 
powerful tools for protein storage in both biotechnology research and healthcare where 
maximising function and reducing side effects for protein therapeutics is essential. 
To further confirm the use of our PEG/PVA formulation in the cryopreservation of 
biological materials, studies consisting of a larger range of proteins and cells would 
need to be undertaken. Optimisation of a L. delbrueckii subsp. bulgaricus expression 
protocol is required before further FT studies can be performed to test the 
cryoprotective ability of polymer formulations on this industrially relevant culture. 
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2.8 Experimental 
2.8.1 Materials 
Poly(ethylene glycol) (200 Da, 400 Da, 1.5 kDa, 2 kDa, 4 kDa, 6 kDa and 8 kDa), 
poly(vinyl alcohol) (10, 23 and 31 kDa), NaCl, insulin, De Man, Rogosa and Sharpe 
(MRS) broth and ampicillin were purchased from Sigma-Aldrich and used as supplied 
unless otherwise stated. Imidazole (Merck), dioxane and glycerol (Fisher Chemical), 
isopropyl-β-D-thiogalactoside (IPTG) (VWR chemical), Novex AP Chromogenic and 
SYTO-9 (Invitrogen) and Coomassie blue stain (Expedeon) were also used as 
supplied. The polymer ampholyte was prepared as previously reported.47  
The Escherichia coli (E. coli) BL21(DE3) cells were purchased from New England 
Biolabs, Bacillus subtilis (B. subtilis) (168 wild type) were donated by Dr Emma 
Denham, University of Bath, U.K., and Mycobacterium smegmatis (M. smegmatis) 
(Mc2155) was kindly donated by Dr. Elizabeth Fullam, University of Warwick, U.K.. 
Monoclonal Anti-polyHistidine antibody produced in mouse, clone HIS-1, ascites 
fluid and goat anti-Mouse IgG (H+L) secondary antibody (AP-conjugated) were 
purchased from Sigma Aldrich and used as received. 
 
2.8.2 Physical and Analytical Methods 
UV-VIS spectroscopy measurements were performed on a Jenway 6300 Visible 
Range Spectrophotometer using an absorbance of 600 nm (OD measurements) and 
560 nm (BCA assays). Samples for western blot analysis were resolved on a 
polyacrylamide gel, transferred to a membrane and detected a using primary 
(monoclonal anti-polyhistidine) antibody and a secondary (goat anti-mouse IgG 
(H+L)) antibody. Fast protein liquid chromatography (FPLC) was performed using 
AKTA pure (GE Healthcare) with a flow rate of 1 mL.min-1 using PBS buffer. A 
Linkam Biological Cryostage BCS196 with T95-Linkpad system controller equipped 
with a LNP95-Liquid nitrogen cooling pump, using liquid nitrogen as the coolant 
(Linkam Scientific Instruments U.K., Surrey, U.K.) was used to anneal ice wafers. An 
Olympus CX41 microscope equipped with a UIS-2 20x/0.45/∞/0−2/FN22 lens 
(Olympus Ltd., Southend on Sea, U.K.) and a Canon EOS 500D SLR digital camera 
was used to obtain all images. Image processing was performed using ImageJ, which 
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is freely available from http://imagej.nih.gov/ij/. Absorbance spectroscopy was 
undertaken using a Synergy HT multi-mode microplate reader (BioTek U.K., 
Bedfordshire, U.K.). Confocal microscopy was performed on a Nikon Eclipse Ti, an 
inverted widefield fluorescence microscope, equipped with LED illumination, 100x 
1.45 NA and 60x 1.4 NA objectives, mCherry and GFP filter sets and a 2k x 2k 
sCMOS Andor camera system. Dynamic light scattering was undertaken on a Malvern 
Zetasizer Nano ZS. 
 
2.8.3 Procedures 
2.8.3.1 Protein Expression and Purification 
2.8.3.1.1 Standard AFPIII Expression 
A plasmid encoding for a hexahistidine-tagged AFP III (T7, pET21b, P19614) was 
transformed into competent Escherichia coli BL21(DE3) cells (New England 
Biolabs). Single colonies were selected and grown overnight in 10 mL Lysogeny broth 
(LB)-medium containing 100 µg.mL-1 ampicillin under continuous shaking (37 °C, 
180 rpm). Preculture was added (40 mL in 1 L) to LB-medium with ampicillin and 
grown until OD600 = 0.6. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was then 
added to the cells to a final concentration of 0.4 mM to induce protein expression 
overnight (16 °C, 180 rpm). The cells were harvested by centrifugation (4 °C, 5000 g, 
10 minutes), the supernatant decanted and the cells resuspended in prechilled 
phosphate buffered saline (PBS) (7 mL, (>18.2 Ω mean resistivity, [NaCl] = 0.138 M, 
[KCl] = 0.0027 M, and pH 7.4)). Pierce protease inhibitor mini-tablets were added to 
the suspension and it was passed through a STANSTED ‘Pressure Cell’ FGP12800 
homogeniser to undergo lysis. BugBuster was added (500 µL) and the sample left 
spinning for 20 minutes. The cell lysate was centrifuged (4 °C, 40,000 g, 45 minutes) 
and the supernatant syringe filtered (0.2 µm) and passed through a pre-equilibrated 
(20 mL PBS) IMAC Sepharose 6 Fast Flow (GE Healthcare) column charged with 
Ni(II) ions. The column was washed first with PBS, then with 3 column volumes of 
30 mM imidazole in PBS. 300 mM imidazole in PBS was used to elute bound AFP III 
and the protein purified via fast protein liquid chromatography (FPLC). Western blot 
and SDS-PAGE gel electrophoresis were used to identify AFP III, and the protein 
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concentration determined using Thermo Scientific Pierce BCA assay kit and verified 
by measuring absorbance at 280 nm and using Beer-Lambert law. 
 
2.8.3.1.2 Auto-induction AFPIII Expression 
Auto-induction media prepared (55.85 g media, 990 mL H2O, 10 mL 50 % glycerol) 
and autoclaved (15 minutes, 121 °C). 5 separate colonies of E. coli overnights grown 
in 10 mL LB (37 °C, 180 rpm). 20 mL of the preculture was then added to 1 L of LB-
medium with added 1 mL ampicillin split into two 500 mL Erlenmeyer flasks and 
grown for 3 hours under continuous shaking (37 °C, 180 rpm). The OD of the cells 
was recorded every 2 hours. Once the OD reached 2, the speed and temperature of the 
samples was reduced (20 °C, 140 rpm) and the cells left overnight. Once the OD no 
longer increased the cells were harvested and centrifuged (40 °C, 5000 RPM, 30 
minutes). The pellet was resuspended in 7 mL prechilled PBS buffer with protease 
tablet dissolved in it. Samples were passed through a STANSTED ‘Pressure Cell’ 
FGP12800 homogeniser twice to undergo lysis, BugBuster (500 µL) was added and 
the sample left shaking for 20 minutes. 
The sample was centrifuged (4 °C, 18000 RPM, 30 minutes) supernatant syringe 
filtered (0.2 µm) and passed through a pre-equilibrated (20 mL PBS) IMAC Sepharose 
6 Fast Flow (GE Healthcare) column charged with Ni(II) ions. The column was 
washed with 5 mM imidazole and shook for 1 hour, then washed with buffer then 
washed with 30 mM imidazole three times. The protein was finally eluted using 300 
mM imidazole. 
 
2.8.3.1.3 Green Fluorescent Protein Expression 
A pWALDO plasmid encoding for a hexahistidine-tagged GFP (Elizabeth Fullam, 
University of Warwick, U.K.) was transformed into competent Escherichia coli 
BL21(DE3) cells (New England Biolabs). A single colony was selected and grown 
overnight in 50 mL of LB-medium containing 100 µg.mL-1 ampicillin under 
continuous shaking (37 °C, 180 RPM). 5 mL of the preculture was then added to 500 
mL of LB-medium in a 2 L Erlenmeyer flask and grown for 4 hours under continuous 
shaking (37 °C, 180 RPM). The temperature was reduced to 16 °C and cells were 
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incubated for an hour further. IPTG was then added to the cells to a final concentration 
of 1 mM. The protein overexpressed overnight, following which the cells were 
centrifuged (4 °C, 4000 g, 30 minutes). 
Pelleted cells were resuspended in 15 mL PBS (>18.2 Ω mean resistivity, [NaCl] = 
0.138 M, [KCl] = 0.0027 M, and pH 7.4). Pierce protease inhibitor mini-tablets were 
added to the suspension and it was passed through a STANSTED ‘Pressure Cell’ 
FGP12800 homogeniser to undergo lysis. The cell lysate was centrifuged (4 °C, 
14,000 g, 30 minutes) and the supernatant syringe filtered (0.2 µm) and passed through 
a pre-equilibrated (20 mL PBS) IMAC Sepharose 6 Fast Flow (GE Healthcare) 
column charged with Ni(II) ions. The column was washed first with 10 column 
volumes of 20 mM imidazole in PBS, then with 5 column volumes of 50 mM 
imidazole in PBS. 250 mM and 1000 mM imidazole in PBS were used to elute bound 
GFP and the imidazole removed from the fractions using PD10 desalting columns (GE 
Healthcare). 
 
2.8.3.2 Ice Recrystallisation Inhibition ‘Splat’ Assay 
Samples were dissolved in PBS buffer (pH 7.4) at concentrations of 10 to 0.05 mg.mL-
1 and 1 drop of the solution was dispensed from a height of 1.4 m onto a glass cover 
slip on a metal disc cooled with dry ice. An ice wafer instantly formed and was 
transferred to a cryostage held at -8 ºC under liquid nitrogen. Samples were left to 
anneal for 30 minutes. Images of the wafer were taken before and after the 30 minutes. 
Image processing was performed using ImageJ software on the 5 largest crystals from 
at least 3 independent wafers giving the MLGS from 15 measurements. 
 
2.8.3.3 Green Fluorescent Protein Stability Assay 
200 µL of 6.89 mg.mL-1 green fluorescent protein (GFP) was diluted in 39.8 mL PBS 
buffer resulting in a stock solution of 0.034 mg.mL-1. PEG and PVA were dissolved 
in 2 mL of the stock solution to make different samples with final concentrations of 
100 mg.mL-1 PEG and 0.5, 1, 2.5, 5 and 10 mg.mL-1 PVA. This was repeated for all 3 
different molecular weights of PVA tested. Aliquots of 80 µL of the GFP/PEG/PVA 
solution were pipetted into wells of a black 96 well plate and fluorescence recorded at 
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27 °C. Fluorescence intensity was compared to that of a GFP/PEG solution with a 100 
mg.mL-1 concentration. The plates were placed in a freezer at -20 °C until frozen and 
then thawed in an Eppendorf SmartBlockTM at 27 °C for 10 minutes. The above freeze-
thaw cycle was repeated 6 times with the fluorescence of the samples recorded after 
each thaw. Fluorescence excitation was measured at 485/20 nm and emission at 528/20 
nm. 
 
2.8.3.4 Insulin Freeze/Thaw Assay 
1 mL of 10.5 mg.mL-1 insulin was diluted in 19 mL PBS buffer resulting in a stock 
solution of 0.525 mg.mL-1. PEG and PVA were dissolved in the stock solution to make 
different samples with final concentrations of 100 mg.mL-1 4 kDa PEG, 50 mg.mL-1 
2 kDa PEG and 1 mg.mL-1 PVA. Insulin in PBS buffer was used as a control against 
solutions of Insulin/PVA, Insulin/PEG2/PVA and Insulin/PEG4/PVA. The samples 
were placed in a freezer at -20 °C for 1 hour until frozen and then thawed in an 
Eppendorf SmartBlockTM at 37 °C for 15 minutes. The above freeze-thaw cycle was 
repeated for 6 and then 12 thaws before hydrodynamic diameter being measured by 
dynamic light scattering.  
 
2.8.3.5 Lactate Dehydrogenase Activity Assay 
NADH and sodium pyruvate were made up to stock concentrations of 63 mM and 10 
mM respectively. NADH (4 µL) and sodium pyruvate (10 µL) were added to 1 mL 
PBS to make the reaction buffer. All potential cryoprotectants (glycerol, 4 kDa PEG, 
10 kDa PVA, PEG/PVA) were added to LDH in a 50:50 volume and frozen in 
triplicate at the chosen temperature (-196 °C or -20 °C). The samples were thawed at 
25 °C after ≥1 cycles. 
5 µL of CPA:LDH samples were added to a 96 well plate and diluted by the addition 
of the reaction buffer (195 µL). Absorbance at 340 nm was recorded over 30 minutes 
at 25 °C using a BioTek Synergy HTX multimode reader and compared to that of an 
unfrozen LDH control and unreacted NADH. 
In storage experiments the samples were stored at -20 °C for either 24 hours, 1 week 
or 4 weeks before thawing. 
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2.8.3.6 Bacteria Freeze/Thaw Assay 
Different molecular weight PEGs (100 mg.mL-1; 200 Da, 400 Da, 1.5 kDa, 4 kDa, 6 
kDa and 8 kDa) and PVAs (1 mg.mL-1; 10, 23 and 31 kDa) were dissolved in PBS for 
comparison in cryoprotective activity alongside the polyampholyte, AFPIII and 
glycerol. Cells (150 µL) were added to separate solutions of the different 
cryoprotectants (150 µL) and snap frozen in liquid nitrogen before thawing at 37 °C 
in a water bath. The freeze (-196 °C) thaw (25 °C) cycles were repeated 7 times then 
the samples were added to LB in 96 well plates (200 µL). Serial dilutions took place 
and the samples plated on ampicillin plates. These were left to grow at 37 °C for 
subsequent colony counts. Confocal microscopy was performed to evaluate the 
number of live/dead cells obtained. 
 
2.8.3.7 Lactobacillus delbrueckii subsp. bulgaricus Freeze/Thaw Assay 
MRS broth was prepared according to manufacturer’s instructions and sterilised to 
make up preculture bottles (30 mL). Cryovials of L. delbrueckii subsp. bulgaricus 
were thawed (5 minutes, 42°C), aseptically transferred to sterilised MRS broth 
containing and grown over 24 hours at 42 °C. 5 mL of the preculture was then added 
to 500 mL of culture medium in a 2 L Erlenmeyer flask and grown for at 42 °C until 
reached the late exponential growth phase. The culture was then transferred to 50 mL 
centrifuge tubes and pelleted (10,000 g, 10 minutes, 4 °C). The cells were 
then resuspended in cryoprotective solutions. Samples then either underwent 7 freeze 
(-196 °C) thaw (25 °C) cycles or varying lengths of long-term storage and then post-
thaw were added to saline in 96 well plates (200 µL). Serial dilutions took place and 
the samples plated on MRS agar plates. These were left to grow under anaerobic 
conditions at 42 °C for subsequent colony counts. 
 
2.8.3.8 Cryoprotectant Toxicity on Bacteria 
Equal volumes of bacteria and cryoprotectant solutions were left shaking at 4 ºC 
overnight. The cryoprotectant samples (20 µL) were then added to LB in wells (200 
µL) in the first column of 96 well plate and serial dilutions of the samples produced 
by transferring 20 µL from column 1 to column 2, mixing, then taking 20 µL from 
column 2 to column 3. This was repeated until column 7 was reached giving dilutions 
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up to 10-7. Dilutions 10-2 to 10-5 were plated on ampicillin plates and colonies grown 
at 37 °C for subsequent counting. Toxicity assays were repeated using 3 PEG 
concentrations (100, 50 and 10 mg.mL-1) combined with a constant PVA 
concentration of 0, 1 or 10 mg.mL-1. 
 
2.8.3.9 OD600 Turbidity Measurements 
Toxicity and protection of cells in liquid culture was studied using absorbance 
spectroscopy. Samples were prepared as before and underwent 7 FT cycles.  The cells 
were then grown in LB (200 mL) over 14 hours under continuous shaking at 37 °C 
and their OD was measured at 600 nm at 10 minute intervals and compared to a control 
sample that underwent no freeze thaw cycles. This growth assay was performed also 
on cells combined with different AFP concentrations (0.1, 2.5 and 5 mg.mL-1) for 
comparison, as well as samples frozen at -20 °C  as well as -196 °C. 
 
2.8.3.10 Live/Dead Bacterial Viability Test 
Following seven freeze/thaw cycles, samples were spun down at 10,000 x g for 10 
minutes and the supernatant was discarded. An aliquot was taken prior to the 
freeze/thaw cycle as a live cell control and a further aliquot was heat killed (incubated 
at 80 °C for 30 minutes) for a dead cell control. Cells were re-suspended in 20 µl of 
0.85 % NaCl solution. 10 µl of this suspension was diluted in 200 µl of 0.85 % NaCl 
solution and the samples were incubated at room temperature for 1 h. Samples were 
pelleted at 10,000 x g for 10 minutes, the supernatant was discarded and the cells were 
re-suspended in 100 µl of 0.85 % NaCl solution. Next, the LIVE/DEAD bacterial 
viability staining mixture was prepared by mixing SYTO-9 and propidium iodide to 
final concentrations of 1.67 mM and 10 mM, respectively. The cells were stained by 
adding 0.3 µl of the staining solution to 100 µl of cell suspension and incubating in 
the dark for 15 minutes (at room temperature). Slides for microscopy were prepared 
by trapping 5 µl of the stained bacterial suspension between a slide and a coverslip. 
Samples were then analysed by means of fluorescent microscopy (at either 100x or 
60x magnification) using GFP (excitation 470/40 nm, emission 525/50 nm) and 
mCherry (excitation 560/40 nm, emission 630/75 nm) filter sets to visualise the 
SYTO-9 and propidium iodide staining, respectively. 
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3.2 Chapter Abstract 
Understanding ice growth is crucial for infrastructure maintenance, the environment 
and preserving biologics in the cold chain, and is vital in enabling translation into real 
world applications. Ice-binding and antifreeze proteins are potent ice recrystallisation 
inhibitors (IRIs), and synthetic materials that mimic this function have emerged, with 
potential biotechnology applications. To evaluate IRI activity, optical microscopy 
tools are typically used to monitor ice crystallite (grain) size, either by end-point 
measurements or as a function of time. However, these methods only provide 2- 
dimensional (2D) information and image analysis is required to extract the data. 
Here wide angle X-ray scattering (WAXS/X-ray powder diffraction (XRD)) is 
explored and compared to that of microscopy-based techniques as an option for 
providing 3-dimensional (3D) data on IRI activity. XRD enables the interrogation of 
100s of ice crystals in 3D, and due to the random organisation of the ice crystals in 
the frozen sample, the total number of orientations measured by XRD is proportional 
to the total number of ice crystals, which can be measured as a function of time. This 
method was used to evaluate the activity for a panel of known IRI active compounds 
and shows strong agreement with results obtained from optical microscopy, as well as 
being advantageous in that time-dependent ice growth is easily extracted. Comparison 
of obtained diffraction patterns for a range of ice-active materials (ice-binding and 
non-binding) in relation to crystal face binding and ice morphology is discussed. This 
method may help in the discovery of new IRI active materials, as well as enabling 
kinetic analysis of ice growth. 
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3.3 Introduction 
3.3.1 Ice Crystal Growth Measurements 
Microscopy has been employed in the majority of experimental work concerning ice 
and ice-active compounds thus far. Despite microscopy being a powerful tool; it shows 
insights at a macroscopic level, it provides little understanding of the bulk ice (only a 
“snapshot” can be considered from the microscope), especially when studying 
microscopic changes e.g. chemical structure, i.e. what is causing the macroscopic 
change observed. X-ray powder diffraction (XRD), discussed here, can be used to 
study, in situ, the bulk of the sample and allows us here to connect angstroms to 
micrometre lengths. Particularly as water cools, there are changes on the Å 
lengthscale (lengths/structures of bonds change), leading to potentially observable 
changes in the radial distribution function and observed Bragg peaks. [Note, the 
terms WAXS and X-ray powder diffraction are interchangeable and XRD is used 
here throughout]. Significant advances in technology, development of full-profile 
analytical methods and synchrotron radiation have aided progress in the X-ray field; 
there have been vast improvements in data precision and speed of data collection,1 in 
particular the PILATUS 100k detector, used in this work, gives a large (up to 220 
photons counted in one pixel per exposure) and fast readout (time of 2.59 ms), as well 
as having a good signal to noise ratio that allows for the observation of fine details, 
and improvement of X-ray imaging applications.2 Ice-active proteins and their 
mimics can act in different ways; these include as antifreezes, ice-nucleants, ice 
recrystallisation inhibitors or by changing the morphology of ice crystals.3 In 
cryopreservation in particular, the macroscopic effects cryoprotectants (CPAs) have 
on hexagonal ice (Ih) are of great interest and evaluating their properties is 
particularly important as changes in the ice crystal morphology leads to 
damaged/burst cells. The macroscopic effects focused on here are IRI, and dynamic 
ice shaping (DIS). 
 
3.3.2 Optical Techniques 
IRI activity is typically measured using either the ‘splat’4,5 or sucrose ‘sandwich’6–8 
assays, which provide comparisons of ice crystal wafers. Both of these assays involve 
nucleating ice crystals and observing their growth over time (or more often at a fixed 
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time point) whilst recrystallisation occurs. [Note, it is crucial to highlight the 
conditions for these experiments as to avoid false positives.4,9] In both assays, smaller 
ice crystals, after annealing at sub-zero temperatures, indicate more IRI activity and 
data is reported as an area or relative to a negative control. Figure 3.1A shows an 
example micrograph from the splat assay, whereby large numbers of ‘small’ ice 
crystals are seeded from a buffer by rapidly freezing a droplet of water. The data is 
typically analysed after a set period of time and reported as a percentage growth 
relative to a PBS control. This can be reported as the mean largest grain size (MLGS), 
where the largest crystal in view is measured or mean grain size (MGS), where the 
average size of all crystals is measured. MLGS is appealing due to its simplicity for 
manual measurement but it fails to probe the whole population. Figure 3.1B shows a 
comparison of MLGS verses MGS data, which are generally in agreement, other than 
MGS being an area (squared) term and thus giving smaller % value for the same 
amount of inhibition. The ice wafers obtained, like that in Figure 3.1A, are 
challenging to analyse by automated image analysis due to the irregular grain 
boundaries, although Ben et al. have used domain recognition software.10 
Figure 3.1. Optical microscopy analysis of ice recrystallisation. A) Example ice wafer 
containing 1 mg.mL-1 10 kDa PVA in PBS after 30 minutes. An example larger grain 
(white circle) is shown, which skews results when only ‘largest grain size’ is 
considered; B) Comparison of MLGS and MGS for some PEG, PVA and AFPIII. 
Concentrations = 1 mg.mL-1. Errors are standard deviation. 
The splat assay has barely changed since its introduction in 1988,11 though an 
alternative method is the sucrose ‘sandwich’ assay, Figure 3.2.6–8 The crystals 
obtained in this assay are more separated due to the high viscosity of the media, and 
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hence image analysis can be used to identify each crystal, as shown by Budke et al.7 
It is also important to be able measure growth in the media of interest, and the 20 - 45 
wt % sucrose required6 for this is not relevant for all conditions, and it has emerged 
recently that salts have a profound effect on growth rates, hence the appeal of 
measurement in buffers.12,13 The mean crystal radius (r3) can be calculated from 
micrographs such as those in Figure 3.2A, and then plotted with their associated 
fittings, Figure 3.2B. (a) shows linear growth for a control solution, indicating that 
ice recrystallisation kinetics in that sample can be described by the bulk diffusion of 
water molecules from smaller crystals to the larger ones. This growth is fully inhibited 
for the higher concentration of AFGP and partially for the lower concentration. [Note, 
the total ice fraction remains constant; greater number of smaller crystals, fewer larger 
crystals, visualised as ice volume fraction (Q) in Figure 3.2B (c).] 
DIS is traditionally studied using sucrose ‘sandwich’ assays, where a sample of 
interest is pressed and sealed between two glass slides, frozen, warmed briefly and 
annealed so crystal habits can be observed, example micrographs shown in Figure 
3.2C.6,8,15 Sucrose is used as this allows liquid to be present at the ice crystal grain 
boundaries, enabling an easier study of the morphology of the ice crystals without 
interference from neighbouring grains.9,16 Generally sucrose solutions are 30 - 45 wt 
% sucrose, depending on procedure followed.8 The crystal habit of pure water is 
circular, and develops a hexagonal ‘snowflake’ shape as the crystal grows. This 
differs to that of samples with added antifreeze (glyco)proteins (AF(G)Ps) where 
needles can form, as seen in Figure 3.2C (b,c).3,17 
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Figure 3.2. A) Micrographs of ice crystals formed in 45 wt % sucrose over time to 
enable measurement of ice crystal growth over 120 minutes, a) control solution, b) 60 
µg.mL-1 AFGP, c) 140 µg.mL-1AFGP; B) Example data obtained through calculating 
mean ice crystal radii, r3, in 45 wt % sucrose solutions from the micrographs, a) control 
solution, b) r3 in solution containing 60 and 140 µg.mL-1 AFGP, and their associated 
fits (solid lines), c) temporal development of ice crystal volume fraction, Q, of data 
from a) and b). Adapted from Budke et al. (J. Phys. Chem B, 2009).7 All data obtained 
at -8 ℃. Errors are standard deviation. C) Ice morphology observed in micrographs 
obtained from sucrose assays; a) pure water, b) in the presence of dilute AFP solution, 
c) in the presence of high concentration AFP solution. Adapted from Griffith and 
Yaish (Trends Plant Sci., 2004).14 
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3.3.3 X-ray Techniques 
The microstructure of solids was under debate until the late 19th century when Max 
von Laue suggested the use of X-rays,18 theorising that 3D crystals could be 
visualised by X-ray diffraction. Since then, due to its interdisciplinary nature, 
crystallography has been of vital importance to biologists19 and chemists,20 and a 
range of techniques have been developed, including XRD (which includes powder 
and single crystal diffraction), small-angle X-ray scattering (SAXS), X-ray 
absorption (XAS) and emission (XES), for the analysis of solids.21 XAS (up to sub-
nm resolution)22 and XES (~0.2 – 2 eV energy resolution dependent on setup)23 
provide complementary information on the electronic structure of materials, 
including speciation and coordination chemistry24,25 so of less interest here. SAXS 
measures large features (5 – 500 nm) as the scattering angle is inversely proportional 
to size, and provides information on the morphology and dynamics of samples. Other 
parameters such as molecular mass, particle shape, particle size, quaternary structure 
of proteins and radius of gyration can also be obtained.26,27 XRD differs in that it 
makes 0.1-5 nm measurements, and can provide information on secondary structures 
of biomacromolecules (single crystal XRD), interatomic distances (powder XRD), 
crystallinity and structural changes (powder XRD). It is sensitive to small changes,27 
22 grain size and orientation, and is the method focused on here. 
A more detailed description of the theory behind diffraction can be found in 
Giacovazzo’s work but a description is provided below.1 When a crystalline sample 
is illuminated with X-rays and constructive interference (when waves are in phase) 
occurs, diffraction patterns are observed. The X-rays are electromagnetic waves that 
interact with electrons in atoms and will scatter by the process of elastic (wavelength 
of scattered X-rays remains the same) or inelastic (wavelength of scattered X-rays 
changes) scattering. The X-rays measured in diffraction experiments are those that 
undergo elastic scattering. When atoms are positioned periodically in a lattice, 
diffracted waves will consist of sharp interference maxima (peaks) with the same 
symmetry as in the distribution of atoms in a unit cell (as the peaks are directly 
related to atomic distances), enabling structural determination of the sample. Figure 
3.3A shows an example of atoms, represented as green spheres, which form different 
sets of planes in a crystal. When the lattice spacing between two planes is 𝑑𝑑 and the 
X-ray angle of incidence is 𝜃𝜃, then the difference in path lengths can be calculated 
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using 2𝑑𝑑 sin 𝜃𝜃. 
Diffraction of X-rays is governed by Bragg’s Law; 
                                                          2𝑑𝑑 sin 𝜃𝜃 = 𝑛𝑛λ                                                     (3.1) 
where 𝑛𝑛 is the order of reflection, λ is the wavelength of the incoming radiation, 𝑑𝑑 is 
the lattice spacing and 𝜃𝜃 is the incident angle of radiation between the primary beam 
and group of lattice planes with Miller indices h, k and l (Figure 3.3A). Dependent on 
satisfaction of Bragg’s law, diffracted X-rays (due to constructive interference) can 
be detected by scanning the sample through a range of scattering angles (2θ) and the 
signal converted to a count rate (the higher the number of counts the better the signal 
to noise ratio). The angle between the incident and diffracted rays is key for 
identification of a sample as the intensity measured as a function of 2θ provides 
information on the sites of atoms within the unit cell, giving diffractograms, which 
are a ‘fingerprint’ of a sample’s crystal lattice, example shown in Figure 3.3B.28,29 
The peaks are related to the planes of atoms through the Miller indices. Crystal faces 
(planes) and directions (edges) are defined by direction alone, and are described by 
determining where the three axes of the lattice (i.e. a1, a2 and a3) intersect and then 
taking the reciprocals (ensuring the final value is a whole number)) of these values, 
giving the Miller indices. Planes are written (h k l) and edges [h k l].30  
Instead of 2θ, the amount by which the scattered beam has been deflected by can be 
described by Q, the vector that describes the momentum transfer of X-ray scattering, 
allowing powder diffraction data to be plotted independent of the wavelength (λ). Q 
relates to θ by equation 3.2; Q-range depends on instrument, but a wider Q-range can 
provide greater structural information on a sample (Q-range of the Xenocs Xeuss 2.0 
used here is ~1.3 – 3.3 Å-1). 
                                                       Q = (4π/λ) sin 𝜃𝜃                                                    (3.2) 
  Chapter 3 
 
131  
 
Figure 3.3. A) Lattice planes and geometry of Bragg reflections in Bragg’s Law. 
(atoms represented in green form the different sets of crystal planes); B) Example 
idealised diffraction pattern, the Bragg peaks provide the signature of underlying 
structure Information can be obtained from the peak positions, heights, shapes and 
areas. Adapted from Sharma et al. (Recent Res. Sci. Technol., 2012).31 
Analysis of diffractograms can yield information on the phase present, sample 
purity, and how crystalline or amorphous a sample is, as well as indicating structural 
and morphological variations; the formation of flat plate-like and rod-shaped 
crystallites may introduce significant preferred orientation in specific planes (h k l) 
resulting in peak intensity variations or missing peaks. Intensity of the peaks depends 
on size and shape of particles (habits), as well as orientation towards the X-ray beam, 
in particular, preferred orientation can greatly affect peak intensity. Changes in 
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crystal symmetry causing complete cancellation (systematic absences) can also result 
in zero intensity from specific (h k l) planes, for example plates on a flat surface 
align and scatter strongly out-of-plane (002) in hexagonal ice plates leading to peak 
disappearance for (002). Both qualitative (identification of sample pattern) and 
quantitative (comparison of line intensities) analysis can be accomplished.29 When 
physicochemical gradients are applied to a sample the structural changes can be 
directly probed at these specific conditions, allowing time to be explored as another 
variable in the experiment. 
Here XRD is used to provide a description of the crystal structure of frozen solutions; 
these samples are not powdered manually, but form samples that are considered 
‘powdered’ upon freezing in situ in a static capillary, Figure 3.4B. 1.0 mm single use 
syringes and needles are used to transfer liquid samples to capillaries, Figure 3.4A, 
and then transferred to the cryostage for cooling. Once a solution is frozen, if the 
crystals in the capillary align with the beam (shown here as blue lines), it is scattered, 
Figure 3.4C. The use of a capillary reduces interference on the sample from the 
sample holder, whereas if a flat surface is used there will be increased effects due to 
preferred orientation. However, the ice grains formed here are too large (~20 – 120 
μm) to ensure a random distribution is sampled, because of the capillaries used 
here, so there is the possibility of some preferred orientation effects; effect of grain 
orientation is demonstrated in Figure 3.4Ci/ii, though there is minimal diffraction 
interference due to their thickness (0.01 mm). Capillaries of a different diameter 
could be used, though not possible in our setup as larger capillaries would not fit into 
our cold stage. The number of orientations being measured could also be increased 
by using a larger detector or by spinning the capillary. 
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Figure 3.4. Consumables required and schematic of XRD procedure used here. A) 
From left to right, 1.0 mm diameter (0.01 mm thick) quartz capillaries, 1 mL syringe, 
0.8 x 120 mm needle; B) Samples inserted into capillary, precision required to avoid 
any air bubbles that could interfere with scattering, then transferred to the cryostage; 
C) The monochromatic beam hits the crystals in the capillary, those of which that 
constructively interfere diffract the beam for data collection at the detector. 
Orientation of ice crystal grains affects the intensity of the diffraction pattern; i) 
sample with minimum preferred orientation for the (100) plane; ii) sample with 
increased preferred orientation due to size of grain for the (100) plane. 
 
3.3.4 Polycrystalline Material 
Ideal polycrystalline material is an ensemble of a very large number of randomly 
oriented crystallites (grains). If the material is an aggregate of randomly oriented 
crystallites, all the possible orientations with respect to the X-ray beam should be 
observed, offering a route to observing a change in size of a polynucleated sample. 
This is necessary to understand for ensuring that apparent systematic absences are not 
a result of preferred orientation or an insufficient number of crystallites within the 
scattering volume. The crystalline form (crystal habit)32,33 is the general shape of a 
crystal,34 is made up of crystallisation units (ensembles of groups of bonded atoms), 
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and is affected by the internal structure of the crystal but also any interaction between 
solute and solvent, thus may differ for the same materials. The faces of the same 
crystalline form may develop to different extents; these changes in habit are cases of 
distortion from the ‘ideal’ crystal shape due to e.g. rapid crystallisation. Factors often 
considered to influence crystal morphology are the growth rate, confinement and any 
external interactions with atoms or molecules (impurities),35 e.g. strong adsorption of 
an impurity to a certain face will result in particular growth at this face. 
Despite differences in habit, the X-ray peak positions do not change, unlike for 
polymorphs, as the crystals have identical chemical compositions and chemical and 
physical properties.36 The intensities of each diffraction peak may differ however, 
because the total area of each crystal face is different according to crystal habit. The 
intensities can only be used for morphological analysis in powder samples, as ideally 
all orientations should be evenly distributed, and high enough resolution detectors are 
needed for this type of analysis. 
 
3.3.5 XRD of Ice 
Ice has been studied using X-ray techniques for over 100 years37–40 despite the fact 
limited information can be obtained on the positions of the hydrogen nuclei as X-rays 
are scattered by electrons, which hydrogen has few of. This has allowed, however, for 
studies to determine the positions of the oxygen lattice. X-ray techniques provide 
information on any changes that may be due to changes in coordination of the water 
molecules, and any differences in hydrogen bonding observed by changes in the 
lattice. Hydrogen bonds were defined by Pimentel and McCellan as a bond between 
a functional group, A-H, and an atom (or group of atoms, B) in either the same or 
different molecule when there is both evidence of bond formation and evidence that 
this new bond between A-H and B involves the hydrogen already covalently bonded 
to A.41–43 These are a weak type of dipole-dipole interaction (typical energies <40 
kJ.mol-1), resulting from the attractive force between the hydrogen atom bonded to A 
and B, where both are usually electronegative. The hydrogen bonds affected in the 
ice are what are studied in this work, as hydrogen bonding in Ih is weak thus has a 
certain amount of flexibility in the system.44 The hydrogen bond angle and length 
varies with temperature and pressure, with an average O⋯O length of 2.76 Å in Ih 
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and an angle of 109.47 ° between three neighbouring oxygens.28,45 Water molecules 
in crystalline ice are fully hydrogen bonded44 and in order to be ideal ice crystals the 
Bernal-Fowler rules for bonding must be followed.46 The hydrogen bond network is 
considered very important for ice structure and therefore an understanding of any 
changes (as has been seen in doped ice where the density of ice phases has been 
increased by bending hydrogen bonds and enhancing proton ordering)44,47–49 that 
could be observed upon addition of ice-active compounds, e.g. stacking faults, would 
be of great use.  
 
3.3.5.1 Hexagonal Ice 
This work focuses on Ih, the stable phase that forms at ambient pressure and at 
temperatures considered in this work i.e. ≥-80 ℃. The ice-binding planes 
(specifically basal and prism) highlighted in Chapter 1 correspond to the Miller 
indices for the hexagonal unit cell as shown in Figure 3.5A. Figure 3.5C also 
displays two Ih unit cells containing water molecules, one modelled using 12 and the 
other 96, both highlighting the hexagonal form of the crystal. Exemplar X-ray 
diffraction patterns (as seen in the literature) for metastable cubic ice (Ic) and Ih are 
provided in Figure 3.5B with the associated Miller indices for the unit cells. The 
indices are written above the peaks corresponding to the related crystal edge. Data 
obtained here will be analysed and compared to these reference patterns. There are 
peaks that occur in both Ih and Ic, which can make identification of specific phases 
difficult, though it is supposed that the metastable Ic forms initially, and then relaxes 
into Ih, forming a mix of hexagonal and cubic crystallites, which is often referred to 
as ice I.51,52 Reports used to study the Ic to Ih transition support this theory (Ic 
converts quickly to Ih at temperatures above -33 °C).44,53,54 Ic and Ih are similar in 
that they have equivalent densities and they both form 4 hydrogen bonds with their 
nearest neighbours, however oxygen atoms in Ic are arranged in a diamond rather 
than a hexagonal lattice.55 There also is a peak corresponding to the (400) plane (58 °) 
(not shown in Figure 3.5) that is only observed in Ic, allowing identification. The 
cooling rate can also affect if Ic or Ih forms, and if the rate is sufficiently fast, 
amorphous ice (vitreous ice) forms, observed as a broad band rather than sharp peaks 
as for Ih and Ic.56 
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Figure 3.5. A) Hexagonal unit cell (bold) with 3 axes highlighted (a#, blue) from which the 
Miller indices (shown in brackets) are obtained; B) Calculated X-ray diffraction patterns 
of hexagonal (black) and cubic (red) ice with associated Miller indices for the crystal 
planes labelled from 20 – 47 ° (the available range for the setup used here); C) Unit 
cells for hexagonal ice obtained using various scattering experiments. Adapted from 
Santra et al. (J. Chem. Phys., 2013).50 
 
3.3.5.2 Low Temperature XRD 
X-ray crystallography has been of the upmost importance in the biology field; X-ray 
data has led to an increased understanding of mechanisms of action, validation of 
crystallographic structures and characterisation of protein flexibility and folding.26,57,58 
Scattering, specifically SAXS, has been found useful for probing conformational 
switching and aiding in assembly of complexes from atomic structures of subunits.58 
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Radiation from the X-ray beam has been an issue when studying proteins as it causes 
damage. However, recent work using cryo-cooled proteins and nucleic acids shows 
that cryo-SAXS protects the proteins and nucleic acids from radiation.59 Knowing that 
performing experiments at cryo-temperatures protects protein structures is helpful, as 
we can be sure that the ice-active proteins used in this work (AF(G)Ps) will be folded 
correctly when studying their interaction with ice and thus give accurate results. 
Low temperature XRD and SAXS have been used to determine the structures of 
certain additives, though limited research has been taken into their effect on ice 
growth.60,61 Studies have monitored crystallisation, polymorphism, amorphous ice62 
and disorder in the Ih phase of frozen solutes, including ice-active solutes such as 
bovine serum albumin (BSA) and sorbitol.63–67 Brief SAXS studies have been 
performed to study ice formation and growth. These have provided an initial, yet 
incomplete picture.61,68 Cell viability post-thaw has also been examined for a range of 
cryoprotective media and CPAs, including DMSO and antifreeze proteins, alongside 
studies of their impact on ice structure.56,69 As mentioned earlier, two macroscopic 
effects particularly relevant for X-ray experiments are DIS and IRI.70 For example, 
XRD has been used with the aim of clarifying the ice growth inhibition mechanism; 
i.e. do proteins adsorb onto the ice or partition into the quasi-liquid layer (QLL)?67 
Studies include those on AFPs and synthetic mimics and their interaction with specific 
ice faces.71 In these studies interaction is observed by monitoring the 
appearance/intensity of particular Ih diffraction peaks, which correspond to various 
ice planes and therefore morphology variations due to differing distributions of crystal 
orientations.71–73 
Yagci et al. suggested that poly(tartar amides) interfere with the ice crystallisation 
process to cause partially deformed Ih structures.72 A loss in intensity for diffraction 
peaks ((100), (002), (101)) has been suggested to be due to a decrease in crystal size, 
supporting the theory that hyperbranched copolymers containing poly(ethylene 
oxide)-polyethylenimine blocks have IRI activity as they produce crystals of a smaller 
size (submicrometer).73 A complete loss of intensity of the (002) peak has also been 
suggested to confirm a change in morphology of the ice crystals, potentially due to 
binding of the plane corresponding to (002) i.e. preferential growth along the c-axis.74 
However, the disappearance of peaks does not actually confirm activity, (as we 
demonstrate later in the chapter). 
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How PVA exerts its effects on the Ostwald ripening of polycrystalline ice has yet to 
be studied thoroughly using X-ray techniques, though models have been suggested 
(based on molecular dynamics (MD) simulations) including the cooperative ‘zipper’ 
mechanism75 or by using an anchored clathrate binding motif,76 and that PVA binds 
(irreversibly) to the primary (100) prism plane and (reversibly) to the secondary 
(110) prism plane. This binding could theoretically be monitored by XRD.75 
Studies here consist of crystal orientation analysis and diffraction pattern evaluation 
to analyse IRI and DIS. We propose a novel non-invasive method for 3D analysis of 
ice crystal growth, which provides information on the kinetics of the ice growth 
process for ice-active molecules.  
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3.4 Terminology 
Hexagonal ice (Ih) – The phase of ice formed under atmospheric pressure below 0 ℃. 
This phase is named due to its hexagonal symmetry. All further mentions of “ice” in 
this chapter are specifically referring to hexagonal ice unless specifically noted. 
Cubic ice (Ic) - Metastable phase of ice, potentially formed at very low temperatures 
before converting to hexagonal ice. 
Colligative effects - Effects that depend not on the identity of the solute, but the 
concentration of solute molecules dissolved species. 
Non-colligative effects - Effects that depend on the identity of the dissolved species 
and the solvent e.g. IRI. 
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3.5 Chapter Aims 
As written in section 1.3, ice-active additives could work via a range of mechanisms; 
adsorption-inhibition, anchored clathrate, interacting with the liquid-like layer etc. 
Much work has focused on AFPs, are based on molecular dynamics simulations, and 
there are still debates over the mechanism of ice growth and its inhibition. Due to 
their use in studying crystal growth mechanisms and crystal structures, X-ray 
techniques are of particular interest here.36 
This work aims to: 
• Investigate ice-active compounds of different structures and their effect on ice 
using XRD, these included cryoprotectants (CPAs) as well as those with IRI 
activity that cannot be used as CPAs due to toxicity3,70,77 
• Produce a method for kinetic analysis of IRI activity 
• Determine whether ice-binding can be determined and hence establish whether 
different ice-active compounds work via the same/different mechanisms 
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3.6 Results and Discussion 
3.6.1 Compounds Studied 
As in section 2.6.1, ice-active additives were chosen for study, this time using 
microscopy and X-ray diffraction, Figure 3.6. These included AFGP8 (antifreeze 
protein from Dissostichus mawsoni, 2.6 kDa), the shortest naturally occurring AFGP 
fraction, which has great IRI activity as well as ice-shaping abilities,78 type III AFP 
(from Zoarces americanus, 6.5 kDa) and synthetic IRI’s; PVA and safranine-O, as 
well as their respective inactive controls; lysozyme, PEG, and phenosafranin. The 
effect of conjugating antifreeze proteins to gold nanoparticles (AuNP) was also tested 
to study the impact of multivalency on ice- activity. This range of materials was used 
to test the suitability of X-ray and microscopy methods. 
 
Figure 3.6. Structures of compounds studied here with the aim of analysing IRI 
activity and to gain further understanding of how they affect ice growth. Sizes of 
materials tested chosen based on previous known IRI activity and length scales are 
not expected to be of importance. PVA = 10 kDa; AFGP8 = 2.6 kDa; Safranine-O = 
350.8 Da; AFPIII = 6.5 kDa; PEG = 4 kDa; Lysozyme = 14.3 kDa; Phenosafranin = 
322.8 Da. Average AuNP diameters obtained from TEM (mean of 100 particles) for 
SNAP-AFPIII@Au4 = 4.03 ± 1.1 nm and His-AFPIII@Au4 = 4.26 ± 0.9 nm. 
(Structures AFPIII “1KDF” and lysozyme “1GXV” are from the Protein Data Bank). 
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3.6.2 IRI Activity as Measured by Splat Assays 
The splat assay, as mentioned in 3.3.2, is the most commonly used method of 
determining IRI activity, thus has been selected here as the microscopy-based 
method of choice.  
 
Figure 3.7. IRI activity of compounds tested here and relative activity of the different 
types of compounds tested. A) IRI activity as MLGS for proteins tested; B) IRI activity 
as MLGS for synthetics tested; C) Summary of the range of activities observed here 
and in the literature for a range of IRI active compounds. Adapted from Biggs et al., 
(Macromol. Biosci., 2019).9 Grain size is recorded after 30 minutes annealing at -8 ℃. 
Though the appropriate method of reporting IRI data is under debate; both MGS and 
MLGS have been used, and are compared here to identify IRI activity in the 
compounds chosen, Figure 3.7A/B. AFGP8 (black) is confirmed to have the highest 
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IRI activity, with 50 % activity at concentrations as low as 0.15 µg.mL-1, followed by 
AFPIII (bound to both His- and SNAP-tags), then PVA and safranine-O. The 
inactivity of lysozyme, PEG and phenosafranin are also confirmed. As concentrations 
increase for compounds that exert colligative effects on ice e.g. PEG, the crystal size 
does reduce but in a manner that is expected due to the high concentrations in 
solution, Figure 3.7B. 
Taking inspiration from Baardsnes et al.  ̧who showed a gain in antifreeze activity 
upon formation of an AFP dimer,79 and work by Stevens et al. on a dendrimer-linked 
AFPIII that had enhanced TH,80 ice-activity was studied for AFPIII upon 
conjugation to a AuNP scaffold. The AuNP scaffolds were produced by Dr Laura 
Wilkins, University of Warwick. AFPIII was recombinantly expressed with both 
His- and SNAP-tags, and IRI activity tested; both of which lead to high IRI activity 
(red and blue lines respectively), Figure 3.7A. In multimeric ice-active protein 
samples, it has been suggested that the entire AFP ice-binding site is required to be 
sterically available for enhanced activity, indicating that a large scaffold/long linker 
between AuNP and the AFPIII would enable this availability. However, a smaller 
scaffold/shorter linker would enable the AFPIII molecules to be closer in space, 
potentially leading to multiple AFPIIIs binding to the same surface and improving 
activity. Thus, two tags were chosen for the direct comparison of the length of linker; 
His being the shorter and SNAP being the longer. Successful conjugation was 
confirmed using X-ray photoelectron spectroscopy (XPS) and zeta potential 
measurements, and the AFP@Au4 nanoparticles were characterised by DLS and 
transmission electron microscopy (TEM) by Dr Laura Wilkins, University of 
Warwick. Upon conjugation of the recombinant AFPs, the organic character of the 
samples was observed to have changed (N 1s proportion from XPS spectra increased 
from 0 % to ~12 % upon binding AFPIII for both samples and the O 1s peak 
decreased) and the zeta potential of the AuNPs decreased by over 5 mV upon AFPIII 
binding (because of the change in surface composition).81,82 Upon conjugation IRI 
activity was retained, and slightly enhanced for SNAP-AFPIII (green), however 
activity was greatly reduced for His- AFPIII (orange), implying that a larger linker is 
preferable for an increase in activity when using multimeric proteins. 
Other polymers of varying structures, with lower IRI activity, that have been tested 
using splat assays were not studied here, though the mean grain size and relative 
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growth rates compared to AF(G)Ps, PVA and safranine-O are visualised in Figure 
3.8C. 
 
3.6.3 Dynamic Ice Shaping as Measured by Sucrose ‘Sandwich’ 
Assays 
Figure 3.8. Optical microscopy ice morphology analysis of IRI active proteins 
compared to that of Milli-Q H2O and a negative control (lysozyme) cooling over time. 
Scale bars = 100 µm. [AFGP8] = 3 mg.mL-1; [AFPIII] = 2.8 mg.mL-1; [Lysozyme] = 
3 mg.mL-1. 
IRI is not the only macroscopic property of ice-binding/antifreeze proteins; ice 
shaping, due to binding to specific crystal faces also occurs70,77 although it has 
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emerged that binding might not be essential for IRI and hence these macroscopic 
properties are not always present.77,83 DIS is traditionally studied using sucrose 
‘sandwich’ assays, and 45 wt % sucrose solutions were chosen here for the study of 
the samples in Figure 3.6.  
Growth and morphology of ice crystals was monitored using an optical microscope. 
As well as proteins (Figure 3.8), ice shaping properties of polymers and small 
molecules have been tested (Figure 3.10). Typically water and dilute aqueous 
solutions (such as PBS, see control) display a crystal circular in shape, this is because 
this habit reduces interfacial energy between the ice crystal and solvent, which has a 
hexagonal burst pattern upon continued cooling.8 The majority of samples tested 
show some ice shaping, albeit at varying strength and many form dendritic crystal 
shapes. 
The differential affinities of AFGP8 and AFPIII to ice crystal planes compared to that 
of lysozyme are shown in Figure 3.8. Lysozyme is known to have no effect on ice 
formation and growth, and this is confirmed in the micrographs above; the crystals 
observed are similar to that of the control, leading to a hexagonal burst pattern, though 
at a faster rate. Both AFGP8 and AFPIII produce distinctive specular (needle-like) 
crystals due to ice-binding at the primary prism plane. The high IRI activity of these 
samples can also be observed, as the ice crystals at the starting point of the experiment 
are smaller (~3 µm for AFGP8 and AFPIII) than that of the non-IRI active lysozyme 
(~9 µm). 
The dynamic ice shaping abilities of metal-core nanoparticles bearing multiple copies 
of AFPIII bound to their surface compared to that of pure AFPIII were then studied, 
Figure 3.9. Faceting and dendritic morphologies was observed for all samples; 
consistent with ice-binding and shaping, as seen for dendronised AFP.80 Binding of 
His-AFPIII to AuNP negatively affected IRI activity (larger crystals observed), 
supporting the observed results in the splat assays previously, they also affected ice 
morphology; crystals were no longer needle-like. SNAP-AFPIII@Au4 also affected 
the morphology of the ice crystals compared to that of SNAP-AFPIII alone, leading 
to much more dendritic shapes than prisms/columns. The IRI activity is only affected 
slightly (as seen in the splat assays); grains are similar in size. 
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Figure 3.9. Optical microscopy ice morphology analysis of His-AFPIII and SNAP- 
AFPIII alone and bound to gold nanoparticles cooling over time. Scale bars = 100 µm. 
[His-AFPIII] = 2.8 mg.mL-1; [His-AFPIII@Au4] = 2.3 mg.mL-1; [SNAP-AFPIII] = 
0.10 mg.mL-1; [SNAP-AFPIII@Au4] = 0.13 mg.mL-1. 
Synthetic polymers have been designed to reproduce AF(G)P properties even without 
any structural similarities to native antifreeze proteins.3,70,77 In particular, it has been 
shown that IRI activity can be selectively retained, over TH/DIS, implying there are 
multiple mechanisms of action for the different ice-active molecules.84 Sucrose 
‘sandwich’ assays performed on synthetic mimics here (Figure 3.10) show that DIS 
does not occur for some samples, even IRI active ones, supporting the theory that there 
are multiple mechanisms of action and that DIS does not infer IRI activity or vice 
versa.77,83 
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Figure 3.10. Optical microscopy ice morphology analysis of IRI active synthetic 
compounds tested here compared to that of Milli-Q H2O. Scale bars = 100 µm. 
[Sample] = 1 mg.mL-1 bar safranine-O; (a) = 0.1 mg.mL-1 and (b) = 2.5 mg.mL-1 to 
visualise how self-assembly of the small molecule affects the DIS. Ice shaping (green 
tick) or lack of shaping (red cross) indicated. 
It can be observed that PVA shapes ice by binding the prismatic plane leading to the 
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growth of the crystal grains observed in Figure 3.10, whereas PEG alone appears to 
affect the ice grains minimally – producing crystals of a similar shape to that of pure 
water, ruling out strong and specific ice face recognition. Safranine-O, above 1 
mg.mL-1, is known to self-assemble in solution,85 and the effect of self-assembly is 
observed here; ice-shaping is not observed at low concentration (a), however ice- 
shaping is observed for (b), where the concentration is high enough for self-assembly, 
leading to the formation of needle-like crystals. All DIS-inactive samples show a 
slight difference in morphology to the water control (though are similar), this is due 
to the crystal bursting (into the hexagonal burst pattern) at a faster rate as well as the 
ice crystals that remain in these samples (as the sample is warmed) being closer in 
proximity to each other, causing growth of certain planes to be obstructed. 
 
3.6.4 XRD 
Both SAXS and XRD were used initially, however the resolution of SAXS results 
were not high enough to obtain any reliable data so only XRD was continued with. 
Using XRD, the concerning Ih crystals formed under standard conditions were 
examined and from the resulting diffractograms ice-activity was followed for the 
same samples tested in 3.6.2 and 3.6.3. No broad, low intensity peaks were observed, 
indicating no amorphous phases are formed in these samples upon freezing. Thus all 
ice observed in this work is polycrystalline, containing hundreds of crystallites, 
leading to diffraction patterns consisting of all expected diffraction peaks for 
hexagonal ice.52 As mentioned in 3.3.3, a percentage of these crystallites will orient to 
diffract the X-ray beam, meaning it is possible that the peak intensity will differ for 
identical samples, depending on how the crystallites are oriented. Generally, the peak 
intensities (height) are related to the composition and structure of the crystal and are 
what would normally be used for analysing XRD data. Peak width (area) is dependent 
on instrumental function and any size related effects; the smaller the grain size, the 
wider the peak. In this work the ice grains are too large to have much of an effect on 
peak widths, therefore work here considers the number of crystal orientations obtained 
from the integration of the peak areas. 
The XRD Xenocs Xeuss 2.0 used here was particularly useful due to its ability to see 
scattering from individual grains because of the 2D detector. This was only possible 
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because of the large size of the ice grains, which reduces the number of possible 
orientations that can exist in a set sample volume. This means there are not grains 
diffracting at every ψ (psi) angle and allows information proportional to number of 
grains to be calculated. 
Splat assays have been used to follow ice recrystallisation (or lack of), and XRD is 
tested here, as another technique that, due to its use in observation of crystal formation 
in other fields;27,86 including observing nucleation/growth of gold nanoparticles86,87 
and titanium oxide particles over time,88 as well as evaluating phase structure, 
precipitate growth and coarsening of alloys using combined ultra-small, small and 
wide angle X- ray scattering,89 and observing ice polymorphs,44 can observe ice 
growth easily via 3D analysis of an entire sample over time. Here, the diffracted X-
rays hit the Pilatus detector sensor and repeat measurements were taken over 10 s for 
a total of 1800 s. The photons are absorbed and generate a charge cloud, which is 
carried through the sensor by an electric field. These charge-induced photons are 
detected by a readout chip and amplified and digitally stored as data. The data 
obtained for each 10 s measurement is converted into a plot consisting of the 
intensity per pixel as a function of 2θ, with each individual measurement plotted 
together over time, Figure 3.11A. Each peak represents the different lattice planes 
for the ice crystals in the samples [Note, further details on XRD fundamentals 
provided in 3.3.3]. Example diffractograms as a function of time for ice crystals 
annealed at -8 °C in the presence of a potent IRI (PVA) and a negative control (PEG) 
are seen in Figure 3.11A/B. The characteristic peaks of ice at 22.7, 24.2 and 25.8 ° 
(corresponding to the (100), (002) and (101) planes respectively) are clearly visible 
as would be expected for Ih and is in agreement with Figure 3.5. Of note, is that in 
the presence of PVA, the diffractograms are essentially constant over the whole time 
period, indicative of there being no ice recrystallisation (growth). In contrast, the PEG 
sample shows significant decreases in the scattering intensity for most peaks, which is 
consistent with ice recrystallisation (large ice crystals growing). This confirms that in 
principle, XRD should allow for both endpoint and kinetic analysis of IRI activity. 
Example ice wafers from the splat assay under the same conditions are shown in 
Figure 3.11C/D; this technique does not allow continuous data acquisition in the same 
way and measurements are only of the section of sample observed under the 
microscope. 
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Figure 3.11. Example waterfall plots of diffraction patterns obtained in this work that 
are used for kinetic analysis of change in number of crystal orientations over time 
with expected Ih crystal planes included in black below the plots; A) PVA and B) 
PEG; Optical micrographs obtained after 30 minutes annealing for C) PVA and D) 
PEG. All data obtained at -8 ℃. [Polymer] = 2.5 mg.mL-1. 
 
3.6.4.1 Methodology 
XRD provides details on crystallite orientations and intensity; the number of crystallite 
orientations for each sample, and how this number changes over continuous 
measurements. The sum of the intensity of the whole X-ray detector can be calculated, 
as well as the intensity for individual 2θ values. 
To enable quantitative analyses of the ice recrystallisation, the total number of ice 
crystal orientations observed for a sample was calculated, which in a powder sample 
is proportional to the number of crystals, and hence inversely proportional to the size 
of the ice crystals. When ice crystals in a sample increase in size (recrystallisation), 
the number of grains detected by XRD decreases, which may lead to a decrease in 
scattering intensity. 
  Chapter 3 
 
151  
 
Figure 3.12. Example 2D detector images for a powder. A) Ag behenate (used to 
calibrate the sample to detector distance beforehand); B) Example ice measurement; 
orientations are observed as pixels above the determined background value of 1.5 
counts highlighted in semi-transparent band and counted every 0.2 ° over ψ range of 
76 – 105 °. 
To obtain the number of ice crystal orientations (# orientations) over time from 2D 
detector images (examples in Figure 3.12), a series of steps are followed: 
First, the 2θ ranges that cover each of the seven peaks (for the Miller indices that 
correspond to the different planes in Ih) that are measured in the diffraction patterns 
(like those seen in Figure 3.11A) are selected for each time point. An example 2θ 
range for the first peak is shown in Figure 3.13A/B. The 2D detector image is then 
integrated azimuthally [along the powder diffraction rings/bands] as a function of ψ 
seven times with 2θ ranges determined from the diffraction peaks to obtain the 
intensity at each ψ angle. (The step size in ψ for this was 0.2 °. For this work, the size 
of the detector limits the available orientation range in ψ to between 76 and 105 °). 
The intensity versus ψ data for the selected 2θ range is then plotted and the number 
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of data points above a determined background value (1.5 counts used) are then 
counted. These data points are relative to the number of orientations in that particular 
plane, examples of IRI active and inactive samples are shown filled in red in Figure 
3.13C/D. The total counts for each plane are summed to give the total number of 
orientations for a sample. With this methodology orientations are obtained as not 
every individual pixel is counted (unlike in a normal powder pattern). 
 
Figure 3.13. Example plots used in the quantitative analysis of ice recrystallisation. 
A/B) Example XRD plots used to calculate crystallite orientations of; A) IRI active 
PVA and B) non-IRI active PEG, plotted as a function of 2θ. Selected 2θ ranges used 
to analyse the crystallite orientations scattering are coloured red; C/D) Orientation 
plots of C) PVA and D) PEG, plotted as a function of ψ for intensities measured in the 
selected 2θ range. All data obtained at -8 ℃. [Polymer] = 2.5 mg.mL-1. 
As the concentration of an IRI active substance increases, the relative ice growth rate 
is expected to decrease due to the inhibition of ice crystal growth. This is because there 
are many orientations, which correspond to many small crystals. If there is an observed 
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decrease in the number of orientations, this is due to Ostwald ripening; where the 
larger crystals increase in size at the expense of the small crystals. 
One limit in using this technique is reached when the number of grains is large enough 
that diffraction occurs at all ψ angles. Under-determination of number of crystals could 
be an issue if the crystallites are sufficiently small and the number of orientations very 
large (when the number of grains is large enough that diffraction occurs at all ψ 
angles), resulting in the measured intensity being above the threshold value at every 
data point. This would put a limit on the maximum number of orientations that can be 
determined as the total number of data points in the azimuthal integrations. This is not 
an issue in the samples tested here but it is important to highlight that evaluation with 
an optical method in parallel is still required. This limit is equipment dependent and 
could be improved by increasing the sample to detector distance or by using a detector 
with a reduced pixel size. In the lab-based system used here the physical size of the 
detector reduces the total number of peaks that can be measured. Larger detectors are 
available for some lab-based systems and are readily available at synchrotrons. 
 
3.6.4.2 IRI Activity as Measured by XRD 
To assess the use of the above method, the compounds chosen in 3.6.1 were tested and 
compared against the standard splat assay. In each case, XRD experiments were 
performed over 1800 seconds (30 minutes) and then the number of orientations is 
calculated as described above and plotted as inverse number of orientations to enable 
easier comparison to microscopy data. 
A comparison of XRD and microscopy results for AFGP8 and lysozyme are seen in 
Figure 3.14A. The MLGS and XRD methods show broad agreement. There are more 
ice crystal orientations at IRI active concentrations (MLGS <20 %), indicating more, 
smaller crystals. This trend is also observed in Figure 3.14B, where the IRI active 
samples have similar inverse number of crystal orientations, and the inactive samples, 
His-AFPIII@Au, lysozyme and PBS, also have similar inverse number of orientations. 
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Figure 3.14. Comparison of orientation analysis (here shown as inverse number of 
observed ice crystal orientations after 1800 seconds) and IRI activity (shown as mean 
length grain size, MLGS, as a percentage of PBS) over a range of concentrations for; 
A) AFGP8 compared to lysozyme; B) His-AFPIII and SNAP-AFPIII alone and bound 
to gold nanoparticles compared to PBS and lysozyme. [His-AFPIII] = 2.8 mg.mL-1; 
[His-AFPIII@Au] = 2.3 mg.mL-1; [SNAP-AFPIII] = 0.10 mg.mL-1; [SNAP- 
AFPIII@Au] = 0.13 mg.mL-1. All concentrations are in mg.mL-1, errors are standard 
deviation. All data obtained at -8 ℃. 
For PVA, the MLGS values also trend with the inverse number of orientations; with 
MLGS increasing and number of orientations decreasing (due to Ostwald ripening) as 
the concentration decreases, Figure 3.15A. Figure 3.15B shows PEG, indicating 
essentially no activity even at very high concentrations (up to 50 mg.mL-1), where 
non- specific effects dominate. Encouraged by these results, the self-assembling IRI 
active safranine-O was tested, versus phenosafranin, which cannot self-assemble and 
has no IRI. By both MLGS and XRD analysis, it can be seen that only safranine-O 
inhibits ice growth, with the same trend being observed for inverse number of 
orientations and MLGS values as for proteins and PVA, Figure 3.15C/D. These 
results demonstrate that this is a valid analysis method for IRI activity for a range of 
compounds, including more complex structures, and is complementary to the 
traditional optical-based methods. 
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Figure 3.15. Comparison of orientation analysis (here shown as inverse number of 
observed ice crystal orientations after 1800 seconds) and IRI activity (shown as mean 
length grain size, MLGS, as a percentage of PBS) over a range of concentrations for; 
A) PVA; B) PEG; C) safranine-O; D) phenosafranin. All concentrations are in mg.mL- 
1, errors are standard deviation. All data obtained at -8 ℃. 
 
3.6.4.3 Kinetics of Ice Crystal Growth 
A common challenge in the microscopy-based methods is extracting kinetic 
information. For XRD this is far simpler; the Xenocs Xeuss 2.0 used here has a 
PILATUS 100k detector that can collect 3D data every 14 seconds (10 s acquisition 
with a 4 s delay between measurements). This diffraction data includes, for example, 
information on the number of crystal orientations in each 14 s collection. When there 
is Ostwald ripening there is a decrease in the number of crystal orientations. The 
kinetics of this process can be followed by obtaining the rate of change in number of 
orientations over time. 
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Figure 3.16. Examples of how rates of ice recrystallisation are obtained using XRD. 
Changes in orientations observed for A) PEG and B) PVA; C) Comparison of rate 
obtained from the initial gradient of the fit (red line). [Polymer] = 2.5 mg.mL-1. All 
data obtained at -8 °C. 
The change in the number of orientations (i.e. number of crystals) for ice in the 
presence of non-IRI active PEG can be seen in Figure 3.16A. There is a clear decrease 
in number of crystals due to ice growth over the time course of the experiment. The 
same analysis for PVA (Figure 3.16B) shows a constant number of orientations, 
indicating a static process, and hence recrystallisation inhibition. It is important to note 
at this point that the actual magnitude of the number of crystals will vary in each 
sample due to the different nucleation rates (which is also hard to control), however 
the change is the part which is of interest here, and data can be normalised to the t=0 
points. 
Ice crystal growth rates were obtained for PVA and PEG from the gradient of change 
in number of crystal orientations, Figure 3.16C, showing that a parameter for ice 
growth can be extracted if required; the steeper the slope, the faster the ice crystal 
growth. The rate of change in number of crystal orientations is much greater for PEG 
than for PVA. 
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Figure 3.17. Relative ice growth rates compared to that of ice crystal growth for pure 
water for a range of concentrations; safranine-O (black) and phenosafranin (red) 
after 1800 seconds annealing at -8 °C. 
Relative growth rates were also obtained for samples over a certain concentration 
range. Relative rates were calculated by comparing the rate of change in number of 
orientations for a sample to that of a water control. As the concentration of IRI active 
safranine-O increases, the calculated gradient of initial change in number of crystal 
orientations gradually tends towards zero, from an increase in 0.007 crystals.s-1 to 
0.002 crystals.s-1, though the growth is minimal in any case, Figure 3.17. The rate for 
inactive phenosafranin also decreases but is up to 10x faster than that of safranine-O, 
with an average increase of 0.026 crystals.s-1. 
 
Figure 3.18. Number of crystal orientations over time for different proteins studied in 
this work. [Lysozyme] = 0.7 mg.mL-1, [AFPIII-His] = 0.4 mg.mL-1, [AFPIII-SNAP] 
= 0.1 mg.mL-1, [AFGP8] = 0.07 mg.mL-1 
Analysis of number of crystal orientations over time for several protein samples was 
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then obtained, showing similar trends to that of PVA and PEG, with the AF(G)Ps 
showing no change in number of orientations (and number decreasing for lysozyme) 
over 1800 s, Figure 3.18. The concentrations chosen were concentrations at which 
comparable IRI activity has been observed (AFGP8 is known to be highly active 
down to concentrations of 0.15 µg.mL-1), bar lysozyme, as this is a non-IRI active 
material. 
 
Figure 3.19. Relative ice growth rates compared to that of ice crystal growth for pure 
water for a range of concentrations of AFGP8 (black) and lysozyme (red) after 1800 
seconds annealing at -8 °C. 
Further concentrations of AFGP8 were tested by XRD and the relative rate of ice 
crystal growth plotted. For the concentrations of AFGP8 here, Figure 3.19, the mean 
rate of change in ice crystal orientations does not change – this is because AFGP8 is 
extremely active, even at low concentrations (lowest concentration tested here was 
0.005 mg.mL-1). The average rate for all concentrations is 0.00125 crystals.s-1, which 
is much lower than that of the lysozyme control, which is 0.041 crystals.s-1. 3 
concentrations of lysozyme, a non-IRI active protein were tested and the initial rate 
of change in number of crystal orientations barely differed; even between 
concentrations of 1 and 12 mg.mL-1, with rates of 0.042 and 0.031 crystals.s-1 
respectively, thus lysozyme decreases in number of orientations therefore has fewer, 
but larger ice crystals after the 1800 s anneal. The mean rate for the samples was found 
to be 0.041 and was compared to all AF(G)P samples tested. 
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Figure 3.20. A) Inverse average rate of change in number of observed ice crystal 
orientations over 1800 seconds for a small molecule (safranine-O), polymer (PVA) 
and protein (AFGP8) compared to their relative non-IRI active controls 
(phenosafranin, PEG and Lysozyme); B) Box plot of the mean gradients of change 
and standard deviation for IRI active (grey) and inactive samples (red). Mean = black 
square, individual data points = white hexagons. All data obtained at -8 °C. 
The rates obtained from the change in number of crystal orientations are compared for 
safranine-O and PVA compared to AFGP8 in Figure 3.20. The rates of crystal growth 
for all IRI active compounds can be seen to be close to zero, whereas that of the 
inactive controls it is higher, Figure 3.20B. A more thorough investigation of the Ih 
diffraction patterns using a different setup (other diffractometers can more precisely 
record peak widths) would need to be undertaken to obtain the exact number of ice 
crystals and possibly acquire rate constants and allow for a more in-depth discussion 
of the meaning of peak width in relation to strain and crystal size. This could include 
using larger detectors, readily available at synchrotrons, to increase the number of 
crystal orientations measured and improve the counting statistics when measuring 
large grain sizes or a detector that could be moved in 2θ to allow for an increased 
number of points across a peak to be measured than can be achieved when relying on 
the pixel size of a static detector like the one used here. This could be combined with 
a monochromated X-ray source giving pure Cu Kα1 radiation to allow accurate 
comparisons of peak widths. Light scattering is another potential technique that 
could be used to investigate light scattering properties of ice crystals as the scattering 
pattern would be determined by the ice crystal’s size and shape. Though, this 
technique would be of more use in cloud chambers. The X-ray scattering technique 
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works for bulk ice samples because the diffraction pattern is formed by X-rays that 
have only interacted with one crystal grain. The light scattering method would 
struggle when interacting with multiple crystallites. 
 
3.6.4.4 Dynamic Ice Shaping as Measured by XRD 
 
Figure 3.21. Crystal habit modifications by additives. Left) Ice diffraction patterns 
after 1800 s annealing for: samples with known ice-binding and shaping abilities, their 
relative non-binding controls and water/PBS); Right) Optical microscopy ice 
morphology analysis in 45 wt % sucrose of samples in the corresponding 
diffractograms. A) Water control; B) PBS control; C) Safranine-O; D) AFGP; E) 
Phenosafranin; F) Lysozyme. Scale bars = 100 µm. [Safranine-O] = 1.0 mg.mL-1; 
[AFGP8] = 3.0 mg.mL-1; [Phenosafranin] = 1.0 mg.mL-1; [Lysozyme] = 1.0 mg.mL-
1. 
Ice diffraction patterns and ice shaping for all three groups of compounds tested here 
are seen in Figure 3.21. The difference in the diffraction patterns between water and 
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PBS was first analysed to confirm similarities and differences – this was due to the 
salts’ potential colligative effects on ice growth and Ih structure, Figure 3.21A/B. The 
results from PBS samples are more relatable to biological samples and those in water 
would be more relatable to samples used in other fields, for example engineering and 
atmospheric chemistry. The structure for both is deemed to be Ih, though there are 
slight intensity variations for the Ih pattern between the two, but intensity variations 
are also seen in other samples, and are due to which crystallites orient towards the 
beam and not related to any ‘ice-activity’ of PBS. 
The (002) plane (2θ = 24.2 °) has been said to be missing in ice samples with 
additives,72,73 and is often explained as the additive showing ice-binding/DIS activity. 
Here measurements are taken using a static capillary, where the crystallites formed are 
too large to ensure a random distribution is sampled, thus structure analysis cannot be 
completely determined. A potential method to solve this problem would be to perform 
XRD whilst spinning the capillary, however there could still be preferred orientation 
effects. However, the static nature of this setup means that the range of orientation 
angles we are sensitive to does not change over time, meaning that for randomly 
distributed ice crystallites the number of orientations measured are proportional to the 
total in the sample. Due to differences in experimental setup and lack of detail in the 
literature, it is difficult to determine whether studies had randomly oriented 
crystallites/sampled a large enough range of crystallites to confirm ice- 
binding/DIS.73,90,91 Measurements made when freezing on a surface, will be affected 
by preferred orientation, thus may not give clear evidence of binding. Hence, the 
disappearance of a peak cannot solely be used to describe ice crystal 
morphology/binding accurately. For example, AFGP8 affects ice morphology by 
binding the primary prism plane, so would have a peak missing corresponding to this 
plane, but pure water (or PBS) would show all Ih peaks, however the 24.2 ° peak is 
missing in all samples, Figure 3.21A/B/D. The same peak should also be missing for 
safranine-O, however, is observed here, Figure 3.21C. Similarly, phenosafranin and 
lysozyme have no known ice-binding so the lack of 24.2 ° peak seen in Figure 3.21E/F 
cannot represent this. This shaping or lack of ice shaping is observed in the provided 
micrographs. 
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Figure 3.22. Ice diffraction patterns after A) 0 s and B) 1800 s annealing for 4 kDa 
PEG (2.5 mg.mL-1). All data obtained at -8 °C. 
Peak disappearance, if relating to binding, would occur repeatedly, yet PEG at 2.5 
mg.mL-1 shows peak splitting at (002), which becomes more pronounced over the 
1800 s anneal. This peak remains throughout, further refuting the claim that this 
indicates binding to an ice plane, Figure 3.22. 
 
Figure 3.23. Ice diffraction patterns after A) 0 s and B) 1800 s annealing for 4 kDa 
PEG (0.63 mg.mL-1). All data obtained at -8 °C. 
Another example contradicting the theory peak disappearance relates to binding is for 
PEG at 0.63 mg.mL-1, Figure 3.23. PEG is known not to bind ice or affect 
morphology, and at t=0 minutes the (002) peak is observed, however as the ice 
annealed, the intensity of the peak decreased gradually, until at 30 minutes it was no 
longer observed. This supports the theory that peak intensity relates to the size of the 
crystallites rather than ice-binding. This may be because as the grain size increases, 
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the scattering signal from that grain will also increase, but as the grains in the system 
grow in size, the total number of grains decreases, which can also result in a decrease 
in signal. 
When there is a change in ice grain size, particularly growth due to Ostwald ripening, 
fewer crystal orientations are observed and peak intensity changes. This can cause 
particular orientations to not scatter the X-ray beam leading to peak disappearance, 
thus the diffraction pattern peaks cannot be used to describe ice crystal morphology 
accurately in these disordered samples. This is crucial to show the limitations and 
applications of this method to explore the kinetics of ice recrystallisation as a 
complementary tool to optical microscopy. 
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3.7 Conclusion 
XRD was used as a non-invasive method for 3D analysis of ice crystal growth 
(recrystallisation) and compared to the more commonly used optical techniques. This 
method gives the number of orientations in polynucleated samples (which is 
proportional to the number of crystals), rather than the actual number of ice crystals 
that may be counted from a micrograph. This method is complementary, as 
measurements are performed in a capillary (3D conditions), which facilitates the 
measurement of a larger number of crystals in the system, as well as being preferable 
to 2D systems, where the sample holder will have a greater effect on the growth 
mechanisms. This technique provides more information at another lengthscale not 
only micrometres. Furthermore, data can be obtained every 14 seconds (for this 
particular instrument, with the rate depending on individual facilities), enabling real-
time kinetic analysis without analysing each frame from videos/micrographs. 
Using this method, the IRI activity of a range of synthetic and biological ice-active 
compounds was compared and found that it was in good agreement optical methods. 
This was performed by following ice growth by calculating the relative number of ice 
crystal orientations from 2θ ranges that cover each of the seven Ih peaks from each 
diffraction pattern at every time point. A fitting method was then developed to obtain 
simple kinetic data, which provides an advantage over that of optical methods. This 
consisted of plotting the number of crystal orientations as a function of time and 
obtaining the gradient of change in number of orientations, which was then extracted 
as a rate and compared to that of pure water and PBS controls. 
Peak widths (e.g. to determine crystallinity using full width at half maximum 
(FWHM)) have not been analysed in this work, as the data required could not be 
collected, however with newer machines it is possible. Changes in peak width however 
will not affect the number of orientations, as the resolution in counting orientations is 
from the ψ angle and not 2θ. For a more in-depth discussion of peak width in relation 
to strain and crystal grain size, analysis would have to be performed on patterns 
obtained from a higher resolution (not in-lab) setup with a detector that could be 
moved in 2θ, thus allowing for an increased number of points across a peak to be 
obtained. This combined with a monochromated X-ray source giving pure Cu Kα1 
radiation to allow accurate comparisons of peak widths. 
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We also evaluated the ice diffraction patterns obtained in the presence of ice-active 
materials, confirming the phase present was Ih, noting the loss of intensity of the (002) 
peak, in cases where there was, and was not ice-binding, and that any potential changes 
in hydrogen bonding cannot be visualised here, in that they do not affect the oxygen 
lattice. Peak disappearance could be interpreted as indicating specific ice-binding, 
but we show with controls that this cannot be inferred due to preferred orientations 
and insufficient crystallites within the scattering volume. This confirms that the 
method is a useful addition to the suite of tools for discovering and investigating new 
ice recrystallisation inhibitors but that, in the setup used here, care must be taken not 
to overfit the data and extrapolate information about specific crystal face binding. 
Overall, XRD can be successfully used as a supplementary tool to study IRI, however 
thus far provides little extra on the mechanism of action of AF(G)Ps and their mimics 
on ice. 
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3.8 Experimental 
3.8.1 Materials 
Poly(ethylene glycol) (PEG) (4kDa) and poly(vinyl alcohol) (PVA) (10 kDa), 
phosphate-buffered saline (PBS) preformulated tablets, lysozyme and ampicillin were 
purchased from Sigma-Aldrich and used as supplied unless otherwise stated. 
Imidazole (Merck), isopropyl-β-D-thiogalactoside (IPTG) (VWR chemical), 
safranine-O and phenosafranin (ACROS organics), Novex AP Chromogenic and 
Coomassie blue stain (Expedeon) were also used as supplied. IMAC Sepharose 6 Fast 
Flow columns, HiLoad 16/600 Superdex 75 pg gel filtration columns and PD10 
desalting columns were purchased from GE Healthcare and used according to 
manufacturer’s instructions. AFGP8 CC-86-XVII was kindly provided by A. L. 
DeVries (University of Illinois at Urbana-Champaign, USA) and used as received. 
Gold nanoparticles were synthesised as reported previously.82 For washing of AuNPs, 
Amicon Ultra-0.5 centrifugal filter units with Ultracel-30 membrane were used. 40 nm 
citrate-stabilised gold colloid solution was purchased from BBI solutions. The 
pET20b-AFPIII plasmid encoding for a hexahistidine-tagged AFPIII from ocean pout 
(rQAE isoform, M1.1HISPET20b) was kindly provided by Peter Davies (Queens 
University, Kingston, Canada). Competent Escherichia coli BL21(DE3) cells were 
sourced from New England Biolabs. 
 
3.8.2 Physical and Analytical Methods 
A Linkam Biological Cryostage BCS196 with T95-Linkpad system controller 
equipped with a LNP95-Liquid nitrogen cooling pump, using liquid nitrogen as the 
coolant (Linkam Scientific Instruments UK, Surrey, U.K.) was used to anneal ice 
wafers. An Olympus CX41 microscope equipped with a UIS-2 20x/0.45/∞/0−2/FN22 
lens (Olympus Ltd., Southend on sea, U.K.) and a Canon EOS 500D SLR digital 
camera was used to obtain all images. Image processing was performed using ImageJ, 
which is freely available from http://imagej.nih.gov/ij/. 
X-ray diffraction measurements were made using a Xenocs Xeuss 2.0 equipped with 
a micro-focus Cu Kα source collimated with Scatterless slits. The scattering was 
measured using a Pilatus 100k detector with a pixel size of 0.172 mm x 0.172 mm. 
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The distance between the detector and the sample was calibrated using silver behenate 
(AgC22H43O2), giving a value of 0.161(3) m. The detector was fixed at an angle of 36 
° giving a 2θ range of 18.5 to 47.5 °. 
 
Samples were inserted into 1 mm diameter, 0.01 thick, 70 mm long quartz capillaries 
(Capillary Tube Supplies Ltd) and mounted in a Linkam THMS350 furnace. 
Measurements were made with a counting time of 10 seconds and a delay of 4 
seconds between each measurement. 
 
3.8.3 Procedures 
3.8.3.1 Recombinant Expression of His-AFPIII 
A pET20b-AFPIII plasmid encoding for a hexahistidine-tagged AFPIII from ocean 
pout (rQAE isoform, M1.1HISPET20b) was kindly provided by Peter Davies (Queens 
University, Kingston, Canada). The plasmid was transformed into competent 
Escherichia coli BL21(DE3) cells (New England Biolabs). A colony was selected to 
inoculate 50 mL of LB-medium containing 100 µg.mL-1 ampicillin and was grown 
overnight at 37 °C under continuous shaking of 180 rpm. The following day, 5 mL of 
the preculture was added to 500 mL of LB-medium in a 2 L Erlenmeyer flask and 
grown at 37 °C with a shaking speed of 180 rpm till an OD600 of 0.6 was reached. 
The temperature was then reduced to 16 °C and IPTG was added to a final 
concentration of 0.4 mM. The overexpression of the protein was allowed to take place 
overnight following which the cells were centrifuged at 4000 g for 30 minutes at 4 °C. 
Pelleted cells were resuspended in PBS supplemented with Pierce™ Protease Inhibitor 
Mini Tablets. The suspension was passed through a STANSTED ‘Pressure Cell’ 
FPG12800 homogeniser in order to lyse the cells. The cell lysate was centrifuged at 
14,000 g and the supernatant was passed through a 0.45 nm filter and applied to an 
IMAC Sepharose 6 Fast Flow (GE Healthcare) column charged with Ni(II) ions and 
pre-equilibrated with PBS. The column was washed with 20 column volumes of 20 
mM imidazole in PBS. Bound AFPIII was eluted using 300 mM Imidazole in PBS. 
The AFPIII was further purified using a HiLoad 16/600 Superdex 75 pg gel filtration 
column (GE Healthcare) with PBS as the running buffer. Fractions exclusively 
containing the AFPIII were pooled and concentrated to 5 mg.mL-1. Purity was 
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estimated using SDS-PAGE and protein concentration determined using Thermo 
Scientific Pierce BCA assay kit. This was verified by measuring absorbance at 280 
nm and obtaining protein’s extinction coefficient [as predicted by ProtParam 
(http://web.expasy.org/protparam/)] for use in Beer-Lambert law. 
 
3.8.3.2 Recombinant Expression of SNAP-AFPIII 
A genetic fragment encoding for AFPIII fused to a hexahistidine tag was amplified 
using PCR from the pET20b-AFPIII plasmid using 5’- 
GTACGGATCCAACCAGGCTAGCGTTGTG-3’ (BamHI site underlined) as the 
forward primer and 5’-ATTAGCGGCCGCAGCCGGATCTCAGTG-3’ (NotI site 
underlined) as the reverse primer. The BamHI/NotI digested products were ligated 
into a pSNAP-tag® (T7)-2 vector (New England Biolabs). The plasmid was then 
transformed into competent Escherichia coli BL21(DE3) cells (New England 
Biolabs). The subsequent expression and purification was performed as detailed for 
AFPIII. 
AFPIII conjugation to AuNP was performed by Dr Wilkins as described in Wilkins 
et al., (Polym. Chem., 2019) for use in the following ice-activity experiments.82 
 
3.8.3.3 XRD Sample Preparation 
Samples were prepared, in either PBS solution or using Milli-Q ultrapure water with 
resistance < 18 Ω obtained from a Milli-Q© Integral Water Purification System, over 
a range of concentrations and 10 μL was inserted into 1 mm thick quartz capillaries 
using a hypodermic needle (Sterican) and 1 mL syringe, and mounted in a Linkam 
HFSX350 stage and cooled to -35 °C at 30 K.min-1. The samples were then heated to 
-8 °C where X-ray scattering was performed. 
 
3.8.3.4 XRD Data Analysis 
Diffraction pattern plotting, orientation analysis and any statistical tests were 
performed using OriginPro software, version 2018b. Three major diffraction peaks: 
(100), (002) and (101) were focused on. Positions (2θ) of these peaks are 22.7 °, 24.5 
° and 25.8 ° respectively. 
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3.8.3.5 XRD Orientation Analysis 
Measurements as a function of temperature were made with a counting time of 10 
seconds repeatedly, with a 4 second delay between each acquisition, over 1800 
seconds annealing, enabling analysis of the number of crystal orientations observed 
over time and comparison to splat assay data. A radial integration of the 2D scattering 
profile was performed using FOXTROT 3.3.4 software resulting in 1D intensity 
versus 2θ plots. In addition, azimuthal integrations for each Bragg peak were 
performed producing 1D intensity versus ψ plots. Data was then ran through an in- 
house MATLAB (The MathWorks, Natick, MA) code to obtain the number of ice 
crystal orientations. Each data point with an intensity greater than a threshold value 
1.5 counts) was counted as a crystal orientation. The total number of data points 
(#orientations) was calculated for a 1D intensity versus ψ file using the following line 
of code: 
NumberOfOrientations{i}=sum(Intensities{i}>IntensityThreshold); 
 
This was run in a script to calculate the number of orientations for each Bragg peak, 
and to handle the large number of datasets produced in the annealing studies. To 
compare the rate of crystal growth, the gradient of change in orientations over time 
was obtained. 
 
3.8.3.6 Ice Recrystallisation Inhibition ‘Splat’ Assay 
A 10 μL droplet of additive in PBS solution is dropped from 1.4 m onto a glass 
microscope coverslip on top of an aluminium plate cooled to −78 °C using dry ice. 
Upon impact with the plate the droplet instantly freezes, spreading out and forming a 
thin wafer of ice. This wafer is then placed on a liquid nitrogen cooled cryostage 
cooled to −8 °C. The wafer is then left to anneal for 30 min at −8 °C. Three 
photographs are then taken of the wafer in different locations at 20× zoom under cross 
polarizers. Using ImageJ, the numbers of crystals in the images were counted and the 
average crystal size per wafer was calculated as mean grain area (MGS) as well as the 
mean grain length size (MLGS) and reported as a % of area compared to PBS control. 
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3.8.3.7 Modified Sucrose ‘Sandwich’ Ice Shaping Assay 
Samples dissolved in PBS buffer containing 45 % sucrose were sandwiched between 
two glass coverslips and sealed with immersion oil. Samples were cooled to −50 °C 
on a Linkam Biological Cryostage BCS196 with T95-Linkpad system controller 
equipped with a LNP95-Liquid nitrogen cooling pump, using liquid nitrogen as the 
coolant (Linkam Scientific Instruments UK, Surrey, U.K.). The temperature was then 
increased to −8 °C and held for 1 hour to anneal. The samples were then heated at 0.5 
°C.min-1 until few ice crystals remained and then cooled at 0.05 °C.min-1 and the shape 
of ice crystals observed. Micrographs were obtained every 0.1 °C using an Olympus 
CX41 microscope equipped with a UIS-2 20x/0.45/∞/0−2/FN22 lens (Olympus Ltd., 
Southend on sea, U.K.) and a Canon EOS 500D SLR digital. Image processing was 
conducted using ImageJ. 
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Combined solid state NMR dynamics and 
ice recrystallisation inhibition activity 
measurements of synthetic and biological 
antifreeze (macro)molecules. 
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4.2 Chapter Abstract 
Antifreeze and ice-binding proteins have evolved to recognise and inhibit the growth 
of ice, and function via defined ice-binding faces. Synthetic mimics, including PVA, 
are also potent ice growth inhibitors, but are fully flexible molecules without a defined 
ice-binding face. Current understanding is limited to indirect measurements of 
macroscopic outcome or modelling studies. Low temperature solid state NMR 
(SSNMR) measurements of proteins are becoming more commonly used to investigate 
dynamic processes such as ligand binding and folding, as well as characterising the 
timescales of these motions. However, research thus far has focussed on two of the 
components that make up frozen protein samples: the proteins and the liquid water 
phase. The third component, ice, has been rarely studied until recently due to the ice 
protons’ long relaxation times.  
Here a combination of microscopy and SSNMR is used to provide the experimental 
molecular-level details of antifreeze (macro)molecule:ice interactions. We show that 
the critical ice growth inhibition constant for PVA as a function of chain length scales 
with the correlation times (Cτ) of the ice, with longer chains (DP≥20) being IRI active 
and affecting ns - ps dynamics in the ice (Cτ of <200 ps for IRI active PVAs, >350 ps 
for non-IRI active PVAs). This supports a model of extended hydrogen bonding (the 
longer chain PVAs contain more hydroxyl groups available for hydrogen bonding), 
and enthalpy-entropy compensation driving affinity for ice for longer polymer chains. 
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Clear reductions in correlation time are also observed for safranine-O solutions (<100 
ps), indicating more rapid motions for IRI active materials tested here  
2D Exchange Spectroscopy (EXSY) is used to show direct antifreeze 
(macro)molecule:ice interactions absent in controls by detecting chemical or 
conformational exchange. These findings provide clear evidence for how polymeric 
ice growth inhibitors recognise ice surfaces and help our understanding of this 
complex recognition process, as well as the development of new cryoprotectants. 
These studies into the antifreeze (macro)molecule:ice interface present SSNMR as 
another technique that could be further utilised to study the interactions of more 
synthetic cryoprotectants and ice.  
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4.3 Introduction 
Antifreeze and ice-binding proteins (IBPs) have evolved to bind to specific 
crystallographic planes of ice leading to the macroscopic properties of non-colligative 
freezing point depression, crystal shaping and IRI.1–4 Many applications have been 
suggested for these proteins and their ice-interacting mimics, ranging from 
cryopreservation to aerospace/engineering.5–10 The question of how a protein can 
recognise a dynamic interface such as ice in a large excess of water, which also 
undergoes the same range of hydrogen bonding interactions, is a complex one. Crystal 
structures of AFPs reveal large, rigid ice-binding sites, which can potentially pre-
organise clathrate water molecules that then engage with ice.11 In contrast, AFGPs are 
more flexible; though there is no published crystal structure, it is not clear if their 
glycans or the protein backbone engage the ice. Conflicting research states that AFGPs 
may bind either reversibly or irreverisibly.12,13 PVA has emerged as a potent AFGP 
mimic, despite it being fully flexible and not possessing an ice-binding surface,14 and 
a variety of mechanisms have been proposed as to how these antifreezes act. In 
particular, AFGPs are suspected to bind ice via hydrophobic interactions, whereas PVA 
recognizes ice by a zipper mechanism and interacts using hydrogen bonding.12,15 
Koop proposed that the spacing between hydroxyls of PVA matches that of the 
prismatic planes of ice, which agrees with macroscopic observations of changes in 
crystal growth habits.16 Gibson et al. have shown that PVA has a strong molecular 
weight/chain length dependence on its activity, demonstrating a multivalent 
enhancement in its binding affinity, though this is not fully understood.17,18  
Experimental studies, such as XRD and microscopy (explored in Chapter 3), rely on 
macroscopic observations on length, and timescales far greater than that of the likely 
interactions between the PVA and ice. There is no direct experimental observation of 
binding, due to the challenge of using techniques such as, but not limited to, electron 
microscopy on ice, and much research into the role of structure, orientation of 
functional groups and hydrophobicity/hydrophilicity of antifreezes has been 
performed using MD simulations. For example, Naullage et al. have predicted using 
MD, that PVA binds via an extended array of hydrogen bonds, which they describe as 
where the PVA binding follows a regular pattern controlled by distance matching, with 
two out of every three hydroxyl groups hydrogen bonding to the ice. They also discuss 
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entropy-enthalpy compensation as part of the binding mechanism, observing that as 
water molecules are lost from the polymer’s hydration shell (into the ice lattice), the 
enthalpic contribution of the hydrogen bonding is enhanced, potentially through their 
entropy of desolvation. Their findings indicate that longer chain PVAs show increased 
affinity (and thus a ‘switch on’ of ice-activity) due to this entropy-enthalpy 
compensation; as they interpret PVA binding (arising from a different scaling of the 
enthalpy and entropy of binding) to be a function of hydroxyl groups bound.15 
Microscopy has been useful for studying macroscopic effects thus far. However, it 
cannot provide detail at an atomic scale or allow us to study the bulk ice, as only 
snapshots of these activities can be obtained from micrographs. However, these 
snapshots have been important in gaining knowledge of which ice faces are bound by 
different cryoprotectants.19,16 
If we can understand the mechanisms of action of these ice-interacting compounds, 
this could lead to the discovery of more effective, less toxic mimics (AFPs are 
cytotoxic so cannot be used in cryopreservation). More physical techniques including 
XRD and NMR, as well as molecular dynamics (MD) have increasingly become of 
use, as a comprehensive physical understanding on an atomic scale will assist with an 
understanding of how ice-active compounds work further up the chain, i.e. at a cellular 
level.20–23 
All atomic nuclei possess electric charge, mass and spin (also known as angular 
momentum). The latter is critical for NMR, as NMR-active nuclei have non-zero spin 
quantum numbers (I) and are inherently magnetic, which produce a magnetic dipole 
moment (µ). The nuclei transition between different spin states is related to the energy 
difference between the states. When the nuclear spins are placed in an external 
magnetic field (B0), they reorient themselves with or against the magnetic field. In this 
work hydrogen is used as a probe to investigate (macro)molecule:ice interactions since 
this is the most abundant element of interest in these systems. 1H has a spin quantum 
number of ½ and splits into two energy levels when placed in a magnetic field. When 
a sample is being analysed, there is an extremely large number of nuclear spins, and 
net bulk magnetisation (M0) arises parallel to the magnetic field, Figure 4.1A. 
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Figure 4.1. A) Alignment of spins in a magnetic field; when subject to a magnetic 
field (B0) spins are no longer isotropically distributed and aligning with or against the 
field. (A small excess of parallel spins result in a net magnetisation of M0); B) 
Schematic of rotation of bulk magnetisation by RF pulses. When an RF pulse is 
applied, the bulk magnetisation rotates and is transferred to the x-y plane (signal is 
detectable). When the pulse is turned off the protons return to B0 and the signal decays; 
C) NMR signal as an exponentially decaying sine wave (FID). The FID is converted 
into data used in this work. 
To detect NMR in a spectrometer, the magnetic moment is perturbed from the z-axis 
by the application of a radiofrequency (RF) pulse. This rotates the magnetisation from 
the z-axis to the x-y plane (Figure 4.1B), producing a signal that can be detected. 
When the pulse is turned off, bulk magnetisation returns to equilibrium (parallel to z-
axis). The rate at which this occurs depends on longitudinal relaxation (T1) and 
transverse relaxation (T2). T1 describes the return to equilibrium as a result of spins 
interacting with the surrounding lattice and T2 describes the return as a result of spin-
spin interactions. Both T1 and T2 relaxation are caused by transient magnetic fields due 
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to molecular motion/reorientation, however T2 is also caused by the swapping of 
chemical shifts (or coupling constants) due to conformational change or chemical 
exchange. The signal that is detectable decays over time, and is known as free 
induction decay (FID) and is Fourier transformed to obtain an NMR spectrum, Figure 
4.1C. The chemical shift, intensity and linewidth (λ, full peak width at half maximum 
height) can be quantified from the spectra. The linewidth of an NMR signal is 
determined by T2; increased linewidths can be due to short T2 relaxation. When 
relaxation is very fast, broadening may lead to difficulties in detecting the signal. 
NMR has been used to provide information about the actual structure of ice but is also 
informative for determining the time scale for diffusive motion of the protons.24 It is 
particularly relevant for studying ice as it is a non-destructive technique, and SSNMR 
can give atomic resolution information over a range of timescales (picoseconds to 
seconds) over a range of temperatures and can investigate samples that are neither in 
solution nor crystalline as well as interfaces. SSNMR has recently been added to the 
arsenal of techniques used to study AF(G)Ps as crystalline protein is not required and 
has been previously used to study the structure and dynamics of both crystalline and 
non-crystalline molecular assemblies at solid/liquid interfaces.25–28 
Recent research involving MD and NMR includes that of gas-to-ice chemical shifts, 
studies into the local structure of AFGPs, SSNMR and MD of AFPIII concerning the 
ice-binding site (IBS), and ice microstructure.26,29–35 SSNMR investigations has also 
concerned synthetic AF(G)P mimics and ice-binding, for example Ben et al’s work on 
IRI active carbohydrates found ice-binding to not be a requirement for IRI activity. 
This further led them to postulate that IRI activity must relate to a compounds ability 
to alter the bulk water structure rather than interaction with the ice lattice.36 The effect 
ice-active materials have on the bulk water structure is what is of interest here. These 
studies have been useful for discussing the motions in these samples. Agreement 
between experimentally measured relaxation times and predicted ones is important 
and could lead to further understanding of the ice formation and growth process. So 
far, in the ice field little work has been undertaken into NMR (due to the broad peaks), 
with the focus on proteins and the liquid water phase,37  and most simulations consider 
different timescales.  
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Figure 4.2. NMR data obtained in the literature using a variety of techniques: A) 
Change in transverse (spin-spin relaxation in the x-y plane) (T2) relaxation times over 
time for 5 samples. Ice control (black diamonds), ice+BSA (10 µg.mL-1) (white 
circles), ice+[extracellular protein] (10 µg.mL-1) (red circles) ice+IBP (2 µg.mL-1) (red 
triangles) and ice+IBP (4 µg.mL-1) (red squares). Adapted from Brown et al., 
(Biotechnol. Reports., 2014);38 B) Study of type I AFP binding reversibly: NMR 
spectra of deuterated type I AFP (1 mg.mL-1) showing molecular exchange between 
the ice surface and aqueous solution at different exchange times, narrow peaks: 
aqueous signal (indicating protein in aqueous phase), broad flat peaks: solid/ice signal 
(indicating protein bound to ice phase). Adapted from  Ba et al., (J. Am. Chem. Soc., 
2003);27 Chemical shift difference obtained from 13C-13C DARR spectrum for each 
amino acid in C) AFPIII (34 mg.mL-1) frozen in water at -15 ℃ and D) ubiquitin (25 
mg.mL-1). (Samples in water, spectra recorded on 750 MHz spectrometer with mixing 
time of 20 ms, 12 kHz MAS at -15 ℃). Adapted from Siemer and Mcdermott, (J. Am. 
Chem. Soc., 2008).25 
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As ice-binding materials affect the ice interface,14,39–41 there will also be a change in 
the dynamics of the ice and water. SSNMR is an ideal method for studying frozen 
solutions for three reasons: firstly, many biomolecules have hydration shells that do 
not freeze with the bulk solvent; secondly, the existence of a disordered layer, which 
behaves differently to the bulk water space; finally, unlike other techniques, it allows 
the study of AFPs and other antifreezes in situ. A variety of different solution state 
and SSNMR approaches have been used to identify the ice-binding surface of 
AFPs/evidence for a molecular contact surface between ice and AFPIII; including 13C 
spin-lattice relaxation, 1H-1H cross-saturation, T2 relaxation and 13C-13C dipolar 
assisted rotational resonance (DARR) experiments on labelled samples, Figure 4.2.  
Work has been performed on IBPs using solution state NMR, showing that microbial 
extracellular IBPs inhibit recrystallisation activity (short T2 relaxation times for IBPs 
indicate ice growth inhibition) and modify the 3D ice structure. This results in 
persistent small size ice crystals, demonstrating a potential mechanism for microbial 
survival in sub-zero temperatures, Figure 4.2A.38 By measuring the 1H-1H cross-
saturation and cross relaxation of protons in frozen AFP:ice solutions, more detailed 
structural information has been obtained about the direct contact certain AFPs make 
with ice. Cross-saturation and cross relaxation experiments involve mapping protein–
molecule interfaces and are based on 1H resonance signals of a non-deuterated sample 
(e.g. protein), which are saturated, leading to magnetisation of a second lower 
concentration deuterated sample (e.g. ice) by cross relaxation through their interface. 
If there is an interface saturation will be transferred, indicating binding. Ba et al. 
studied AFPI in a similar way, specifically investigating dynamics and reversibility of 
AFPI binding. They observed increased liquid-phase signals for AFPI as molecular 
exchange times were increased from 0.001 to 3 s, indicating desorption of peptide 
from ice surfaces into the aqueous solution at higher exchange times and thus 
reversible binding, Figure 4.2B.27,28 Siemer and McDermott compared frozen 
SSNMR spectra of AFPIII and ubiquitin (as it has no non-colligative antifreeze 
activity) to solution state spectra to examine chemical shift perturbation for the 
different amino acid residues in solid-state experiments compared to that of solution-
state, observing more pronounced chemical shift changes (up to 1.5 ppm) for AFPIII, 
with the largest shifts detected for amino acid residues previously shown to be 
involved in ice-binding, such as Thr18, Figure 4.2C/D.25,42,43 
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The range of techniques applicable to the investigation of ice make SSNMR a valuable 
tool for understanding how ice-interacting proteins impact the 3D vein network and 
recrystallisation processes, which is critical for exploiting the full potential of these 
proteins in biotechnology applications.38 
Considering the above, here the combined use of optical microscopy alongside 
variable temperature SSNMR is reported, and the first experimental evidence that 
PVA can form an extended hydrogen bonded array at the ice surface, which is chain-
length dependent is provided supporting that enthalpy-entropy compensation helps 
drive activity. Additionally, 2D NMR evidence for a direct antifreeze:ice interaction 
is presented.  
 
4.3.1 SSNMR Study of Motions in Solids 
A range of SSNMR techniques can be used to extract dynamic information from a 
solid sample.44 Each technique is sensitive to a certain range of motions; for example 
R1 relaxation measurements can be used to probe motions on the ps – ns timescale, 
which can be due to side chain rotations or molecular tumbling. As well as exploring 
a range of motions, NMR can measure their amplitude and frequency,45 enabling an 
understanding of how these motions arise and their relation to the structure of a 
sample, its properties and any phase transitions. A combination of different SSNMR 
techniques is used here to provide an overall picture of the dynamics in these samples, 
Figure 4.3. [Note, when processes are described as fast or slow, these are on the NMR 
timescale, which is relative to the difference in resonance frequencies between 
exchanging nuclei.] 
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Figure 4.3. SSNMR techniques conducted in this project and their associated 
timescales at which they are sensitive to motions. Techniques include: Chemical 
Exchange Saturation Transfer (CEST), which measures exchange between one 
‘invisible’ low concentration state and a higher concentration state – if exchange 
occurs, two peaks will be observed (timescales covered: ms - s); Relaxation 
Dispersion, which monitors chemical exchange of nuclei between ms – ns timescales; 
2D Exchange, which is used to indicate dipolar cross relaxation between two nuclei 
that are spatially close to one another. 2D experiments are particularly useful for 
determining which signals arise from protons that are close to each other in space even 
if they are not bonded. (timescales covered: 1 ms – 100 s); R1 Relaxation, which 
measures spin-lattice relaxation (restoration of spin to equilibrium state via z plane), 
originating from local motions, such as rotation (timescales covered: 10 ps – 10 ns); 
R2 Relaxation, which measures transverse relaxation (restoration of spin to 
equilibrium state via x-y plane) (timescales covered: ns – ms); Adapted from Stevens, 
R.A., (PhD, University of Warwick, 2018).46 
As mentioned previously, when performing NMR experiments, a RF pulse affects the 
magnetisation of a sample. Relaxation is the change in time as the system moves back 
towards equilibrium from some non-equilibrium state imposed by these pulses.47 The 
relaxation rate of a sample changes depending on motion in the sample; it is sensitive 
to the nucleus’ environment and its dynamics. Relaxation measurements have 
successfully been used to extract information on solids,45 membrane protein 
structures48,49 and dynamics in e.g. lipid bilayers50 and ion channels,51,52 as they 
provide information on the motion’s timescales, amplitudes and, in some cases, 
directionality. Relaxation measurements are used here to characterise molecular 
motions in the solid water. 
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Proton dynamics in polycrystalline hexagonal ice can include proton translation, 
diffusion and Bjerrum defect dynamics.53,54 The dynamics of the protons determine 
the ice phase, and any defects in the hexagonal structure, which may originate from 
distortions in the hydrogen bond network (e.g. due to OH-rotation), should be 
considered when analysing (macro)molecule:ice interactions. It has been observed that 
antifreezes affect the dynamics in ice, and this potentially relates to defects in the 
structure of the water. Generally, the Bernal Fowler (BF) rules are violated leading to 
defects in ice crystals, such as Bjerrum (D- or L-defects) and ionic defects.55 Point 
defects such as interstitials or Schottky (vacancies), where one or more water 
molecules are missing from the regular ice lattice, can also form. In samples of Ih, 
both, Bjerrum defect dynamics and translational diffusion of protons have been 
identified by 2H NMR stimulated echo experiments,53 and it has been theorised that 
the most reasonable mechanism of fast reorientation dynamics in Ih, such as those 
seen in R1 experiments, is due to a Bjerrum defect at the central oxygen atom.53  
 
4.3.2 Magic Angle Spinning 
 
Figure 4.4. An example SSNMR rotor spinning at the "magic angle" (54.74 °) with 
respect to the strong magnetic (B0) field at a frequency of νMAS, which sufficiently 
narrows peaks obtained in SSNMR experiments. Most modern rotors are made of 
zirconia and have decreased in diameter over the years as magic angle spinning (MAS) 
technology has advanced. 
A major difference between NMR in the solid state and in the solution state is the lack 
of rapid overall motion in solids. Molecules tumble quickly and undergo random 
motions in solution, thus NMR parameters that are orientation dependent (anisotropic) 
will be averaged out to their orientation independent (isotropic) values, but this is not 
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the case in the solid state. “Magic angle” spinning (MAS) is routinely applied in 
SSNMR experiments as it improves the averaging out of the anisotropic interactions 
and so narrows the linewidths i.e. removes line–broadening effects due to various 
interactions by introducing artificial motion, thus simplifying NMR spectra, Figure 
4.4.  
The frequency at which this is applied has to be significantly larger than the size of 
the interaction. Due to recent advances MAS of up to 150 kHz is possible, with 60 
kHz typically being chosen for protein SSNMR experiments. Here a frequency of 10 
kHz has been chosen, as the larger the spinning frequency the smaller the rotor chosen 
to spin the sample. 4 mm rotors were chosen here.  
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4.4 Chapter Aims 
This work focuses on observing solid water in the presence of various ice-interacting 
materials that act as non-colligative antifreezes (proteins, polymers and a small 
molecule) to further understand ice-activity of synthetic antifreezes. [From this point 
onwards all ice-active “non-colligative antifreezes”, including IRI active and those 
that shape ice are termed “antifreezes”.] 
• Investigate the mobility of nuclei in frozen water and how it is affected by 
antifreezes using SSNMR 
• Compare the IRI activity of antifreezes and ice proton mobility using 
relaxation by measuring R1, R2 and R1ρ of antifreeze:ice samples; observe 
where activity ‘turns on’ for different length PVAs 
• Monitor any changes in relaxation over time as ice crystals grow 
• Investigate exchange between ice and antifreezes via 2D EXSY 
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4.5 Results and Discussion 
Three types of ice-interacting materials were investigated for further analysis in this 
work (Figure 4.5): 
• PVA - polymer known to have non-colligative antifreeze properties 
• Safranine-O - small molecule recently found to be an antifreeze56 
• AFP type III (AFPIII), AFP type I from Liposetta pinnifasciata (barfin plaice) 
(bpAFPI) and AFGP8 – antifreezes found in nature 
Additional samples were used as negative controls for the three types of antifreezes: 
PEG, phenosafranin and lysozyme, respectively; these were selected as they have no 
non-colligative antifreeze properties.  
It is likely that there are regions of water/ice present, e.g. a disordered layer such as 
the quasi-liquid layer (QLL), rather than a specific antifreeze:ice interface, and that 
water molecules will exchange between these regions. These regions may have 
different structures, dynamics and capabilities of binding to antifreezes. SSNMR 
provides measurements averaging dynamics of the water protons from all the regions 
involved, and a combination of different SSNMR techniques (Figure 4.3) are used to 
obtain information on motions and exchange in these samples. 
 
4.5.1 PVA; Chain Length and IRI Activity 
As mentioned in Chapter 3, the IRI and shaping effects of AF(G)Ps have been well 
studied using optical techniques, but this is less so for synthetic mimics. Ice-activity 
of these proteins and synthetic mimics has been studied in this thesis so far using both 
microscopy and XRD, providing results supporting that of the literature, as well as an 
alternative technique for gauging activity. This chapter delves further into the 
mechanism by which IRI activity is ‘turned on’ in PVA as the polymer chain length 
increases. [Note, the degree of polymerization (DP) is written after the polymer, i.e. 
PVA20 corresponds to chain length of 20. Both molecular weight and DP are used to 
describe PVA throughout]. Results for IRI activity (‘splats performed by Dr Thomas 
Congdon, University of Warwick) are shown in Figure 4.6.  
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Figure 4.5. IRI activity as mean largest grain size (MLGS) for PVAs over a range of 
chain lengths. A) 0 to 10 mg.mL-1; B) Magnification of A, showing activity for 0 to 1 
mg.mL-1. Grain size is recorded after 30 minutes annealing at -8 ℃. Errors are 
standard deviation of at least 3 measurements. 
As the polymer chain length increases, IRI activity also increases; activity is non-
existent for chain lengths shorter than 10 units (black), with MLGS being almost the 
same as that of the PBS control at all concentrations tested. Activity for the longest 
chain tested (DP = 246), which is the chain length of the 10 kDa PVA tested in Chapters 
2 and 3, is highest with IRI activity at 0.05 mg.mL-1 (MLGS = 47.5 %). This analysis 
also highlights the dramatic increase in IRI activity of PVA as the chain length 
increases; from 10 units (MLGS = 95.4 %) to 19 units (MLGS = 31.1 %). 
Analysis of individual ice crystal morphology also confirmed that PVA tested here has 
a preference for the prism plane of ice (when tested at 1.0 mg.mL-1). This binding is 
observed as capped column crystals, Figure 4.7A. This morphology can be explained 
using the schematic in Figure 4.7B, where PVA binds to the prism plane of the ice 
crystal preventing growth at this face upon addition of water molecules. When water 
adds onto the crystal it binds the basal plane causing growth along the c-axis, and thus 
the formation of a new prism plane. No further PVA binds, therefore, as water 
molecules add to the crystal, they preferentially bind this new face leading to faster 
growth there, leading to a capped morphology.  
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Figure 4.6. A) Ice growth habit analysis for a range of PVA molecular weights used 
here; (PVA20, PVA64, PVA98, PVA230). [Polymer] = 1 mg.mL-1. Scale bar = 50 
µm. Samples frozen in sucrose solution. Images recorded after a period of melting to 
leave a few crystals and then taken whilst cooling at 0.2 ℃ intervals; B) Schematic of 
example ice habit growth due to PVA binding the primary prism plane. 
The observations in Figure 4.6 and Figure 4.7 provide insight into the potency of 
PVA, but are only macroscopic. That is, they provide indirect evidence of a molecular 
level interaction and do not show the mechanism for the change in activity between 
DPs of 10 and 20, where IRI is ‘turned on’. The results also do not prove that the PVA 
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is hydrogen bonding to the ice, as opposed to a hydrophobic interaction which is 
proposed to occur for AF(G)Ps and some synthetic inhibitors.57  
 
4.5.2 Optimisation of SSNMR Methods 
The relaxation properties of protons in hexagonal ice are generally challenging to 
observe using NMR due to very long longitudinal (spin-lattice) relaxation times and 
very short transverse (spin-spin) relaxation times.58,59 These lead to line-broadening 
(and potentially a loss of signal) and can make analysis of direct (macro)molecule:ice 
interactions difficult.26,60,61 Due to recent improvements in noise reduction and 
optimisation of SSNMR methods, line-broadening can be minimised and as different 
protons in frozen solutions exchange, informing us of the crystalline and ‘bulk’ water, 
SSNMR is being used more readily to study ice.  
Under the conditions employed here (all the experiments samples were frozen in situ 
at -36 °C and data obtained at temperatures between -36 and -5 °C), the spectra are 
dominated by the more mobile interfacial water (similar to ‘crystal’ water described 
in previous studies on protein-water interactions)62 with shorter longitudinal relaxation 
rates (allowing for faster repetition of experiments) and longer transverse relaxation 
times (resulting in narrower lines). While this is a disadvantage for studies of the bulk 
crystalline ice, it is beneficial here, as we focus on the interactions between antifreezes 
and ice. It is important to keep in mind that even though the interfacial water dominates 
the relaxation measurements, that relaxation data obtained is an average, which does 
not distinguish between different types of water molecules within the sample. 
The dynamics of water molecules in frozen solutions of antifreezes were determined 
by studying relaxation rates (R1 and R2) as well as by performing relaxation dispersion 
(R1ρ) experiments. All measurements focus on the ice peak in the 1D 1H spectra 
collected, so results provide information on the dynamics of the ice (rather than the 
antifreezes). An example 1D 1H spectrum for the liquid and solid water peaks obtained 
in these SSNMR experiments can be seen in Figure 4.8. The 1H NMR spectrum for 
H2O and antifreeze:H2O comprises a single line, which broadens and changes shape 
on decreasing temperature. This occurs for all samples, enabling us to know that the 
sample has frozen. These spectra match those of Lee et al. and Wittebort et al., 
supporting our confirmation of ice formation.50,63 Any isotropic peaks observed in the 
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middle of sample spectra indicate molecules experiencing rapid reorientational 
motions. As these peaks disappear by –35 °C, all experiments were performed at this 
temperature or below, unless stated otherwise. 
 
Figure 4.7. A) Example assigned 1D 1H spectra (a spectra obtained from a one-
dimensional NMR experiment after Fourier transformation of the FID; the x axis 
corresponds to the frequency axis and the y axis corresponds to the intensity of the 
signal) of 10.0 mg.mL-1 safranine-O in H2O at 10 °C (red) and -10 °C (blue). Peak 
observed at 1.52 ppm corresponds to signal for safranine-O. 
 
4.5.3 T1 and T2 Relaxation 
Two types of relaxation are focused on here: longitudinal (spin-lattice) relaxation 
(Figure 4.8A), which is relaxation in the z-axis; and transverse (spin-spin) relaxation 
(Figure 4.8B), which occurs in the x-y plane. The time taken for the return of the 
longitudinal magnetisation is called spin-lattice relaxation time (T1) and the time taken 
to decay magnetisation in the x-y plane is spin-spin relaxation time (T2). Relaxation 
times are measured from saturation recovery spectra. 
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Figure 4.8. Schematic of the mechanism of A) spin-lattice relaxation: the longitudinal 
magnetisation, represented by the blue arrow as it returns to its equilibrium value along 
the z-axis; B) spin-spin relaxation: the transverse magnetisation, represented by the 
red arrow as it returns to equilibrium. 
T2 are measured from signal arising from the entire volume of the ice sample and 
therefore represent an average over the three-dimensional space. 
Initial studies consisted of T1 measurements at two different temperatures comparing 
synthetic antifreezes over time, Figure 4.9. In most cases during the first 2.5 hours 
after freezing the T1 value rapidly increased before reaching a plateau, suggesting that 
there could be a decrease in motion during the ice annealing process. This can be 
explained by the relationship between T1 and motion not being linear, Figure 4.9B. 
 
Figure 4.9. A) Preliminary T1 results for PVA20, safranine-O and phenosafranin for 
two different temperatures; B) Schematic of relaxation times and associated 
correlation times (Cτ) for compounds of different size/viscosity. Adapted from  
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Bloembergen et al. (Phys. Rev., 1948).64 [PVA20] = 1.0 mg.mL-1; [safranine-O] = 1.0 
mg.mL-1; [Phenosafranin] = 1.0 mg.mL-1.  
There is also an obvious temperature dependence for safranine-O, Figure 4.9; T1 
values recorded at -24.5 °C are much higher than those recorded at -37 °C. This is not 
observed as clearly for PVA, and phenosafranin does not show this result. This may 
be explained using the schematic in Figure 4.9B. If the initial T1 is in the lower field 
for a sample at -37 °C, the T1 value will increase whilst annealing (or if the 
concentration increases - due to an increase in viscosity). If the sample is annealed at 
-24.5 °C instead, the T1 value may decrease due to increased motion at this higher 
temperature. However, at some point the average molecular motions become slower 
than ν0, and T1 becomes longer again, thus there is a possibility for the T1 to cross the 
minimum and increase: this is seen by the changes in T1 for phenosafranin at -24.5 °C. 
Phenosafranin has been frozen at a higher temperature (-24.5 °C rather than -37 °C) 
so the T1 value is to the left of the minimum, as it anneals the motion may decrease 
due to increasing viscosity, then the T1 will shorten and subsequently cross the 
minimum leading T1 to increase again. 
T1 experiments for different polymer samples were repeated until the T1 values were 
no longer changing significantly, and relaxation times compared to that of IRI activity 
results from splat assays, Table 4.1 and Figure 4.10.  
Table 4.1. Comparison of IRI activity data (compared to that of a PBS control) and 
SSNMR ice relaxation times (recorded in water) for PVA230. 
Time (minutes) T1 (ms) T2 (ms) MGS (%PBS) MLGS (%PBS) 
30 212.6 0.260 8.1±0.7 30.0±1.4 
60 211.3 0.261 9.1±1.2 30.9±2.0 
90 139.6 0.259 9.8±0.6 28.8±0.5 
120 137.5 0.255 9.1±0.3 33.1±2.8 
150 136.8 0.261 8.7±0.7 37.8±1.7 
180 137.4 0.251 15.1±1.0 36.3±0.7 
The length of crystals (mean largest grain size, (MLGS)) can be measured along any 
axis and the mean ice grain area (MGS) is calculated from the number of crystals 
observed. The smaller the crystals, the more potent the IRI inhibitor. 
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The average T1 value (after plateauing) of each PVA and PEG was compared to IRI 
activity shown as ci (a term used to describe the concentration at which the ice 
recrystallisation rate is reduced by 50 %); this method monitors the average crystal 
radii over time, (ci values obtained by Carsten Budke), Figure 4.10A. There is an 
obvious trend in T1 plateau values, which decrease as the size of PVA increases and 
IRI activity increases; the more IRI active the polymer (smaller ci) the faster the 
relaxation time. Figure 4.10B follows the T1 up to 250 minutes, showing a drop in T1 
for all samples, bar PVA20, during the initial 30 minutes annealing. Once plateaued, 
the average T1 value is 137.85±1.23 ms. Figure 4.10C shows micrographs of the 
PVA230 crystals over the same time period recorded for the T1 experiments. These 
show minimal change in the crystal size observed for PVA230 over the 180 minutes, 
with MGS and MLGS increasing by 5 %, which is in agreement with the lack of 
change in T1. No change in T2 is observed either, with all values being 0.25±0.002 ms, 
Table 4.1.  
Figure 4.10. T1 data and IRI activity data for polymer samples; A) T1 plateaus (black) 
compared to that of critical inhibition concentration (ci) (red); B) T1 over time; C) 
Splats over time for PVA230. [Polymer] = 1 mg.mL-1 unless stated otherwise. 
Gaining specific conclusions with regards to the antifreeze activity of these samples 
is challenging as so many factors affect the T1 value. However direct comparisons 
between, for example, safranine-O and phenosafranin in identical conditions may lead 
to some conclusions: on average the T1 values of safranine-O are slower than 
phenosafranin, suggesting more motion in the safranine-O sample. Nevertheless, 
factors such as viscosity need to be taken into account (safranine-O forms a 
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supramolecular structure in solution, phenosafranin does not) as this is also likely to 
influence the T1 values. Due to difficulties optimising these T1 and T2 experiments, R1 
and R2 relaxation rate experiments were then focused on to provide more informative 
results. 
 
4.5.4 R1 and R2 Relaxation Rate Measurements 
An alternative way of describing the relaxation process can be by a rate.65 Rates can 
be calculated over a range of temperatures (variable temperature 1H longitudinal 
relaxation rates (VT R1 or R2)) and from the rate correlation times (Cτ) can be 
calculated. 
The R1 relaxation rate is calculated as: 
𝑅𝑅1 =
1
𝑇𝑇1
(4.1) 
 
To calculate the R2 relaxation rate equation 4.2 is used: 
𝑅𝑅2 =
1
𝑇𝑇2
(4.2) 
 
4.5.4.1 Longitudinal Relaxation (R1) and Calculated Correlation Times (Cτ) 
First, we measured VT R1 for frozen water in the presence of different additives. 1H 
chemical shifts of ice verses water could be clearly distinguished (as described in 
4.5.2), and due to the concentrations of the additives to be probed (typically < 1 
mg.mL-1), the ice peaks dominated. R1 rates report on fast motions, i.e. motions 
occurring on a nanosecond - picosecond timescale. By using a series of 90° pulses 
separated by variable delays (0.01 - 5.0 s), relaxations on the nanosecond – picosecond 
timescale, which include bond rotations and vibrations (could include that of hydrogen 
bonds), could be observed as the temperature was increased between -36 and -10 °C. 
Under the employed experimental conditions detailed in 4.7.3.2.1, a process called 
proton spin diffusion (SD) leads to a very fast polarisation transfer between protons, 
resulting in averaging of the relaxation rates between water molecules characterised 
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by different dynamic behaviours. However, the fastest relaxing molecules, which here 
correspond to the interfacial waters, typically dominate the observed average.  
 
Figure 4.11. VT 1H R1 of ice in the presence of different DP PVAs and PEG (4 kDa). 
Variable Temperature 1H relaxation experiments were performed on frozen polymer 
solutions to obtain the ice proton relaxation rates, Figure 4.11. At –36 °C, the ice 1H 
R1 values in the presence of longer PVAs with DP ≥20 are much higher than that of 
shorter DP PVAs with DP < 20, Figure 4.11. The R1 rates equalise at around -26 °C; 
rates for longer PVAs drop and those of shorter chain lengths increase, with rate 
maxima around –33 °C for the longer chains and –20 °C for the shorter chains. As a 
negative control, 1H R1 values for ice in the presence of PEG were compared to that 
of PVA samples.66 The observed R1 trends were very similar to the shorter PVA, 
supporting macroscopic observations that above DP10, PVA gains the ability to 
modulate the behaviour of water molecules at the ice-additive interface at the 
molecular level. 
The predominant relaxation mechanism often depends on magnetic dipole-dipole 
interactions, which are mediated by random molecular motions described by 
correlation times.67 [Cτ here is defined as the amount of time for the frozen water 1Hs 
to move 1 radian from a starting position, thus the larger Cτ the slower motion and 
vice versa.] The correlation times for the fast motions of the interfacial water 
molecules that dominate the relaxation measurements can be estimated by fitting the 
1H R1 trends (fitting script written and performed by Dr Stevens and not included as 
beyond the scope of this work but can be found in Stevens R.A., PhD. Thesis, 
University of Warwick, 2018).46 These can include bond rotations accompanied by a 
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transient breakage of a hydrogen bond. Hydrogen bonding between two species leads 
to slower bond rotation and translation due to the formation of a ‘complex’ larger than 
nonbonded species, leading to a change in Cτ. Because of this, it is of interest to study 
R1 as a function of temperature or concentration to potentially provide information on 
hydrogen bonding. 
 
Figure 4.12. Cτ for safranine-O (green) and PVA (DP8-230) (orange) compared to 
their respective negative controls (phenosafranin (teal) and PEG (yellow)) at 5 mg.mL-
1. Calculated Cτ for the ice protons are recorded at -30 °C. 
The shifting of the R1 maxima for PVA20 and PVA230 to lower temperatures 
compared to lower DP PVAs and PEG indicates an increase in frequency of the fast 
motions at the same temperatures. For example, as shown in Figure 4.12, significantly 
shorter effective correlation times were observed for PVA20 and PVA230, compared 
to that of lower DP PVAs and PEG.  
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Figure 4.13. Cτ and IRI activity of PVA samples. A) MLGS % of PVA (DP9-230) 
and PEG (black) compared to correlation time (red) at 5 mg.mL-1; B) Comparison of 
ci black) and Cτ (red). 
To compare the value of correlation times, they were compared to both MLGS and ci 
for 3 different DP PVAs at 5 mg.mL-1, showing that as the PVA chain length increases 
there are faster Cτ, Figure 4.13. Even at this high polymer concentration, PVA9 which 
is known to be non-IRI active (crystals are 70 % of the size of PBS and >1000 µmol.L-
1 required for 50 % activity), has a correlation time similar to that of PEG, indicating 
no concentration dependence in this sample. 
 
Figure 4.14. VT 1H R1 of ice in the presence of IRI active safranine-O (black) and 
inactive phenosafranin (red) at 2 concentrations. 
Safranine-O (active) and phenosafranin (inactive) were also tested, Figure 4.12 and 
Figure 4.14, with correlation times showing similar trends to PVA; the estimated Cτ 
for water molecules in ice in the presence of safranine-O and PVA230 are significantly 
shorter than that of the controls, and are similar at the same concentration (~97 ps).  
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There is likely a disruption of the ice network in the presence of these antifreezes, 
which relates to the grain boundaries between crystals; when ice crystals are smaller 
there are larger boundaries, and therefore a greater liquid-like disordered layer will be 
present. At these boundaries H2O molecules are less immobilised than those within 
the ice, and (on average) can move faster than H2O molecules within ice crystals. 
These ‘boundary’ molecules will thus have faster average observed relaxation rates 
and will potentially dominate any rates and Cτ obtained. As IRI activity increases, the 
fraction of ‘boundary’ molecules increases, leading to, on average, faster relaxation 
rates (which we observe here) thus confirming a disruption of sorts in the ice network. 
These relaxation experiments were performed on a range of AF(G)Ps, however the 
results were inconclusive for a variety of reasons, including large errors in obtained 
rates and difficulty in sample preparation; proteins denature more quickly in water (the 
samples could not be prepared in PBS, as the salt interfered with the NMR spectra), 
thus are not included here. 
 
4.5.4.2 Transverse Relaxation (R2) 
R2 relaxation is another key relaxation process commonly studied. As R2 relaxation is 
dominated by relatively slow dynamics (millisecond – nanosecond), compared to R1, 
VT 1H R2 were performed to ensure observation of slower motions at timescales not 
covered by R1 experiments. These experiments allow analysis of a sample to see 
whether reorientational motion dominates. 
In general, as the temperature of a sample increases, R2 will decrease due to local 
motions such as reorientational motions. This would be observed by a simple decay in 
rates over an increase in temperature.68 Besides local motions, exchange and coherent 
contributions can contribute to the R2 value. Determination of the extent that coherent 
contributions affect R2 was not possible, however these contributions are not affected 
by a temperature change. Thus, variations observed in the following variable 
temperature measurements are only due to local motions or exchange. Exchange 
processes could be slow (𝑘𝑘 ≪ |∆𝑣𝑣|) or fast (𝑘𝑘 ≫ |∆𝑣𝑣|) relative to the difference in 
chemical shift (∆𝑣𝑣) between the two states (𝑎𝑎 and 𝑏𝑏) exchanging;68 if there is 
contribution from slow exchange, R2 should increase with temperature, as chemical 
exchange will add to the relaxation rate:  
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𝑅𝑅2𝑜𝑜𝑜𝑜𝑜𝑜 = 𝑅𝑅20 + 𝑘𝑘 (4.3) 
Where 𝑅𝑅2𝑜𝑜𝑜𝑜𝑜𝑜 is the observed relaxation rate, 𝑅𝑅20 is relaxation in absence of exchange 
and 𝑘𝑘 is the rate of exchange. 
Over the same temperature change, if there are contributions from fast exchange 
processes, these will decrease as R2 increases: 
𝑅𝑅2𝑜𝑜𝑜𝑜𝑜𝑜 = 𝑅𝑅20 +
𝑝𝑝𝑎𝑎𝑝𝑝𝑜𝑜∆𝜔𝜔2
𝑘𝑘
(4.4) 
Where 𝑝𝑝𝑎𝑎 and 𝑝𝑝𝑜𝑜 are the populations of states 𝑎𝑎 and 𝑏𝑏, and ∆𝜔𝜔2 is the difference in 
chemical shift between the two states. 
There are different trends for the 1H R2 for the samples tested here, indicating that 
contributions are not only from reorientational motions. However, reorientation of 
water molecules generally dominates R2 relaxation rates rather than slow exchange. 
 
Figure 4.15. VT 1H R2 of the bulk ice in the presence of IRI active samples and 
controls. A) PVA (DP5-230) and PEG. [Polymer] = 1 mg.mL-1; B) Safranine-O, 1 mg. 
mL-1 and 5 mg.mL-1 (black), phenosafranin, 1 mg.mL-1 and 5 mg.mL-1 (red). 
R2 values over a range of temperatures for all negative controls are low (initial rate 
~1000 s-1) and decrease upon heating, indicating that the rates in these samples are in 
line with the relationship mentioned above, and that the reorientation of water 
molecules rather than slow exchange dominates the R2 rates. 
Three trends are observed for the different length PVA samples, Figure 4.15A. R2 
rates of frozen solutions of shorter chain PVAs (DP<20) are similar to that of control 
samples, once again indicating that reorientation dominate in these samples. This is to 
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be expected as these PVAs have been shown to have no antifreeze activity and thus 
should lead to no difference in dynamics. DP20 R2 values (blue) appear to be 
dominated by reorientational motions at temperatures below 30 ℃. Then, as the 
temperature increases these values also increase, indicating a contribution from slow 
exchange. For PVA150 and PVA230, simple decays are also observed, though these 
polymers produced higher R2 values (>3500 s-1) than the low DP PVAs. However, 
having a higher DP (or concentration) needs to be considered, as both cause an 
increase in the viscosity of the sample,69,70 which will slow motions and lead to an 
increase in reorientational contribution to R2. PEG used here has an average DP of 90, 
though has low R2 values (orange), thus appears to not cause a significant increase in 
viscosity. 
Trends in R2 of safranine-O are similar to that of PVA20, Figure 4.15B; where, as 
temperature increases, R2 also increases. These trends are confirmed by concentration 
range experiments, which show that R2 values of safranine-O are not affected by 
concentration, potentially due to the ‘small’ size of the compound. 
Initial VT 1H R2 experiments were performed on AF(G)Ps, but results were 
unsatisfactory and inconclusive. 
 
4.5.5 Spinlock 1H RD Relaxation Dispersion Measurements 
The third type of relaxation studied was spin-lattice relaxation in the rotating frame 
(R1ρ). This is a R1 measurement undergoing a spin-lock pulse of varying lengths (0.001 
– 1.5 ms). This relaxation also is sensitive to motion on the millisecond – nanosecond 
timescale. Nevertheless, it is considered more suitable for measuring slow dynamics 
than R2, as R2 is to a greater extent affected by other processes and interactions. 1H 
R1ρ relaxation dispersion signifies presence of a chemical exchange, which is a 
reversible process whereby water molecules in ice exchange on a microsecond time 
scale between two (or more) states. As the main difference between the studied 
samples is the presence of the additives, one of the most plausible interpretations 
would be that the observed process corresponds to a reversible binding of ice to the 
additives. 
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Spinlock R1ρ relaxation dispersion measurements were performed on samples to 
investigate exchange; if there are motions in a sample at the microsecond timescale an 
exponential decay should be observed (measured by monitoring the change in R1ρ as 
a function of the spin-lock frequency). Exchange can be probed by applying different 
spinlock powers to samples; at lower powers exchange dominates R1ρ measurements. 
 
Figure 4.16. VT 1H R1ρ of ice in the presence of; A) PVA5; B) PVA230; C) PEG. 
[Polymer] = 1 mg.mL-1. 
For ice in the presence of PVA230 a pronounced exponential decay is observed, 
indicating motion and a large contribution from a millisecond chemical exchange 
process, Figure 4.16B. This is in support of the formation of an extended hydrogen 
bond network between the PVA and the ice, as well as the model of entropy-enthalpy 
compensation; when the polymer is sufficiently long, the enthalpic gains of hydrogen 
bonding overcome the entropic penalty of binding. The shorter chain PVA and PEG 
(not antifreezes) have a more gradual decline indicating no exchange at these 
timescales, Figure 4.16A/C. Some PVAs were repeated at lower concentrations such 
as 0.1 mg.mL-1 (not shown), and the R1ρ values were observed to be slightly lower 
than those observed at 1 mg.mL-1 but not significantly different.  Therefore, there does 
not appear to be concentration dependence for R1ρ of polymer:ice systems.  
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Figure 4.17. VT 1H R1ρ of ice in the presence of proteins; A) AFPIII; B) bpAFPI; C) 
AFGP8; D) Lysozyme. [AFPIII] = 0.659 mg.mL-1; [bpAFPI] = 1.0 mg.mL-1; [AFGP8] 
= 12.0 mg.mL-1; [Lysozyme] = 12.0 mg.mL-1. 
Evidence that AFGP8 affects ice differently to AFPI and AFPIII is seen in the R1ρ plots, 
Figure 4.17. There is a large change in base R1ρ for AFGP over the recorded 
temperature range and little change in dispersion, indicating that exchange may be in 
slower microsecond regime, whereas bpAFPI shows greater dispersion suggesting 
potential contributions from exchange in the faster microsecond regime. AFPIII differs 
again, with values similar to that of lysozyme, meaning microsecond motions are not 
affected by any significant contribution from exchange. 
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Figure 4.18. VT 1H R1ρ of ice in the presence of; A) safranine-O and B) phenosafranin. 
[Small molecule] = 1 mg.mL-1. 
Safranine-O also is seen to have significant contributions from microsecond exchange, 
Figure 4.18, signaling that the synthetic samples here work in the same way as 
bpAFPI, and showing that both directly interface with an ice surface. PEG, lysozyme 
and phenosafranin do not show this decay suggesting that only the antifreezes have 
this particular 100 ρs – 2ms motion or exchange.  
 
4.5.6 2D 1H-1H Exchange Spectroscopy 
The debate as to whether ice-binding for different antifreezes is reversible continues. 
The most commonly used model, the adsorption-inhibition model, assumes that 
AF(G)Ps bind irreversibly to ice,13,71 though evidence now support both reversible and 
irreversible binding for a range of AF(G)Ps.14,27,30,72–76 
Preliminary studies of 2D 1H-1H exchange spectroscopy (EXSY) measurements were 
performed on PVA230, AFPIII and AFGP8 alongside their relative negative controls 
to determine whether any samples bind to water molecules, and potentially elucidate 
whether they reversibly or irreversibly bind. In 2D EXSY chemical or conformational 
exchange between nuclei is measured, here this can indicate potential binding as there 
will be cross relaxation between two nuclei that are spatially close. 
These measurements involve a mixing period after the initial 90° pulse, during which 
magnetisation can exchange, due to the nuclear Overhauser effect (NOE) or slow 
chemical exchange. After mixing, acquisition of nuclei at their new frequency is 
recorded and spectra obtained. These spectra will have off-diagonal crosspeaks 
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between nuclei that are exchanging or are close in space. An example spectrum with 
off-diagonal crosspeaks between nuclei showing interactions and off-diagonal 
crosspeaks can be seen in Figure 4.19. 
 
Figure 4.19. 2D EXSY Schematic of crosspeaks (blue filled circles) that would be 
observed if there is any binding between protons in antifreezes and ice. 
The aim of these experiments was to look for exchange (crosspeaks) between the ice 
peak (~4.7 ppm) and any of the antifreeze peaks. The longer the exchange period, the 
greater the time for exchange: both a 100 ms delay and no delay were chosen for 
comparison. In all of the 2D spectra here, the red peaks represent no delay and the blue 
peaks represent the signal after a 100 ms exchange period, Figure 4.20.  
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Figure 4.20. 2D 1H-1H EXSY measurements at -10 °C for A) PVA230; B) PEG; C) 
AFGP8; D) AFPIII; E) Lysozyme. Mixing times were 0 ms (red spectra) and 100 ms 
(blue spectra). [PVA230] = 5.0 mg.mL-1; [PEG] = 5.0 mg.mL-1; [AFGP8] = 12.0 
mg.mL-1; [AFPIII] = 0.659 mg.mL-1; [Lysozyme] = 12.0 mg.mL-1. 
R1ρ data for AFGP, bpAFPI and synthetic polymer mimics showed an exchange 
process at the microsecond timescale is taking place. This was not observed for 
AFPIII. The crosspeaks observed in the EXSY spectra show that PVA230, AFGP8 
and AFPIII bind to water molecules, Figure 4.20A/C/D; crosspeaks for AFGP are 
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observed between the bulk water and aliphatic protons, supporting the theory that 
AFGP8 directly binds to the primary prismatic plane of ice via methyl groups, for 
AFPIII they are seen between bulk water and amide protons. Importantly, crosspeaks 
for PVA230 are observed to be between bulk water, aliphatic protons and potentially 
hydroxyls, providing the first direct evidence for PVA binding to ice on a molecular 
level, suggesting that PVA hydroxyls could be reversibly binding the ice.  
Hydration around the methyl side chains of threonine residues has been observed in 
the literature and becomes significant at low temperatures as it is said to stabilise the 
anchored clathrate water array leading to dual H-bonding.77 The importance of these 
methyl side chains may link to the proteins studied here where crosspeaks are observed 
between aliphatic protons and water, indicating that these proteins may bind via an 
anchored clathrate mechanism where the AFP adsorbs to the ‘cage’ around the 
threonine CH3 groups. 
PEG and lysozyme do not show any interaction between bulk water and the sample; 
further supporting the theory if there is no interaction with bulk ice molecules will not 
be IRI active. Low DP PVAs were not studied, however, as all other results indicate 
similar effects on dynamics as PEG, it can be inferred that they will not produce off-
diagonal crosspeaks. This agrees with the crystal faceting data, which showed that IRI 
inactive PVAs cause no faceting (no binding), whereas IRI active PVAs efficiently 
bind and thus giving rise to the observed macroscopic properties (faceting and IRI).  
 
Figure 4.21. Illustration of how safranine-O and water may interact. Distances 
measured in Angstroms. 
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Crystal structures of safranine-O show that the molecules form alternating stacks with 
the distance between two NH2 groups in the stack being 7.40 Å,56 Figure 4.21. This 
is a smaller distance than that of the gap between every third hydroxyl in PVA (7.56 
Å);15 therefore even though safranine-O has not been studied thus far using EXSY, it 
may interact with ice in a similar way. The phenosafranin crystal structure is much 
less ordered and does not form these same stacks and therefore cannot have the same 
interaction with the ice, thereby not having IRI or TH activity, and a good choice for 
a negative control.  
bpAFPI also was not studied by 2D EXSY, however considering the results already 
obtained, bpAFPI would bind bulk water in a similar way to the IRI active samples. 
These results along with relaxation data infer that PVA bind ice reversibly. 2D 1H-1H 
measurements were recorded on liquid samples to determine whether samples were 
binding the liquid or solid water. These did not display the expected crosspeaks seen 
in the frozen solutions; therefore, the IRI active compounds are binding to ice. 
 
4.5.6.1 Antifreeze Macromolecule:ice Interactions 
Theories on how antifreezes bind ice are based on molecular dynamics simulations 
but SSNMR has allowed the investigation of these theories physically by probing 
motions and facilitated the answering of questions such as: Do PVA, AF(G)Ps and 
safranine-O affect the ice structure in the same way? Or, can ice-binding be observed? 
If the different types of ice-binding materials have the same macroscopic effects, 
potentially they would have the same molecular mechanism.  
The exact mechanism of action of different ice-active compounds, and the extent of 
actual ice-binding is not clear;78 with different proteins targeting different 
crystallographic faces of ice, either through hydrophobic interactions in AFGPs12 or 
by anchored clathrates in some AFPs.79 Data obtained through modelling AFPs 
supports the anchored clathrate mechanism, which is where water molecules in the 
protein’s solvation shell at the IBS become more structured and less dynamic as the 
temperature decreases leaving the ice-like water at the IBS with a lower energy barrier 
to ice formation, finding that hyperactive AFPs bind ice through distinct anchored 
clathrate motifs.80 Data obtained in the 2D EXSY experiments conducted here differs 
to that of the literature; some work states the methyl side-chains of threonine residues 
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in AFPs lead to water ordering and stabilise the anchored clathrate array,77 however 
crosspeaks with aliphatic protons are only observed for AFGPs with amines observed 
for AFPs. 
The common structure between all of the antifreezes used here is that the hydrophilic 
group (either –OH or –NH2) is next to a hydrophobic group (-CH3 or -CH2-). There 
will be hydrogen bonding between the hydrophilic group and the ice, but clearly the 
hydrophobic group has an important role too. Perhaps the ice forms a hydrogen bond 
with the hydrophilic group but then the nearby hydrophobic group causes this bond to 
be unfavourable, leading to the water breaking this hydrogen bond, rotating 180° and 
forming the opposite hydrogen bond. This could repeat causing the water molecule to 
constantly rotate and make and break hydrogen bonds with the antifreezes. In the 
AFPs, where the threonine group can freely rotate any way this effect could be 
enhanced even more.  
There is also the potential for the creation of ionic defects in the ice networks upon 
addition of antifreezes, leading to changes in relaxation and thus the observed 
macroscopic effects. It is possible that there is a substitution (-OH or –NH2) for a water 
molecule leaving a bond that lacks a proton, leading to the rotation of the water 
molecule below in order to provide a proton to that bond, resulting in a defect and 
consequently a change in relaxation values. From the work here however, it cannot be 
determined whether specific defects are formed, but rather that the dynamics in 
antifreeze macromolecule:ice samples as well as binding mechanisms do in fact differ.  
Future work using, such as molecular dynamics simulations, could elucidate this 
further. 
 
4.5.7 SSNMR of 1H-13C Labelled Protein 
The major purposes for protein labelling are monitoring of biological processes, 
reliable quantification of compounds and specific detection of protein modifications 
and isoforms in multiplexed samples, enhancement of detection sensitivity, and 
simplification of detection workflows. Proteins can be labelled during cell growth 
by incorporation of amino acids containing different isotopes, or in biological fluids, 
cells or tissue samples by attaching specific groups to the ε-amino group of lysine, 
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the N-terminus, or the cysteine residues.81 1D 1H-13C experiments were performed to 
further investigate binding of antifreezes to ice. 
 
Figure 4.22. A) Western Blot showing no expression/minimal of 13C,14N labelled 
AFPIII; Attempted optimisation of AFPIII expression to see the issue in protein 
expression; B) AFPIII whole cell gel; C) AFPIII lysed cell gel. Black triangle 
represents where AFPIII should appear on the gel. 
1H-13C labelled AFPIII was expressed using the same protocol as for unlabelled 
AFPIII, though a very low mass of protein was obtained. This issue during expression 
was tested by performing cell growth at 37, 22 and 16 °C, as well as by using three 
different concentrations of IPTG to determine which stage of expression errors 
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occurred, Figure 4.22. Whole cell and lysed cell gels were taken to see whether the 
protein had expressed but had been lost in the lysis process. 
Initial 1D 1H-13C experiments were run using 1H-13C labelled AFPIII, however no 13C 
signal was obtained (as such no plots displayed here). In future, a higher protein 
concentration, once expression is optimised, should be used.  
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4.6 Conclusion 
For the first time, direct evidence for the interaction of PVA to ice crystals is 
presented, as well as support for the ice-binding of AF(G)Ps to ice. The relaxation 
measurements confirm the addition of IRI active compounds greatly affect the bulk 
ice 1H dynamics compared to that of negative controls (ensuring any colligative 
contributions are negated), even at low concentrations. SSNMR studies indicated to 
that relaxation rates (R1 and R2) as well as relaxation times (T1 and T2) differ for ice-
active and ice-inactive materials. The relaxation time measurements were complex, 
and values obtained were dependant on temperature, time frozen, concentration and 
viscosity, hence proved challenging to make clear comparions between samples. 
Relaxation measurements were chosen to focus on and provided many interesting 
trends. Variable temperature R2 measurements showed a clear difference between 
antifreezes (large R2, exponential decay) and negative controls (small R2, little 
variation, not exponential). This difference is thought to be due to exchange 
dominating the measurements rather than the ms – ns motions. 
Quantitative ice growth measurements confirm that above a critical chain length of 10 
units PVA’s unique IRI activity is activated. Using SSNMR, the R1 relaxation of bulk 
ice in the presence of PVA was measured and was found to scale with the macroscopic 
critical inhibitory concentrations and MLGS values, with longer polymers being more 
active inhibitors and having faster correlation times. This supports a mechanism of 
the PVA forming an extended hydrogen bonded network to the prism planes of ice but 
only above the critical chain length, and hence enthalpy-entropy compensation is a 
driving force. Spin-lattice relaxation measurements showed significant exchange 
process in IRI active polymers compared to negative controls supporting a reversible 
binding process, again consistent with the need for multivalent presentation of the 
hydroxyls to provide sufficient affinity. 
Safranine-O is seen to work similarly to PVA, further supporting that ice dynamics are 
affected by frozen solutions of IRI active compounds and not their respective controls 
or in a colligative manner, and that ice proton motions are of importance for IRI 
activity. 
Finally, 2D EXSY experiments showed through-space correlation between PVA of 
DP>20 and ice, demonstrating binding is occurring. Taken together, these results 
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prove how a flexible macromolecule such as PVA can reversibly bind and inhibit ice, 
through an extended hydrogen bonded ‘zipper’, and that multivalency is essential. 
These results are significant as it is the first example of molecular, rather than indirect 
macroscopic, measurements of a synthetic IRI demonstrating ice-binding. Safranine-
O also shows a decrease in Cτ as well as exchange, indicating reversible binding in 
this case also. Ice-binding was additionally observed for AFPIII and AFGP8, though 
the data obtained from relaxation experiments was insufficient to allow confirmation 
of whether these proteins bind reversibly or irreversibly. 
These results are significant in both basic cryo-science and in the development of new 
materials for low temperature applications. The next steps in this area would be to 
continue relaxation experiments with labelled antifreeze samples, as attempted briefly 
in 4.5.7, as well as by performing 2D EXSY using D2O, where this would elucidate 
further the exchange occurring and allow site-specific interrogation of intermolecular 
contacts and structures. 
Potentially, this work will lead to the use of SSNMR as an assay to see if samples 
could have antifreeze activity. 
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4.7 Experimental 
4.7.1 Materials 
Poly(ethylene glycol) (PEG, 4 kDa),  polyvinyl alcohol (PVA230 10 kDa), safranine-
O, and phenosafranin were purchased from Sigma Aldrich and used as supplied unless 
otherwise stated. Phosphate-buffered saline solution was prepared using in Milli-Q 
water (>18.2 Ω mean resistivity) to give [NaCl] = 0.138 M, [KCl] = 0.0027 M, and 
pH 7.4) Tetrakis(trimethylsilyl)silane was purchased from Fisher Scientific. PVA 
DP≤20 were produced as previously described.82 AFPIII and AFPI and AFGP8 were 
used as provided. Expression and purification of the antifreeze proteins detailed in 
Chapter 1. 
 
4.7.2 Physical and Analytical Methods 
All samples were studied using 1H saturation recovery MAS NMR and spin echo MAS 
NMR spectra which were acquired on a Bruker Avance III spectrometer operating at 
11.75 T (1H resonance frequency of 500 MHz) using a 4.0 mm Bruker triple resonance 
probe, using temperatures between -30 and 10 °C. (0.20 ppm reference) soaked in 
methanol was put into the rotor and used as an internal thermometer. 
 
4.7.3 Procedures 
4.7.3.1 Ice Recrystallisation Inhibition ‘Splat’ Assay 
Samples were dissolved in PBS buffer (pH 7.4) at concentrations of 10 to 0.05 mg.mL-
1 and dropped onto a glass cover slip on a metal disc cooled with dry ice (-78 °C). An 
ice wafer instantly formed and was transferred to a cryostage held at -8 ºC under liquid 
nitrogen. Samples were left to anneal for 30 minutes. Images of the wafer were taken 
before and after the 30 minutes. Image processing was performed using ImageJ 
software on the 5 largest crystals from at least 3 independent wafers giving the MLGS 
from 15 measurements. 
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4.7.3.2 SSNMR 
Saturation recovery spectra were acquired to measure the T1 and T2 of hydrogen in 
H2O in the different samples and the obtained data was analysed by calculating 
correlation functions for the nuclear spin interactions acting on the observed spin, from 
these calculations the relaxation time is obtained. The experiments were repeated 
multiple times to improve the signal to noise ratio and yield more accurate relaxation 
rates. 
Samples for all experiments were dissolved to appropriate concentrations using Milli-
Q ultrapure water and transferred to rotors (50 µL), which were then sealed with top 
caps. The rotors were inserted into 4.0 mm triple-resonance MAS probes and placed 
in the SSNMR. MAS was confirmed to be at 10 kHz spinning frequency then samples 
were cooled to –36 °C. The temperature was recorded using a variable temperature 
unit (VTU) and calibrated by calculating the difference between methyl and hydroxyl 
1H chemical shifts in methanol using TTMSS as a reference. The sample temperature 
was regulated using Bruker BCU-Xtreme cooling unit. Experiments were performed 
as a function of sample temperature between -36 and 10 °C (0.20 ppm reference); the 
upper limit of which was restricted only by the sample melting point. All the 
measurements were performed after equilibration time to allow for freezing of the 
sample as indicated by the broadening of the water 1H resonance. The chemical shifts 
for liquid and solid water overlap, however the intensity of these peaks differ greatly; 
the ice peak is broad with low intensity and the water peak narrow with intensity orders 
of magnitude higher. Therefore, frozen samples were determined by the highly 
observable change in intensity. 
 
4.7.3.2.1 Variable Temperature 1H Relaxation Experiments (R1) 
The samples were set up as described above and the spins saturated with a series of 
90° pulses separated by variable delays (0.01 – 5 s). The data obtained from these 
experiments refers to motions in the sample on the nanosecond – picosecond 
timescale. 
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4.7.3.2.2 Variable Temperature 1H Relaxation Experiments (R2) 
Samples were prepared as described above and R2 recorded using a CPMG pulse 
sequence. Measurements were initialised by a 100 kHz π/2 1H pulse, followed by n 
spin-echoes. The pulse sequence was repeated n times in line with the number of spin-
echoes. The data obtained from these experiments refers to motions in the sample on 
the millisecond – nanosecond timescale. 
 
4.7.3.2.3 Variable Temperature 1H Relaxation Dispersion (R1ρ) 
These samples were initialised with a 100 kHz π/2 1H pulse followed by a spin-lock 
pulse of varying length and power. These experiments access only motions at the 
microsecond timescale in the ice and are recorded as R1ρ. These experiments were 
performed over a range of temperatures to investigate the relationship between motion 
and temperature. 
 
4.7.3.2.4 2D 1H-1H Exchange Spectroscopy 
Samples were initialised with a 100 kHz π/2 1H pulse followed by indirect evolution 
time (t1). This is followed by another a 100 kHz π/2 1H pulse, a mixing time of 0 or 
100 ms, a final a 100 kHz π/2 1H pulse and then a direct acquisition period.  
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5.1 Declarations 
Setup of the µL-NIPI nucleation drop assay and LabView program optimised by Dr 
Thomas Whale (University of Warwick). Lignins provided by Dr Goran Rashid 
(supervised by Professor Tim Bugg, University of Warwick). Metal organic 
frameworks provided by Ehsan Ghadim (supervised by Professor Richard Walton, 
University of Warwick). 
 
5.2 Chapter Abstract 
The phenomenon of ice nucleation has both intrigued and demanded the attention of 
scientists from a wide range of disciplines. Control of ice formation has broad 
applications in the food, pharmaceutical, and chemical industries, e.g. anti-icing 
coatings for aircrafts; reducing frost and ice accumulation in refrigerators and heat 
exchangers to improve heat transfer efficiency; controlling nucleation temperatures 
for cell cryopreservation. Much work has focused on synthesis of materials for 
inhibiting the growth of ice crystals, but control of ice nucleation is less studied. 
Here a range of previously untested compounds, including metal organic frameworks 
and lignins, have been tested for their ice nucleating efficiency using droplet freezing 
assays (a type of immersion technique where a sample of interest is 
dissolved/immersed in water), in the hope of providing potential future solutions for a 
range of icing problems. One particular lignin, alkali lignin, was found to nucleate ice 
well in the immersion mode but not to inhibit ice recrystallisation, whereas the other 
tested compounds had neither IRI nor nucleating activity. Nucleant concentration and 
experimental cooling rate were varied to test their effect on lignin ice nucleation 
efficiency, finding, strikingly, that there was no concentration or cooling rate 
dependence on the efficiency for alkali lignin. Two lignin samples were also filtered 
to establish the size of particles responsible for ice nucleation, finding that ice 
nucleating particles (INP)s for alkali lignin are <0.2 µm, which are much smaller than 
atmospheric INP, and those of GreenValue are >0.2 µm.  
Different wet-dispersion measurement techniques were studied for their use in 
observing nucleation activity, with the µL-NIPI-based (µL-Nucleation by Immersed 
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Particle Instrument) nucleation drop assay providing the most useful, high-throughput 
results. 
A discussion of further experiments that could be performed to further understand the 
origin of lignin’s ice nucleation efficiency is included e.g. characterisation and 
aggregation studies. 
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5.3 Introduction 
5.3.1 Importance of Ice Nucleation 
Sub-microlitre volumes of liquid water can supercool to temperatures below -35 ℃, 
therefore, despite ice Ih being the thermodynamically stable form of water below 0 
℃, ice nucleation needs to occur before ice crystal growth can take place.1 Ice 
nucleation is the process which initiates freezing of supercooled liquid water. There is 
an energy barrier to the formation of ice clusters large enough to grow, so called 
critical nuclei, resulting from the interfacial tension between supercooled liquid water 
and ice. Once an ice cluster larger than the critical size is present crystal growth can 
proceed. In general, ice nucleation is achieved through the addition of a heterogeneous 
ice nucleating particle (INP), which lowers the energy barrier to nucleation thus 
promoting nucleation above the homogeneous freezing temperature.2  
As mentioned in 1.3.1, ice nucleation is of great importance for freeze-tolerant 
organisms, the survival of certain pathogens and for cloud formation. An 
understanding of this process, and of INPs themselves will have substantial 
implications for biological ice nucleation promotion and anti-icing/de-icing 
strategies.3 A brief description of modes of heterogeneous ice nucleation and a 
discussion of currently known INPs and experimental methods for studying ice 
nucleation are provided, with the aim of detailing the motivation for the work 
performed here.  
 
5.3.2 Heterogeneous Nucleation 
Nucleation is divided into homogeneous (without the addition of an INP) and 
heterogeneous (promoted by presence of INPs). Homogeneous nucleation is well 
described by classical nucleation theory (CNT). Heterogeneous ice nucleation, which 
is less well understood, and the only relevant type of nucleation occurring in the real 
world,4,5 is focused on here. Heterogeneous ice nucleation is caused by foreign 
particles/surfaces, usually solids. A more comprehensive description of currently 
researched nucleators is provided in 5.3.3,6 and ice nucleation happens via two modes; 
deposition and freezing. Deposition is described as a gas to solid phase transition 
where ice nucleates on an INP from supersaturated vapour. Freezing nucleation is a 
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liquid to solid phase transition where nucleation occurs within a body of supercooled 
liquid due to the presence of an INP. Freezing nucleation is then further subdivided 
into immersion freezing (INP is immersed in water), contact freezing (INP comes into 
contact with supercooled water at the air-water interface) and condensation freezing 
(freezing occurs simultaneously with liquid water formation). This project centres on 
immersion mode ice nucleation due to its relevance to cryobiology, where biological 
materials are frozen in liquid solutions. 
Heterogeneous ice nucleation has been extensively studied since the 1940’s,7 yet 
understanding of the process remains incomplete, with the mechanism by which INPs 
work generally unknown. 
 
5.3.3 Good Heterogeneous Ice Nucleators 
Research into heterogeneous ice nucleation has focused on determining the ice 
nucleation effectiveness of potentially atmospherically relevant nucleants.8,9 There is 
a vast range of different nucleators; including biological aerosol particles, mineral 
dusts, soots, sea sprays particles and volcanic ash. Non-atmospheric substances  
including anti-icing surfaces and superhydrophobic coatings have also been studied 
extensively.10,11 
A common component of atmospheric aerosol is biological aerosol particles. These 
consist of viruses, algae, spores, pollen, bacteria, protozoa and small plant fragments, 
ranging in sizes from 5 – 50 nm, though some bacteria of diameters including up to 
0.2 – 1 mm have been observed nucleating ice.12 These particles have been observed 
to initiate freezing at very warm temperatures up to -2 ℃.13–15 One bacteria observed 
nucleating ice in the range of -2 ℃ to -4 ℃ is Pseudomonas syringae, Figure 5.1Ai.16 
P. syringae, along with Pseudomonas fluorescens and Pantoea agglomerans 
(previously named Erwinia herbicola), is a bacteria found to promote ice nucleation 
and thus frost formation on plant leaves, enabling the pathogen to survive by digesting 
nutrients from the plants more readily.17 It has been confirmed that an ice nucleating 
protein found on the surface of the bacteria causes this nucleation, a ribbon 
representation of the protein is given in Figure 5.1Aii. These proteins are large and 
efficient INPs,16,18 and are thought to order water molecules into an ice-like lattice by 
an anchored clathrate water mechanism similar to AFPs. The INP from P. syringae 
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has a unique hydrophobic-hydrophilic pattern, which is thought to enhance ice 
nucleation.  
 
Figure 5.1. Selection of materials known to nucleate ice A) P. syringae; i) SEM 
micrograph;19 ii) Ribbon representation of a β-helical INP from P. syringae, depicting 
the structure of the 144-residue INP model after 300 ps of solvated MD;20 B) 
Photographs of birch pollen grains; i) pre-water uptake (25 µm diameter); ii) grains 
post-water uptake;12 C) SEM images with a 6000× magnification of 3 types of quartz 
particles; i) Quartz I, average surface diameter 0.5 µm; ii) Quartz II, average surface 
diameter 1.2 µm; iii) Quartz III, average surface diameter 4.8 µm;21 D) Chemical 
structures of the various of carbon nanomaterials tested for their ice nucleation 
activity; carboxylated graphene nanoflakes (cx-GNF); oxidized-multiwall carbon 
nanotubes (o-MWCNT); graphene oxide (GO); oxidized-single-wall carbon 
nanotubes (o-SWCNT). GO sheets have an average lateral diameter of ∼1 μm, while 
the GNFs have an average lateral diameter of ∼30 nm.22 
Some studies also claim AFPs may nucleate ice.23 Du et al. suggested that specific 
interactions between AFPIII proteins are required for binding to ice, and that the self-
assembly of AFPIII on the surface of ice may be expected.24,25 AFPIII presents 
hydrophilic and hydrophobic regions (akin to INPs), and from results based on ice 
nucleation, surface tension, and dynamic light scattering studies, Du et al. proposed 
that above a critical protein concentration value (2.5 mg.mL-1), the amphipathic 
AFPIII self-assembles into micelle-like structures. It has been suggested that these 
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aggregation properties could play a key role in antifreeze efficiency; at critical 
aggregation concentrations AFPIII has been observed to inhibit nucleation by 
adsorbing onto both the ice surface and foreign particles thus improving growth 
inhibition (antifreeze activity is related to surface activity of AFPs), however at higher 
aggregation concentrations they appear to promote nucleation, which could hinder 
their ice growth inhibition. However, there is debate as to whether this work was 
correctly interpreted as later studies showed that AFPIII does not form aggregates at 
higher concentrations thus the surface activity of AFPIII may not correlate with 
aggregation of the protein. 
Other ice nucleating compounds from bacteria (and insects, plants, lichen, fungi etc.) 
include polysaccharides and lipoproteins, some of which have been found to not be 
bound to the ‘particles’ and have been found to nucleate ice when separated from 
them.26–29 For example, certain types of pollen release INPs when immersed in water.30 
One pollen known to nucleate ice efficiently is birch pollen.30 Pollen is a large 
biological aerosol particle with diameters between 10 – 100 µm,12 with birch pollen 
grains being approximately 25 µm in diameter, photographs of which are provided in 
Figure 5.1B. The pollen appears to take up water as well as release ice nucleating 
macromolecules. These macromolecules are thought to be polysaccharides that bear 
carboxylate functional groups, they have been observed to have ice-binding 
capabilities and IRI activity,31 and it has been proposed that they gain ice nucleation 
activity by forming clusters/aggregates. 
Mineral dusts are another type of aerosol particle that has been observed to nucleate 
ice effectively, though it is unclear what the exact nature of nucleation sites on these 
INPs is. These dusts’ compositions mirror soil cover and the continental crust in that 
they are mainly composed of clay minerals, quartz and feldspars (group of aluminium 
silicates) and are thought to be important for nucleation in clouds due to their 
abundance in the atmosphere.32 Feldspar and quartz are two of which that have been 
thoroughly studied, and although they nucleate, they are not as effective as many 
biological INPs.33 K-feldspar in particular has been recorded to have the highest ice 
nucleating ability out of Na-, Ca-and K-feldspar (up to -2 ℃),17,34 with nucleation 
occurring over a range of temperatures for the different feldspars. SEM images of three 
types of quartz can be seen in Figure 5.1C, of which quartz I (the sample containing 
the largest fraction of particles of diameters <1 µm) showed the most ice nucleating 
Chapter 5 
234 
 
activity, again only -21 ℃ (which is much lower than the -2 ℃ caused by biological 
INPs). Work by Zolles et al. shows that it is not a perfect surface, but rather local 
defects that nucleate ice, though further work needs to be undertaken into 
understanding the mechanism by which these defects nucleate ice (e.g. by lattice 
matching).21 
A range of carbon-based synthetic materials have been studied in relation to ice 
nucleation, Figure 5.1D. These include carbon nanotubes, graphene nanoflakes 
(GNF), graphene oxide (GO) and associated structures.22,35 GO, large sheets of carbon 
with alcohol, epoxide and carboxylic acid groups present with an average diameter of 
1 µm, has significant IRI activity and cryoprotective ability (reducing crystal growth 
to 20 % MLGS at 5 mg.mL-1) thus appeared of great interest.36 cx-GNFs are small 
graphene sheets (~0.03 µm), the edges of which consist of only carboxylic acid groups. 
o-MWCNTs are needle-like tubes consisting of multiple single layers of carbon and 
o-SWCNTs are tubes but consist of one layer of carbon. These are oxidised species 
and chosen due to the fact that their oxidised nature enables them to disperse in water. 
Whale et al. found that water droplets containing cx-GNFs, GO, MWCNTs and 
SWCNTs all nucleated ice at temperatures higher than pure water; with the median 
ice nucleation temperature (Tn) of cx-GNFs being -21.3 ℃ and -12.2 ℃ for MWCNTs 
(median Tn water: ~-26.5 ℃). Shape and degree of oxidation appears to be important 
for these materials, as the carbon nanotubes were observed to be more effective ice 
nucleators than the flat graphene species, and the less oxidised materials (carbon 
nanotubes) nucleated ice more effectively than more oxidised species (GO and cx-
GNFs). 
One way to compare the activity of different heterogeneous ice nucleators is to 
compare their ice active site densities. This is a measurement of activity that allows 
for comparison between nucleants and can be normalised to surface area of nucleator 
(ns) (calculating ns from droplet data is performed using equation 5.1), volume of 
water in which the INP is suspended (K) (equation 5.2) or mass of INP (nm) (equation 
5.3). Normalisation can be performed by applying the relevant multiplier to the 
temperature and number of drops frozen/unfrozen data. These calculations are based 
on the differential nucleus spectrum (graphical representation of the concentration of 
active nuclei in a volume derived from drop-freezing experiments), which directly 
Chapter 5 
235 
 
connects with the frozen fraction curves obtained by recording nucleation 
temperatures.37 
Calculating normalisation are performed using: 
𝑛𝑛𝑠𝑠(𝑇𝑇) = −
1
𝐴𝐴
ln(1 −
𝑁𝑁𝐹𝐹(𝑇𝑇)
𝑁𝑁0
) (5.1) 
Where ns(T) is the measure of the number of sites per unit surface area, A is the surface 
area of the nucleator per droplet, NF(T) is the number of droplets frozen at temperature 
T and N0 is the total number of droplets. 
For normalisation to droplet volume used in the experiment, A is changed to V, the 
droplet volume: 
𝐾𝐾(𝑇𝑇) = −
1
𝑉𝑉
ln(1 −
𝑁𝑁𝐹𝐹(𝑇𝑇)
𝑁𝑁0
) (5.2) 
For normalisation to mass, A is changed to m, mass of the ice nucleating particle per 
droplet: 
𝑛𝑛𝑚𝑚(𝑇𝑇) = −
1
𝑚𝑚
ln(1 −
𝑁𝑁𝐹𝐹(𝑇𝑇)
𝑁𝑁0
) (5.3) 
A comparison of different INPs from the literature is plotted as ns as a function of 
temperature in Figure 5.2, highlighting the many studies into mineral dusts, pollen 
and bacterial nucleators, showing that biological nucleators are generally more 
effective than inorganic nucleators, with P. syringae nucleating much more effectively 
than any other nucleant reported. Silver iodide (AgI) is also reported, and is more 
effective than the other non-biological nucleators tested but is still not as effective as 
P. syringae.38 
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Figure 5.2. Ice nucleation activity obtained from a range of nucleation activity studies 
in the literature. Results for nucleation activity written as ice active site density 
normalised to surface area (ns). Adapted from Whale, T.F., (PhD, University of Leeds, 
2015).33 
 
5.3.4 How Do Nucleators Work? 
Despite the quantification of various ice nucleators and their comparative efficiencies, 
there is little insight into why certain species are more effective than others. It is 
challenging to determine the physical properties required for a substance to be an 
efficient ice nucleator as the nucleation event is rare (typically nm across in µm to mm 
scale droplets) and happens on very short timescale. However, there are some 
properties that are thought to make a ‘good’ heterogeneous ice nucleant. 
INPs are often assumed to be ‘large’ in size,39–41 and Tn do relate to particle size and 
characteristics of crystals.37  Reports from Georgii and Kleinjung relating to biological 
INPs implies larger biological particles should show efficient ice nucleating ability.12 
Lattice matching is considered important for ice nucleation properties;7 this is the idea 
that substances that have similar crystal structures to ice, have similar lattice constants 
thus there is a structural match with the first layer of ice. Hydrophobicity is thought to 
be involved,42 and the concentration of hydroxyl groups important in lattice matching. 
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AgI was thought to have the potential to be a ‘good’ nucleator due to its similar crystal 
structure to ice,43 and this was found experimentally correct. However, the role of 
lattice matching has been debated; Zettlemoyer et al. argued that topography/oxidized 
sites on the AgI surface may be involved in ice-binding and thus nucleation rather than 
the lattice matching of the crystal itself.44 Finnegan and Chai have also suggested that 
nucleation promoted by AgI may work via a mechanism where surface charge clusters 
control it, and that lattice matching may be coincidental.45 
Specific locations have been determined to affect ice nucleation; for example 
molecular roughness of carbon surfaces impacts ice nucleation efficiency.22 These 
nucleation ‘active sites’ are considered to be where the critical ice embryo forms and 
can vary with between different nucleants;21,46,47 for biological INPs such as for P. 
syringae, the active site is thought to be where the ice nucleating proteins 
cluster/aggregate on the cell membrane,29 whereas this is considered to be a defect or 
nanoscale crack in feldspar materials.48 Active sites have been followed by high speed 
cameras; Gurganus et al. performed droplet freezing experiments seeing no propensity 
for nucleation at the same sites, indicating that no specific sites on their material 
nucleated ice more efficiently than others.49 Later work of theirs considered different 
textured surfaces, indicating that topography is important for ice nucleation behavior, 
and that nucleation processes are at least partly ‘site specific’.50 
 
Chapter 5 
238 
 
 
Figure 5.3. Representative micrographs of the nucleating spot in ice nucleating 
feldspar. Sequence of images taken from individual freezing experiments of two 
separate droplets, on the A) (010) and B) (001) faces. A 1 μL droplet of water is placed 
on a thin section of feldspar and cooled at 1°C min−1 until nucleation is detected with 
a high-speed camera operating at 3000 frames per second (fps). Adapted from Holden 
et al, (Sci. Adv., 2019).48 
Zolles et al. suggested that defects in the surface of a material are important for ice 
nucleation,21 and Whale et al. determined that topography acts to promote ice 
nucleation,51 inspiring Holden et al. to identify ice nucleation sites (INS) on 
macroscopic feldspar, finding that substrate heterogeneities are important in 
promoting nucleation.48 Figure 5.3 shows an example sequence of images recorded 
during a high-speed observation of droplet freezing, recorded at 10,000 fps; Figure 
5.3A follows cooling of water droplets on the (010) plane and Figure 5.3B follows 
droplets on the (001). The nucleation site is identified by the white arrows, from which 
dendritic ice grows. These INS were found to be contained within a micron-scale 
pore/crack. To ensure the identified active sites were the INS, repeat freeze/thaw 
cycles were performed, finding that a small number of INS existed for each sample, 
which nucleated at similar temperatures in multiple repeat measurements. 
No universal mechanism of action for nucleators has been agreed upon, and it remains 
unclear as to the extent of importance of lattice matching, topography and chemical 
composition. 
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5.3.5 Experimental Methods Used to Study Ice Nucleation 
In general, techniques used to analyse ice-activity involve direct observation of a 
sample. Recorded activity, whether TH, IRI or ice nucleation, can vary depending on 
technique performed (within or between laboratories), with potential results affected 
by human error, contamination (due to condensation or extraneous samples) or setup. 
Experimental investigation of the critical nuclei is near impossible due to the size and 
rarity of the nuclei and rate at which crystal growth occurs post-nucleation thus the 
majority of techniques focus on quantifying ice nucleation effectiveness of materials, 
which is much more straightforward.  
A range of approaches have been used in attempt to mimic the actions of biological 
nucleators as well as to determine ice nucleation efficiency,52 these study the effect of 
a range of variables including, INP concentration, temperature, cooling rate (or 
isothermal experiments),53–55 time and droplet size.  
The two broad families of techniques used to determine ice nucleation effectiveness 
are wet dispersion and dry dispersion methods.52 Wet dispersion methods involve 
dispersing INPs in water, unlike in dry methods, where particles are dispersed in air 
then exposed to wet air to generate water droplets containing the particles. Wet 
dispersion techniques are focused on in this work, with droplet assays and differential 
scanning calorimetry, both being performed to provide Tn. Droplet assays, are the most 
commonly utilised wet dispersion methods, and include approaches where droplets 
are supported on surfaces and where droplets are suspended in oils or gases.9 Samples 
are dispersed in water, which is then cooled and freezing monitored. Nucleation data 
from these assays is obtained in the form of fraction of droplets frozen as a function 
of time and temperature. Droplet volumes have varied widely, with studies conducted 
using everything from millilitre to picolitre volumes.56 The size of droplet is important, 
as larger droplets of a particular sample may run into ‘background problems’ where 
the native nucleation temperature of the system is warmer than that of the nucleants 
under investigation. Smaller (pL or nL) droplets enable measurements much closer to 
the homogenous freezing temperature as there is a lower probability for contaminants 
but do not allow investigation of rarer, more active INPs/INS.52,57 
The droplet freezing method used here is based on µL-Nucleation by Immersed 
Particle Instrument (µL-NIPI) from Whale et al. where a camera is used to monitor 
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droplet freezing, observed as an abrupt flash due to light scattering from numerous 
rapidly formed ice crystals.58 The µL-NIPI was designed to measure the effectiveness 
of atmospherically relevant INPs in µL water droplets. It uses an electronic 
micropipette to produce an array of droplets, the freezing temperatures of which are 
then measured. The technique is advantageous as it allows experiments to be 
performed relatively quickly, relatively high numbers of droplets (50+) can be 
measured simultaneously, no cooling fluids (such as liquid nitrogen) are required and 
the instrument is highly portable.33 However, many repeat measurements have to be 
taken (as with all droplet assays), but this is less of a problem due to the ease and speed 
of each measurement. 
Other wet dispersion techniques include using emulsions of water droplets in oil, 
microfluidics and calorimetry.1,21,59,60 DSC has been used as a method for studying 
AFP activity since 1988, when Hansen and Baust recorded the freezing temperatures 
of TmAFP suspended in oil.60 Calorimetry, especially when used in combination with 
microfluidics (using microemulsions),61 can provide the option to record nucleation 
temperatures without the problem of contamination from surfaces (as in microscopy 
based techniques), though may lead to a change of location of INPs in droplets. Other 
techniques that have been developed, one of which by Harrison et al., involves the use 
of an infra-red camera (InfraRed-Nucleation by Immersed Particle Instrument (IR-
NIPI)) to monitor 50 µL scale droplets, Figure 5.4.62 IR-NIPI involves using an 
infrared camera to follow the temperature of individual wells of sample to be 
monitored. Samples are divided into 50 µL droplets per well, and freezing 
temperatures of these drops are determined by detecting the change in temperature for 
each well (an increase caused by a release of heat). 
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Figure 5.4. A) Illustration of the IR-NIPI technique developed by Harrison et al., 
(Atmos. Meas. Tech. Discuss., 2018).62 The Infra-red camera is positioned above the 
multiwell plate and monitors the freezing events as the cold stage cools; B) Example 
colour map taken during the course of an experiment. The black circle represents a 
sample nucleating in an individual well (exothermic reaction leads to the higher 
temperature in this well). Warmer temperatures are represented in red, transitioning to 
blue for colder temperatures and finally black at −30 ℃ and below. Cooling rates used 
is 1 ℃ min−1. 
Molecular dynamics (MD) is often used to study the physical nature of nucleation 
processes, due to the difficulty of experimental observation of critical nuclei,5,47,63–65 
in particular assisting in understanding the nucleation event and critical nucleus itself, 
though these can suffer from miscalculations, in particular for heterogeneous 
nucleation, due to incorrect estimations of properties of samples and nuclei e.g. radius 
of curvature.66  
It has been shown that there are many effective approaches for controlling ice crystal 
growth (see Chapter 1), however, as yet it has proven challenging to control ice 
nucleation. There is great difficulty in predicting what foreign particles or surfaces 
may promote nucleation, and due to experimental challenges the mechanism of action 
by which currently known effective INPs work is unclear.67 
 
5.3.6 Finding new nucleators 
As it is unclear as to how nucleators work, there is no preferred structure focused on 
for identifying new nucleators. No current technique can locate or measure the 
physical properties of the critical nuclei that form in ice. Due to this, ice nucleators 
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and their effectiveness are currently inferred from experimental results. IRI activity is 
generally not been observed for nucleators (except for AFPIII potentially at high 
concentrations), thus polymers such as PVA and AF(G)Ps used in previous chapters 
were not selected for study in this work. Instead, using a blue-sky approach (as many 
different materials are nucleators), a selection of materials with large structures or that 
form extended arrays were selected, because if structure/size is important to nucleation 
there may be a correlation with efficiency.  
 
Figure 5.5. Schematic of concept behind the decision to study Zirconium-based MOFs 
for ice nucleation. A) Concept Underlying the Synthesis of Metal–Organic 
Frameworks; B) Schematic illustration of the structure features of an example 
selection of MOFs that could be studied: UiO-66 (−NH2, −OH), UiO-67, and MOF-
808, showing their large extended surfaces. Adapted from Zhu et al, (J. Am. Chem. 
Soc., 2019).71 
Metal organic frameworks (MOFs) are materials consisting of coordination bonds 
between multidentate organic linkers (ligands) and transition-metal cations. They are 
made via reticular synthesis, where the inorganic and organic linkers are assembled 
together, the assembly of the elementary unit and final MOF is depicted in Figure 
5.5A. They have many uses including gas storage, catalysis, biomedical imaging and 
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drug delivery.68–70 They are characterised by their open frameworks and can highly 
porous. MOF structures can be modified, thus their adsorption properties can be tuned, 
leading to the possibility for structures that may bind ice because of particular spacing 
of functional groups/ligands on the surface.71 
If MOFs nucleate ice well, they could be used for cloud seeding, providing a possible 
application in arid regions to increase rainfall. MOFs have been also observed to 
absorb water from air, so act as desiccants.72 Zhu et al. found a zirconium based MOF 
had IRI activity, cryopreserved red blood cells and had potential nucleation properties. 
A range of MOF structures tested by Zhu et al. for activity are shown in Figure 5.5B. 
A separate, biological material of interest is lignin. Lignin is a major component of 
plant biomass, which consists of two carbohydrate polymers (cellulose and 
hemicellulose) as well as lignin, which is an aromatic polymer.73,74 Lignocellulosic 
biomass is the major component in all types of plants and is the most abundant carbon 
source on Earth. Lignin itself is found in a range of woody plants and non-woody 
plants, including grasses.75 This polymer provides structure to the plant, assists in 
modifying cell permeability and temperature stability, supports tissues and gives a 
certain stiffness and woodiness.76 Some industrial uses of lignin include feedstock and 
biofuels,73,75,77 leading to them being readily available for research. 
 
Figure 5.6. Three important basic building blocks of lignins; A) ρ-coumaryl alcohol; 
B) coniferyl alcohol; C) sinapyl alcohol, which give rise to ρ-hydroxyphenyl, guaiacyl 
and syringyl residues in lignin. 
Lignin is biosynthesised from three monolignols (coumaryl alcohol, coniferyl alcohol 
and sinapyl alcohol), Figure 5.6,78 percentages of which vary in different types of 
wood/crops. For example, hardwoods consist of more coniferyl alcohol and sinapyl 
alcohol units, whereas softwoods (and plants) consist of more coumaryl alcohol.74 
These monolignols conjugate in a variety of ways during biosynthesis to form 3D 
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polymers that do not consist of regular, ordered macromolecular structures, leading to 
the great diversity in lignin structures due to the numerous different combinations of 
ρ-hydroxyphenyl, guaiacyl and syringyl available.79 
Lignins are generally insoluble and hydrophobic in nature, thus enabling woody 
materials to resist chemical and biological degradation.80 This property may be useful 
for ice nucleation, as efficient ice nucleants such as mineral dusts are also insoluble. 
They also have a large number of polar hydrophilic groups (hydroxyls), therefore some 
may have similar functional group patterns allowing them to crystallographically 
match that of ice, leading to nucleation. However, there is debate as to the importance 
of hydrophilicity.46 Lignocellulosic materials may act as heterogeneous ice nucleating 
agents; they have been observed assisting in nucleation of other materials, for example 
polypropylene,81 and cellulose particles themselves have been observed to be potential 
sources of atmospheric INPs, though further investigation is required.82 Isolation of 
pure lignins is futile, due to its covalent bonding to carbohydrates forming lignin-
carbohydrate complexes (LCCs).78 Thus if these materials nucleate ice, deciphering 
the active site/characteristics involved in nucleation will be a challenging task. 
If any materials show promise, further study can take place on a more specific range 
of MOF or lignin structures.  
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5.4 Chapter Aims 
• Test a range of previously untested compounds for their ice nucleation activity 
with the aim of obtaining next-generation promoters of ice nucleation, thus 
providing potential new ice nucleating compounds based on polymers and 
composites to control freezing temperatures during cryopreservation.  
• Compare different wet-dispersion techniques for observing nucleation activity 
in these samples. 
• Compare concentration ranges and cooling rates for their effect on nucleation 
activity, i.e. assist in determining what causes nucleation in these samples.  
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5.5 Results and Discussion 
5.5.1 Samples Tested 
The materials chosen for study here include larger, extended structures, none of which 
have been tested in any meaningful way for ice nucleation activity bar safranine-O. 
Metal organic frameworks (MOFs) were chosen as they have many, varied, highly-
designable, easily-modified structures (over 20,000 different MOFs have been 
reported),74 meaning there is a possibility for tuneable ice-activity due to the 
possibility for lattice-matching with ice.71 A variety of ligands were chosen with 
phenolic acid/carboxylic acid groups arrayed around a cerium ion giving an extended 
structure such as that in Figure 5.8.  
Figure 5.7. A) Chemical structures of ligands used for MOFs tested here. 1,4-benzene 
dicarboxylic acid (BDC), naphthalenedicarboxylate (NDC), benzene-1,3,5-
tricarboxylic acid (BTC); B) Extended structure of the MOFs provided by Ehsan 
Ghadim. 
The common ice growth inhibitor safranine-O was also tested, structure shown in 
Figure 5.8A. Safranine-O, with its flat planar structure, and propensity to self-
assemble into supramolecular aggregates at concentrations above 1.0 mg.mL-1, has 
been observed interacting with specific ice faces, leading to ice shaping as well as 
growth inhibition. In the literature there is no mention of ice nucleation activity. 
Safranine-O’s structure differs from the other materials tested here; it has amine 
groups rather than hydroxyls/carboxylic acids. The hydroxyls are not required for IRI 
activity, and may not be essential for nucleation either, though the supramolecular 
structure may be involved.83  
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Figure 5.8. Chemical structures of other materials tested here. A) Safranine-O; B) 
Alkali lignin (471003) 10 kDa (Structure from Sigma-Aldrich). The producer’s 
elemental analysis data states a carbon content of 47-51 % and that this technical Kraft 
lignin has a remaining sulfur content of ~4 %. 
A range of lignins were also tested, one of which is commercially available from 
Sigma Aldrich; Alkali lignin (471003) (average molecular weight: ~10 kDa), structure 
shown in Figure 5.8B. The structure of lignin is defined as an amorphous polyphenolic 
polymer material and is not regarded to be an inherently defined compound but as a 
composite.84  Structural analysis has been studied using elemental analysis, 1H-NMR, 
13C-NMR, FTIR and gel permeation chromatography (GPC). These enable 
quantification of the lignin substructures (within the lignin) shown in Figure 5.6, for 
example this alkali lignin has been determined to contain a guaiacyl unit. The other 
lignins chosen for testing can be extracted from a range of plant genera, these include 
Triticum commonly known as wheat (MK lignin), Populus (ammonia lignin), 
Miscanthus (miscanthus lignin), Eucalyptus globulus (OrganoSolv) and a range of 
hard woods (OrganoAlkali). The two final lignins tested were Zambezi and 
GreenValue, which can be extracted from multiple different botanical origins 
comprising of wood, corn, sugar beet and sugarcane.  
Lignins were chosen because they are highly abundant natural resources that, if ice-
active, have the potential to be technologically useful; e.g. they are stable enough to 
be mixed with acrylic resins so could be used in 96-well plates during cryopreservation 
experiments (they are thermally stable and have been used in the production of plastics 
and integrated with acrylic monomers previously).73,85 The lignins are named after the 
process by which they are isolated; they are often fractionated by processes such as 
delignification by alkali [labelled as alkali lignin here], organosolv pre-treatment 
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[labelled as OrganoSolv here],86,87 Kraft process, hydrolysis etc. or by the plant they 
are extracted from. 
If nucleation is a structure related event, and other materials with large flat structures 
(GO) have been observed to nucleate ice effectively, lignins, which also have this 
structure, may also nucleate. The phenolic hydroxyl group may be of interest, as many 
currently researched INPs have these same functional groups, or phenolic 
acid/carboxylic acid groups. 
 
5.5.2 Comparison of Experimental Methods 
As mentioned in 5.3.5, there is a range of different methods that can be utilised for the 
study of ice nucleation. A description of the two methods used in this work are 
provided here. 
 
5.5.2.1 Calorimetry-based Methods 
Calorimetry techniques measure the thermal properties of materials, and how these 
physical properties link to changes in temperature.74 These techniques have been used 
in chemistry, cell biology, biotechnology, physics and nanoscience, measuring the 
thermodynamic properties of a range of materials, biomolecules and ice phases.88–91 
DSC is a technique that monitors the heat flow of a sample whilst the temperature of 
a sample is changed, thus monitoring changes in phase/state in a sample due to a 
change in temperature with time.92 The amount of heat absorbed or released by the 
sample is recorded and to account for any background, the change in heat flow for a 
sample is compared to that of an empty crucible. Samples for nucleation can be 
directly pipetted into the crucible, or can be dispersed in oil/emulsions, and the 
nucleation event followed by the production of an exotherm upon freezing. These are 
known as closed droplet systems where monitoring of freezing can be difficult as the 
droplets are not visible.93 Example DSCs traces from work by Wilson et al. detail the 
endo- and exotherms obtained from the heating and cooling runs in a typical 
experiment and the point at which the Tn would be obtained off the graph for Ih, 
Figure 5.9A.94 Initial obtained data for our pure water sample can be seen in Figure 
5.9B, the axes have not been reversed to highlight how the data looks on the Perkin 
Elmer DSC6000 used here. Again the point at which the Tn is recorded is noted in red. 
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Figure 5.9. DSC traces and how nucleation temperatures are extracted from this data. 
A) Example DSC traces of liquid water transitioning to Ih (and melting back to liquid) 
from the literature. Two scans from the same sample, where the ice was warmed at 
either 5 °C.min-1 (solid line) or at 1 °C.min-1 (dashed line). Both the cooling and 
heating runs have been included i.e. both endotherms and exotherms are shown and 
the point at which the nucleation temperature would be recorded highlighted in red. 
Adapted from Wilson et al. (Biophys. J., 1999);94 B) Raw DSC trace of pure water 
cooling from 0 °C to -35 °C obtained in this work. Nucleation temperatures are 
extracted at the point at which the exotherm corresponding to the phase change occurs. 
It can be seen that the peak slants unlike in the literature example; B) Temperatures 
obtained from DSC with one 10 µL droplet in direct contact with the aluminium pan; 
and C) Temperatures obtained from DSC of a few 1 µL droplets dispersed in oil (i.e. 
not in direct contact with pan) compared to that of the DSC trace for oil (black), water 
(red), safranine-O (green) and alkali lignin 471003 (blue), their apparent nucleation 
temperatures (recorded as an exotherm). [Sample] = 1.0 mg.mL-1.  
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Initial tests on safranine-O and alkali lignin (471003) were performed using 
differential scanning calorimetry (DSC) and compared to that of pure water, Figure 
5.9C/D. The first experiment involved 10 µL droplets being directly pipetted into the 
aluminium pan and then transferred into the DSC. Using this method, it appears that 
safranine-O nucleates ice at ~-21 ℃, alkali lignin at ~-25 ℃, and water at ~-28 ℃. It 
is difficult to follow homogeneous nucleation, and there will generally be an impurity 
leading to heterogeneous nucleation (nucleation seen occurring at between -24 ℃ and 
-31 ℃ rather than between -35 and -40 ℃).4 There was a large change in heat flow for 
the samples, which was affected by the high sample volume in the crucible (10 µL), 
leading to oddly oriented DSC traces, Figure 5.9C, thus the values obtained cannot 
be considered accurate. 
To improve the first method by reducing sample volume, and reduce any potential 
error due to contamination of sample (the crucible itself may consist of INS), the 
samples were then dispersed in immersion oil filled crucibles, Figure 5.9D. The DSC 
traces obtained here were more typical, with freezing temperatures observed <-30 ℃ 
for water, between -25 and -30 ℃ for safranine-O and ~-22 ℃ for the lignin, these 
were also compared to the DSC trace of oil to ensure there was no effect on nucleation 
temperature due to addition of oil. However, as only a few droplets can be recorded at 
once there is a high possibility for error/low statistical significance as well as potential 
contamination from sample preparation; many chances for contamination as sample 
transferred to crucible and then into DSC.  
The increase in nucleation temperature for safranine-O in Figure 5.9C is probably due 
to contamination. Potentially the Tn of safranine-O solutions in Figure 5.9D may be 
attributable to homogeneous ice nucleation itself, as they are observed much closer to 
this temperature range, or more likely, heterogeneous nucleation. 
These calorimetry-based techniques require more optimisation and many more runs to 
obtain enough data to ensure nucleation temperatures are accurate, thus are not focused 
on in the remainder of this work. 
 
5.5.2.2 Microscopy-based Methods 
Microscopy-based multi-point freezing assays (droplet freezing assays) using cameras 
were used to visually observe ice nucleation; once ice nucleation occurs droplets 
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freeze on a short time scale, over the course of a fraction of a second. As such, any 
observation of freezing can be tied directly to a nucleation event. The probability of 
two nucleation events occurring in a single droplet is vanishingly small. In a droplet 
freezing assay, an aqueous suspension is taken and subdivided into ideally identical 
volume aliquots, which are cooled identically. A diagram of a typical setup for this 
microscopy-based immersion technique is shown in Figure 5.10. The setup consists 
of a cold stage, chamber to ensure humidity of an experiment is controlled and a digital 
camera to follow the nucleation process. Hydrophobic glass slides (22 mm diameter, 
0.22 mm thick, Hampton Scientific) were used to reduce heterogeneous nucleation 
caused by the surface to a minimum. Prior to running any experiments these slides 
were cleaned using methanol and water. A gentle flow of dry gas is used to stop 
freezing droplet influencing their neighbours.  
 
Figure 5.10. Diagram illustrating the µL-NIPI-based nucleation drop assay setup used 
in this work. 
The first multi-point freezing assays used a crude setup consisting of a basic camera, 
a cryostage cooled using a T95-Linkpad system controller with liquid nitrogen pump, 
and no dry gas flow. These were performed to provide a proof of concept for later 
nucleation experiments. Example photographs obtained for freezing droplets in this 
way are seen in Figure 5.11. Between 10 and 20 drops can be observed using this 
setup, due to the size of the cryostage focal window. As expected, nucleation is 
observed by the change in light scattering (frozen drops circled in red). The assays 
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here were not filmed but photographs taken every 0.1 ℃.min-1. The size of the droplets 
in immersion assays is important, so that the Tn recorded is not affected by, for 
example, a range in droplet volumes (smaller droplets nucleate at lower 
temperatures)9,33,56 and here this is controlled as much as possible by using a Picus 
Biohit electronic pipette. The dispersity of nucleants in a sample may vary, particularly 
at low concentrations, this is accounted for by the high number of droplets counted, as 
well as by performing up to 5 repeat experiments (i.e. 20 – 100 droplets are monitored 
for their Tn). If a sample has nucleating efficiency, then the dispersity should not affect 
the freezing temperature, as the water droplet will freeze at the same temperature   
 
Figure 5.11. Example photographs from a multi-point freezing assay. Frame (A) was 
taken at -25.0 °C, before the onset of freezing, frame (B) immediately after the first 
two droplets had frozen (-26.2 °C), frame (C) at -27.5 °C and frame (D) at -30.1 °C, 
after the completion of freezing. Frozen droplets highlighted in red. 
After performing these initial studies, further experiments were performed with more 
precise temperature control and measurement as well as a dry nitrogen gas flow (0.2 
L.min-1) and a video camera, allowing for videos of the nucleation assay continuously 
monitored. This provided a higher-throughput technique (experiments can be 
performed relatively quickly), with more accurate temperature reading and simpler 
data analysis. Individual frames where freezing occurs are selected from videos, and 
the associated freezing temperature of each droplet recorded. Example photographs 
obtained for freezing droplets in this way are seen in Figure 5.12.  
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Figure 5.12. Example photographs from a nucleation drop freezing assay based on 
µL-NIPI. Frame (A) was taken at -10.0 °C, before the onset of freezing, frame (B) 
immediately after the first two droplets had frozen (-18.0 °C), frame (C) at -22.5 °C 
and frame (D) at -30.7 °C, after the completion of freezing. Frozen droplets 
highlighted in red. Droplets of this size (1 mm) typically take 2 – 4 seconds to freeze 
completely. The initial change in the droplet leading to freezing is taken as the 
occurrence of ice nucleation. 
With this setup between 30 and 50 drops can be observed, a much greater number than 
with the previous assay. Having the dry gas flow ensured prevention of condensation 
of water and ice on the slide, and thus leading to less error in the nucleation 
temperatures recorded, as droplets would not be contaminated and would remain the 
same size throughout the experiment. The peltier chiller requires no cooling fluids 
unlike in the first assay. Drops were pipetted onto the slides using a Picus Biohit 
electronic pipette to ensure that each individual droplet contained the same volume of 
material. 
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Figure 5.13. Temperatures obtained from nucleation drop assay (45-55 1 µL droplets 
per slide, 2-5 repeat experiments per sample). Milli-Q water (red), safranine-O (green) 
and alkali lignin 471003 (blue). Temperature uncertainty of µL-NIPI-based method is 
±0.4 ℃. [Sample] = 1.0 mg.mL-1. 
The frozen fraction of droplets as a function of temperature can be obtained from 
photographs recorded in µL-NIPI-based assays, Figure 5.13. All droplet nucleation 
temperatures from repeat experiments are plotted for each sample (i.e. the total number 
of data points for one sample consists of 100 – 250 individual temperature 
measurements) and droplets that nucleate at the same temperature are included in the 
same data point. As with DSC experiments, safranine-O and alkali lignin were tested 
using the µL-NIPI-based method and compared to that of pure water. A difference in 
nucleation temperature for safranine-O was not observed unlike in the DSC, further 
supporting that safranine-O is not an INP, suggesting that in the previous DSC 
experiments only one end of the distribution of nucleation temperatures was observed 
(only 1-3 droplets recorded). However, nucleation of the alkali lignin does seem to 
occur at a higher temperature than water (-15 to – 25 ℃), with 50 % of the droplets 
freezing (T50) at ~-21 ℃, which is similar to the freezing temperature observed in 
Figure 5.9B.  
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Figure 5.14. Temperatures obtained from nucleation drop assay (45-55 1 µL droplets 
per slide, 2-5 repeat experiments per sample). Milli-Q water (red) and safranine-O 
(green). Temperature uncertainty is ±0.4 ℃. [Sample] = 2.5 mg.mL-1. 
Safranine-O at a concentration above 1 mg.mL-1 self-assembles,83  and was tested in 
Chapter 3 for ice shaping using a concentration of 2.5 mg.mL-1, here this concentration 
has also been used to study ice nucleation to check whether there is an increase in 
activity for this concentration, Figure 5.14. However, even at this higher 
concentration safranine-O does not promote ice nucleation, with the T50 of water being 
-26.3 ℃ and safranine-O -25.3 ℃. 
The above results obtained from the µL-NIPI-based drop assay are encouraging; using 
1 µL droplets allows for the monitoring of a range of nucleation temperatures and the 
ease at which it is performed means a large number of repeat measurements can be 
performed. The addition of materials to water, may affect the surface tension of the 
droplets, which in turn could also affect the Tn. This is because surface tension 
decreases with increasing curvature, in turn reducing the equilibrium radius of an ice 
embryo, thus increasing the probability of a nucleation event.95 This was not tested 
here, but the contact angle of the water droplets could be measured in future 
experiments. A change in viscosity may also affect nucleation temperatures 
(potentially leading to a reduction in ice nucleation efficiency, as observed in Fayter 
et al’s research on hydrogel nucleation),96 this is because as viscosity increases, the 
diffusion constant for the water molecules reduces, leading to a lengthening of 
diffusional mixing time and a larger barrier to molecular rearrangements within the 
sample, which hinders the formation of a critical nucleus causing the Tn to decrease. 
This could be monitored by performing rheometry or viscometry experiments. 
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5.5.3 Metal Organic Frameworks 
Splat assays testing IRI activity for Ce-NDC-UiO-66 synthesised via a range of 
processes were performed. These include synthesis using acetic acid, acetic acid:water 
solutions and ethanol:water solutions, Figure 5.15A. UiO-66 was originally chosen as 
a ligand for MOFs tested here as Zhu et al. found that UiO-66 structures 
(concentrations included 0.1 to 2 mg.mL-1) had IRI activity and potential nucleating 
activity.71 The different synthetic routes were chosen to study whether the synthesis 
had an effect on ice-activity, as the samples may incorporate acetic acid or ethanol as 
impurities, which may lead to promotion of ice nucleation.   
Ce-NDC-UiO-66 [from here called Ce-NDC] synthesised using 50:50 ethanol:water 
has slightly higher IRI activity than the other samples (MGS of 71.9 %), though this 
is not a beneficial level of IRI activity for cryopreservation. This synthesis was 
repeated and purified further and the IRI activity dropped, implying the impurities in 
that sample were what led to activity. Experiments using zirconium-based MOFs were 
then performed to see if there was any change in IRI activity due to the Zr. This is 
because ZrAc has been found to be IRI active97 and potentially, if due to the Zr, the 
MOFs will also be IRI active. Zr-MOFs were in fact slightly less active than the Ce-
MOFs, Figure 5.15B, with both MLGS and MGS being ~100 % of PBS. Another Ce-
MOF (Ce(BTC)3.6H2O) was compared to Ce-NDC and no IRI activity was observed 
here either. 
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Figure 5.15. IRI activity for a range of MOFs; A) Ce-NDC-UiO-66 synthesised via 
different synthetic routes as a percent of PBS; B) Ce-MOFs and Zr- MOFs. Black = 
MGS and red = MLGS. [MOF] = 10 mg.mL-1. 
IRI activity for Ce-NDC-UiO-66 was also tested over a range of concentrations (1.0 
mg.mL-1 to 10 mg.mL-1), with no activity observed at any concentration; a slight 
increase ‘activity’ from 1 to 10 mg.mL-1 was observed for all synthetic routes; 
however the crystals are still ≥71.9 % of the size of PBS crystals. 
 
Figure 5.16. IRI activity for Ce-NDC-UiO-66 synthesised via different synthetic 
routes as a percent of PBS over 3 concentrations.  
Nucleation was then performed on these samples, as nucleation and IRI are not 
expected to be linked. Neither Ce-NDC (blue) nor the two Zr-MOFs (red/green) have 
nucleation activity, with all three Tn being that of water, Figure 5.17. From the work 
performed so far, results indicate that the previously recorded IRI activity of ZrAc 
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does not solely relate to the Zr metal or acetic acid, and that its antifreeze activity is 
complex. 
 
Figure 5.17. Frozen fraction of 1 µL droplets containing 3 different MOFs (1.0 
mg.mL-1) compared to that of a Milli-Q water control. (45-55 1 µL droplets per slide, 
2-5 repeat experiments per sample). 
Despite the extended structures the MOFs tested here and the possibility for lattice 
matching with the ice surface there may be more to being an INP. 
 
5.5.4 Lignins 
 
Figure 5.18. Frozen fraction of droplets containing 3 different lignin samples (1.0 
mg.mL-1) compared to that of a Milli-Q water control. (10-20 1 µL droplets per slide, 
2-5 repeat experiments per sample). 
The first nucleation assays on lignins were performed using a cryostage setup and 
compared to that of water, indicating promise (though the values obtained for water 
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are too cold for this type of setup), Figure 5.18. The slopes for the three lignin samples 
are similar, with the Tn shifting along the x-axes to higher temperatures. Alkali lignin 
appeared to nucleate ice at the highest temperatures (T50: -23.1 ℃) followed by MK 
lignin (T50: -25.7 ℃) and then GreenValue (T50: -30.8 ℃). From this data, a 
mechanism of action cannot be inferred, though the mechanism by which the lignins 
nucleate could be the same, with the alkali lignin nucleating more efficiently. This 
may be due to surface tension or viscosity changes in the droplets, which would need 
to be studied in more depth using viscometry or rheometry. Despite these Tn being 
much lower than that of any biological nucleants, there is a definite temperature shift 
between lignins and pure water, leading us to believe lignins are another potential INP. 
Our next steps to ensure these findings were correct involved using the µL-NIPI-based 
method, as the method, described above, has less error in recording nucleation 
temperatures. 
  
Figure 5.19. Frozen fraction of droplets containing Alkali lignin 471003 (blue) 
compared to that of Milli-Q water (black) recorded using two different setups. 
Nucleation temperatures observed on the cryostage = open square/circle, temperatures 
obtained using µL-NIPI = filled square/circle. [Lignin] = 1.0 mg.mL-1 
Using the µL-NIPI-based method, alkali lignin was tested again; the results comparing 
Tn of water and lignin are shown in Figure 5.19. Minimal variation in Tn is observed 
between the lignin samples, however there is a difference in the water samples. 
Implying, even though the water nucleation temperatures may be inaccurate for the 
cryostage setup (due to the large error in taking measurements at  below -30 ℃) under 
those conditions, that the alkali lignin does in fact nucleate ice between -16 and -20 
℃, which is higher than that of the water control, and a similar nucleation temperature 
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to other non-biological nucleants. After this, all experiments were carried out using 
the µL-NIPI-based method only. 
 
Figure 5.20. Nucleation activity of a range of lignins. A) Frozen fraction of droplets 
containing 8 different lignin samples (5.0 mg.mL-1, sonicated for 2 minutes); B) 
Frozen fraction of droplets containing 3 different lignin samples (1.0 mg.mL-1) 
compared to that of a Milli-Q water control. 
Nucleation for a range of lignins was tested, showing as with the cryostage setup, a 
larger increase in Tn for alkali lignin (471003) and MK lignin, and a smaller one for 
the others, indicating that there may be specific features required for nucleation 
activity, Figure 5.20A. This potentially could relate to the fact that all lignins have 
linkages to different carbohydrates, thus have different concentrations of 
contaminants/fragments of contaminants, which are assisting in nucleation.98 Further 
characterisation of the lignins tested would need to be performed to understand their 
structures and degradation assays performed (biological, chemical or enzymatic) on 
MK and alkali lignin to study what causes a loss in activity. Lignin degradation has 
been studied for a range of species; some fungi are known to decay wood and lignin;74 
bacteria has been observed to be directly involved in lignin mineralisation and more 
recently has involvement in degradation; yeasts have been reported to depolymerise 
short lignins (200 – 600 Da)99 as well as modify the structures in general.100 Lignin-
degrading enzymes are well known and much research has been performed into those 
from fungi in particular. 
These two active lignins and GreenValue (chosen as a less nucleating comparison) 
were tested at 1 mg.mL-1, Figure 5.20B. Interestingly, nucleation appeared to be 
enhanced for all 3 lignins at this lower concentration, not just alkali and MK. As the 
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alkali lignin is commercially available and a structure is available for it, further tests 
into its ice-activity, and the effect of different variables on its ice nucleation efficiency 
were performed. 
 
Figure 5.21. IRI activity for alkali lignin (471003) over a range of concentrations 
compared to that of PBS. 
Alkali lignin was tested for IRI activity, Figure 5.21, showing crystals at ~70 % of the 
size of a PBS control at 1 mg.mL-1, but generally no ice growth inhibition. 
Interestingly the increase in activity from 0.5 to 1 mg.mL-1 decreases again upon 
increase in concentration, with larger ice crystals formed for both 5 and 10 mg.mL-1 
concentrations. Indicating that there is an upper and lower limit to activity for this 
sample. 
Active sites on INPs are hard to find, so a range of variables were tested to see if the 
nucleating activity of alkali lignin could be understood further. 
 
5.5.4.1 Effect of Concentration 
Firstly, three different concentrations of alkali lignin were tested to monitor the change 
in ice nucleating efficiency, Figure 5.22. Over the three concentrations tested, the 
nucleation activity of the lignin appears to remain the same (within error), suggesting 
that nucleation is not concentration dependent, and that even if the number of potential 
INS is increasing, there is a limit to the number of sites available for binding on the 
growing ice face. 
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Figure 5.22. Frozen fraction of droplets containing Alkali lignin (471003) at 3 
different concentrations compared to a Milli-Q water control. (45-55 1 µL droplets per 
slide, 2-5 repeat experiments per sample). 
Two further concentrations were tested; 0.1 mg.mL-1 (to test where activity was lost) 
and 50 mg.mL-1 (to test if there was an upper limit to activity). Frozen fractions for all 
5 concentrations are compared to water in Figure 5.23. 
 
Figure 5.23. Frozen fraction of droplets containing Alkali lignin (471003) at 5 
different concentrations compared to a Milli-Q water control. (45-55 1 µL droplets per 
slide, 2-5 repeat experiments per sample). 
It can be observed that alkali lignin no longer appears to nucleate ice at 0.1 mg.mL-1, 
with all Tn occurring within temperature ranges that pure water nucleation also occurs. 
According to Beydoun et al. nm curves for a system should remain the same as the 
concentration is varied, and only if there is a decrease in particle concentration, a shift 
in frozen fraction curves would occur.101 This is observed between 50 mg.mL-1 (grey) 
and 7 mg.mL-1 (orange), thus 50 mg.mL-1, though appearing to be a more efficient 
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concentration for ice nucleation, may not be and this may be in fact due to the increase 
in particles available.  
Beydoun et al. proposed that there is a critical area threshold, that below which the 
distribution of any nucleating sites will have changed and that, rather than a shift, a 
broadening of the curve will occur.101 This however, does not appear to be the case 
between 0.1 mg.mL-1 (red) and 1.0 mg.mL-1 (green), implying there is no threshold 
between these two concentrations, though there is a decrease in particle concentration 
(curve shifts). 
To test for any effect on concentration/mass variation, normalisation of the data from 
Figure 5.23 was performed, and represented as cumulative total number of nucleation 
sites per gram as a function of temperature, Figure 5.24. Uncertainty in this work is 
estimated using a Monte Carlo procedure described by Vali,74 (program written by Dr 
Thomas Whale, University of Warwick) where 100 modelled ‘runs’ of  µL-NIPI 
assays are simulated using Poisson distributed random numbers. These are generated 
lists of possible values for number of active sites per droplet (k) which are related to 
the fraction of droplets frozen. This is performed because there is a certain randomness 
to the distribution of active sites in each drop in droplet freezing experiments and, 
theoretically, if 100 – 1000 experiments were performed then the results obtained 
would mirror that of the calculated results. 
The results for normalisation are written here as ice nucleation active site density (nm) 
normalised to mass. In general nm does not change with decreasing concentration, 
though a slight step in nm between 1.0 and 5.0 mg.mL-1 can be observed, with nm 
increasing as the concentration decreases, implying there is potentially a critical area 
threshold here. There is, however, agreement (within error) between 0.1 and 1.0 
mg.mL-1 and the 3 samples ≥5.0 mg.mL-1 indicating that the ice nucleation efficiency 
of lignin between these groups is similar.  
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Figure 5.24. Ice nucleation efficiency expressed as sites per mass (g-1) of lignin as a 
function of temperature (nm(T)) for alkali lignin (471003) tested in this study. Values 
normalised to mass per droplet. Each line consists of between two and five 
experiments. Due to the significance of nucleation temperatures differences between 
lignin and water no background subtraction was conducted. Error bars calculated using 
the Poisson Monte Carlo procedure. For clarity, as errors were representative, only 1 
out of 4 errors bars plotted. Temperature uncertainty is ±0.4°C 
 
5.5.4.2 Effect of Sample Preparation 
Generally INPs are considered to be large particles (atmospheric INP efficiency 
correlates with particles being larger than 0.5 µm in diameter),38 so to test the size of 
the lignin INP, both alkali lignin and GreenValue were filtered through filters (0.2 µm 
diameter pores) and the filtrate tested for nucleation activity and the frozen fractions 
compared. 
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Figure 5.25. The effect filtering has on nucleation. A) Frozen fraction of droplets 
containing alkali lignin (471003) filtered and unfiltered (5.0 mg.mL-1); B) Frozen 
fraction of droplets containing alkali lignin (471003) filtered and unfiltered (50 
mg.mL-1) compared to Milli-Q water. Unfiltered = red, filtered = green. (45-55 1 µL 
droplets per slide, 2-5 repeat experiments per sample). 
The alkali lignin’s Tn were not affected by filtering, Figure 5.25, indicating that the 
size of the INPs are <0.2 µm, which is much smaller than suggested for the 
atmospheric INPs. 50 mg.mL-1 was tested to see if filtering had any difference at this 
higher concentration, as potentially there would be a loss in efficiency if any particles 
had aggregated (and because there is a difference in nm for these two samples). 
 
Figure 5.26. Frozen fraction of droplets containing GreenValue lignin filtered and 
unfiltered solutions compared to Milli-Q water (1.0 mg.mL-1). Unfiltered = red, 
filtered = green. (45-55 1 µL droplets per slide, 2-5 repeat experiments per sample). 
Green value lignin was then tested again filtered; as the sample does not fully dissolve 
in pure water, 1 mg.mL-1 was filtered and then tested for nucleation activity in the 
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filtrate, Figure 5.26, where a drop in activity was observed, indicating the size of the 
nucleants are >0.2 µL. 
 
5.5.4.3 Effect of Cooling Rate 
Cooling rates have been studied for a range of materials, with some showing 
nucleation has either weak or no cooling rate dependence compared to that of 
temperature dependence,9,102,103 and others exhibit a certain dependence at high 
concentrations.53 If there is a particular INS, Tn should not be affected by cooling rate, 
as this site would promote nucleation at the same temperature (temperature required 
for a particular size critical nucleus) each time. 
 
Figure 5.27. Frozen fraction of droplets containing Alkali lignin 471003 frozen at 
different cooling rates compared to that of a Milli-Q water control (black, cooled at 1 
℃.min-1). A) Four different rates compared; B) comparison of 1.0 ℃.min-1 (red) and 
10 ℃.min-1 (orange). (45-55 1 µL droplets per slide, 2-5 repeat experiments per 
sample). [Lignin] = 1 mg.mL-1. 
To check for any effect of cooling rate on Tn for alkali lignin, assays were performed 
using four different cooling ramp rates, Figure 5.27A. It can be seen that modifying 
the cooling rate of this system (between 1 and 10 ℃.min-1) does not greatly affect the 
temperatures at which alkali lignin nucleates ice. The fastest (10 ℃.min-1, orange) and 
slowest (1.0 ℃.min-1, red) cooling rates are magnified in Figure 5.27B, showing that 
there is little effect on Tn overall.  20 % of droplets have frozen for both rates at -19.2 
℃, and though the percent of frozen droplets differs as the sample cools, with 55 % 
of those cooled using the 1.0 ℃.min-1 rate frozen by -21.6 ℃ but only 40 % for those 
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cooled with the 10 ℃.min-1 rate, 100 % of the droplets are frozen by -25.5 ℃ (10 
℃.min-1) and -25.7 ℃ (1.0 ℃.min-1). 
In general, if two sets of droplets that contain the same mass/surface area of INP are 
cooled at different rates, a greater percentage of droplets will be frozen, at a given 
temperature (e.g. -20 ℃), for the droplets cooled at the slower rate. This is because 
the longer the time interval, the greater probability for freezing. This can be a problem 
when analysing potential INPs, as the rate may interfere with results i.e. giving false 
positives. In this work there appears to be little correlation between rate and Tn thus 
the nucleating efficiency of alkali lignin can be confirmed to be correct. Herbert et al. 
derived the Framework for Reconciling Observable Stochastic Time-dependence 
(FROST) to assist in reconciling data obtained from experiments via different cooling 
rates.54 Full details of this work are beyond the scope of this work, but it is important 
to note, for future work, that any effect of rate due to different experimental setups, 
experiment timescales and different materials can be compared using this framework. 
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5.6 Conclusion 
Using a blue-sky approach in combination with µL-NIPI was successful, in that the 
high-throughput nature of the technique allowed a variety of different materials to be 
tested quickly and easily.  
Metal organic frameworks were demonstrated to have no ice nucleation, or IRI 
activity, despite their potential to lattice match with the ice surface. Findings of Zhu 
et al. are challenged in this work, as MOF concentrations used in this work are both 
the same and higher, and yet no ice-activity can be observed. Further investigation 
into structural motifs required for activity need to be performed in order to potentially 
use MOF-like structures. Though, despite their inactivity, the MOFs could be used as 
another option for protein scaffolds, enabling multivalency in a similar way to the 
AuNP in Chapter 3. 
Safranine-O was also confirmed to not perform as a nucleator at concentrations where 
self-assembly is known to occur, indicating that despite having a structure conducive 
for ice growth inhibition and shaping, self-assembling in general does not lead to 
nucleating efficiency. However, large disordered structures were found to have some 
nucleation activity; alkali lignin and MK lignin were observed to have the highest 
nucleating efficiency out of the 8 different lignins tested, with the focus of later 
experiments on alkali lignin, due to its commercial availability. 
In an attempt to understand the nucleation effectiveness of alkali lignin, different 
variables were tested. Firstly concentration; where nucleation effectiveness was found 
to remain constant over a range of concentrations, indicating that despite any change 
in quantity of potential INS, only a low number is required for activity. Secondly, in 
order to determine whether the INS were on particles in a particular size range, alkali 
lignin was filtered, the filtrate analysed (and compared to that of GreenValue filtrate) 
and was observed to have no influence on effectiveness for alkali lignin, indicating a 
smaller particle size. 
To further confirm alkali lignin’s efficiency droplet assays were performed using 
different cooling ramp rates, and again nucleation efficiency remained equal over 
different rates, thus not necessitating specific further analysis using frameworks such 
as FROST. 
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This work highlights the differences in results obtained from different wet-dispersion 
techniques, with the nucleation temperatures for pure water, as well as samples, 
changing depending on type of DSC protocol followed. The droplet assays were 
shown to provide a faster, more thorough method of data acquisition, with the 
capability to monitor nucleation for up to 50 droplets at once, compared to between 
one and three for DSC, thus ensuring a lower level of error in the obtained results. 
Further optimisation of calorimetry-based techniques is required for their use. 
More indepth investigations are required to understand the importance of the particles 
themselves and what causes nucleation. In particular, characterisation of both alkali 
and MK lignins would enable understanding of any similarities in their structures that 
may be leading to their higher nucleation efficiency. Gel permeation chromatography 
(GPC) could be performed to obtain molecular weight fractions, which could then be 
tested for nucleation efficiency. Potentially, chemical/enzymatic degradation could be 
performed to assist with determining the structural subunits that lead to this increase 
in activity. 
Overall, if nucleation could be related to particular structures/subunits, then more 
control could be achieved. If nucleation temperatures could be increased to >-10 ℃, 
there would be potential cryopreservation applications. 
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5.7 Experimental 
5.7.1 Materials 
Safranine-O and alkali lignin (471003) were purchased from Sigma-Aldrich and used 
as supplied unless otherwise stated. Phosphate-buffered saline solution was prepared 
using in Milli-Q water (>18.2 Ω mean resistivity) to give [NaCl] = 0.138 M, [KCl] = 
0.0027 M, and pH 7.4). GreenValue, MK, zambezi, ammonia, organosolv, miscanthus 
and OrganoAlkali lignins were kindly provided by Dr Goran Rashid, University of 
Warwick and Ce(BTC)3.H2O, Ce-NDC, Zr-BDC-UiO66 and Zr-1,4-NDC MOFs were 
kindly provided by Ehsan Ghadim, University of Warwick. 
 
5.7.2 Physical and Analytical Methods 
A Linkam Biological Cryostage BCS196 with T95-Linkpad system controller 
equipped with a LNP95-Liquid nitrogen cooling pump, using liquid nitrogen as the 
coolant (Linkam Scientific Instruments U.K., Surrey, U.K.) was used to anneal ice 
wafers. An Olympus CX41 microscope equipped with a UIS-2 20x/0.45/∞/0−2/FN22 
lens (Olympus Ltd., Southend on Sea, U.K.) and a Canon EOS 500D SLR digital 
camera was used to obtain all images. Image processing was performed using ImageJ, 
which is freely available from http://imagej.nih.gov/ij/. Absorbance spectroscopy was 
undertaken using a Synergy HT multi-mode microplate reader (BioTek U.K., 
Bedfordshire, U.K.). Differential scanning calorimetry was performed using a Perkin 
Elmer DSC6000 with intracooler and autosampler using 40 µL aluminium crucibles 
(Perkin Elmer, USA). The Peltier cold stage used for NIPI-style experiments consisted 
of a Meerstetter TEC-1091 driving a TEC-12704 Peltier. An aluminium plate was 
bonded to the Peltier using thermal paste. The temperature of the plate (and the droplet 
mounted on it) was monitored using two Netshushin wound PT100 thermometers 
monitored by PT-104 temperature loggers. A 0.22 mm thick, 22mm diameter 
hydrophobic glass slide (Hampton research) was placed on the aluminium plate and 
covered by a droplet shield. Droplets were pipetted into the slide using a Picus Biohit 
electronic pipette and were monitored through a glass window using a digital camera. 
A Teca Ameritemp™ recirculating chiller attached was used to cool the hot side of 
the Peltier. 
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5.7.3 Procedures 
5.7.3.1 Ice Recrystallisation Inhibition ‘Splat’ Assay 
Samples were dissolved in PBS buffer (pH 7.4) at concentrations of 10 to 0.05 mg.mL-
1 and 1 drop of the solution was dispensed from a height of 1.4 m onto a glass cover 
slip on a metal disc cooled with dry ice. An ice wafer instantly formed and was 
transferred to a cryostage held at -8 ºC under liquid nitrogen. Samples were left to 
anneal for 30 minutes. Images of the wafer were taken before and after the 30 minutes. 
Image processing was performed using ImageJ software on the 5 largest crystals from 
at least 3 independent wafers giving the MLGS from 15 measurements. 
 
5.7.3.2 Differential Scanning Calorimetry 
Aluminium crucibles (40 µL) were weighed, then either single drops of sample (10 
µL) were pipetted directly into the crucibles, or multiple drops of sample (1.0 µL) 
were pipetted into crucibles containing immersion oil type B, which were then sealed 
and reweighed.  
Crucibles were then inserted into the Perkin Elmer DSC600 via an autosampler. 
Samples were then cooled to -40 ºC at a cooling rate of 1.0 ℃.min-1 and nucleation 
temperatures recorded as the temperature at which a phase change is observed on the 
DSC trace. Data was analysed using Perkin Elmer Pyris thermal analysis software 
version 13.1.1.0160. 
 
5.7.3.3 Cryostage Nucleation Drop Assay 
Samples were dissolved in Milli-Q water. Drops of sample (1.0 µL) were pipetted onto 
clean coverslips with a hydrophobic organosilane coating (Fluka, 5 % 
dimethyldichlorosilane in heptane) ensuring the glass cover slip did not interfere with 
ice nucleation. The coverslip was placed in a Linkam Cryostage, which was rapidly 
cooled to 0 °C at a rate of 50 °C.min-1, then held at this temperature for 3 minutes to 
allow the temperature of the glass slide and droplets to equilibrate. The samples were 
then cooled from 0 °C to −49 °C at 1.0 ℃.min-1. Nucleation was recorded using a USB 
microscope and Veho Microcapture software version 1.3. 
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5.7.3.4 µL-NIPI-based Drop Assay 
Samples were dissolved in Milli-Q water. 45-55 1 µl droplets were placed on a 0.22 
mm thick silanised slide (Hampton Research HR3-231) supported by a Teca 
Ameritemp™ solid-state peltier chiller using a Picus Biohit electronic micropipette. 
Suspensions were made up using 18.2 MΩ Milli-Q water and carefully weighed 
quantities of the nucleant under test. Temperatures were measured using a PT-104 
temperature logger reading two Netshushin wound PT100 thermometers. A custom 
LabView software combines the temperature and video footage into easily analysed 
data using VirtualDub 1.10.4. 
The peltier is used to cool down the droplets in the custom-made apparatus at a 
controlled rate and a Meerstetter TEC-1091 thermoelectric controller is used to control 
and monitor temperature. In this study a cooling rate of 1.0 ℃.min-1 has been used 
unless otherwise stated. The slide and droplets were covered by a Perspex chamber 
with a port for a camera and a gas inlet and outlet. Dry nitrogen (gas flow 0.2 L.min-
1) was gently flown over the droplets to prevent condensation of water and ice. A 
camera was used to monitor droplet freezing. Figure 5.10 shows the layout of the 
apparatus. This assay is used to determine the fraction of droplets frozen at a given 
temperature. All datasets reported here consist of multiple (2-5) individual 
experiments. 
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6.1. Overview of Thesis 
The development of synthetic ice recrystallisation inhibition (IRI) active materials 
with activity rivalling that of AF(G)Ps remains a challenge, with current methods often 
limited to analysis of macroscopic effects using microscopy, in particular the use of 
older techniques that have not been updated since their introduction that have issues 
of only providing data on a ‘snapshot’ of a whole sample. Modelling has provided a 
useful insight into the molecular-level activities and mechanisms of action of both 
natural and synthetic ice-active compounds, however experimental work has yet to 
provide a final verification for these theories. 
AF(G)Ps are extremely effective non-colligative antifreezes, though are less suitable 
for other applications, particularly in cryopreservation due to toxicity, expense and 
challenges in production at large scale. Hence discovery, development and 
understanding of synthetic mimics is of particular interest. This thesis has shown that 
IRI active PVA in combination with non-IRI active PEG, as a formulation, has the 
capability to work as a potent cryoprotectant for both bacteria and proteins, enabling 
storage without the need for organic solvents, using much lower concentrations. 
Chapter 2 highlights this disruptive approach to store bacteria and proteins in the 
frozen state through modulation of ice recrystallisation with synthetic polymer 
formulations that mimic the antifreeze proteins used in nature to survive extreme 
environments. AFPIII was expressed and purified for use as a comparison for both 
IRI activity and cryoprotective ability, showing that PVA works as a more 
competent cryoprotectant despite its lower IRI activity, potentially due to its lack of 
ice shaping activity. The PEG/PVA cryopreserving formulation was seen to be highly 
IRI active and the least bactericidal, resulting in a 4-fold increase in E. coli yield post- 
thaw, compared to glycerol, and was found to be equal to or better than glycerol for 
other cell types. The use of a secondary hydrophilic polymer is essential as a bulking 
agent in these systems and the formulation was found to work by preventing 
aggregation of proteins, and by inhibiting ice recrystallisation (whilst being less toxic 
than glycerol) in cells, unlike in traditional solvent-based cryoprotectants, which 
function by distinct mechanisms. 
To further test these results and their potential wide-reaching application across 
biology and the biotechnology industry, cryopreservation studies of a wider range of 
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proteins and cell-lines should be undertaken, in particular by testing more 
industrially relevant cells, including L. delbrueckii subsp. bulgaricus. Preliminary 
work was performed on this species in this project but optimisation of expression 
and growth of this strain needs to be completed to confirm cryopreservative ability 
of our polymer formulation for this culture. Further work could also include 
repetition of freeze/thaw assays in other laboratories, to ensure the protocols, and 
subsequent results, can be transferred successfully to other research groups, as well 
as performing further experiments to confirm cell viability post-thaw. This work 
centred around colony counting and live/dead assays, however studies could be 
performed, on E. coli for example, post-thaw to ensure these cells are viable i.e. can 
still be used for protein expression etc. 
The microscopy-based techniques allow for observation of size and morphology of 
ice grains, however, do not help elucidate the mechanisms of action behind ice-
active materials. In Chapter 3, XRD was investigated as another method for analysis 
of ice recrystallisation. A method was developed, and was found to be a successful, 
complementary, non-invasive method for 3D analysis of crystal growth. Real-time 
kinetic analysis is possible with this method without the need for time-consuming 
analysis of individual video-frames obtained during optical techniques. IRI activity 
results obtained via XRD for a range of compounds was compared to that of optical 
methods and was found to be in good agreement. Diffraction patterns were analysed 
and no specific indications for ice-binding were observed. In this work peak widths 
were not analysed and would be interesting to study. Full width at half maximum 
(FWHM) could be used to characterize crystal properties, analyse stress/strain and 
determine crystallinity of a sample. Changes in peak width does not affect the 
number of orientations in this work as resolution here is obtained from the ψ angle 
and not 2θ, however, analysing results using a detector that could be moved in 2θ 
combined with a monochromated X-ray source giving pure Cu Kα1 radiation would 
enable a more in-depth discussion of peak width in relation to strain and crystal grain 
size. As the hydrogens in the ice lattice cannot be easily studied via XRD, neutron 
studies could be performed to provide further information on the positioning of the 
protons, hydrogen bonding in the system and any deformation of the hexagonal ice 
structure upon addition of ice-active materials. 
As XRD provides little extra on the mechanism of action of AF(G)Ps and their mimics 
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on ice, Chapter 4 focused on providing a more fundamental understanding using 
SSNMR. SSNMR techniques are extremely versatile and have been used on a range 
of materials, with relaxation measurements applied to antifreeze-ice systems in this 
thesis, which have provided detailed information on these dynamic systems. 
Evidence for the interaction of PVA with ice crystals was obtained for the first time 
using 2D EXSY, and support for AF(G)P ice-binding obtained. Relaxation 
measurements, for the first time, confirm that the addition of IRI active compounds 
greatly affects the bulk ice 1H dynamics unlike negative controls (ensuring any 
colligative contributions are negated), even at the low concentrations used in this 
work. Relaxation measurements provided interesting trends, with variable temperature 
R2 measurements showing a clear difference between antifreezes and negative 
controls, with the difference thought to be due to exchange dominating rather than ms 
– ns motions. It was confirmed that above a chain length of 10 units PVA’s unique 
ice-activity is ‘switched on’, and the R1 relaxation of bulk ice in the presence of PVA 
scaled with the macroscopic critical inhibitory concentrations and MLGS values, with 
longer polymers being more active inhibitors and having faster correlation times. The 
results from the range of relaxation measurements support a mechanism of PVA 
forming an extended hydrogen bonded network to the prism planes of ice where PVA 
binds reversibly, and that enthalpy-entropy compensation is a driving force. Safranine- 
O was seen to work via a mechanism like that of PVA, supporting the idea that ice 
dynamics are affected by frozen solutions of IRI active compounds and not their 
respective controls or in a colligative manner, and that ice proton motions are of 
importance for IRI activity. 
Further information could be obtained by performing these SSNMR measurements 
on a wider range of proteins; initial studies have been included on bpAFPI, AFPIII 
and AFGP8, nonetheless these results cannot yet be generalised across all antifreeze 
proteins and antifreeze glycoproteins as there is such a great range that may work via 
different mechanisms, as visualised in Chapter 1. Further SSNMR measurements 
could be performed, including 2H and 13C-labelled measurements, as well as 
additional 2D exchange measurements on unlabelled and 13C-labelled antifreezes to 
elucidate the exchange occurring and allow site-specific interrogation of 
intermolecular contacts and structures. SSNMR measurements, in combination with 
findings from other techniques, will hopefully lead to the determination of the 
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mechanisms of action of ice-active materials and thus enable production of well 
understood, improved cryopreservation formulations and hence improve the viability 
of cryopreserved biological materials. 
In Chapter 5 µL-NIPI was successfully utilised as a technique to study nucleation 
efficiency for a range of previously untested materials. Calorimetry was used to 
compare to µL-NIPI, finding it to be a slower and less thorough technique for 
following ice nucleation here. MOFs were found to not have IRI activity or promote 
ice nucleation, though further investigation could be undertaken into potential 
structural motifs required for nucleation activity, though this may be of difficulty due 
to the wide-ranging structures that make up metal organic frameworks. Safranine-O 
was used as a comparison, as it has thus far no known nucleating efficiency, finding 
no activity, even at self-assembling concentrations, indicating that self-assembly 
does not directly infer nucleating effectiveness. 8 different lignins were tested, with 
all showing at least minimal nucleation activity. Alkali lignin, which nucleated ice at 
high temperatures, and is commercially available, was focused on. Multiple variables 
were modified to test this lignin’s nucleation efficiency, finding that effectiveness 
does not change over a range of concentrations, cooling rates or upon filtration, thus 
the INP/INS involved is small. This initial work implies more control of Tn could be 
achieved with further investigation into the lignin particles and their topography, and 
that if nucleation temperatures could be increased to >-10 ℃, there would be 
potential cryopreservation applications. 
Further investigation is required to understand what is causing nucleation in the 
lignins, i.e. defects on the particles/relevant surface features, size of particles or 
functional groups involved. Microscopy could also be used to identify individual 
features that nucleate ice and characterisation could be undertaken using gel 
permeation chromatography as well as by using chemical or enzymatic degradation 
to identify structural subunits involved in nucleation efficiency for these materials. In 
regards to the µL-NIPI technique, automation of freezing detection would be greatly 
beneficial and allow for much quicker data generation. Other research groups have 
attempted this by using video analysis software and infra-red cameras and could be 
something used in the future here also. 
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6.2. Final Remarks 
This project confirms that the relationship between physical and chemical properties 
of different materials and ice-activity is complex, and that despite shedding light on 
techniques that assist in analysis of these activities and their underlying mechanisms 
of action, a great deal remains to be understood. Results have shown that a vast 
range of materials have ice-activity, and that mimics can be obtained for AF(G)Ps 
that have much potential as cryoprotectants. Clearly, these materials tested here may 
not perform as well in cryoprotecting other biologics, we have however laid the 
groundwork for future experimental work in this area. We wanted to link the 
macroscopic findings from traditional optical-based methods to the atomic scale and 
study the bulk ice and have successfully utilised XRD to obtain further detail on ice 
growth. Significant advances in SSNMR technology and methodology have enabled 
us to use this tool for the study of these complicated samples, and there is great 
potential for this rapid development to continue. This project represents progress in 
the understanding of how ice-active materials behave and these results overall are 
significant in both basic cryo-science and in the development of new materials for 
low temperature applications. 
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Appendix A – Chapter 2 
A.1 Cryopreservation of Lactobacillus delbrueckii subsp. bulgaricus 
L. delbrueckii, a gram-positive anaerobic organism, is an important lactic acid bacteria 
used in the dairy industry to manufacture fermented products.116 In particular, it is 
used as a starter culture as well as providing flavour, texture and nutritional value to 
products. Accordingly storage of this important bacteria is of great interest. The FT 
protocol used previously was also used here to obtain preliminary results. CPAs were 
added to cells of L. delbrueckii (BBA-365 strain) in a 1:1 weight ratio using PBS for 
dilutions. The cells were snap frozen in liquid nitrogen and stored at -80 ℃ over two 
storage periods and cell recovery compared to cells that underwent 7 FT cycles, 
Figure A2.1. Upon thawing there is little observed difference in cell recovery between 
the control (no CPA), glycerol and PEG/PVA. The most colonies were recovered after 
1 week storage. 7 FT and 1 month storage lead to a much lower colony count. Further 
work needs to be performed in this area to perfect the lactobacillus cell growth and 
assay protocol, to ensure valid results are obtained. 
 
Figure A2.1. Comparison of average number of colonies of Lactobacillus strain BAA-
365 grown after freezing and storage under 3 different conditions (black = 7 
freeze/thaw cycles at liquid nitrogen temperatures, red = 1 week storage at -80 ºC, 
green = 1 month storage at -80 ºC) with no cryoprotectant, 25% glycerol, or PEG/PVA. 
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X-ray diffraction to probe the kinetics of ice
recrystallization inhibition†
Alice Fayter, a Steven Hubandb and Matthew I. Gibson *a,c
Understanding the nucleation and growth of ice is crucial in fields ranging from infrastructure mainten-
ance, to the environment, and to preserving biologics in the cold chain. Ice binding and antifreeze
proteins are potent ice recrystallization inhibitors (IRI), and synthetic materials that mimic this function
have emerged, which may find use in biotechnology. To evaluate IRI activity, optical microscopy tools are
typically used to monitor ice grain size either by end-point measurements or as a function of time.
However, these methods provide 2-dimensional information and image analysis is required to extract the
data. Here we explore using wide angle X-ray scattering (WAXS/X-ray powder diffraction (XRD)) to interro-
gate 100’s of ice crystals in 3-dimensions as a function of time. Due to the random organization of the ice
crystals in the frozen sample, the number of orientations measured by XRD is proportional to the number
of ice crystals, which can be measured as a function of time. This method was used to evaluate the
activity for a panel of known IRI active compounds, and shows strong agreement with results obtained
from cryo-microscopy, as well as being advantageous in that time-dependent ice growth is easily
extracted. Diffraction analysis also confirmed, by comparing the obtained diffraction patterns of both ice
binding and non-binding additives, that the observed hexagonal ice diffraction patterns obtained cannot
be used to determine which crystal faces are being bound. This method may help in the discovery of new
IRI active materials as well as enabling kinetic analysis of ice growth.
Introduction
Despite water’s heterogeneous freezing point of 0 °C, many
organisms have evolved to survive in sub-zero climates; these
include the wood frog (Lithobates sylvaticus), Antarctic fish
such as Zoarces americanus and Macrozoarces americanus, and
various cold tolerant plants.1–4 These extremophiles produce
increased levels of small molecule cryoprotectants such as
glycerol5,6 and trehalose,7 but also macromolecular cryoprotec-
tants such as antifreeze proteins (AFPs, also known as ice
binding proteins) and antifreeze glycoproteins (AFGPs) provid-
ing freeze-tolerance or freeze avoidance.4,8–10 These proteins
are potent ice recrystallization (growth) inhibitors (IRIs). Ice
recrystallization is the process whereby larger crystals grow at
the expense of smaller ones, reducing the surface area to
volume ratio over time due to Ostwald ripening. This can be
particularly lethal to biological matter, as ice recrystallization
leads to dehydration and cellular damage, therefore is of inter-
est, particularly in the cryopreservation of cells and tissue, as
well as proteins.2,11
Synthetic mimics of AF(G)Ps have emerged that can repro-
duce their properties and benefit from the scalable and tune-
able synthesis of synthetic polymers.12–14 However, questions
remain if these function by the same mechanisms.12,15
These include C-linked glycopeptides,16–18 a range of small
molecules,3,19,20 polyampholytes,21,22 oxidized quasi-carbon
nitride quantum dots (OQCNs),23 safranine-O,24 graphene
oxide,25 zirconium acetate (ZrAc),26 nanocelluloses,27 and poly
(vinyl alcohol) (PVA); which is one of the most active mimics
reported to date.28–31 The development and use of appropriate
assays of activity is crucial to develop this field and understand
the mode of action.
Optical microscopy has been employed in the majority of
experimental work concerning ice and ice-active compounds
thus far. IRI activity is typically measured using either the
‘splat’28,31,32 or sucrose ‘sandwich’4,33 assays, providing visual
comparisons of ice crystal wafers. Both of these assays involve
nucleating small ice crystals and observing their growth over
time (or more often at a fixed time point) whilst recrystalliza-
tion occurs. Challenges with these microscopy techniques
include time-consuming data analysis, small sampling size
(micrographs of isolated regions analysed rather than whole
sample) and that only 2D information is obtained.
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c9an02141h
aDepartment of Chemistry, University of Warwick, Gibbet Hill Road, CV4 7AL, UK.
E-mail:
bDepartment of Physics, University of Warwick, Gibbet Hill Road, CV4 7AL, UK
cWarwick Medical School, University of Warwick, Gibbet Hill Road, CV4 7AL, UK
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X-ray powder diffraction is used to study, in situ, the bulk of
the sample.34,35 [Note, the terms WAXS and X-ray powder diffr-
action are often interchangeable and XRD is used here
throughout]. Significant advances in technology, development
of full-profile analytical methods and synchrotron radiation
have aided progress in the X-ray field, as there have been vast
improvements in data precision and speed of data collection.36
XRD is highly sensitive to small changes and aids identifi-
cation of structural similarities and changes, especially phase
or particle size changes,34,37 and has been used in many areas
to monitor these changes; including observing nucleation/
growth of gold nanoparticles38 and titanium oxide particles
over time,39 as well as evaluating phase structure, precipitate
growth and coarsening of alloys using combined ultra-small-,
small- and wide-angle X-ray scattering,40 for example. Using
X-ray techniques it is possible to report crystallographic form,
polymorphism, peak intensity changes, peak splitting and
peak disappearance.41,42 Scattering has been used to obtain
crystal structures of cryoprotectants such as AFPs,43 though
little research has been taken into their effect on ice growth.44
Studies have also monitored crystallization, polymorphism
and disorder of ice upon addition of solutes such as bovine
serum albumin (BSA) and sorbitol45,46 as well as investigating
potential ice growth inhibition mechanisms.47 However XRD
has not been used thus far to study the kinetics of ice growth,
which is crucial in the design of new IRIs.
Here we report the use of XRD to probe the kinetics of ice
recrystallization (and inhibition) using a range of IRI active
macromolecules. The relative change in ice crystal size is deter-
mined by calculating the change in number of crystal orien-
tations over a set time. The number of orientations is inversely
proportional to the size of the ice crystals, and is obtained by
integrating each individual diffraction peak as a function of ψ
(psi), and then plotting intensity versus ψ to obtain time-
dependant data points proportional to the number of crystals.
This is significant as it enables automated analysis of ice
recrystallization (or inhibition of) with high temporal resolu-
tion, and interrogates 100’s of crystals, unlike traditional
optical methods. This method may help provide understand-
ing and discovery of new IRI active materials, alongside estab-
lished optical microscopy methods.
Experimental section
Materials
Poly(ethylene glycol) (PEG) (4 kDa) and poly(vinyl alcohol)
(PVA) (10 kDa), phosphate-buffered saline (PBS) preformulated
tablets, lysozyme and ampicillin were purchased from Sigma-
Aldrich and used as supplied unless otherwise stated.
Imidazole (Merck) and glycerol (Fisher), isopropyl-β-D-thioga-
lactoside (IPTG) (VWR chemical), safranine-O and phenosafra-
nin (ACROS organics), Novex AP Chromogenic and coomassie
blue stain (Expedeon) were also used as supplied. IMAC
Sepharise 6 Fast Flow columns, HiLoad 16/600 Superdex 75 pg
gel filtration columns and PD10 desalting columns were pur-
chased from GE Healthcare and used according to manufac-
turer’s instructions. AFGP8 CC-86-XVII was kindly provided by
A. L. DeVries (University of Illinois at Urbana-Champaign,
USA) and used as received. The pET20b-AFPIII plasmid encod-
ing for a hexahistidine-tagged AFPIII from ocean pout (rQAE
isoform, M1.1HISPET20b) was kindly provided by Peter Davies
(Queens University, Kingston, Canada). Competent Escherichia
coli BL21(DE3) cells were sourced from New England Biolabs.
Gold nanoparticles were synthesised as reported previously.48
For washing of AuNPs, Amicon Ultra-0.5 centrifugal filter units
with Ultracel-30 membrane were used. 40 nm citrate-stabilised
gold colloid solution was purchased from BBI solutions.
X-ray sample preparation
Samples were prepared, in either PBS solution or using Milli-Q
ultrapure water with resistance <18 Ω obtained from a Milli-Q©
Integral Water Purification System, over a range of concen-
trations and 10 μL was inserted into 1 mm thick quartz capil-
laries and mounted in a Linkam THMS350. Samples were
cooled to −35 °C at 30 C min−1, then heated to −8 °C where
X-ray scattering was performed.
XRD data analysis
A Xenocs Xeuss 2.0 equipped with a micro-focus Cu Kα source
and a Pilatus 300k detector was used for XRD measurements.
Diffraction pattern plotting, orientation analysis and any stat-
istical tests were performed using OriginPro 2019 software.
Three major diffraction peaks: (100), (002) and (101) were
focused on. Positions (2θ) of these peaks are 22.7°, 24.5° and
25.8° respectively.
XRD orientation analysis
Measurements were made repeatedly, with a counting time of
10 seconds and a 4 seconds delay between each acquisition,
over 1800 seconds annealing, enabling analysis of the number
of crystal orientations observed over time and comparison to
‘splat’ assay data. A radial integration of the 2D scattering
profile was performed using FOXTROT 3.3.4 software resulting
in 1D intensity versus 2θ plots. In addition, azimuthal inte-
grations for each Bragg peak were performed producing 1D
intensity versus ψ plots. Data was then run through an in-
house MATLAB (The MathWorks, Natick, MA) programme to
obtain the number of ice crystal orientations.
Ice recrystallization inhibition ‘splat’ assay
The sample was prepared in PBS solution, and 10 µL was
dropped onto a glass microscope coverslip atop an aluminum
plate cooled to −78 °C with dry ice. The thin wafer of ice that
forms upon contact with the coverslip was transferred to a
cryostage held at −8 °C using liquid nitrogen, and left to
anneal for 1800 seconds at this temperature. Three images
were taken at different locations on this wafer at 20× zoom
under cross polarizers. Using ImageJ, the numbers of crystals
in the images were counted and the average crystal size per
wafer was calculated as mean grain area (MGS) as well as the
mean grain length size (MLGS).
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Sucrose ‘sandwich’ ice shaping assay
Samples dissolved in PBS buffer containing 45 wt% sucrose
were sandwiched and sealed between two glass coverslips.
Samples were cooled to −50 °C and then heated to −8 °C to
anneal. The samples were then heated at 0.5 °C min−1 until
few ice crystals remained and then cooled at 0.05 °C min−1
and the shape of ice crystals observed. Micrographs were
obtained every 0.1 °C.
Results and discussion
In microscopy-based assays, smaller ice crystals (less growth)
after annealing at sub-zero temperatures indicate more IRI
activity, and data is reported as an area/length relative to a
negative control. [Note, it is crucial to highlight the conditions
for these experiments to avoid false positives.15,49] Fig. 1A is an
example micrograph from a ‘splat’ assay. The data is typically
analysed after a set period of time, and reported as a percen-
tage growth relative to a PBS control. This can be reported as
the mean largest grain size (MLGS), where the largest crystal in
view is measured from multiple samples or mean grain size
(MGS), where the average size of all crystals is measured.
MLGS is appealing due to its simplicity for manual measure-
ment, but it fails to probe the whole population and a single
large crystal can dominate the measurement (example shown
in Fig. 1A). Fig. 1B shows a comparison of MLGS verses MGS
data, which are generally in agreement, other than MGS being
an area (squared) term and thus giving smaller % value for the
same amount of inhibition. The ice wafers obtained, such as
in Fig. 1A, can be challenging to analyse by automated image
analysis due to the irregular grain boundaries, although Ben
et al. have used domain recognition software.50 Alternatively,
the sucrose ‘sandwich’ assay, which is also used to study
dynamic ice shaping (DIS); indicating ice-binding properties of
a sample, Fig. 1C, is used. In this assay the crystals are more
separated due to the high viscosity of the media, and image
analysis can be used to identify each crystal, as shown by
Budke et al.51 It is also important to be able measure growth
in the media of interest, and 20–45 wt% sucrose required for
this is not relevant for all conditions, and it has emerged
recently that salts have a profound effect on growth rates
hence the appeal of measurement in buffers.52,53
Fig. 2A/B shows example powder diffractograms as a func-
tion of time for ice crystals annealed at −8 °C in the presence
of the potent IRI (poly(vinyl alcohol)), PVA, and a negative
control (poly(ethylene glycol)), PEG. The characteristic peaks
of ice at 22.7, 24.2 and 25.8° (corresponding to the (100), (002)
and (101) planes respectively) are clearly visible, as would be
expected for hexagonal ice.54 Of note, is that in the presence of
PVA, the diffractograms are constant over the whole time
period, indicative of no ice recrystallization (growth). In con-
trast, PEG shows significant decreases in the scattering inten-
sity for most peaks, which is consistent with ice recrystalliza-
tion (larger ice crystals). This confirms that in principle,
powder diffraction should allow for both end-point and kinetic
analysis of IRI activity. Example ice wafers from the ‘splat’
assay under the same conditions are shown (Fig. 2C/D).
In this XRD analysis, no broad, low intensity peaks were
observed, indicating no amorphous phases are formed in
these samples upon freezing. Thus all ice observed here is
polycrystalline; containing hundreds of crystallites. A percen-
tage of these crystallites will orient to diffract the X-ray beam,
thus there is a possibility the peak intensity will differ for iden-
tical samples, depending on how the crystallites are oriented.
Therefore an understanding of the number of crystallites is
required for evaluating the diffraction pattern. From here we
will consider the number of crystal orientations as well as the
observed diffraction patterns.
XRD provides details on crystallite orientations and inten-
sity; the number of crystallite orientations for each sample,
and how this number changes over continuous measurements.
The sum of the intensity of the whole X-ray detector can be cal-
culated, as well as the intensity for individual 2θ values. To
enable quantitative analyses of ice recrystallization the total
number of ice crystal orientations observed for a sample was
calculated, which in a powder sample is proportional to the
number of crystals, and hence inversely proportional to the
size of the ice crystals. When ice crystals in a sample increase
in size (recrystallisation), the number of grains detected by
XRD decreases, which may lead to a decrease in total scatter-
ing intensity. To obtain the number of ice crystal orientations
over time, the 2θ ranges that cover each of the seven peaks that
are measured in the diffraction patterns are selected for each
time point. An example 2θ range for the first peak is shown in
Fig. 3A/B. The 2D detector image is then integrated azimuth-
ally as a function of ψ (psi) seven times with 2θ ranges deter-
mined from the diffraction peaks. The step size in ψ for this
was 0.2°. The size of the detector limits the available orien-
tation range in ψ to between 76 and 105°. The intensity versus
ψ data for the selected 2θ range is plotted and the number of
data points above a determined background value (1.5 counts
used) are then counted, these data points refer to the number
of orientations and are filled in red to show an example of IRI
active and inactive samples in Fig. 3C/D. As the concentration
of an IRI active substance increases, the relative ice growth rate
is expected to decrease due to the inhibition of ice crystal
growth. This is because there are many orientations, which
correspond to many small crystals. If there is an observed
decrease in the number of orientations, this is due to Ostwald
ripening; where the larger crystals increase in size at the
expense of the small crystals.
To evaluate the use of this method, a range of known IRI
active compounds (biological and synthetic) were tested and
compared against the standard ‘splat’ assay, Fig. 4. In each
case, XRD experiments were performed over 1800 seconds
(30 min). Fig. 4A shows PVA, with the MLGS values trending
with the inverse number of orientations. Fig. 4B shows PEG (a
negative control), indicating essentially no activity even at very
high concentrations (up to 50 mg mL−1), where non-specific
effects dominate. Encouraged by these results, the self-assem-
bling IRI active safranine-O was tested, verses phenosafranin,
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Fig. 1 Optical microscopy analysis of ice recrystallization. (A) Example ice wafer containing 1mg mL−1 10 kDa PVA in PBS after 30 minutes. An
example larger grain (white circle) is shown, which skews results when only ‘largest grain size’ is considered; (B) comparison of MLGS and MGS for
some IRI active compounds. Concentrations = 1 mg mL−1. Errors are standard deviation; (C) micrographs of ice crystals grown in 45 wt% sucrose: (a)
control solution, (b) 60 µg mL−1 AFGP, (c) 140 µg mL−1AFGP; (D) data obtained through calculating mean ice crystal radii, r3, in 45 wt% sucrose solu-
tions from the micrographs, (a) control solution, (b) r3 in solution containing 60 and 140 µg mL−1 AFGP, and their associated fits (solid lines), (c) tem-
poral development of ice crystal volume fraction, Q, of data from (a) and (b). Reprinted (adapted) from with permission from Koop et al.,51 J. Phys.
Chem. B, 2009, 113(9), 2865–2873. Copyright (2009) American Chemical Society. All data obtained at −8 °C.
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Fig. 2 Example XRD and microscopy data. (A and B) Waterfall plots of diffraction patterns used for kinetic analysis of change in number of crystal
orientations, obtained using powder diffraction, over time for (A) PVA and (B) PEG; (C and D) Example micrographs for (C) PVA and (D) PEG. All data
obtained at −8 °C. [Polymer] = 3 mg mL−1.
Fig. 3 Extraction of ice recrystallization data. (A and B) Example XRD plots used to calculate crystallite orientations of (A) IRI active PVA and (B) non-
IRI active PEG, plotted as a function of 2θ. Selected 2θ ranges used to analyse the crystallite orientations scattering are coloured red; (C and D)
Orientation plots of (C) PVA and (D) PEG, plotted with as a function of ψ for intensities measured in the selected 2θ range.
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which cannot self-assemble and has no IRI.24 By both MLGS
and XRD analysis, it can be seen that only safranine-O inhibits
ice growth. Fig. 4E, shows a comparison of AFGP8 (antifreeze
glycoprotein from Dissostichus mawsoni, 2.6 kDa) which is one
of the most potent IRI’s known,15 and lysozyme as a negative
protein control. Again, the MGLS and XRD methods show
broad agreement, demonstrating that this is a valid analysis
method for IRI activity and is complementary to the traditional
optical based methods.
A common challenge in the microscopy-based methods is
extracting kinetic information. For XRD this is far simpler; the
Pilatus 300K detector system used here enables 3D data collec-
Fig. 4 Comparison of orientation analysis (here shown as inverse number of observed ice crystal orientations after 1800 seconds) and IRI activity
(shown as mean largest grain size, MLGS, as a percentage of PBS) over a range of concentrations for all molecules used here; (A) PVA; (B) PEG;
(C) safranine-O; (D) phenosafranin; (E) AFGP compared to lysozyme; (F) Structures of all used. All concentrations are in mg mL−1. All data obtained
at −8 °C. Errors are standard deviation from at least 3 individual repeats. NB. Not all concentrations of inhibitors were tested using each assay.
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tion every 14 seconds. This diffraction data includes, for
example, information on number of crystal orientations for all
measurements, which can be analysed to give kinetic infor-
mation. Fig. 5A shows the change in the number of orien-
tations (i.e. total number of crystals) for ice in the presence of
non-IRI active PEG. There is a clear decrease in number of crys-
tals due to ice growth over the time course of the experiment.
The same analysis for PVA shows a constant number of orien-
tations, indicating a static process, and hence recrystallization
is fully inhibited. It is important to note at this point that the
Fig. 5 IRI analysis by XRD. Kinetic profiles for (A) PEG (3 mg mL−1) and (B) PVA (3 mg mL−1) at −8 °C; (C) comparison of PVA/PEG rates of ice growth
from A/B. [Polymer] = 3 mg mL−1; (D) number of crystal orientations as a function of time for a range of proteins. [Lysozyme] = 0.7 mg mL−1,
[AFPIII-His] = 0.4 mg m−1, [AFPIII-SNAP] = 0.1 mg mL−1, [AFGP8] = 0.07 mg mL−1; (E) inverse average rate of change in number of observed ice
crystal orientations over 1800 seconds for a small molecule (safranine-O), polymer (PVA) and protein (AFGP) compared to their relative IRI inactive
controls (phenosafranin, PEG and lysozyme); (F) box plot of the mean gradients of change and standard deviation for IRI active (grey) and inactive
samples (red). Mean = black square, individual data points = white hexagons. All data obtained at −8 °C.
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actual magnitude of the number of crystals will vary in each
sample due to the different nucleation rates (which is also
hard to control), however the change is the part which is of
interest here, and data can be normalised to the t = 0 points.
Relative ice crystal growth rates were obtained from the gra-
dient of change in number of crystal orientations, examples
shown in Fig. 5, showing that a parameter for ice growth can
be extracted if required. The steeper the slope, the faster the
ice crystal growth. The rate of change in number of crystal
orientations is much greater for PEG than for PVA. Fig. 5D
shows this analysis for several other compounds also, confirm-
ing the trends. For example, the rate of change in ice crystal
orientations for AFPs are slightly faster than that of AFGP8,
this may be due to their slightly lower IRI activity, (see ESI†).
Further measurements on more complex structures have been
performed, which exhibit the same trends, showing that this
XRD method works for a range of structures, Fig. S1.† However
they are still much lower rates than that of lysozyme. The rates
of crystal growth for IRI active molecules tested can be seen to
be close to zero, whereas that of the inactive controls it is
higher, Fig. 5E/F.
IRI is not the only macroscopic property of ice binding/anti-
freeze proteins. Ice shaping, due to binding to specific crystal
faces also occurs12,13 although it has emerged that binding
might not be essential for IRI and hence the two properties are
not always present.3,12 Fig. 6 shows ice diffraction patterns and
ice shaping for all three groups of compounds tested here. The
difference in the diffraction patterns between water and PBS
was first analysed to confirm similarities and differences – this
was due to the salts’ potential colligative effects on ice growth
and hexagonal ice (Ih) structure, Fig. 6A/B. The results from
PBS samples are more relevant to biological samples and
Fig. 6 Crystal habit modifications by additives. Left: Ice diffraction patterns after 1800 s annealing for: samples with known ice binding and shaping
abilities, their relative non-binding controls and water/PBS. Right: Optical microscopy ice morphology analysis in 45 wt% sucrose of samples in the
corresponding diffractograms. Scale bars = 100 µm. [Safranine-O] = 1.0 mg mL−1; [AFGP8] = 3.0 mg mL−1; [phenosafranin] = 1.0 mg mL−1; [lyso-
zyme] = 1.0 mg mL−1.
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those in water would be more relatable to samples used in
other fields, for example engineering and atmospheric chem-
istry. The structure for both is deemed to be Ih, though there
are slight intensity variations for the Ih pattern between the
two, but intensity variations are also seen in other samples,
and are due to which grains orient towards the beam and not
related to any ‘ice-activity’ of PBS.
Sometimes the (002) plane (2θ = 24.2°) is said to be missing
in ice samples with additives55,56 and is often explained as the
additive showing ice binding/DIS activity. Here measurements
are taken using a static capillary, where the ice grains formed
are too large to ensure a fully random distribution is sampled,
thus structure analysis cannot be completely determined. A
potential method to solve this problem would be to perform
XRD whilst spinning the capillary, however there could still be
preferred orientation effects. Due to differences in experi-
mental set-up it is difficult to determine whether previous
studies had randomly oriented grains/sampled a large
enough range of grains to confirm ice binding/DIS.47,56,57
Measurements made by freezing on a surface (i.e. flat), in par-
ticular, will be strongly affected by preferred orientation and
thus may not give clear evidence of binding. Hence, the dis-
appearance of a peak cannot solely be used to describe ice
crystal morphology/binding accurately. For example, AFGP
affects ice morphology by binding the primary prism plane, so
would have a peak missing corresponding to this plane, but
pure water (or PBS) would show all Ih peaks, however the 24.2°
peak is missing in these samples, Fig. 6A/B/D. The same peak
should also be missing for safranine-O, however is observed
here, Fig. 6C. Similarly, phenosafranin and lysozyme have no
known ice-binding so the lack of 24.2° peak seen in Fig. 6E/F
cannot represent this. This shaping or lack of ice shaping is
observed in the provided micrographs. When there is a change
in ice grain size, particularly growth due to Ostwald ripening,
fewer crystal orientations are observed and peak intensity
changes. This can cause particular orientations to not scatter
the X-ray beam leading to peak disappearance, thus the diffrac-
tion pattern peaks cannot be used to describe ice crystal mor-
phology accurately in these disordered samples. This is crucial
to show the limitations and applications of this method to
explore the kinetics of ice recrystallization as a complementary
tool to optical microscopy.
Conclusions
Here, X-ray powder diffraction is used as a non-invasive
method for 3D kinetic analysis of ice crystal growth (recrystalli-
zation) and compared to the more commonly used optical
techniques. This method is complementary as measurements
are performed in a capillary (3D conditions), which facilitates
the measurement of a larger number of crystals in the system,
as well as being preferable to 2D systems, where the sample
holder will have a greater effect on the growth mechanisms.
Furthermore, data can be obtained every 14 seconds (in this
particular instrument, with the rate depending on individual
facilities), enabling real-time kinetic analysis without analysing
each frame from videos. Ice growth was followed by calculating
the relative number of ice crystal orientations from 2θ ranges
that cover each of the seven Ih peaks from each diffraction
pattern at every time point. We developed a fitting method to
obtain kinetic data, which consisted of plotting the number of
crystal orientations as a function of time and obtaining the
gradient of change in number of orientations. This was then
extracted as a rate and compared to that of pure water and PBS
controls. Using this method we compared the IRI activity of a
range of synthetic and biological IRI’s and found that it was in
good agreement optical methods with the advantage that for
each sample kinetic data was obtained.
We also evaluated the diffraction patterns obtained in the
presence of the antifreeze-active compounds noting the loss of
intensity of the (002) peak. This could be interpreted as indi-
cating specific ice binding, but we show with controls that this
cannot be inferred due to preferred orientations and insuffi-
cient crystallites within the scattering volume. This confirms
that the method is a useful addition to the suite of tools for
discovering and investigating new ice recrystallization inhibi-
tors but that, in the set up used here, care must be taken not
to overfit the data and extrapolate information about specific
crystal face binding.
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Sub-zero temperature mechanically stable low
molecular weight hydrogels†
Alice E. R. Fayter, a Matthew I. Gibson ab and Emily R. Draper *c
We show here a low molecular weight hydrogelator based on a functionalised-dipeptide which is stable
down to temperatures of 12 1C despite being made from 499% water. This stabilty at low temperature
can be extended to B40 1C by gelling water : glycerol mixtures. The temperature range is wider than
that of the glycerol : water mixtures alone. The rheological properties of the gels do not change at this
low temperature compared to that of gels at 25 1C. This freezing point depression offers a potentially
new method of transporting gels and offers the prospect of hydrogels being used at much lower working
temperatures whilst retaining the desired rheological properties, this is useful for cryopreservation.
Introduction
Freezing-point depression of water is useful when low working
temperatures are needed, for example in cryopreservation of
bacteria, mammalian cells and enzymes.1–3 All of these can be
damaged by high temperatures, so storage at low temperatures is
desirable. However, they can also be damaged by the formation of
ice crystals, so the inhibition of these ice crystals is needed.2,4
Other situations where low temperature stability is also essential
include when using smart materials in an uncontrolled temperature
setting, such as windows on the outside of buildings, which go
through various temperature changes throughout the day and year.5
Some analytical methods, such as Dynamic Nuclear Polarisation
(DNP) NMR work at very low temperatures, so if one wanted to
analyse something in solution such as a hydrogel, this would be
almost impossible without a freezing point suppressant. Decreasing
the freezing point can be achieved by using freezing depressant
additives such as salts, glycerol, sorbitol, glycoproteins, or organic
solvents with low freezing points.6 However, the addition of some
additives is detrimental to biological samples or can completely
change the properties of the water they are in, and so completely
change the sample.7–9
Low molecular weight gels (LMWGs) are a class of material
with interesting and diverse range of properties and have been
used with biological samples such as in cell culture and drug
delivery.10–13 In the case of hydrogels, they can be made from
499% water, with less than 1% of material self-assembling
into long fibrous structures that entangle and trap the water.
It is these long gel fibres which can be used as artificial
extracellular matrices but also as conductive fibres, depending
on what they are made from.14,15 They are now finding uses in
water purification,16 solar fuel cells, electronic devices, actuators
etc. all of which will be subject to a range of working
temperatures.
There are many examples of the effect of heat on these gels
to either form the gels via a heat–cool trigger, to control the
supramolecular structures formed from the LMWGs and so
control morphology of the gel fibres or behaviour of the gel
properties.17–20 Melting of the gels can also be used to determine
gel fibre composition in multicomponent gel systems.21,22 There
are however very few examples of these gels at low temperatures,
apart from to the control the kinetics of gelation.23 Berillo et al.
looked at gelling a Fmoc-Phe-Phe gelator in water at 12 1C with
and without salt present.24 They found gels formed in the cold
temperatures were less mechanically strong than ones formed at
room temperature. In polymer systems, the upper/lower critical
solution temperatures (U/LCST) are often considered as their
phase behaviour (solubility) is modulated by the external tem-
perature but this is rarely discussed for LMWGs.25 Polymer gels
can be used as actuators and can swell, move and even change
shape in response to an increase in temperature.26 There are
many examples of temperature stable polymer gels using PVA
with or without glycerol present in the systems.27–30 In anti-
freezing polymer gel systems, the water is often replaced entirely
with a solvent with a lower freezing point or an additive added
into the water. For example, recently Zhou and co-workers
showed an organohydrogel based on a Ca-alginate/polyacrylamide
blend where they replaced water with either glycol, sorbitol or
glycerol and showed stability of the gel down to70 1C.31 However,
the shape and the mechanical properties were dramatically altered
by this process and so the original properties of the gel were not
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retained. Since a significant amount of the water was replaced
with the additive, the biocompatibility would also be different to
the original gel. LMWGs would be expected to be less tolerant to
these cold temperatures as they are held together by weak
non-covalent bonding compared to polymer gel systems, and
they generally contain less structuring materials. The formation
of ice would logically be expected to destroy the LMWG network,
as opposed to making the polymers gels more mechanically
ridged or sometimes more fragile.32
Here, we use a LMWG based on a dipeptide, which we refer
to as 2NapFF throughout (Fig. 1a). We gel 2NapFF in water
at different concentrations and assess the stability at low
temperatures by monitoring the rheological properties and by
microlitre nucleation measurements to separate heterogeneous
nucleation events. We then use glycerol as an additive to
improve the properties of the gels at low temperatures.
Results and discussion
2NapFF solutions were prepared at 2.5, 5 and 10 mg mL1. The
gelator was dissolved in water by the addition of one molar
equivalent of NaOH and made up to the correct volume with
distilled water. The samples were stirred overnight until all the
gelator had dissolved. This resulted in a viscous transparent
solution at pH 9.33,34 In the case of the of the glycerol:water
solutions, these were all prepared at a concentration of 5 mg mL1
of 2NapFF. The solutions were prepared as described above but the
water replaced with 20 : 80, 40 : 60 and 60 : 40 glycerol : water by
volume (higher volumes of glycerol did not result in a gel).
A slow acidification method was used to gel the solution.
This was achieved by adding 8 mg mL1 of glucono-d-lactone
(GdL) per 5 mg of gelator in solution.35 The GdL was gently
mixed in the solutions by hand to ensure dissolution, and then
the samples left untouched overnight to result in self-supporting
gels with a pH of around 3.3 (Fig. 1b). Gels were prepared in
aluminium cups for rheological measurements to ensure efficient
heat transfer from the rheometer to the gels. The effect of gelator
concentration on freezing point was investigated. Each of the gels
was first characterised by rheological strain and frequency sweeps at
25 1C (Fig. S1, ESI†). The gels were reproducible and each yielded at
low strains (between 5–10%), flowed at higher strain (4100%) and
varied in storage modulus (G0) and loss modulus (G00) depending on
gelator concentration, with 10 mg mL1 being the stiffest and
2.5 mg mL1 the softest. The concentration affected the strain
behaviour as well as G0 and G00. The gel at 2.5 mg mL1 was
found to have essentially a single fracture break (Fig. S1a, ESI†),
whereas 5 and 10 mg mL1 showed multiple yield points before
flowing (Fig. S1c and e, ESI†). 2NapFF structures in the gel
phase have been shown to be dependent on concentration
previously, explaining the different strain behaviours.33,34 All
the gels showed behaviour that was independent of frequency.
Adams and co-workers have previously studied the effect of
concentration on 2NapFF GdL gels. They found that at all
concentrations the morphology and gel fibres were very similar,
and the differences in G0 and G00 were a result in density of the
fibres present, rather than a different gel network or fibre
morphology.34
The temperature stability of the gels was then determined.
This was done by lowering the temperature of the gel at a rate of
0.5 1C min1 at 10 rad s1 and 0.5% strain (within the linear
viscoelastic region (LVR) of the gel as determined from the
previous measurements). The freezing point was determined by
the point at which G0 and G00 dramatically increased in value
due to ice crystals being formed and the sample becoming a
solid (Fig. 2a and Fig. S2, ESI†). All of the gels measured showed
very little change in mechanical properties until the gel froze.
This is seen by there being no change in tan d when the
temperature is lowered until the gel freezes and tan d changes
dramatically. The freezing point of the gels were depressed in
line with the concentration of gelator in the gel, with 10 mg mL1
having a freezing point of12 1C, 5 mg mL1 a freezing point of
9 1C and 2.5 mg mL1 a freezing point of 8 1C. What is most
Fig. 1 (a) Chemical structure of gelator 2NapFF. (b) Photographs of 2NapFF
at (left to right) 10 mg mL1, 5 mg mL1, 2.5 mg mL1, 20 : 80 glycerol : water
(5 mg mL1), 40 : 60 glycerol : water (5 mg mL1) and 60 : 40 glycerol : water
(5 mg mL1). Scale bar is 1 cm.
Fig. 2 (a) Bar chart showing the expected freezing point of the water vs.
the freezing point of the gels at different concentrations of 2NapFF.
Hatched bars are the measured freezing point and red bars are the freezing
point of distilled water on the rheometer (Fig. S2d, ESI†). (b) Strain sweeps
performed at 10 rad s1 for 2.5 mg mL1 2NapFF at 25 1C (black data) and
at 7 1C (blue data). In both graphs, G0 is the closed shapes and G00 is the
open shapes. No error bars included for clarity.
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remarkable is that the rheological properties of the gels just
before the freezing point were the same as if they were at
room temperature (Fig. 2b and Fig. S3, ESI†) showing despite
changing the temperature dramatically, the mechanical properties
of the gels remain the same. The difference in the freezing points
could be due to there being more organic material in the gel,
which suppresses the freezing point by colligative effects. Alter-
natively, the increased amount of organic material may result in a
denser network leading to segregation of any ice crystals which do
nucleate, preventing them spreading. The gel fibres could also be
acting as a freezing point suppressant in a similar way to glycerol
by having an extended hydrogen bonded network which changes
the hydrogen bonding between the water molecules.36
The differences in the frozen gels and unfrozen gels could be
clearly seen by eye. The frozen gels would stick to the geometry
of the rheometer and were opaque whereas the unfrozen gels
(still at a cold temperature) remained transparent and soft
(Fig. S4, ESI†). To investigate if the gels were inhibiting the
heterogeneous nucleation of ice (the most common form of ice
nucleation due to impurities) a microlitre ice nucleation assay
was employed. As nucleation is a stochastic process, small droplets
are essential to reduce the number of unwanted nucleators, and a
large number of repeats are necessary as the individual nucleator
temperatures will always vary.37 Fig. 3 shows example freezing
of microlitre drops of set gels as a function of temperature in a
cryo-microscope, with freezing identified by the droplets
becoming cloudy. In this system pure water showed a homo-
geneous freezing point of B35 1C, as expected taking into
account some thermal gradients in the system. 2NapFF gels
showed heterogeneous nucleation temperature of 20 to 28 1C
as the concentration increased (Fig. 3b). These values are lower
than the bulk, as the mechanical action of the rheometer will
promote ice nucleation in super-cooled water.
Another method of suppressing the freezing point is to add
a cosolvent into the water. The additive would need to be miscible
with water and not affect the gelation ability of 2NapFF. A gelator
concentration of 5 mg mL1 was used to examine the addition of
glycerol into the water. Glycerol is known to lower the freezing
point of water38 and is widely used a cryoprotective agent in
microbiology.39 Different ratios of glycerol to water can be used
to tune the freezing point of the water, and therefore the gel. Ratios
of 20 : 80, 40 : 60, 60 : 40 and 80 : 20 glycerol : water were compared
to the data for 0 : 100 described above. The 80 : 20 mixture did not
result in gelation, but gelation occurred in the other mixtures.
Gelation of the glycerol : water mixtures using the 2NapFF were
reproducible, with gels at 20 : 80 and 40 : 60 having comparable
rheological properties to that of water-only gels at the same
concentration (Fig. S5a–d, ESI†).
This suggests that the glycerol is not having a significant
effect on the gelation process. The gels at 60 : 40 had a slightly
lower G0 and G00 value than the other gels but have a similar
strain behaviour (Fig. S5e and f, ESI†).
Again, the temperature dependence and freezing points of
the glycerol : water gels were determined by keeping a constant
strain and frequency and lowering the temperature until the
gels froze (Fig. 4a and Fig. S6, ESI†). For the gel prepared at
20 : 80, the freezing point was 22 1C, the gel at 40 : 60 27 1C
and the gel at 60 : 40 did not freeze at 40 1C, which is the
lowest temperature to which the rheometer is able to achieve.
Interestingly the freezing points are lower than the expected
colligative freezing point values of water and glycerol mixtures.40
For glycerol : water mixtures, a mixture of 20 : 80 should freeze at
5 1C, 40 : 60 at15 1C and 60 : 40 at34 1C.38 This suggests that
the 2NapFF and the glycerol are acting synergistically to reduce
the freezing point of the gels. Compared to the freezing point
of the 100% water gel of 9 1C, this a dramatic increase in
the freezing point with little to no change to the rheological
properties. The strain sweeps were then conducted a few
degrees above the freezing point (Fig. 4b and Fig. S7, ESI†).
The gels prepared at 20 : 80 and 40 : 60 have almost identical
rheological properties to the gels prepared at 25 1C, showing
that the cold temperature has no effect on the mechanical
properties of the gels.
The gels could be chilled at a temperature above the freezing
point and held at that temperature before being returned to
room temperature and again the mechanical properties are
Fig. 3 Ice nucleation assay. (a) Example multi-point freezing assay used
to assess the nucleation temperature as the temperature is reduced.
Nucleating droplets are circled in red. (b) Mean nucleation temperature
as a function of gelator concentration.
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unaffected (Fig. S8, ESI†). However, if the gel was allowed to
freeze and then warmed back up the gel had been damaged and
was now significantly changed mechanical properties due to
the network being damaged due to ice-crystal formation
(Fig. S9, ESI†). Microlitre nucleation assays were again used
to probe the nucleation temperature of glycerol-containing gels,
(Fig. 5 and Fig. S9, ESI†). Increasing glycerol concentration as to
60 : 40 reduced the nucleation temperature to 38 1C, which
agreed with the rheology data confirming the depression of the
freezing point is due to colligative effects.
Next, we wanted to look whether other dipeptide gelators
exhibited the same behaviour. We looked at gelators that formed
different structures at high pH, had very different chemical
structures, and also examples that had similar aggregation at
high pH to 2NapFF (Fig. S10, ESI†). These included 2NapVG,
which doesn’t form aggregates at high pH,41 PBI-H which forms
worm-like micelles at high pH but has a very different chemical
structure,42 ThFF which has a similar chemical structure and
forms aggregated structures at high pH43 and ArFF which has a
very similar chemical structure and also exhibits the same
behaviour to 2NapFF after heating and cooling.17
All these samples were prepared at 5 mg mL1 of gelator
with 20 : 80 glycerol : water, and 8 mg mL1 of GdL was used to
trigger gelation. For ThFF, PBI-H and 2NapVG, these all had
freezing points of around 12 1C, and so lower than that of
2NapFF with 20 : 80 glycerol : water, but still lower than
expected from the glycerol content (Fig. S11 and S12, ESI†).
However, ArFF had a freezing point of 20 1C, similar to that of
2NapFF. This suggests that the freezing point depression is not
to do with the molecular structure of the LMW gelators, but
rather due to the increased viscosity. As viscosity increases the
diffusion constant for the water molecules reduces, leading to a
lengthening of diffusional mixing time, thus there is a larger
barrier to molecular rearrangements within the sample hindering
the formation of a critical nucleus causing the nucleation
temperature to decrease.
Conclusions
We have been able to show that the freezing point of hydrogels
can be significantly depressed by either changing the concentration
of gelator, or by gelling a glycerol : water mixture. The freezing point
can also be tailored by changing the amount of glycerol present in
the gel. The amount that the freezing point is depressed is more
than that of glycerol : water mixtures alone can achieve and so shows
that the gelator network is acting synergistically with the glycerol
to prevent the formation of ice crystals. This offers the exciting
possibility of using these gels not only at ambient conditions, but
also at more extreme conditions. This is normally done using
organogels with organic non-biocompatible solvents with low
freezing points or using polymer systems which require a lot of
processing to achieve this temperature stability. These results
also potentially open up the opportunity of enabling easier
transporting or handling as gels are less likely to dry out at the
colder temperatures and/or with the addition of glycerol. In
addition, these cold gels could be used to store and transport
enzymes and other biological tissues as a means of cryopreservation.
There is also the potential for these gels to be used to study kinetics
within gels where processes are slowed down making them easier to
follow, for them to be used in smart technologies where they are
used outside where there is often a more demanding temperature
requirement than in the laboratory, and also possibly in techniques
such as DNP NMR where low temperatures are necessary.
Experimental
Rheological measurements
All rheological measurements were performed using an Anton
Paar Physica 301 rheometer, fitted with a chiller to help with
the cold temperature measurements. Temperature calibrations
were performed between 30 1C and 80 1C before starting the
temperature measurements to ensure the correct temperature
was being recorded. All data was collected using a vane (ST10-
4V-8.8/97.5) and cup geometry (H-24-D) so samples could be
prepared in aluminum cups to remove any loading issues.
There was a gap distance of 1.5 mm between the bottom of the
Fig. 4 (a) Bar chart showing the expected colligative freezing point of the
water vs. the freezing point of the gels at different ratios of glycerol : water.
Hatched bars are the measured freezing point and red bars are the
expected freezing points.38 * For 60 : 40 the freezing point was not reached,
but is beyond 40 1C. (b) Strain sweeps performed at 10 rad s1 for 40 :60 at
25 1C (black data) and at 25 1C (blue data). In both graphs G0 is the closed
shapes and G00 is the open shapes. No error bars included for clarity.
Fig. 5 Mean nucleation temperature of LMWG formed in presence of glycerol.
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gel and the cup. A zero force of 0 N was maintained throughout
the experiments. Measurements were recorded in triplicate. All
measurements were recorded in the linear viscoelastic region of
the gels as determined by the strain sweeps, which are recorded
first. G0 and G00 are determined from the frequency sweeps at
10 rad s1. The yield point is determined at the point at where G0
and G00 deviate from linearity in the strain sweep, and the flow
point where G00 crosses over G0.
Strain sweeps. Strain sweeps were recorded from 0.1–1000%
strain at 10 rad s1. They were recorded at 25 1C in triplicate.
They were then lowered to a temperature few degrees above the
freezing point as determined by the freezing point experiments
at a rate of 0.5 1C min1 and then a strain sweep was recorded.
Frequency sweeps. Frequency sweeps were recorded from
1–100 rad s1 at a strain of 0.5%. They were recorded at 25 1C in
triplicate. They were then lowered to whatever temperature at a
rate of 0.5 1C min1 and then a strain sweep was recorded.
Freezing point determination and temperature stability
measurements. G0 and G00 and were recorded over time at a
frequency of 10 rad s1 and a strain of 0.5%. The temperature
was then lowered at a rate of 0.5 1C min1 from 25 1C until
there was dramatic increase in G0, this indicated that gel had
frozen. The rheometer is only calibrated to 40 1C and so that
was the lowest temperature the gels were taken down to, so in
the case of 60 : 40 glycerol : water the gels did not freeze and so
the freezing point could not be determined. To ensure the
correct sample temperature a Eurotherm type K thermocouple
was also used. This allowed us to check the temperatures past
what the rheometer was calibrated to, so that the freezing point of
60 : 40 gels could be determined. In order to reduce the temperature
of the rheometer to 40 1C, a water circulator was used at 10 1C,
and cardice was used to cool the top of the cup holder.
Ice nucleation assay
The gels were prepared as stated previously giving Z15 0.7 mL
droplets on each slide. The slide was placed inside a Linkham
Scientific cryostage. The cryostage was rapidly cooled to 0 1C at a
rate of 50 1C min1 and then held at this temperature for 3 min to
allow the temperature of the glass slide and droplets to equilibrate.
The samples were then cooled from 0 1C to 49 1C at a rate of
2 1C min1. Ice nucleation was observed using a Veho Discovery
VMS-004 Deluxe USB microscope and Veho Microcapture
software V 1.3. The experiment was repeated until at least 30
droplet freezing temperatures were recorded. The nucleation of
the gels was compared to that of Milli-Q water, the nucleation of
which was recorded in the same manner.
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